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Summary 
Pseudomonas aeruginosa is a common industrial contaminant associated with costly recalls of home and 
personal care (HPC) products. Preservation systems are used to prevent bacterial contamination and protect 
consumers, but little is known about the mechanisms of preservative resistance in P. aeruginosa.                            
The aim of this research was to map genetic and metabolic pathways associated with preservative resistance 
and bacterial growth in HPC products. 
The genome of the industrial strain P. aeruginosa RW109 was sequenced, functionally annotated, and 
compared to other strains of the species. This revealed the first complete genome of a P. aeruginosa isolate 
from the HPC industry. Comparative analysis with 102 P. aeruginosa strains from various sources, showed 
industrial strains’ genomes to be significantly larger than clinical and environmental strains, and RW109’s 
genome was the largest of the species (7.8 Mbp) and included two plasmids. 
Identification of differentially expressed genes by RNA-Seq (more informative than mini-Tn5-luxCDABE 
mutagenesis), revealed complex genetic networks utilised by RW109 when exposed to benzisothiazolone 
(BIT), phenoxyethanol (POE) and a laundry detergent formulation. Differential expression of five sets of 
genes was consistently observed in response to these industry relevant conditions - MexPQ-OpmE efflux 
pump, sialic acid transporter and isoprenoid biosynthesis (gnyRDBHAL) genes were frequently up-
regulated; whereas phnBA and pqsEDCBA genes encoding PQS production and quorum-sensing, 
respectively, were consistently down-regulated. Genome-scale metabolic network reconstruction of 
RW109, the first with a P. aeruginosa industrial strain, along with integration of transcriptomic data, 
predicted essential pathways for RW109’s preservative resistance (e.g. cell membrane phospholipid 
biosynthesis as a key pathway for POE resistance). 
This study highlights the utility of integrating genomic, transcriptomic and metabolic modelling approaches 
to uncover the basis of industrial bacterial resistance to preservative and product formulations. The ability 
to predict the metabolic basis of P. aeruginosa preservative resistance will inform the development of 
targeted industrial preservation systems, enhancing product safety and minimising future resistance 
development. 
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1. Introduction
1.1 Pseudomonas aeruginosa
Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative, non-fermentative, aerobic rod-shaped 
bacterium, with a cell diameter of 0.5-1.0 μm and length of 1.5-3.0 μm. Optimum growth occurs at 37 °C, 
although the bacterium has the ability to grow in a wide range of temperatures, reported between 4 °C and 
42 °C (Morrison and Wenzel, 1984, LaBauve and Wargo, 2012). P. aeruginosa demonstrates proficiency 
at surviving with minimal nutritional levels and exhibits multiple metabolic capabilities, allowing the 
microorganism to grow and proliferate within a variety of environments (Stover et al., 2000, Rossolini and 
Mantengoli, 2005, LaBauve and Wargo, 2012).  
The pathogenic potential of P. aeruginosa renders it an important clinical microorganism, commonly 
causing disease in the immunocompromised, especially in transplant recipients, individuals with 
abnormally low neutrophil levels (neutropenia), those receiving chemotherapy and patients with HIV 
(Sadikot et al., 2005, Bodey, 2001, Vidal et al., 1999). This pathogen is the causative agent of a broad 
spectrum of infections associated with the respiratory system, urinary tract, inner ear, blood stream and 
wounds (Kerr and Snelling, 2009, Rossolini and Mantengoli, 2005, Sadikot et al., 2005, Wagenlehner and 
Naber, 2006). P. aeruginosa rarely causes disease in healthy individuals (Lyczak et al., 2000, Sadikot et 
al., 2005), which characterises this bacterium as an opportunistic pathogen. In cystic fibrosis (CF) patients, 
P. aeruginosa is a dominant pathogen and results in chronic, severe pulmonary infections which are
largely responsible for the morbidity and mortality observed with CF (Govan and Deretic, 1996, Oliver et 
al., 2000). P. aeruginosa infections in the CF lung are extremely difficult to eradicate (Gómez and Prince, 
2007), especially with the increased occurrence of multidrug resistance reported with this pathogen, which 
is of great concern with in the research field of P. aeruginosa (Langan et al., 2015).  
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1.1.1 The environmental versatility of P. aeruginosa 
The ubiquitous nature of P. aeruginosa results in its ability to colonise a diverse range of habitats. This 
microorganism is commonly isolated from a variety of settings including marine habitats (Khan et al., 
2007), freshwater systems (Tripathy et al., 2007), soil (Marques et al., 1979), plants and vegetables (Green 
et al., 1974, Kominos et al., 1972) and hospital locations (Whitby and Rampling, 1972). The ability to 
colonise different environments results in the bacterium being able to infect and cause disease in 
numerous hosts other than humans, such as animals (Haenni et al., 2015), insects (Miyata et al., 2003, 
Apidianakis and Rahme, 2009) and plants (Elrod and Braun, 1942). P. aeruginosa also has the ability to 
grow in extreme environments which have high and low pH levels, excesses of hot and cold, elevated 
amounts of toxic compounds, increased and decreased salinity and high-pressure levels (Pikuta et al., 
2007, Montgomery et al., 2013). Examples of harsh settings where P. aeruginosa has been reported 
growing include crude oil and petroleum hydrocarbons (Guo-liang et al., 2005, Song et al., 2006), the 
Antarctic (Villeret et al., 1997), hazardous chemicals used in conventional leather-making (Lama et al., 
2012), disinfectants (Dantas et al., 2008, Kung et al., 2010) and pharmaceutical and cosmetic products 
(Jimenez, 2007). The degradative abilities of Pseudomonas spp. also results in their common 
incorporation into bioremediation of environmental pollutants such as heavy metals pesticides and phenols 
(Wasi et al., 2013), with P. aeruginosa being reported as functional in the removal of cadmium (Wang et 
al., 1997).  
P. aeruginosa has the ability to exist in diverse environments as either planktonic unicellular cells which
are free floating or they can form multicellular aggregates of communicating sessile cells, which attach to 
surfaces and are recognised as biofilms (Spoering and Lewis, 2001, Moradali et al., 2017). The ability to 
survive as planktonic cells allows the organism to move around its environment, initiate colonisation and 
cause acute infection (Chua et al., 2014). Existing as a multicellular community enables prolonged 
persistence and established infections to occur, with 65-80% of all human chronic microbial infections 
being associated with biofilms (Spoering and Lewis, 2001, Donlan, 2002).  
Successful adaptation to a wide-range of environmental niches, each presenting unique challenges, 
demands exceptional functional versatility from a microorganism. P. aeruginosa exhibits a broad 
metabolic capacity demonstrated by the ability to grow on 75 organic compounds (Stanier et al., 1966) and 
can survive in low-nutrient conditions, exhibited by the aptitude for growing in distilled and bottled water 
(Favero et al., 1971, Eckmanns et al., 2008). The metabolic potential of P. aeruginosa is also emphasised 
by the capacity to proliferate in very low oxygen levels (Alvarez‐Ortega and Harwood, 2007) where it can 
utilise nitrogen as a terminal electron acceptor to respire anaerobically (Sharma et al., 2006). The multiple 
secondary metabolites and virulence factors produced by this bacterium are also indicative of its extensive 
metabolic proficiencies (Latifi et al., 1995, Gallagher and Manoil, 2001, Balasubramanian et al., 2012).  
The metabolic versatility of P. aeruginosa has also been demonstrated via the modelling of its 
biochemical networks (Oberhardt et al., 2008, Oberhardt et al., 2011, Bartell et al., 2017), which represent 
the gene-protein-reaction relationships and metabolic potential. In the clinical reference strain PA14, a 
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number of  distinct biological functional groups (14) represented the reactions, genes and metabolites 
within a genome-scale metabolic model; the majority of biochemical pathways were associated with 
central metabolism such as lipid, amino acid and carbohydrate metabolism as well as nutrient transport 
(Bartell et al., 2017). Although metabolic models represent a small proportion of a microorganisms 
metabolic potential, in combination with whole genome sequencing, they have demonstrated the 
assortment of biochemical pathways available to P. aeruginosa.   
1.1.2 Linking genome size with the complex biological functionalities of P. aeruginosa 
The genome size of P. aeruginosa ranges between ~5.2–7.0 Mbp, which is among the largest recognised 
in Gram-negative bacteria and encodes around 5,570 open reading frames (Schmidt et al., 1996, Stover et 
al., 2000, Winsor et al., 2016). This extensive genomic size is indicative of the genetic complexity of P. 
aeruginosa, providing the microorganism with an extensive availability of multipurpose genes. A high 
number of genes (8.4%) are associated with regulatory networks and two component systems, as well as 
those linked to the utilisation of various carbon sources and nutrient transporters (Stover et al., 2000, Arai, 
2011, Nishijyo et al., 2001). This observation suggests a reason for the ability of P. aeruginosa to 
metabolise and utilise various compounds for nutritional purposes, and would permit environmental 
adaptability. It has previously been characterised that large bacterial genomes are excessively enriched in 
genes associated with regulation, secondary metabolism and to a lesser extent energy conversion-related 
genes, whereas those linked to protein translation, DNA replication, cell division, and nucleotide 
metabolism have less representation (Konstantinidis and Tiedje, 2004, van Nimwegen, 2006). Bacteria 
with larger genome sizes are better adapted at persisting in environments with insufficient but varied 
resources, due to their portrayed wide-ranging metabolic diversity and regulatory functions 
(Konstantinidis and Tiedje, 2004).  
The P. aeruginosa genome is comprises a single, supercoiled circular chromosome which resides in the 
cytoplasm (Klockgether et al., 2011, Vallet-Gely and Boccard, 2013). The presence of additional plasmids 
which incorporate antimicrobial resistance genes have also been reported (Shahid and Malik, 2003). 
Investigations of the large genome have revealed 4000 “core genes” which are generally well conserved 
and invariable between P. aeruginosa isolates (Klockgether et al., 2011, Freschi et al., 2015) and another 
20% of genes representing the “accessory genome”, commonly identified on bacterial genomic islands and 
indicative of horizontal gene transfer (Rumbaugh, 2014, Juhas et al., 2009). The “accessory genome” is 
strain specific and contains genes involved in metabolism, virulence and antibiotic resistance (Rumbaugh, 
2014, Kung et al., 2010). The variability observed with the “accessory genome” accounts for the strain 
diversity of P. aeruginosa and contributes to the wide ranging environmental niches where the bacterium 
can be isolated (Kung et al., 2010). Defining and characterising the genome of P. aeruginosa is central to 
understanding the diverse functionality of this microorganism.  
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1.2 P. aeruginosa as a multidrug resistant microorganism 
The International Nosocomial Infection Control Consortium reported that P. aeruginosa hospital acquired 
infections have become a worldwide healthcare issue (Rosenthal et al., 2016). The World Health 
Organisation (WHO) has also recognised P. aeruginosa within the most critical group of “antibiotic 
resistant priority pathogens” which pose the greatest threat to human health (WHO, 2017). This 
microorganism has substantial antimicrobial resistance capabilities and is notoriously difficult to control 
with antibiotics and disinfectants (Hancock, 1998, Lambert, 2002). Antibiotic resistance is classified as 
the capability of a bacterium to survive in antibiotic concentrations that normally inhibits growth of most 
other bacteria (Russell, 2000). P. aeruginosa displays low susceptibility to antimicrobials due to its 
intrinsic genetically encoded resistance mechanisms (Livermore, 2002). It also has the ability to acquire 
resistance via temporary or permanent adaptive mutations and through exogenous genetic materials such 
as plasmids (Flores et al., 1997, Hancock and Speert, 2000).     
The increased occurrence of reported resistance in P. aeruginosa is a result of de novo mechanisms, which 
develop during prolonged and frequent exposure to antimicrobials in hospital settings, along with the 
spread of resistant organisms between patients (Carmeli et al., 1999, Fridkin and Gaynes, 1999, Aloush et 
al., 2006). Medical settings however are not the only environment where antimicrobial resistance can 
develop. Locations which are subjected to contamination with human pollution include sewage works 
(Amos et al., 2014), industrial pharmaceutical settings (Ahmad et al., 2017), aquaculture facilities 
(Buschmann et al., 2012) and agricultural environments (Witte, 1998) and usually have elevated bacterial 
loads (Berendonk et al., 2015). These areas are also frequently exposed to sub-inhibitory concentrations of 
antimicrobials, resulting in bacteria further developing and acquiring resistant mechanisms, which can 
then spread throughout the environment (Angulo et al., 2004, Di Cesare et al., 2013, Ahmad et al., 2017). 
As discussed previously, P. aeruginosa is capable of living within a wide range of diverse settings and as 
a result undoubtedly encounters antimicrobials on a recurrent basis.  
1.2.1 Antimicrobial resistance mechanisms of P. aeruginosa 
The wide-ranging antimicrobial aptitudes of P. aeruginosa result from a combination of elements such as 
the low permeability of its cell wall, the genetic capacity to encode numerous resistance mechanisms such 
as efflux pumps and degradative enzymes, and ability to form multicellular aggregations known as 
biofilms (Aloush et al., 2006, Hancock, 1998, Stewart and William Costerton, 2001). These resistant 
mechanisms may already be innate to the bacterium and can also become accessible via mutations of 
chromosome resistance regulation genes (Oliver et al., 2004, Lister et al., 2009) and through obtaining 
plasmids and transposons which encode additional resistance genes (Livermore, 2002, Lambert, 2002, 
Shahid and Malik, 2003). Three widely acknowledged modes of resistance actions are used by P. 
aeruginosa to reduce its susceptibility to antimicrobials, which include obstructing antimicrobial 
penetration, decreasing antimicrobial accumulation within the cell and preventing antimicrobials from 
reaching target sites. (Aloush et al., 2006, Lambert, 2002). Resistance mechanisms are frequently used 
simultaneously, especially when pathogens display multi-antimicrobial resistance characteristics (Higgins, 
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2007, Livermore, 2002). Another feature of P. aeruginosa is the ability to form surface-attached microbial 
biofilm communities which when compared with planktonic equivalents can be 10–1,000 times more 
resist to antimicrobials (Hoyle and Costerton, 1991, Hancock, 1998, Mah et al., 2003).  
1.2.1.1 Obstructed entry into the cell
An important factor behind the intrinsic resistance of P. aeruginosa to antimicrobial agents is 
associated with the low permeability of its cell envelope (Chapman, 1998, Lambert, 2002) 
which restricts antimicrobial uptake. The highly structured multi-layered bilayer arrangement of the 
Gram-negative cell wall includes an outer membrane of phospholipids and lipopolysaccharides (LPS), 
a thin peptidoglycan layer and a phospholipid inner cytoplasmic membrane (Figure 1) (Chapman, 
1998, Brown et al., 2015, Zgurskaya et al., 2015). P. aeruginosa has a high cell wall lipid content 
(Schweizer, 2001) and an outer membrane permeability identified as 10–100 fold lower when compared 
to other Gram-negative bacteria, such as Escherichia coli (E. coli) (Hancock and Speert, 2000, 
Schweizer, 2001). The narrow nonspecific porins and specific uptake channels of the outer membrane 
restrict the penetration of antimicrobials by their size (Hancock, 1998, Zgurskaya et al., 2015).  LPS 
consists of three elements, a highly conserved lipid A glycolipid hydrophobic outer membrane 
attachment protein, central core polysaccharide, with two well-conserved 3-deoxy-d-mannooctulosonic 
acid residues, a more changeable oligosaccharide region and the architecturally varied O-antigen 
(Wang and Quinn, 2010). The P. aeruginosa LPS phospholipid bilayers are more inflexible 
compared to standard bilayers, which reduces the passive diffusion of hydrophobic compounds 
(Zgurskaya et al., 2015). Strong links between the LPS molecules are also facilitated by a high Mg+ 
outer membrane content (McDonnell and Russell, 1999).  
A large portion of the P. aeruginosa genome encodes for surface molecules and two extremely long open 
reading frames, identified in PAO1 (PA2462 and PA41) are predicted to be involved in the synthesis 
of LPS and extracellular polysaccharides (Stover et al., 2000). The proteins associated with the 
outer membranes interact with the surrounding environment and transmit signals to the cytoplasm, which 
enable the bacterium to adapt appropriately to changes in the surrounding conditions (Koebnik et al., 
2000). A large amount of proteins are exported out of the cytoplasm for use in the cell wall and 
include those associated with nutrient uptake, pili and flagella biogenesis, immunogenicity, 
antimicrobial resistance, phospholipid assembly and environmental sensing (Molloy et al., 2000, 
Lewenza et al., 2005). The Gram-negative P. aeruginosa cell wall provides the bacterium with an intrinsic 
first line of defence when faced with antimicrobials and has an imperative role in obstructing entry into 
the cell. 
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Figure 1. Representation of the P. aeruginosa Gram-negative cell wall 
The P. aeruginosa Gram-negative cell wall is made up of a cytoplasmic inner membrane, a thin 
peptidoglycan layer within the hydrophilic periplasmic space, periplasm and an outer membrane.                    
The hydrophobic outer membrane consists of phospholipid molecules as well as lipopolysaccharide 
(LPS) molecules, lipoproteins and also porins which permit the entry and exit of hydrophilic low-
molecular weight substances and may be specific or non-specific. The hydrophobic cytoplasmic 
membrane is a phospholipid bilayer and contains associated membrane proteins.  Adapted from 
(Brown et al., 2015). 
Porin
Lipopolysaccharides (LPS)
Peptidoglycan
Phospholipids Membrane associated 
proteins
Lipoprotein
Outer 
membrane
Periplasmic 
space
Cytoplasmic inner
membrane
CHAPTER 1 - Introduction 
7 
1.2.1.2 Reducing intracellular accumulation of antimicrobials 
1.2.1.2.1 Efflux pumps of P. aeruginosa 
The cell wall of P. aeruginosa is also important due to the numerous active efflux pump systems it 
encompasses (McArthur et al., 2013, Askoura et al., 2011); these systems work to prevent the 
accumulation of toxic agents within the cell by actively removing them (Lambert, 2002, Poole, 2005b). 
The synergy between the low-permeability of the cell wall and active efflux systems are considered the 
major mechanisms of antimicrobial resistance, which have allowed P. aeruginosa to become a prevalent 
pathogen in hospital acquired infections (Poole, 2001, Poole, 2005b, Schweizer, 2003). Efflux systems are 
composed of three protein structures; an energy-reliant cytoplasmic membrane transporter, a porin outer 
membrane protein and linker proteins which couple the structures together within the periplasm (Figure 2) 
(Poole, 2001, Paulsen, 2003, Piddock, 2006, Lister et al., 2009).  
Efflux pumps actively expel chemicals from within the bacterial cell and a variety of these systems are 
used by P. aeruginosa (Table 1), with the MexAB-OprM system acting as the primary efflux pump which 
can export a wide range of antimicrobials out of the cell (Askoura et al., 2011, Poole, 2001). The major 
efflux pumps of P. aeruginosa belong to the Resistance-Nodulation-Division (RND) (Poole, 2011, Soto, 
2013, Avrain et al., 2013) (Table 1). The structure of these efflux pump systems (Figure 2) allows the 
direct expelling of toxic substances from the inner membrane directly to the extracellular environment 
(Avrain et al., 2013). The MexAB-OprM and MeXY-OprM systems are continuously expressed at a base 
line level in P. aeruginosa, with the expression of  MexAB-OprM being the most notable (Lister et al., 
2009). The genes encoding these two pumps can also be up-regulated in response to antimicrobials (Riou 
et al., 2010), along with the other efflux systems shown in Table 1; the genes associated with the other 
pumps are not constantly ‘on’ in P. aeruginosa (Avrain et al., 2013). The RND efflux pumps are 
associated with multi-drug resistant strains of P. aeruginosa as they are capable of transporting numerous 
types of antimicrobials (Schweizer, 2003, Piddock, 2006).  
The importance of efflux pumps in P. aeruginosa biofilms have also been identified, with genes encoding 
these systems demonstrating increased expression in biofilms when compared to planktonic bacteria 
(Zhang and Mah, 2008). Disruption of genes associated with efflux pump systems, renders the 
P. aeruginosa biofilms more susceptible to antibiotics (Wright, 2005), highlighting efflux as an 
important mechanism behind biofilm associated antimicrobial resistance. 
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Figure 2. Structure of a typical Gram-negative resistance-nodulation division (RND) family 
efflux pump 
The P. aeruginosa resistance-nodulation division (RND) family efflux pumps comprise an energy-
reliant transporter protein located in the cytoplasmic membrane, a periplasmic membrane fusion-
linker protein and an outer membrane porin protein channel. Efflux pumps can be specific for one 
substrate or may transport a range of structurally dissimilar compounds. The resistance from efflux 
pumps can be intrinsic to the bacteria and may be acquired via mutations resulting in the up-
regulation of efflux systems. Adapted from (Piddock, 2006, Lister et al., 2009, Askoura et al., 
2011).  
Porin outer 
membrane channel
Membrane fusion 
protein
Energy-reliant 
cytoplasmic inner 
Membrane transporter
Antimicrobials actively transported out 
of the bacterial cell
CHAPTER 1 - Introduction 
9 
Table 1. RND Efflux pumps of P. aeruginosa 
Efflux pump system Types of substrates exported References 
MexAB-OprM 
β-lactam, SDS, fluoroquinolones, tetracycline, 
novobiocin, chloramphenicol, macrolides, 
trimethoprim, triclosan, ethidium bromide, 
aromatic hydrocarbons, thiolactomycin, 
cerulenin, acylated homoserine lactones, 
colistin.  
(Nehme and Poole, 
2007, Sugimura et al., 
2008, Pamp et al., 
2008, Masuda et al., 
2000) 
MexCD-OprJ 
β-lactam, fluoroquinolones, tetracycline, 
chloramphenicol, novobiocin, macrolides, 
trimethoprim, triclosan, ethidium bromide, 
SDS, aromatic hydrocarbons, crystal violet, 
acriflavin, chlorheximide,  benzalkonium 
chloride 
(Srikumar et al., 1998, 
Schweizer, 2003, 
Masuda et al., 2000, 
Fraud et al., 2008, 
Morita et al., 2003) 
(Köhler et al., 1999, 
Llanes et al., 2011, 
Schweizer, 2003) 
MexGHI-OprD Vanadium, acylated homoserine lactones 
(Aendekerk et al., 
2002, Aendekerk et al., 
2005) 
(McArthur et al., 2013, 
Mima et al., 2005, 
Lister et al., 2009, 
Thaden et al., 2010) 
MexXY (OprA and OprM) 
Tetracycline, erythromycin, aminoglycosides, 
fluoroquinolones  
(Morita et al., 2012, 
Hocquet et al., 2003, 
Mine et al., 1999, 
Masuda et al., 2000) 
MexJK (OprM and OpmH) Tetracycline, erythromycin, triclosan 
(Chuanchuen et al., 
2002, Chuanchuen et 
al., 2005) 
chloramphenicol, erythromycin,  acriflavin 
(Li et al., 2003) 
MexMN-OprM Chloramphenicol, thiamphenicol (Mima et al., 2009) 
CzrAB-OpmN Cadmium, Zinc (Schweizer, 2003) 
TriABC-OpmH Triclosan (Mima et al., 2007) 
MexEF-OprN 
Fluoroquinolones, chloramphenicol, 
trimethoprim, triclosan, aromatic hydrocarbons,
 ciprofloxacin 
Fluoroquinolones, tetracycline, 
chloramphenicol, erythromycin, macrolides, 
metal ions
MexPQ-OpmE 
 
Fluoroquinolones, tetracycline,
MexVW-OprM 
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1.2.1.2.2 Modification of the Gram-negative cell wall 
Certain antimicrobial agents are able to cross the Gram-negative cell wall barrier and reach target sites. 
Hydrophobic antimicrobials utilise a lipid-mediated pathway and hydrophilic agents diffuse through 
porins within the cell wall (Delcour, 2009). P. aeruginosa is able to become resistant to these types of 
antimicrobials by altering the pathways used to cross the cell envelope barrier in order to reduce 
intracellular accumulation (Tumah, 2009). The organism can adapt by structurally altering the 
hydrophobic properties of the membrane, replacement of porins with more-selective channels, completely 
removing a particular porin via null mutations and through the modification of individual 
lipopolysaccharide binding sites (Delcour, 2009, Blair et al., 2015). Decreased permeability due to 
alterations in the P. aeruginosa LPS outer membrane, is well documented in aminoglycoside-resistant 
clinical isolates, especially in strains from CF patients (MacLeod et al., 2000, Poole, 2005a). A decreased 
availability of the OprD P. aeruginosa porin protein, has been reported to reduce the entry of the 
carbapenem antibiotic imipenem into the cell (Fukuoka et al., 1993).  The modification of the cell wall 
composition can also occur within the phospholipid bilayer and increased content of important cell wall 
components such as phosphatidylglycerol (Arendt et al., 2012) and cardiolipins (Bernal et al., 2007), have 
been shown to reduce antibiotic permeability across the cell membranes. This highlights the importance of 
modifying the cell wall as a resistance mechanism of P. aeruginosa.  
1.2.1.3 Preventing antimicrobials within the cell reaching target sites 
If an antimicrobial is successful at crossing the Gram-negative cell wall barrier and is not expelled by 
efflux pumps, other resistance mechanisms can be employed which prevent the agent from reaching its 
target within the cell. These resistance traits are usually acquired either through genes encoded on mobile 
genetic elements such as plasmids and via mutation or the up-regulation of chromosomally encoded 
resistance genes (Livermore, 2002, Strateva and Yordanov, 2009) 
1.2.1.3.1 Inactivating antimicrobials with enzymes 
The inactivation of antimicrobials by enzymes is a mechanism used by Gram-negative bacteria to reduce 
susceptibility to these agents and prevent them from reaching target sites within the cell (Lambert, 2002). 
P .aeruginosa can adapt to antimicrobial exposure via the production of enzymes which degrade or 
modify the agent (Figure 3A). Multiple bacterial antibiotic degrading enzymes have been identified in P. 
aeruginosa (Wright, 2005). It has been well established that genes encoding beta-lactamases are up-
regulated in response to the presence of beta-lactam antibiotics, and in particular an overexpression of a 
chromosomally encoded regulatory ampR gene is observed (Lambert, 2002). Beta-lactamase enzymes 
break down antibiotics through hydrolysing the β-lactam ring which is present in penicillin, cephalosporin, 
monobactam, and carbapenem antibiotics (Santajit and Indrawattana, 2016). Modification of 
aminoglycoside antibiotics has been characterised in P. aeruginosa and as commonly carried out by 
aminoglycoside-acetyltransferases, aminoglycoside-adenyltransferases and aminoglycoside-
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phosphotransferases, with genes encoding these enzymes frequently found on mobile genetic elements 
(Ramirez and Tolmasky, 2010, Poole, 2005a).  
1.2.1.3.2 Modification of antimicrobial target sites 
The alteration, protection and overproduction of bacterial target sites have also been identified as 
mechanisms used by P. aeruginosa to reduce susceptibility to those antimicrobials with the ability to cross 
the Gram-negative cell wall (Figure 3B) (Lambert, 2005, Kohanski et al., 2010). Alteration of target sites 
usually occur due to spontaneous bacterial chromosome gene mutations and antibiotic selection pressures 
(Lambert, 2005). The alteration of the fluoroquinolone DNA gyrase target in P. aeruginosa has also been 
reported as a common resistance mechanism in response to this antibiotic (Mouneimné et al., 1999, 
Mesaros et al., 2007). In P. aeruginosa the binding of the aminoglycoside antibiotics to bacterial 
ribosomes can be compromised by the ability of the bacterium to modify the ribosomal RNA (rRNA) 
binding sites of the antibiotic through methylation of 16S rRNA (Gutierrez et al., 2013).  
Protection of target sites can be implemented to prevent antimicrobials from binding and causing 
disruption in the cell (Figure 3B). This technique can be achieved via the production of ribosomal 
protection proteins which confer resistance to antibiotics such as tetracycline, macrolides, 
chloramphenicol erythromycin and phenicols (Thaker et al., 2010, Zhou et al., 2015a). Another 
mechanism involved in the modification of target sites, is an over production of a protein which can also 
be bound by the antimicrobial (Figure 3B). The up-regulation of bacterial genes which synthesise 
antimicrobial-insensitive sites of action, prevents the agent from efficiently binding to its target, rendering 
it inactive within the cell (Dever and Dermody, 1991). The alteration of metabolic pathways to induce 
overproduction of a specific metabolite which competes for the active target site of an antimicrobial, is 
also a reported mechanism of resistance (Zhou et al., 2015a).  
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Figure 3. Resistance mechanisms used to prevent antimicrobials within the cell from 
reaching target sites 
In order to prevent antimicrobials which are able to enter the cell from reaching their intended 
target sites, antimicrobial inhibiting enzymes can be encoded by antimicrobial resistance genes 
(A). These enzymes can break up the antimicrobial or alter its structure, ensuring it’s not able to 
reach its intended target from within the cell.  The antimicrobial target sites can also be modified 
and protected so the antimicrobial cannot interact with it effectively or the target sites can be 
overproduced (B), which minimises the impact of the antimicrobial.   
A)
B)
Antimicrobial 
degrading 
enzymes
Antimicrobial 
altering 
enzymes
Antimicrobial 
resistance genes 
(R) encoding
enzymes =
Active 
antimicrobial
Active 
antimicrobial
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antimicrobial
Inactive 
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2. Over-production of antimicrobial
target site
A change in expression or 
mutations of antimicrobial 
resistance genes (R) =
1. Alteration of antimicrobial cell targets
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1.2.1.4 P. aeruginosa biofilm formation 
P. aeruginosa is able to produce a polysaccharide alginate layer which can provide an additional barrier
when exposed to antimicrobials and environmental stresses (Orgad et al., 2011, Taylor et al., 2014). The 
alginate polysaccharide and other secreted moieties enable the bacteria to aggregate and grow as a biofilm 
structure (Figure 4). This is a complex accumulation of bacteria embedded within self-produced, hydrated 
polymer exopolysaccharide (EPS) matrix (Whiteley et al., 2001, Flemming and Wingender, 2010); the 
EPS represents 85% of the total biofilm biomass (Flemming et al., 2007). P. aeruginosa chronic biofilm 
infections are commonly reported in patient tissues and body surfaces as well as and on medical devices 
including indwelling venous and urinary catheters and joint replacements (Mulcahy et al., 2014). Biofilms 
of P. aeruginosa have also been found in waste water treatment systems and are difficult to eradicate 
(Breathnach et al., 2012).  
The formation of a biofilm is an endless cycle and involves planktonic cells reversibly attaching to a biotic 
or abiotic surface with the adhesion becoming irreversible with the production of an EPS matrix (Figure 4, 
stages 1 and 2) (Ma et al., 2009). Multicellular biofilm communities then become more densely structured 
with non-colonised space quickly becoming filled with bacteria and a three-dimensional community is 
observed (Figure 4, stages 3 and 4) (Flemming and Wingender, 2010). Lastly, bacterial cells detach from a 
mature sessile biofilm structure and revert back to a planktonic state to spread and restart colonisation and 
initiation of biofilm formation on other surfaces (Figure 4, stage 5 and 1) (Chua et al., 2014, Rasamiravaka 
et al., 2015). A swarming distribution technique has also been described in non-mucoid P. aeruginosa 
strains, where after initial biofilm growth and the development of an outer layer of sessile bacteria, motile 
cells of planktonic phenotype are observed within the inner regions and can swarm out of the multicellular 
community (Tolker-Nielsen et al., 2000, Sauer et al., 2002). A hollow mound in the centre of a biofilm is a 
characteristic of this swarming dispersal technique (Hall-Stoodley et al., 2004) 
Exploring the regulatory networks involved in biofilm formation has recognised cyclic diguanosine 
monophosphate (ci-di-GMP) as a common initiator of biofilm formation (Karatan and Watnick, 2009). 
Increased intracellular levels of ci-di-GMP have been shown to promote the adjustment from a planktonic 
to sessile lifestyle in Gram-negative bacteria (Simm et al., 2004, Karatan and Watnick, 2009). The 
importance of two-component regulatory systems has also been recognised in regulating P. aeruginosa 
biofilm development, with the highly conserved GacS-GacA system being involved in EPS production via 
the use of small regulatory RNAs (Wei and Ma, 2013, Mikkelsen et al., 2011b). Biofilm communities 
have been shown to communicate via quorum sensing (QS) molecules which enable cells to identify each 
other’s presence and regulate gene expression based on the extent of the population (Camilli and Bassler, 
2006, Wei and Ma, 2013). Quorum sensing involves the production, secretion, and detection of Auto-
Inducer (AIs) molecules such as acyl-homoserine-lactone (AHL), which can alter bacterial community 
responses within a biofilm (Camilli and Bassler, 2006).  Null mutations in genes associated with QS, such 
as the P. aeruginosa PQS gene clusters pqsABCD, phnAB and pqsH, impact on the development and 
structural integrity of a biofilm (Lee and Zhang, 2015, Vital-Lopez et al., 2015).  
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In addition to exopolysaccharides, the production of large quantities of extracellular DNA has been 
reported during P. aeruginosa biofilm formation (Muto and Goto, 1986, Whitchurch et al., 2002, 
Allesen‐Holm et al., 2006). This extracellular DNA is organised into distinctive grid-like patterns within 
the biofilm matrix (Allesen‐Holm et al., 2006). High concentrations are identified on the outer parts of a 
mature biofilm, suggesting a cause for the build-up of migrating bacteria frequently observed in this area 
(Allesen‐Holm et al., 2006, Flemming and Wingender, 2010). The origin of extracellular DNA within a 
biofilm appears to be from indiscriminate chromosomal DNA (Allesen‐Holm et al., 2006) and the 
autolysis of cells, controlled by the QS system, within multicellular communities (Webb et al., 2003, 
Montanaro et al., 2011, Zemke and Bomberger, 2016). The presence of extracellular DNA has also been 
shown to contribute to antimicrobial resistance in P. aeruginosa biofilms (Mulcahy et al., 2008, Wilton et 
al., 2016).  
Growing as a biofilm community provides the bacteria with considerably diminished susceptibility to 
antimicrobials when compared to planktonic cells (Stewart and William Costerton, 2001, Singh et al., 
2017). This increased resistant characteristic of biofilms is a result of reduced or incomplete diffusion of 
antimicrobials; the EPS matrix restricts the amount of antimicrobials which can reach the bacteria below 
the outer layers of the biofilm, causing limited target binding (Stewart and William Costerton, 2001, 
Walters et al., 2003). The interaction of EPS matrix glucose polymers with antimicrobial agents has also 
been suggested as a mechanism of preventing agents from reaching target sites. P. aeruginosa with a 
mutation in an ndvB gene was unable to produce periplasmic glycans, and biofilms were more susceptible 
to treatment with the tobramycin antibiotic compared to the wild-type strain (Mah et al., 2003). It is 
proposed that glucose polymers are able to isolate antimicrobial agents within the periplasm, preventing 
their diffusion throughout the biofilm. Antibiotics which are able to penetrate and diffuse P. aeruginosa 
biofilms, such as tobramycin and ciprofloxacin, are still not effective at completely eradicating cells 
(Walters et al., 2003). Within a biofilm structure a number of cells, termed persisters undergo 
physiological changes due to the limited access to oxygen and nutrients, resulting in reduced metabolic 
activity and limited growth rate (Whiteley et al., 2001). As antimicrobials are more effective against 
metabolically active bacteria, persister cells demonstrate increased tolerance levels and are able to remain 
viable within a biofilm after exposure to antimicrobial treatments (Tumah, 2009, Walters et al., 2003).   
The wide-ranging characteristics of P. aeruginosa (Figure 5) contribute to its success as an important 
opportunistic pathogen. Its metabolic versatility, low nutritional requirements, proficiency at forming 
biofilms and antimicrobial resistance mechanisms, also enable this microorganism to contaminate 
pharmaceutical and home and personal (HPC) products, which present harsh environmental conditions to 
survive in. The next section will consider the problem of HPC microbial contamination, the use of 
preservation systems in product formulations and known antimicrobial resistance mechanisms used in 
response to industrial antimicrobials.  
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Figure 4. Stages in the formation of a biofilm 
P. aeruginosa is able to grow as free living bacterial cells or as a multicellular accumulation of sessile cells known as a biofilm. The stages of
biofilm formation involve planktonic cells attaching to a surface and forming aggregates followed by the development of an exopolysaccharide
matrix and increased cell to cell communication. The cells then proliferate to form a mature biofilm which has limited oxygen levels and reduced
antimicrobial penetration. Planktonic cells are able to detach from a mature biofilm and start the formation of a new biofilm elsewhere. Adapted
from (Ma et al., 2009, Flemming et al., 2007, Taylor et al., 2014).
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The key functional characteristics of P. aeruginosa enable the bacterium to survive in a wide range of environments owing to its limited nutritional requirements and 
metabolic versatility. The microorganism is an opportunistic pathogen which can cause a wide range of infections and a major concern is the growing problem of multi-
drug resistance. The overall versatility observed with P. aeruginosa is linked to the large genome size which ranges between 5.2-7.0 Mbp.   
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Figure 5. Overview of the ubiquitous microorganism Pseudomonas aeruginosa 
CHAPTER 1 - Introduction 
17 
1.3 The challenge of microbial contamination in home and personal care industry 
1.3.1 Microbial contamination in home and personal care products 
The home and personal care (HPC) industry manufactures a broad range of products from household 
cleaners and laundry detergents through to shampoos, soaps, body creams and cosmetics (Orth et al., 
2006, Orus and Leranoz, 2005). The abundancy of HPC product types results in high quantities being used 
globally on a daily basis (Daughton and Ternes, 1999, Boxall et al., 2012). There is no requirement for 
HPC products to be sold sterile (Lundov et al., 2009), however there is a legal responsibility for 
manufacturers to ensure product safety for consumer use (Brannan, 1995, Orus and Leranoz, 2005, FDA, 
2017b). Good Manufacturing Practices (GMPs) are incorporated into industrial manufacturing procedures 
to reduce the occurrence of unacceptable levels or types of microorganisms, from contaminating the 
unsterile raw materials and water to be incorporated into products (Brannan, 1997, Jimenez, 2001, El-
Housseiny et al., 2013).  
The microbial contamination of HPC products can occur, especially in those with a high water content 
(Siegert et al., 2011), with reports of Gram-negative contamination in consumer products such as body and 
hand creams (Álvarez-Lerma et al., 2008, Becks and Lorenzoni, 1995), mouthwashes (Stephenson et al., 
1984, Prevention, 1998, Kutty et al., 2007) and hand washes (Zapka et al., 2011). The proliferation of 
bacteria within a HPC product can result in financial and reputational losses for the manufacturer due to 
product recalls, may present a risk to consumer health and could be problematic for immunocompromised 
individuals (Russell, 2003b, Orth et al., 2006, Jimenez, 2007). Microbial contaminants can also 
breakdown the product which can result in alterations to the pH value, colour, odour, and viscosity, ehich 
can all impact on the product performance (Smart and Spooner, 1972); packaging of HPC products may 
also swell and become damaged with the production of microbial gases. Even though HPC products are 
not natural environments for microorganisms to grow, they do contain a variety of nutrients suitable for 
metabolism such as water, lipids, polysaccharides, amino acids, glycosides, peptides and vitamins 
(Herrera, 2004, Neza and Centini, 2016) 
Contamination of HPC products can occur either through the manufacturing process or by the consumer 
themselves (Farrington et al., 1994, Siegert et al., 2011). Products may already have a high microbial 
burden when sold to consumers, resulting from poor production procedures, storage and transport of 
goods. Raw materials and water containing bacteria can become incorporated into the product 
manufacturing process, and non-sterile industrial environments can introduce microbes (Jimenez, 2001, 
Kulakov et al., 2002, Siegert et al., 2011, El-Housseiny et al., 2013). Furthermore, non-sterile products can 
acquire microorganisms from the consumer and the domestic environment after purchase, especially if 
kept after the recommended ‘best used before’ and ‘period after opening’ guidelines as implemented by 
the European Union (Jimenez, 2001, Baird, 2007, Lundov et al., 2009, Orus and Leranoz, 2005).  
The Gram-negatives P. aeruginosa and Burkholderia cepacia are considered the most common bacteria 
related to recalls of non-sterile HPC products (Wong et al., 2000, Lundov and Zachariae, 2008, Chen et 
al., 2010, Neza and Centini, 2016). Other frequently isolated microbial contaminants include Salmonella 
CHAPTER 1 - Introduction 
18 
spp., Staphylococcus aureus, Enterobacter gergoviae, Enterococcus spp., Klebsiella oxytoca, Serratia 
marcescens and Escherichia coli (Jimenez, 2001, Jimenez, 2007, Lundov and Zachariae, 2008, Neza and 
Centini, 2016) as well as Candida albicans and Rhodotorula (Dadashi and Dehghanzadeh, 2016). There is 
also a high number of unidentified microorganisms which are recovered from recalled products (Jimenez, 
2007, Sutton and Jimenez, 2012). Currently there is no requirement for HPC manufacturers to disclose and 
publish incidences of product contamination, which results in a reduced appreciation of the different 
bacterial species capable of proliferating within consumer products. This also causes consumers to be 
unaware of the problem of microbial contamination as well as prevention and protection measures.  
1.3.2 Preventing microbial contamination in the HPC industry 
Preservative formulations in the HPC industry are key strategies, which aim to achieve microbial sterility 
of products after being sold to a consumer. Preservatives are a class of biocide antimicrobials with a broad 
spectrum of activity and are added to products with the intent to inhibit the growth of microorganisms and 
prevent the breakdown of industrial formulations (Reinhard et al., 2001, Ikarashi et al., 2009, Mikami et 
al., 2002, Gilbert and McBain, 2003). Globally by weight, preservatives are the most common type of 
antimicrobial which microorganisms are exposed to, due to the high occurrence of HPC product usage 
(Gilbert and McBain, 2003, Ikarashi et al., 2009, Alvarez-Rivera et al., 2012). Currently, isothiazolinones 
and alcohol-based preservatives are widely used in industry to avoid the proliferation of bacteria within 
aqueous-based home and personal care products (Reinhard et al., 2001, Alvarez-Rivera et al., 2012, 
Brannan, 1997). These two forms of preservatives are of great interest to the HPC industry, and there is a 
requirement to increase the understanding of their mechanisms of action and how bacteria respond when 
exposed to them. This form of investigation can enhance the development of preservation formulations, 
which incorporate isothiazolinones and alcohols.  
Other types of preservatives not as commonly utilised in HPC products include parabens, the biguanide 
biocide chlorhexidine, formaldehyde and formaldehyde-releasing agents. The reduced use of these 
preservatives is due to concerns over their safety with reports of parabens being linked to tumour 
development (Harvey and Everett, 2004) and a rise in the incidences of contact allergies when 
formaldehyde preservatives are incorporated into personal care products (Lundov et al., 2009, Sasseville, 
2004). Rare but severe allergic reactions have also been reported with increased contact of chlorhexidine 
on the skin (FDA, 2017a).  
Preservative enhancers are also of interest to the HPC industry as these can amplify the antimicrobial 
efficacy of product preservation formulations without the need to increase concentrations of the 
antimicrobials (Orth et al., 2006). Examples of enhancers which can be incorporated into HPC products 
include chelating agents, such as ethylenediamine tetracetic acid (EDTA), which increases cell membrane 
permeability by interfering with levels of Mg2+ and Ca2+ (Brannan, 1997). Compounds which can 
interrupt the phospholipid bilayer such as caprylyl glycol, ethylhexylglycerin and sorbitan caprylate, are 
also used to enhance the performance of preservation systems (Papageorgiou et al., 2010). Agents which 
can restore the susceptibility of microorganisms to an antimicrobial, which have become resistant due to 
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efflux pumps, are also of interest to the HPC industry (Askoura et al., 2011). Phenyl-arginine-beta-
naphthylamide (PAβN) can act as an efflux pump inhibitor and also increases the penetrability of the 
Gram-negative cell membrane when used in combination with several antibiotics (Lamers et al., 2013).  
When compared to antibiotics, preservative mechanisms of action are not as well established and appear to 
have multiple cellular targets. The activity and application of two widely used HPC preservative 
categories will now be considered.  
1.3.2.1 Isothiazolinone preservatives 
The isothiazolinone preservatives, also known as isothiazolones, are heterocyclic chemical compounds 
that include benzisothiazolone (BIT), N-methylisothiazolone (MIT), 5-chloro-N-methylisothiazolone 
(CMIT) and a blend of chloro-N-methylisothiazolinone and N-methylisothiazolinone (CITMIT). These 
agents are commonly used to prevent the proliferation of microorganisms in settings such as cooling 
towers, paint products, the manufacturing of paper and textiles as well as HPC products (Laopaiboon et 
al., 2001, Xu et al., 2009, Lundov et al., 2014). Isothiazolinones have a wide application range against 
Gram-positive and Gram-negative bacteria and also fungi (Pucci et al., 2011, Lundov et al., 2014) which 
makes them suitable as preservatives for HPC products. These types of preservatives have also been 
associated with contact allergies (Lundov et al., 2009, Chomiczewska-Skóra et al., 2014), with only MIT 
and CITMIT approved for use in personal care products at concentrations 0.01% and 0.0015% active 
respectively. However, their use is limited in these types of products, as industrial companies seek to 
uphold their reputation at delivering safe products. BIT is widely incorporated into preservation systems 
of household cleaning products such as washing up liquids and laundry detergents in order to prevent 
microbial contamination (Table 2) (Alvarez-Rivera et al., 2012). The recommended concentration usage 
levels of BIT in these products is 0.05 – 0.15% active.  
The main mechanism of action for isothiazolinone preservatives is the oxidation of the thiols groups found 
frequently on bacterial enzymes and proteins; this results in the inhibition of growth and metabolic activity 
of microorganisms (Collier et al., 1990a, Collier et al., 1990b, Williams, 2007). The oxidation effects of 
these preservatives can also result in the generation of free radicals causing oxidative stress and further 
irreversible damage to the cell (Williams, 2007). Isothiazolinones have been shown to have direct 
inhibitory effects on metabolic enzymes such as dehydrogenases (Collier et al., 1991), isomerases (DNA 
gyrase and topoisomerase IV) (Cheng et al., 2007, Pucci et al., 2011), oxidoreductases (Collier et al., 
1991), acetyltransferases (Stimson et al., 2005, Dekker et al., 2009, Furdas et al., 2011), polymerases (Yan 
et al., 2007) kinases (Lippa et al., 2006, Reddy et al., 2012), lipases (King et al., 2009), synthases (Gedi et 
al., 2011). This therefore highlights the multifactorial isothiazolinone impact on bacterial metabolism. 
Investigations into mechanisms of action of the preservative BIT and its derivatives, have identified its 
ability target and inhibit the sortase-A enzyme which is involved in Gram-positive peptidoglycan cell wall 
biosynthesis (Zhulenkovs et al., 2014). In P. aeruginosa the regulatory c-di-GMP phosphodiesterase RocR 
enzyme was inhibited by a BIT derivative and a reduced swarming ability was also noted (Zheng et al., 
2016). It was suggested the BIT derivative was not suitable for growth inhibition purposes, but would be 
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useful to attenuate the virulence of P. aeruginosa, as mutants deficient in c-di-GMP phosphodiesterase 
remained viable but had reduced virulence.  
1.3.2.2 Alcohol-based preservatives  
Alcohol-based preservatives can also be incorporated into HPC preservation formulations and types used 
include phenoxyethanol (POE) (Ikarashi et al., 2009, Krowka et al., 2014), benzyl alcohol, (Nair, 2000, 
Mikami et al., 2002) and phenethyl alcohol (Ziosi et al., 2013). The use of POE in personal care products 
has increased due the low occurrence of allergy contact sensitisation reported with this preservative 
(Poudrier, 1990, Steinberg, 2008, Johnsson et al., 2011, Krowka et al., 2014). Under European Union 
regulations, POE is recommended to be used in concentrations between 0.5-1% in personal care products 
(Table 2) and this preservative is also highly compatible with numerous product formulations (Krowka et 
al., 2014).  
POE demonstrates antimicrobial properties against Gram-negative bacteria such as P. aeruginosa, (Orth et 
al., 2006) and the proposed mechanism of action is the disruption of bacterial cell membranes, cell lysis 
and leakage of cellular protein material (Fitzgerald et al., 1992, Maillard, 2002, Langsrud et al., 2016). 
However, the exact mechanism of POE antimicrobial activity is not fully comprehended. Gilbert et al. 
carried out numerous studies on the effect of POE with E. coli, in the 1970’s and multiple mechanisms, 
which caused inhibitory and bactericidal actions, were noted. The antimicrobial activity of POE was 
associated with disruptions and inhibitions of malate dehydrogenase enzyme-systems involved in the 
Krebs cycle (Gilbert et al., 1976a, Gilbert et al., 1976b) and RNA, DNA and protein-biosynthesis 
pathways (Gilbert et al., 1979) as well as leakage of membrane protons which decreased cell wall 
permeability (Gilbert et al., 1977). These investigations into the mechanisms of action of POE 
demonstrate the multiple potential targets of the preservative. It has also been suggested that the 
antimicrobial activity is concentration dependant and bactericidal effects result from the preservative 
interfering with several of the proposed targets, causing irreversible cell damage (Langsrud et al., 2016). 
The effectiveness of POE is also enhanced when combined with other preservatives such as chlorhexidine 
(Fitzgerald et al., 1992) isothiazolinones (Lundov et al., 2011) and ethylhexylglycerin (Beilfuß et al., 
2005, Langsrud et al., 2016).  
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Table 2. Important isothiazolinones and alcohol-based preservatives used in the HPC industry 
Preservative 
Category
Preservative trade name, active ingredient, 
solvent, supplier and recommended usage levels. 
Chemical 
structure
Preservative applications Targets and mechanisms of action References
Isothiazolinones
PROXEL GXL
• Active ingredient: I,2-benzisothiazolinon-3-one BIT
supplied as 20% active.
• Soluble in dH2O.
• Yellow brown Solution
• Supplied by Arch UK Biocides Ltd LONZA, UK.
• Recommended usage levels: 0.05 – 0.15% active.
House hold products:
• Liquid laundry detergents and
fabric softeners.
• Dishwasher detergents.
• All purpose cleaners.
• Polishes/waxes.
• Incorporated into raw materials
and surfactants used in the
Household products.
• Not used in personal care
products due to sensitising
capabilities.
 Nonspecific mode of action/multiple
cellular targets. 
 Bacteriostatic effects.
 Electrophilic agents which react with
nucleophilic cell entities. 
 Oxidation of thiol groups, found on
enzymes and other proteins, which are
essential for function. 
 Loss of proteins as thiols disrupts
pathways critical for cell metabolism.
 Direct inhibitory effects on following
metabolic enzymes: dehydrogenases, 
oxidoreductases, acetyltransferases, 
kinases, DNA gyrase and topoisomerases, 
lipases, kinases, polymerase, and
synthases. 
 Oxidation generates free radicals which
further damage the cell. 
(Collier et al., 1990a, 
Collier et al., 
1990b,Collier et al., 
1991, Lippa et al., 
Stimson et al., 2005,  
2006, Williams 2007, 
Cheng et al., 2007, 
Yan et al., 2007, 
Dekker et al., 2009, 
King et al., 2009, Gedi 
et al., 2011, Furdas et 
al., 2011, Pucci et al., 
2011, Alvarez-Rivera 
et al. 2012, Reddy et 
al., 2012, Zhou et al.,
2014, Zhou et al., 
2015b)
Alcohols
PHENOXETOL
• Active ingredient: 2-Phenoxyethanol POE supplied
as >99 % active.
• Soluble in dH2O.
• Supplied by Clariant Produkte GmbH, Germany.
• Recommended usage levels: 0.5 – 1.0 % active.
Personal care products: 
• Personal skin care preparations
due to its low sensitising
capabilities.
• Aqueous based home and
personal care products such as
shampoos, foam baths, shower
gels or liquid detergents.
• Cosmetic makeup products.
 Good activity against Gram-negative
bacteria. 
 Exhibits a micro-biocidal activity. 
 Membrane active lytic agent, disrupting
cellular membranes and causing the
leakage of intracellular components. 
 Increases permeability of the cell
membrane due to proton leakage
 Denaturing of essential proteins and
enzymes. 
 Disrupts RNA, DNA and protein synthesis. 
 Inhibits malate dehydrogenase which is
involved in the Krebs cycle. 
(Gilbert et al., 1976a, 
1976b, 1977,1979), 
(Poudrier 1990, 
(Fitzgerald et al., 
1992Maillard 2002, 
Orth et al., 
2006Ikarashi  et al., 
2009, Krow ka et al., 
2014, Langsrud et al., 
2016) 
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1.3.3 P. aeruginosa as a contaminant of the HPC industry 
Due to its dominance as a health care pathogen, research has mainly focused on the epidemiology, 
pathogenesis and treatment of clinical P. aeruginosa isolates. In comparison, there is an incomplete 
understanding of P. aeruginosa strains isolated from the natural environment (Chavarría et al., 2013) and 
much less is known about isolates which are successful contaminants of non-sterile cosmetic, personal and 
household products (Jimenez, 2007, Lundov and Zachariae, 2008, Siegert et al., 2011, Siegert, 2012). As 
previously noted, P. aeruginosa can be recovered from numerous environmental niches (Figure 5), and 
due to its metabolic versatility, has the ability to proliferate in harsh chemicals and disinfectants (Dantas et 
al., 2008, Kung et al., 2010, Lama et al., 2012). Consequently its aptitude to grow within the unnatural 
setting of a HPC product is not surprising, and a recent analysis of recalled contaminated products, 
identified P. aeruginosa as the most frequently isolated microorganism (35.48%) (Neza and Centini, 
2016).   
Due to the opportunistic characteristics of this pathogen, high levels of the bacterium within a product 
could be harmful to those with weakened immune systems. The action of some personal care products can 
cause damage to skin and mucous membranes, which could promote infection if microbial contaminants 
are present (Neza and Centini, 2016). P. aeruginosa is commonly found in cosmetics (Tan et al., 2013), 
shampoo products (Neza and Centini, 2016), contact lens solutions and eye cosmetic products, where it 
has been reported to cause a number of infections of the eye and surrounding tissues (Reid and Wood, 
1979, Blumenfeld et al., 2005, Hazlett, 2004, Manuj et al., 2006). This highlights the requirement to 
minimise the occurrence of HPC product contamination with this pathogen through the improvement of 
manufacturing practices, and with enhanced product preservation systems. P. aeruginosa strains which are 
resistant to isothiazolinone preservatives are regularly identified from incidences of product contamination 
where spoilage has occurred (Chen et al., 2010). This suggests the bacterium is able to overcome 
preservation strategies used in industry. In order to understand P. aeruginosa in an industrial context, 
those isolated from contaminated products should be analysed in depth and resistant mechanisms used in 
response to preservative formulations require characterisation.  
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1.4 Mechanisms of resistance to industrial antimicrobial agents  
The majority of research investigating P. aeruginosa antimicrobial resistance has focussed on the 
mechanisms employed to reduce susceptibility to antibiotics. There is limited knowledge of the resistance 
mechanisms used by P. aeruginosa when exposed to industrial antimicrobials such as preservatives 
(Chapman, 1998). Industrial preservatives have been observed to target multiple sites within bacteria and 
cause universal damage with efficient bactericidal effects. However, the presence of preservatives at sub-
lethal concentrations can result in incidences of adaptive resistance in P. aeruginosa (Brözel and Cloete, 
1994, Winder et al., 2000, Mc Cay et al., 2010, Abdel-Malek and Badran, 2010). This section will 
consider characterised bacterial mechanisms of resistance in response to industrial antimicrobial agents.  
1.4.1 Alteration of cell wall structures in response to industrial antimicrobials 
A principal resistance mechanism of Gram-negative bacteria in response to preservatives is the reduction 
of cellular permeability, by altering or removing cell envelope components such as proteins, phospholipids 
and fatty acids (Chapman, 2003, Tumah, 2009). A characterised P. aeruginosa resistance mechanism in 
response to the isothiazolinone CITMIT, was associated with an alteration in the outer membrane, via the 
removal of the OprD protein (Brözel and Cloete, 1994). The protein was readily detected in non-resistant 
strains, however in those with decreased susceptibility to isothiazolinones, OprD could not be detected 
(Brözel and Cloete, 1994). This suggests OprD was the mode of entry for isothiazolinones and P. 
aeruginosa had adapted to exposure via the modification of the cell wall structure. Winder et al., (2000) 
also identified the removal of the OprD in the outer membrane in a PAO1 strain with induced resistance to 
BIT, MIT, and CMIT. Furthermore this study found OprD reappeared when resistant strains were 
passaged without a preservative, however induced resistance was not fully reversed, suggesting the 
occurrence of additional adaptations (Winder et al., 2000). In addition, induced resistance towards 
isothiazolinone preservatives resulted in decreased susceptibility to other thiol-interactive agents.  
A P. aeruginosa strain with adapted resistance to the preservative POE also demonstrated alterations in 
the outer membrane protein profile, with decreases in protein densities observed (Abdel-Malek and 
Badran, 2010). An interesting observation was the cross-resistance demonstrated with unrelated biocides 
and with penicillin and aminoglycoside antibiotics. In the presence of the preservative BIT, a three-fold 
reduction in susceptibility was observed with the POE adapted strain, suggesting these two preservatives 
have a common point of entry in P. aeruginosa. The reduced susceptibility observed was not suggested to 
be linked to an efflux pump as the resistance did not reduce in the presence on an efflux pump inhibitor 
(Abdel-Malek and Badran, 2010). These investigations highlight modification of cell wall structures as a 
fundamental P. aeruginosa resistance mechanism in response to HPC preservatives.  
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1.4.2 The use of efflux pumps in response to industrial antimicrobials 
In order to reduce intracellular concentrations of antimicrobials, which are able to cross the cell wall, 
Gram-negative bacteria overexpress efflux systems. However, there is limited research identifying the 
specific pump systems used by P. aeruginosa in response to industrially used antimicrobials. Efflux 
pumps associated with multidrug resistance are able to transport a range of structural substrates as 
demonstrated by Table 1; these established systems within P. aeruginosa could also be used to expel 
industrial preservatives and prevent their accumulation within the cell.  
The use of efflux as a primary resistance response to the broad-spectrum industrial biocide triclosan was 
identified in the up-regulation of multiple efflux pump systems in P. aeruginosa due to mutations in the 
nfxB and mexL regulatory genes (Schweizer, 2001, Chuanchuen et al., 2001, Chuanchuen et al., 2002). 
The MexJK efflux system (Table 1) functions as a two-component RND pump to expel triclosan, however 
the presence of an outer membrane channel protein is necessary to form a tripartite antibiotic efflux 
system (Chuanchuen et al., 2002, Chuanchuen et al., 2005). A P. aeruginosa triclosan specific efflux 
pump has also been identified TriABC-OpmH (Table 1) (Mima et al., 2007). These studies all demonstrate 
the importance of efflux as a principal P. aeruginosa resistance mechanism in response to triclosan.     
Another example of efflux as a biocide resistance mechanism in Pseudomonas spp., was identified with 
glutaraldehyde, a widely used antimicrobial in hospitals and water treatment (Vikram et al., 2015). 
Transcriptomic analysis identified up-regulation of genes encoding an efflux pump in Pseudomonas 
fluorescens which had high homology to the P. aeruginosa MexEF-OprN efflux pump (Table 1) (Vikram 
et al., 2015). When PAO1 was treated with both glutaraldehyde and an efflux pump inhibitor, it 
demonstrated increased susceptibility compared to treatment with glutaraldehyde only (Vikram et al., 
2015). This study proposed efflux as a P. aeruginosa resistance mechanism in response to the 
glutaraldehyde biocide. The MexCD-OprJ efflux pump system in P. aeruginosa (Table 1) is also inducible 
during exposure to the disinfectants chlorhexidine and benzalkonium chloride as well as other membrane 
lytic agents (Morita et al., 2003, Fraud et al., 2008).  
Transcriptomic research has also identified an RND efflux pump as a key resistance mechanism when a 
Burkholderia lata (B. lata) strain with induced resistance to isothiazolinone preservatives was exposed to 
CMIT (Rushton et al., 2013). B. lata are also common Gram-negative bacterial contaminants of the HPC 
industry (Wong et al., 2000). This suggests efflux as a possible resistance mechanism in response to 
preservative formulations, which could also be used by P. aeruginosa HPC product contaminants.  
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1.4.3 Alteration of bacterial targets sites and inhibition of industrial antimicrobial agents 
The alteration of antimicrobial target sites within the cell has also been identified as a resistance 
mechanism of P. aeruginosa in response to triclosan. This biocide targets the bacterial enoyl-acyl carrier 
protein (ACP) FabI reductase within the fatty acid biosynthetic pathway (Chuanchuen et al., 2001). P. 
aeruginosa is able to confer resistance when exposed to triclosan by alteration of the FabI enzyme, 
rendering it insensitive to the biocide (Chuanchuen et al., 2001, Schweizer, 2001). There is limited 
research to suggest the modification of target sites is utilised by P. aeruginosa to reduce susceptibility to 
industrial preservatives, due to the broad spectrum activity demonstrated by these antimicrobials 
(Williams, 2007, Alvarez-Rivera et al., 2012). The inhibition of industrial antimicrobial agents is 
demonstrated by the ability of P. aeruginosa to detoxify formaldehyde via a NAD+ gluthathione-
dependent dehydrogenase enzyme, which is predicted to be plasmid-encoded (Cloete, 2003).  
Recent transcriptomic investigations of an isothiazolinone-resistant P. aeruginosa strain when exposed to 
CITMIT, identified a number of differentially expressed genes associated with nitrogen metabolism and 
oxidative phosphorylation pathways (Zhou et al., 2016). It was proposed that the upregulation of 
genes encoding nitric oxide synthases was to increase the availability of nitric oxide (NO) in the cell 
(Zhou et al., 2016). NO can structurally alter and inhibit toxic compounds and alleviate the oxidative 
stress, which increases tolerance to a wide-range of antibiotics such as lactams, aminoglycosides, 
and quinolones (Gusarov et al., 2009, McCollister et al., 2011). The isothiazolinone-resistant 
strain also generated increased levels of NO when compared to the wild-type strain, (Zhou et al., 2015b, 
Zhou et al., 2016), thus highlighting the importance of increased NO production in the resistance of P. 
aeruginosa to CITMIT.  
1.4.4 Biofilm resistance and industrial antimicrobial agents 
A delay in the ability of industrial antimicrobials to penetrate P. aeruginosa biofilm structures is also a 
characterised resistance mechanism. When the biocidal activity of peracetic acid and benzalkonium 
chloride was assessed, the presence of the EPS matrix obstructed the ability of the biocides to diffuse 
throughout the P. aeruginosa biofilm (Bridier et al., 2011). A reduced susceptibility to the oxidative 
biocides monochloramine and hydrogen peroxide when P. aeruginosa formed thin biofilms, has also been 
reported in comparison to planktonic cells (Cochran et al., 2000). In B. lata strains which demonstrated 
decreased susceptibility to CMIT isothiazolinone preservatives and the biocide benzethonium chloride, an 
increase in biofilm biomass formation was also observed (Rushton et al., 2013). This suggests biofilm 
development is a possible resistance mechanism for strains, which are able to contaminate HPC products 
such as B. lata and P. aeruginosa.  
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1.4.5 Cross-resistance between industrial antimicrobial agents and antibiotics 
The overuse of industrial antimicrobial agents may contribute to the emergence of highly resistant 
microorganisms, and increased tolerance to preservatives could select for strains which are also less 
susceptible to clinically-relevant antibiotics (McBain et al., 2002, Poole, 2002, Russell, 2003a). Resistance 
mechanisms used by P. aeruginosa in response to triclosan have been shown to also convey resistance to 
numerous antibiotics (Carey and McNamara, 2014) especially when sub-inhibitory concentrations are 
utilised (Schweizer, 2001).  Cross-resistance between triclosan and antibiotics such as ciprofloxacin in P. 
aeruginosa is facilitated by the overexpression a multidrug efflux pump MexCD-OprJ (Table 1) as a result 
of mutations in its regulatory gene nfxB, selected for by triclosan (Chuanchuen et al., 2001). Preservative 
cross-resistance and altered antibiotic susceptibility was also reported in a B. lata strain with induced 
resistance to benzethonium chloride and isothiazolinones including BIT (Rushton et al., 2013). Another 
interesting link between preservative and antibiotic resistance was observed with the reduced 
susceptibility of a POE adapted P. aeruginosa strain to clinically relevant antibiotics and other unrelated 
preservatives and biocides (Abdel-Malek and Badran, 2010). A P. aeruginosa strain with increased 
tolerance to the isothiazolinone CITMIT was also found to display cross-resistance to triclosan and 
ciprofloxacin (Zhou et al., 2016). This suggests the preservatives used in HPC products such as POE and 
isothiazolinones, are capable of initiating cross-resistance to antibiotics in P. aeruginosa.  
The high quantities of HPC products being used on a daily basis results in their continuous release into the 
environment (Daughton and Ternes, 1999). Consequently bacteria will be exposed to the preservative 
formulations, which are likely to be diluted and at sub-lethal levels. Strains, which are successful 
contaminants of HPC products, are also proficient at overcoming the preservation system. Therefore, the 
occurrence of reduced susceptibility towards industrially used preservatives and the evidence of cross-
resistance, may result in the appearance of hyper-resistant antibiotic P. aeruginosa strains.  
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1.5 Project Aims 
The Biotechnology and Biological Sciences Research Council (BBSRC) funded this PhD studentship in 
collaboration with the industrial CASE sponsor Unilever Safety and Environment Assurance Centre 
(SEAC). The interests of Unilever, with the intention of informing industrial practices, guided the research 
questions addressed. The overall aim of this work was to identify important genetic pathways, which 
contribute to preservative resistance in an industrial P. aeruginosa strain. The main approaches used to 
achieve the aims of this PhD project are summarised in Figure 6.  
1.5.1 Research project rationale 
Industry utilises preservative systems for non-sterile cosmetic and household items to inhibit microbial 
contamination, these agents are essential to prevent product spoilage and potential consumer infection. 
However, P. aeruginosa has the ability to overcome preservation formulations and the resistance 
mechanisms utilised to survive the presence of industrial antimicrobials are not well established. A better 
understanding of these mechanisms can contribute to optimal use of HPC preservation strategies via 
the development of targeted preservative formulations. The adaptive resistance mechanisms employed 
by P . aeruginosa in response to industrially used antimicrobials, may also be sufficient to confer 
multidrug resistance in a clinical environment. Therefore, there is concern that excessive 
industrial use of preservatives, may contribute to the emergence of highly antimicrobial resistant 
strains. This further highlights the requirement for industry to minimise the use of antimicrobials 
through the optimisation of preservation strategies.  
The purpose of this project was to characterise key genetic pathways involved in resistance to industry 
relevant antimicrobials, to provide a better understanding of the success of P. aeruginosa as a HPC 
product contaminant. The identification of key genes and regulatory pathways is an invaluable approach 
when investigating microbial resistance mechanisms. An industrial P. aeruginosa strain RW109, isolated 
from a contamination incident, was chosen for this project. RW109 served as a model organism for 
investigating industrial antimicrobial resistance due to its previous exposure to HPC preservatives and 
product formulations. The use of the RW109 strain in this project also demonstrates the genetic and 
metabolic determinants, which enable P. aeruginosa to become a successful contaminant of the home and 
personal care industry. The antimicrobial agents selected for investigation included BIT to represent a 
commonly used preservative in household products for example, laundry detergents and washing-up 
liquids and POE, which is widely incorporated into personal care products such as shampoos, shower gels 
and cosmetics. The results of this work will inform the future development of targeted preservation 
systems to enhance product sterility whilst also minimising future resistance development.  
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The specific aims of the project were as follows: 
1) Characterise the complete genome of an industrial P. aeruginosa strain (Chapter 3). A complete
genome of the industrial strain RW109 was obtained using PacBio Single Molecule, Real-Time
(SMRT) technology. This enabled a comprehensive annotation of the functional characteristics of an
industrial strain. A comparison of RW109 with a panel of P. aeruginosa genome sequences
representing strains isolated from clinical, environmental and industrial sources was also completed.
2) Investigate the genetic basis of industrial P. aeruginosa preservative resistance (Chapter 4). A
mini-Tn5-luxCDABE transposon library was constructed using the RW109 industrial P. aeruginosa
strain. A screening procedure was developed to identify mutants with altered light emission responses
when exposed to industry relevant preservatives. Mutants of interest were linked to the putative gene
pathways of the RW109 P. aeruginosa genome to identify genetic determinants of preservative
resistance.
3) Investigate the global gene expression response of P. aeruginosa RW109 when exposed to
industry-relevant conditions (Chapter 5). Appropriate industrial exposure and growth conditions
were determined which enabled the extraction of good quality RNA for subsequent transcriptomic
investigations of the RW109 strain. An RNA-Seq experiment was implemented following exposure of
RW109 to individual preservatives, preservative combinations and a HPC product with and without
the addition of a preservative. The differentially regulated genes with significant increases and
decreases in expression when exposed to the industry relevant conditions were analysed.
4) Reconstruct and utilise a genome-scale metabolic model specific to the industrial P. aeruginosa
RW109 strain (Chapter 6). A recently published PA14 genome-scale metabolic model was updated
to represent the industrial RW109 strain. RNA-Seq transcriptomic data was integrated to generate
condition-specific models that represent RW109 when exposed to industrial conditions. These models
were used to predict the essentiality of metabolic reactions when RW109 was exposed to HPC
preservatives and product formulations.
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Four key strategies were used to identify genetic pathways and metabolic networks involved in industrial P. aeruginosa preservative resistance. These included: 
1) Whole genome sequencing of an important industrial strain isolated from a source of contamination. 2) The use of a mini-Tn5-luxCDABE mutant library to
identify mutants of interest when screened with preservatives. 3) An investigation of the global gene expression response when exposed to industry relevant
conditions, with the use of RNA-Seq. 4) Genome-scale metabolic modelling of an industrial strain and integration of transcriptomic data to predict the
essentiality of genes and reactions when the industrial strain was exposed to HPC preservatives and product formulations.
Figure 6. The main experimental approaches used to investigate the genetic basis of preservative resistance in an industrial P. aeruginosa strain
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2. Materials and methods
2.1 Chemicals and growth media 
The chemicals used throughout this study were supplied by Sigma-Aldrich (Dorset, UK), and Fisher 
Scientific (Loughborough, UK), unless otherwise stated. All media was prepared according to the 
manufacturer’s guidelines using double-deionised water and sterilised by autoclaving at 121ºC for 15 
minutes. Trytone soya medium (TSA agar and TSB broth) and Luria bertani (LB) medium were obtained 
from Oxoid Ltd (Basingstoke, UK) and were routinely used for growing P. aeruginosa and Escherichia 
coli (E.coli) strains respectively.    
2.2 Bacterial Strains  
2.2.1 Storage of bacterial isolates 
Bacterial stocks used in this study were stored at -80°C in TSB or LB containing 8% Dimethylsulfoxide 
(DMSO) (Fisher Scientific). 
2.2.2 Routine growth conditions of an industrial P. aeruginosa strain 
Throughout this project, the industrial P. aeruginosa challenge test strain, RW109, was used. This strain 
was isolated from a contamination incident and was routinely incorporated into the industrial sponsor’s 
challenge testing processes. These tests were used to determine the susceptibility of a product to microbial 
contamination, and the efficacy of the preservative system. RW109 had previously been exposed to 
industrial preservatives and product formulations, and served as a model organism to investigate industrial 
antimicrobial resistance. RW109 was routinely revived from a freezer stock onto TSA, and incubated 
static for 24 hours at 30°C. Overnight liquid cultures were prepared by inoculating 3 ml of TSB with 
confluent growth from a 24-hour plate culture, and incubated for 18 hours shaking with aeration at 30°C. 
Throughout this project, the lower incubation temperature of 30°C was used to be more representative of 
industrial product manufacture and storage temperatures, but still enabling sufficient growth for 24 and 
18-hours incubation times.  
2.2.3 Enumeration of viable bacteria 
Bacterial cultures were enumerated using the Miles and Misra surface viable plate count method (Miles et 
al., 1938). Serial dilutions were performed in TSB broth unless otherwise stated; 100 μl drops were spread 
onto triplicate TSA plates and incubated at 30°C for 24 hours. Individual colonies were counted and the 
number of viable cells calculated and expressed as colony forming units per ml (CFU/ml). 
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2.3 Antimicrobial agents   
2.3.1 Preservatives and formulations 
Throughout this study, the preservative benzisothiazolone (BIT) was used to represent the isothiazolinones 
group and phenoxyethanol (POE) was used to represent the alcohol preservative category. Information 
about the preservatives used in this study and their source information can be found in Chapter 1, Table 2.  
Stock concentrations of preservatives were prepared in sterilised double-deionised water on day of use to 
0.05% activity for BIT and 2% activity for POE. Stock concentrations were then further diluted in growth 
media to obtain the required test concentrations. In addition, an unpreserved laundry detergent formulation 
containing C12-15 Pareth-7 and Sodium Laureth Sulfate, was prepared by the industrial sponsor and used 
for bacterial RNA expression analysis (see Section 2.7)  
2.3.2 Antibiotics 
Antibiotic stock solutions were prepared for tetracycline (Tc) at 50 mg/ml on day of use in DMSO, and -
20°C freezer stocks solutions of polymyxin B (Pmx) were prepared in autoclaved double-deionised water 
at 600,000 units/ml, filter sterilised and used within 2 months. Antibiotic stock solutions were further 
diluted to the required concentration in growth media. 
2.4 DNA Extraction from bacterial cells  
2.4.1 Rapid DNA extraction using Chelex®100 resin 
The following procedure was used for rapid bacterial DNA extraction for screening techniques such as 
PCR. A sterile 200 µl plastic pipette tip was lightly dipped into confluent growth of a strain grown for 24 
hour on agar and material transferred into 50 μl of 5% Chelex® 100 resin solution (Bio-rad, Hertfordshire, 
UK; autoclaved prior to use). A c1000™ Thermal Cycler (Bio-Rad) was used to run the following 
conditions: samples were heated to 98ºC for 5 minutes, then placed at 4ºC for 5 minutes, process was 
repeated and sample then centrifuged at 800 x g for 1 minute to deposit the Chelex® resin and cellular 
debris. Crude DNA from the supernatant was used in stated PCR procedures, with 2-5 µl added to each 
reaction. Storage of the DNA was at 4ºC and DNA was used on the same day as the Chelex® preparation 
was performed. 
2.4.2 Automated Maxwell® 16 system 
The Automated Maxwell® 16 instrument nucleic acid purification system, along with the Maxwell® 16 
Tissue DNA purification kit (Promega) were used to extract genomic DNA from bacterial cultures, 
following the manufacturer’s instructions. Cells from a 3 ml overnight culture were centrifuged (1,400 x g 
for 10 minutes), the pellet re-suspended in 300 μl TE buffer (10 mM Tris, 1 mM EDTA, pH 8) (Sambrook 
et al., 1989) and added into the DNA purification kit cartridges. The instrument was cycled through its 
normal DNA extraction protocol and the final DNA extracts (approximately 250 µl) were stored short-
term at 4 ºC and at -20 ºC for long-term storage. 
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2.4.3 Quantitation and quality assessment of Genomic DNA 
Gel electrophoresis was used to analyse bacterial genomic DNA; a 1.5% high resolution (w/v) agarose gel 
(molecular grade agarose; Severn Biotech Ltd.), stained with SafeView (NBS Biologicals Ltd., 
Cambridgeshire, UK; 10 μl SafeView per 100 ml of agarose gel) was run at 80V for 8 cm (approximately 
3-3.5 hours). A Qubit™ fluorometer system (Invitrogen, Massachusetts, USA) was used to quantify the 
genomic DNA, according to the manufacturer’s instructions and nuclease free water (Severn Biotech Ltd.) 
was used if DNA dilutions were required. Quality assessment of DNA was carried out by measuring the 
absorbance ratios 260/280 nm and 260/230 nm using a NanoDrop Spectrophotometer (Thermo Fisher 
Scientific, Massachusetts, USA); ratios of ≥1.8 were used as an indication of good quality DNA. 
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2.5 Whole genome sequencing and comparative genomics of P. aeruginosa strain RW109 
2.5.1 Single Molecule, Real-Time (Pacific Biosciences) sequencing of the RW109 strain  
Genomic DNA from RW109 was extracted using the automated Maxwell® 16 system and quantitation 
and quality assessment was carried out as described in Section 2.4.3. A 1.5 ml aliquot of the overnight 
culture used for the DNA extraction was prepared as a freezer stock via the addition of 8% DMSO; purity 
of the culture was checked through the preparation of a streak plate from the freezer stock. The extracted 
DNA was sent as 100 μl at 236 ng/μl to the Centre for Genomic Research, University of Liverpool. 
Sequencing was carried out using two Single Molecule, Real-Time (SMRT) cells with P6/C4 chemistry on 
a Pacific Biosciences (PacBio) RSII. All subsequent bioinformatics analysis was carried out using a 
virtual machine, hosted by the Cloud Infrastructure for Microbial Bioinformatics (CLIMB) consortium 
(Connor et al., 2016).  
2.5.2 Sequence assembly and annotation 
The following protocol was used to create FASTQ DNA sequence files from the raw data PacBio files. 
From each sequencing run, three bax.h5 files and one bas.h5 file (a pointer file to the three bax.h5 files) 
resulted from each SMRT cell. The bax.h5 files contained the base call information from the sequencing 
run, and both sets from the two SMRT cells were converted into two separate binary format (bam) files 
using the bax2bam tool (v0.0.8, PacBio, California). The two resulting bam files were merged and a single 
FASTQ was extracted using the BamTools toolkit (v2.4.0, https://github.com/pezmaster31/bamtools). 
Assembly of the FASTQ sequence data was carried out as follows. The contigs were created from FASTQ 
files using the Canu Assembler (v1.3) (Koren et al., 2017). Assembled contigs were checked for 
overlapping ends and trimmed where necessary using Circulator (v1.2.1) (Hunt et al., 2015). The resulting 
assembly was polished using the GenomicConsensus Package (v2.1.0, PacBio) The FASTA sequence file 
of the RW109 genome was run though the Quality Assessment Tool for Genome Assemblies (QUAST), 
(v4.5.5) (Gurevich et al., 2013). Annotation of the assembly was carried out using Prokka (v1.11) 
(Seemann, 2014), which analyses a variety of databases to associate the genome’s CDS with predicted 
biological functions. The annotation tool first uses BLAST+ to search against a panel of well-
characterised bacterial proteins obtained from UniProtKB and databases specific to the genus of the 
bacteria (Seemann, 2014). A HMMER3 based search is then carried out to examine bacteria specific 
Prokka-HMM libraries for finalisation of the CDS functional predictions (Seemann, 2014).  
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2.5.3 Identifying the basic features of the RW109 whole genome sequence 
Basic genome features of RW109 such as the total number of bases, numbers of coding sequences (CDS), 
transfer RNA (tRNA), ribosomal RNA (rRNA) and transfer-messenger (tmRNA), were obtained from the 
Prokka annotation summary files, and the DNA  G + C content taken from the QUAST analysis. The 
complete genome sequence FASTA files of the clinical P. aeruginosa reference strains UCBPP-PA14 
(PA14) (Accession: CP000438) and PAO1 (Accession: AE004091) were obtained from the Pseudomonas 
Genome Database (Winsor et al., 2016), annotated using Prokka and run through QUAST as described in 
Section 2.5.2. The genome features of these two strains after annotation with Prokka were used as a 
comparison against the RW109 strain.  
2.5.4 Identifying plasmids in the assembled genome 
2.5.4.1 Nucleotide BLAST comparison 
To identify if the RW109 genome contained plasmids, six circular P. aeruginosa complete plasmid 
sequences were downloaded as a single multi-FASTA file from the PathoSystems Resource Integration 
Center (PATRIC) database (v3.3.10) (Wattam et al., 2014, Wattam et al., 2017). A BLAST database was 
created from the plasmid sequences using a command line standalone NCBI BLAST (BLAST v2.2.29+) 
(Camacho et al., 2009). The assembled un-annotated amino acid sequence of RW109 was compared to the 
plasmid BLAST database using a command line Nucleotide (BLASTn) search.  
2.5.4.2 ACT: the Artemis Comparison Tool 
The Artemis ACT comparison tool (Carver et al., 2005) was used to construct comparative synteny line 
plots between the assembled annotated RW109 genome and various plasmid sequences and the P. 
aeruginosa reference strain PA14. Comparison crunch files for input into ACT were generated using 
BLASTall (v2.2.26).  
2.5.5 Assigning functional groups to the RW109 whole genome sequence 
2.5.5.1 Cluster of Orthologous Group (COG) functional annotation  
The COG functional annotation (Tatusov et al., 2000) of the RW109 Prokka predicted coding sequences 
(CDS; specifically translated amino acid sequences) was carried out with the command line EggNOG-
mapper downloaded from the evolutionary genealogy of genes: Non-supervised Orthologous Groups 
(EggNOG) database (v4.5.1) (Huerta-Cepas et al., 2016a, Huerta-Cepas et al., 2016b). Functional 
orthologs were assigned using the EggNOG HMMER3 based homology search to the optimised bacterial 
database and the COG categories and accession numbers were extracted. COG categories were divided 
into three well characterised functional classes’ information storage and processing, cellular processes and 
signalling and metabolism. A poorly characterised functional class was also used where the COG category 
was unknown.  
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2.5.5.2 Determining the interaction of RW109 CDS 
The STRING database (v10.5) (Szklarczyk et al., 2016) was used to predict interactions between the 
RW109 CDS via their assigned COG accession numbers. A multiple list of the COG accession numbers 
were entered into the database, the organism Pseudomonas was selected and interactions were predicted 
(the following active interaction sources were applied: neighbourhood, gene fusion, co-occurrence, co-
expression, experiments, and databases). Networks between CDS were determined at a medium 
confidence level score of 0.400 and were grouped via the STRING k-means clustering data-mining 
algorithm, which divides data into a fixed number of groups, without any prior knowledge of their 
relationships. In the network output, each node represents a COG accession number and the edge 
demonstrates the interaction confidence scores.  
2.5.5.3 Kyoto Encyclopedia of Genes and Genomes (KEGG) functional module assignment and 
determining the metabolic and physiological potential 
KEGG Orthology (KO) terms were assigned to the RW109 translated amino acid sequences from Prokka 
predicted CDS, using the KEGG Automatic Annotation Server (KAAS) (Moriya et al., 2007) through the 
NCBI BLAST single-directional best hit search method, against the prokaryotes organism list. The 
Metabolic and Physiological Potential Evaluator (MAPLE) tool (v2.1.0) (Takami et al., 2016), was 
subsequently used to map the groups of KO-assigned CDS to KEGG defined modules. These modules are 
a collection of functional units linked to specific metabolic abilities and phenotypic features, and 
identified with M numbers. KEGG modules are grouped into pathway modules, structural complexes, 
functional sets and signature modules (Takami et al., 2016). The percentage of a module’s completeness 
was determined by calculating the module completion ratio (MCR), which evaluated how many KO 
components of the module were present. If all KO assigned CDS within each module were present, the 
MCR was equal to 100%, according to a Boolean algebra-like equation (Takami et al., 2016). For each 
MCR, a Q-value was also calculated which indicated the significance of the module completion. The 
MAPLE tool inferred that reaction modules with Q-values of less than 0.5 were biologically feasible even 
if the MCR is less than 100% (Takami et al., 2016). 
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2.5.5.4 Identifying putative antimicrobial resistance and virulence genes in the RW109 genome 
The ABRicate tool (v0.5-dev, https://github.com/tseemann/abricate.git) via the command line was used to 
screen the Prokka annotated nucleotide sequence of RW109 to identify antimicrobial and virulence genes. 
The following databases downloaded with ABRicate were searched against; Resfinder (Zankari et al., 
2012), Antibiotic Resistance Gene-ANNOTation (ARG-ANNOT) (Gupta et al., 2014), the Comprehensive 
Antibiotic Resistance Database (CARD) (McArthur et al., 2013), and the Virulence Factor Database 
(VFDB) (Chen et al., 2016). A ≥80% cut off was used for both coverage and identity ABRicate scores.  
2.5.5.5 Identifying antibacterial biocide and metal resistance genes in the RW109 genome 
The BacMet database (v1.1) (Pal et al., 2013) of antibacterial biocide and metal resistance genes was 
downloaded and the Prokka annotated amino acid sequence of RW109 was compared against it using 
command line BLASTp. Similarity matches were determined using an Expected-value (E-value) cut-off of 
1E-40, a BIT score cut off of 400 and setting the best-hit filtering algorithm overhang parameter to 0.25. 
CDS identified by the BacMet database were termed BacMet resistance genes.  
2.5.6 Identifying RW109 genomic islands 
RW109 genomic islands (GIs) were predicted using Islandviewer (v4.0) (Bertelli et al., 2017) with the 
Prokka generated GeneBank file with default settings applied. The results from IslandViewer prediction 
methods SIGI-HMM and IslandPath-DIMOB was used to identify the total number of GIs within the 
RW109 whole genome sequence.  
2.5.7 Identifying prophages in RW109 genome 
Prophage sequences within the RW109 genome were predicted using PHAge Search Tool Enhanced 
Release (PHASTER) (v1.0) (Arndt et al., 2016, Zhou et al., 2011). Comparisons against the PHASTER 
databases and feature identifications were carried out with the Prokka generated GeneBank file. Phage 
sequence regions were given a PHASTER score and were identified as being complete if the score was > 
90, questionable with a score of 70-90 and incomplete with a score < 70.  
2.5.8 Visualising the RW109 whole genome sequence 
The Circular Genome Viewer (CGView) application and CGView source code (Stothard and Wishart, 
2005) were used via the command line to convert Prokka generated GeneBank files into CGView XML 
files for generation of a RW109 genome circular map. The CDS were coloured according to the assigned 
COG categories, and the RW109 GIs and prophage sequences were also illustrated on the map.
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2.5.9 Comparative genomics of the RW109 whole genome sequence  
2.5.9.1 Comparing RW109 annotated functional categories with PA14 and PAO1 
The Prokka translated amino acid sequences of P. aeruginosa PA14 and PAO1 (see Section 2.5.3) were 
assigned COG functional annotations, KEGG functional modules and MAPLE MCRs, as described in 
Sections 2.5.5.1, 2.5.5.2 and 2.5.5.3. The antimicrobial resistance and virulence genes were also identified 
in PA14 and PAO1, as described in Sections 2.5.5.4 and 2.5.5.5. The results from these annotations were 
used to compare against the functional annotations of the industrial P. aeruginosa RW109 strain.   
2.5.9.2 Roary: Rapid large-scale prokaryote pan genome analysis and core-gene alignment 
The Roary pipeline (v3.7.0) (Page et al., 2015) was used for pan-genome comparisons of the RW109 
strain with genome sequences of P. aeruginosa strains isolated from clinical, environmental and industrial 
sources (Table 3). In total 102 genomes were obtained; 70 complete genome FASTA files of P. 
aeruginosa strains were downloaded from the Pseudomonas Genome Database (Winsor et al., 2016) and 9 
were obtained from GenBank. Also included in the analysis were 23 unpublished P. aeruginosa strain 
genome sequences, previously used as a panel by a Cardiff University PhD student (Weiser, 2015). All the 
FASTA sequences of the strains were annotated using Prokka, as described in Section 2.5.2. The resulting 
GFF files of the 102 P. aeruginosa genome sequences were used in the Roary analysis along with the GFF 
file of the RW109 strain. The –e parameter was applied to create a multi-FASTA codon aware alignment 
of all the core genes using PRANK (Löytynoja, 2014). The resulting core-gene multi-FASTA alignment 
file was used to build a phylogenetic maximum-likelihood tree based on 1,000 bootstrap resampling 
replicates with FastTree (v2.1.8), (Double precision, No-SSE3, OpenMP) (Price et al., 2010). The 
Generalized Time-Reversible (GTR) model with default settings was applied. The tree was visualised with 
FigTree (v1.4.3, http://tree.bio.ed.ac.uk/software/figtree/). 
2.5.9.3 Comparison of antimicrobial resistance genes across 103 P. aeruginosa genome 
sequences 
The FASTA sequences of the 102 P. aeruginosa genomes from Section 2.5.9.2 were input into the 
ABRicate tool to identify CARD antimicrobial resistance genes. A ≥80% cut off was used for both 
coverage and identity ABRicate scores. The ABRicate summary reports from each genome sequence and 
the RW109 genome were combined into a single spreadsheet to show the presence and absence of 
antimicrobial resistance genes. This spreadsheet along with the phylogenetic tree built with FastTree in 
Section 2.5.9.2 were uploaded to the online Interactive Tree of Life (iTOL) (v3.5.4) (Letunic and Bork, 
2016) to construct a tree annotated with a heat map illustrating the presence/absence of the identified 
antimicrobial resistance genes for each of the P. aeruginosa sequences.  
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2.5.9.4 Identifying the unique genes of RW109 when compared to the 102 P. aeruginosa genome 
sequences 
From the Roary pan-genome analysis (Section 2.5.9.2), the gene presence and absence output was used to 
determine the genes specific to the P. aeruginosa RW109 strain which were not identified in the 102 P. 
aeruginosa genome sequences. The position of these genes in the RW109 genome and their functional 
annotations such COG, KEGG, antimicrobial and virulence identifications were analysed.  
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Table 3. P. aeruginosa genome sequences used in the Roary pan genome analysis 
Strain Name Strain Type Isolation Source Reference 
GenBank           
Accession Number 
12-4-4.59 Clinical 
Blood culture of a burn 
patient 
(Karna et al., 2016) CP013696 
19BR Clinical 
Collected as part of a 
Brazilian Surveillance 
study between 2002 and 
2004 
(Boyle et al., 2012) AFXJ00000000 
213BR Clinical 
Collected as part of a 
Brazilian surveillance study 
between 2002 and 2004 
(Boyle et al., 2012) AFXK00000000 
8380-3922 Clinical Human gut (Ichise et al., 2015) AP014839 
AES-1R-2482 Clinical 
Sputum of a 14 month old 
infant with cystic fibrosis 
(Naughton et al., 
2011) 
CP013680 
ATCC-15692 Clinical Infected wound Not published CP017149 
ATCC-27853 Clinical Unknown (Feng et al., 2016) CP015117 
B136-33 Clinical 
Infant with community 
acquired diarrhoea 
Not Published CP004061 
BAMC-07-48 Clinical Combat injury wound (Sanjar et al., 2016) CP015377 
Carb01-63 Clinical Unknown Not published CP011317 
DHS01 Clinical Nose of a patient (Valot et al., 2014) CP013993 
DK2 Clinical CF sputum (Rau et al., 2012) CP003149 
DN1 Environmental Soil, China Not published CP017099 
DSM-50071 Clinical Hospital, Japan (Nakano et al., 2015) CP012001 
F9676 Environmental Diseased rice, China Not published CP012066 
F22031 Clinical Pubic bone Not published CP007399 
FA-HZ1 Environmental 
Wastewater, 
dibenzufuran_degrading 
bacterium 
Not published CP017353 
FRD1 Clinical CF sputum Not published CP010555 
IOMTU-133 Clinical 
Female participant in the 
dbGaP microbiome study 
Not published AP017302 
F9670 Clinical Unknown Not published CP008873 
F23197 Clinical Unknown Not published CP008856 
F30658 Clinical Unknown Not published CP008857 
F63912 Clinical Unknown Not published CP008858 
H5708 Clinical Unknown Not published CP008859 
H27930 Clinical Unknown Not published CP008860 
H47921 Clinical Unknown Not published CP008861 
M1608 Clinical Unknown Not published CP008862 
M37351 Clinical Unknown Not published CP008863 
S86968 Clinical Unknown Not published CP008865 
T38079 Clinical Unknown Not published CP008866 
T52373 Clinical Unknown Not published CP008867 
T63266 Clinical Unknown Not published CP008868 
W16407 Clinical Unknown Not published CP008869 
W36662 Clinical Unknown Not published CP008870 
W45909 Clinical Unknown Not published CP008871 
W60856 Clinical Unknown Not published CP008864 
X78812 Clinical Unknown Not published CP008872 
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LES431 Clinical 
CF sputum, Liverpool 
epidemic strain 
(Jeukens et al., 2014) CP006937 
LESB58 Clinical 
CF sputum, Liverpool 
epidemic strain 
(Winstanley et al., 
2009) 
FM209186 
M18 Environmental Plant isolate, China (Wu et al., 2011) CP002496 
MTB-1 Environmental 
Hexachlorocyclohexane 
contaminated soil 
(Ohtsubo et al., 2014) CP006853 
N17-1 Environmental Soil Not published CP014948 
NCGM2.S1 Clinical 
Isolated from a hospital in 
Japan 
(Miyoshi-Akiyama et 
al., 2011) 
AP012280 
NCGM257 Clinical Urine, Japan Not published AP014651 
NCGM1900 Clinical Urinary catheter Not published AP014622 
NCGM1984 Clinical Urinary catheter (Tada et al., 2016) AP014646 
NCTC10332 Clinical Unknown Not published LN831024 
D1 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012585 
D2 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012578 
D5 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012579 
D9 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012580 
D16 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012581 
D21 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012582 
D22 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012583 
D25 Clinical 
Clinical isolate from 
ventilator associated 
pneumonia patient 
Not published CP012584 
PA1 Clinical Respiratory tract infection (Lu et al., 2015) CP004054 
PA1R Clinical Respiratory tract infection (Lu et al., 2015) CP004055 
PA1RG Clinical/environmental Hospital sewage (Li et al., 2016) CP012679 
PA7 Clinical 
Non-respiratory clinical 
isolate 
(Roy et al., 2010) CP000744 
PA121617 Clinical CF Sputum Not published CP016214 
PACS2 Clinical CF Sputum Not published AAQW01000001 
PAO1 Clinical Wound isolate (Stover et al., 2000) AE004091 
RP73 Clinical CF Sputum (Jeukens et al., 2013) CP006245 
SCV20265 Clinical CF Lung 
(Eckweiler et al., 
2014) 
CP006931 
UCBPP-PA14 Clinical Burn patient (Lee et al., 2006a) CP000438 
USDA-ARS-
USMARC-41639 
Environmental 
Nasopharynx of a cow in 
Kansas, USA 
Not published CP013989 
VA-134 Clinical Burn wound (Miller et al., 2016) CP013245 
VRFPA04 Clinical 
Corneal button from patient 
with corneal keratitis 
(Murugan et al., 2016) CP008739 
YL84 Environmental Compost (Chan et al., 2014) CP007147 
PA96 Clinical 
Clinical isolate from 
Guangzhou, China 
(Déraspe et al., 2014) CP007224 
S04-90 Environmental Microbial mat material Not published NZ_CP011369 
N002 Environmental Crude oil contaminated soil (Roy et al., 2013) ALBV00000000 
Table 3. Continued 
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SJTD-1 Environmental Soil (Liu et al., 2012)  CP015877 
ATCC-700888 Environmental Industrial water system (Chugani et al., 2012) AKZF00000000 
E2oS Environmental Soil (Stewart et al., 2014) ASQV00000000 
MSH-3 Environmental 
Environmental, Mount St. 
Helens 
(Stewart et al., 2014) ASQU00000000 
ATCC-14886 Environmental Soil (Chugani et al., 2012) AKZD00000000 
MSH-10 Environmental Environmental (Stewart et al., 2014) ASWW00000000 
XMG Environmental Soil, China (Gao et al., 2012) AJXX00000000 
NCTC-12903* Clinical 
Antibiotic efficacy testing 
reference strain; originally 
isolated from blood 
Not published Not available 
RW18* Clinical Chronic prostatitis isolate Not published Not available 
RW27* Clinical CF sputum 
(Mahenthiralingam et 
al., 1996) 
Not available 
RW30* Clinical CF sputum 
(Mahenthiralingam et 
al., 1996) 
Not available 
RW99* Environmental 
Domestic isolate, washing 
machine drawer biofilm 
Not published Not available 
RW110* Industrial 
Strain used in Unilever 
preservative efficacy 
testing 
Not published Not available 
RW130* Industrial 
Dish washer liquid; Italy; 
isolated 2010 
Not published Not available 
RW131* Industrial 
Dish washer liquid; Italy; 
isolated 2010 
Not published Not available 
RW138* Industrial 
Liquid abrasive cleaner; 
Italy; isolated 2001 
Not published Not available 
RW146* Industrial 
Dish washer liquid; Italy; 
isolated 2004 
Not published Not available 
RW149* Industrial 
Personal care product; 
origin location unknown; 
isolated 2003 
Not published Not available 
ATCC-9027* Clinical 
Reference strain used in 
industrial testing; isolated 
from an outer ear infection 
Not published Not available 
RW168.2* Industrial Unknown Not published Not available 
RW172* Industrial 
Dish washer liquid; 
suspected origin is 
Thailand; isolated 2009 
Not published Not available 
RW176* Industrial 
Dish washer liquid; 
Indonesia; isolated 2010 
Not published Not available 
RW184* Industrial 
Dish washer liquid; UK; 
isolated 2006 
Not published Not available 
RW192* Industrial 
Surface cleaner; isolated 
from a contaminated 
Unilever product in 2012 
 
Not published Not available 
ATCC-13388* Unknown 
Origin unknown; reference 
strain used in industrial 
testing (ISO 846C) 
Not published Not available 
ATCC-15442* Environmental 
Reference strain used in 
industrial testing; isolated 
from an animal room water 
bottle 
Not published Not available 
RW199* Industrial 
Metal working fluid 
product 
Not published Not available 
RW200* Industrial Timber care product Not published Not available 
RW202* Industrial 
Liquid abrasive cleaner; 
EU; isolated 2012 
Not published Not available 
RW204* Industrial 
Dish washer liquid; isolated 
2012 
Not published Not available 
 
Footnotes = 
* 
Panel of 23 isolates used by a previous Cardiff University PhD Student (Weiser, 2015).  
Table 3. Continued 
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2.6 Transposon mutagenesis experiments 
2.6.1 Construction of a mini-Tn5-luxCDABE transposon library in RW109 P. aeruginosa strain 
Random mini-Tn5 transposon mutagenesis was initiated by performing a bi-parental conjugal mating with 
the recipient P. aeruginosa RW109 strain and an E. coli S17-1 λpir donor strain carrying pUTmini-Tn5-
luxCDABE-Tc (Winson et al., 1998). The E. coli was revived on LB agar containing 10 µg/ml Tc at 37°C. 
Overnight 3 ml liquid LB and 10 µg/ml Tc cultures of the E. coli strain were prepared by inoculating with 
confluent growth from a 24-hour plate culture and incubated for 18-hours with aeration at 37°C. 
2.6.1.1 Optimising transconjugant selective media: Minimum Inhibition Concentration (MIC) 
testing of antibiotics using broth and agar assays 
A micro-dilution broth assay was used to determine the MIC of the donor and recipient strains in the 
presence of the antibiotic Tc. This form of assay allowed a wide range of Tc concentrations to be assessed 
before carrying out an agar dilution assay. Twelve individual Tc test concentrations at 0, 15, 20, 25, 30, 
35, 40, 45, 50, 100, 150 and 200 µg/ml were assessed and prepared at double the concentration with 100 
µl added to wells of a clear flat bottom 96 well plate (Fisher Scientific). The concentrations were halved to 
the required concentration when inoculated with 100 µl of an overnight culture at approximately 106 
cfu/ml. The 96 well plates were incubated shaking (150 rpm) at 30°C, and after 24 hours the optical 
density (OD) at 600 nm of each well was recorded using the absorbance function of a Tecan Infinite® 
M200 PRO plate reader (Labtech International LTD, UK). The MIC was taken as the lowest concentration 
of the Tc antibiotic, at which there was an 80% or more reduction in OD when compared to growth in 
control wells containing TSB-only. Experiments were performed in triplicate using different starting 
cultures and Tc stock solutions to obtain biological replicates, with each repeat having four technical 
replicates. 
An agar dilution assay was used to investigate the susceptibility of donor and recipient strains to Tc and 
Pmx antibiotics. TSA agar was cooled to 50ºC after autoclaving, and an appropriate volume of antibiotic 
stock added to the 25 ml of agar to achieve final concentration ranges of 0, 100, 125 and 150 µg/ml for Tc, 
and 0, 100 and 120 units/ml for Pmx. Concentrations were assessed separately and in combination for Tc 
and Pmx. Strains were cultured as described previously and 50 µl of approximately 106 cfu/ml of culture 
was transferred to the surface of triplicate agar plates and spread evenly. Visual assessments and colony 
counts were performed following 24 – 48 hours of incubation at 30°C.   
2.6.1.2 Conjugal transfer of mini-Tn5 
Overnight cultures of recipient and donor cells were harvested by centrifugation (1,400 x g for 10 
minutes) and washed with LB + 10 mM MgSO4. As a control for background growth, 50 µl of 
approximately 106 cfu/ml of both recipient and donor cultures were plated onto the transconjugant 
selective media. Recipient cells were heat shocked for 10 minutes at 42°C prior to being mixed with the 
donor at a ratio of 1:1. 100 µl of the mating mixture was transferred onto a 25 mm sterile nitrocellulose 
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filter membrane (0.22 µm pore size, Sigma-Aldrich) which was placed centrally on the surface of a warm 
dry LB+10 mM MgSO4 plate. After 18-hour incubation at 37°C, the mating mixture was recovered from 
the membrane and re-suspended in TSB.  
To selectively kill the E. coli donor and the RW109 recipient but select for transconjugants carrying the 
mini-Tn5-luxCDABE transposon, 50 µl of re-suspended mating mixture at 10-1 dilution was transferred to 
selective TSA plates. All plates were incubated at 30°C for approximately 48 hours. Using sterile wooden 
tooth picks, transconjugants were individually picked into flat-bottom white 96-well micro-titre plates 
(Greiner, BioOne) containing 200 µl TSB and 50 µg/ml Tc, with wells H:6 and H:12 containing TSB-
only, acting as blank controls.  
Plates were cultured in the dark for 24 hours at 30°C and mutant relative light units (RLU), were measured 
in triplicate using the luminescence function of a Tecan plate reader with a 4-second integration time. The 
mean RLU of the blank wells was subtracted from each mutant well to normalise measurements. Mutants 
were individually identified based on their well positon within each master plate and were categorised 
according to the baseline bioluminescence measurement as follows: ≥ 1.00E+06 RLU (Category 1), ≥ 
1.00E+05 RLU (Category 2), ≥ 1.00E+04 RLU (Category 3), ≥ 1.00E+03 RLU (Category 4), ≥ 5.00E+02 
RLU (Category 5) and ≤ 4.99E+02 RLU (Category 6). After reading the baseline light emissions, 8% 
DMSO was added to each well for long-term storage as master plates at -80°C. 
2.6.2 Identifying the mini-Tn5-luxCDABE transposon in low light emitters 
Twenty mutants in light emission Category 6, the lowest emission category as assigned above, were 
checked to determine if they contained the mini-Tn5-luxCDABE transposon using a PCR that amplifies a 
region of the luxA gene. Twenty category 6 mutants from across the constructed mutant bank were 
isolated and grown on TSA agar. DNA was extracted using Chelex®100 resin and used as template for a 
PCR reaction with a luxA_forward primer (5’-CGGTTTGGTATTTGCCGAGG-3’) and luxA_reverse 
primer (5’GTAGGCCAAATTGAGCA GCC-3’). The reaction took place in a c1000™ Thermal Cycler 
according to the following cycling conditions:  95°C for 2 minutes, 35 cycles of 94°C for 30 seconds, 
60°C for 30 seconds and 72°C for 1 minute and 30 seconds and a final extension step of 72°C for 5 
minutes. Each PCR reaction mixture was prepared with an overall volume of 25µl, with reagents obtained 
from Qiagen, UK. The mixtures contained sterile H2O, 1X PCR buffer, 1X Q-solution, 200 µM of each 
dNTP, 0.4 pmol/µl of each primer, 1U of Taq DNA polymerase and 2 µl of the template DNA 
(approximately 20 ng). The PCR reaction products were run along with a 2-Log DNA ladder (New 
England Biolabs, NEB UK; 0.1-10.0 kb) on 1.5% high resolution (w/v) agarose-TAE gels stained with 
Safeview and run at 80V for 8 cm (approximately 3-3.5hr). The wild-type RW109 strain was used a 
negative control and a high light emitter along with the E.coli donor strain were used as positive controls; 
the expected size of the PCR product was 262 bp to confirm the presence of the luxA gene.  
CHAPTER 2 – Materials and methods 
44 
2.6.3 Random Amplified Polymorphic DNA (RAPD) typing of PA RW109 lux mutants 
Eighteen mutants of varying light emissions were randomly selected from across the library and analysed 
using a RAPD PCR as described by (Mahenthiralingam et al., 1996). This was carried out to ensure the 
picked transconjugants had the same genotype as the recipient RW109 strain. The majority of mutants 
selected were from the lowest light emission category; the PCR also included the recipient, donor and a 
negative control. Mutants were isolated, grown on TSA agar and DNA was extracted using Chelex®100 
resin and used as template for a PCR reaction with a RAPD 272 primer (5’-AGC GGG CCA A-3’). Using 
a c1000™ Thermal Cycler the following cycling conditions were run: 94ºC for 5 minutes, 4 cycles of 
36ºC for 5 minutes, 72ºC for 5 minutes, 30 cycles of 94ºC for 1 minute, 36ºC for 1 minute 72ºC for 2 
minutes followed by a final extension step of  72ºC for 6 minutes. PCR reaction mixtures for each mutant 
sample were prepared with an overall volume of 25µl, with reagents supplied by Qiagen. The mixtures 
contained Sterile H2O, 10x Coralload buffer, 1 x Q-solution, 25 mM MgCl2, 200 µm (dNTPs), 1.6 µM 
RAPD 272 primer, 1 U Taq DNA polymerase and 2µl of the template DNA (approximately 20 ng). 12 μl 
of the PCR products and 10 µl of a 2-Log DNA ladder (0.1-10.0 kb) were loaded into a 1.5% high 
resolution (w/v) agarose gel stained with Safeview with and run at 80V for 8 cm.  
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2.6.4 MIC testing of industrial preservatives using a broth doubling dilution method 
To obtain approximate MIC values for the preservatives BIT and POE, serial doubling dilutions of 
aqueous stock solutions were prepared in TSB to achieve final concentrations ranging from 0 – 0.075% 
for BIT and 0 – 2% for POE. Preservatives were prepared at double the concentrations and 96 well plates 
were set up for MIC testing and carried out as described in Section 2.6.1.1. Preservative MIC values were 
taken as the lowest concentration at which there was an 80% or more reduction in OD when compared to 
the growth control wells containing TSB-only. Experiments were performed in triplicate using different 
starting cultures and preservative stock solutions to obtain biological replicates with each repeat having 
four technical replicates. 
2.6.5 Screening the transposon library to identify preservative responding mutants 
2.6.5.1 Master plate screening 
To identify mutants with altered light emission responses when exposed to industrial preservatives, master 
plates were replicated and screened with the preservative at sub-MIC concentrations; the MIC was an 
approximate calculation for the wild type RW109 strain. A 96-pin replicator was used to replicate master 
plates into 2.0 ml deep-well plates (Nunc, Thermo Scientific) containing 1.5 ml of TSB which were 
incubated shaking (150 rpm) for 24 hours at 30°C. The replicated master plate was then sub-cultured by 
transferring 100 µl of the left side (columns 1-6) to both the left and right side of triplicate white 96-well 
micro-titre plates (Figure 7). This was also repeated for the right side of the master plate (columns 7-12) 
(Figure 7). Mutants on the left side of sub-cultured plates were exposed to 100 µl of TSB-only (control 
condition) and the right side was exposed to 100 µl of screening preservative (test condition) (Figure 7). 
Plates were incubated at 30°C in the dark and after 24-hours following the addition of TSB and 
preservative, the RLU was measured using the luminescence setting of a Tecan plate reader. Triplicate 
RLU readings were normalised to the mean RLU of the blank wells and individual mutants of interest 
were isolated from the replicated master plate revived on TSA and freezer stocks prepared. Mutants were 
selected for isolation depending on the RLU fold change between the control and test conditions after 24 
hours; those which demonstrated a ≥0.4 fold RLU increase (positive responding mutants) and a ≥0.3 fold 
RLU decrease (negative responding mutants) in the master plate screen were isolated. The fold RLU 
selection criteria used may not represent true preservative responding mutants, but it allowed for the 
isolation of a wide range of transconjugants that demonstrated various responses to BIT exposure. Mutants 
which displayed minimal light emission change when exposed to BIT (RLU fold change between +0.05 to 
–0.05; minimal change mutants), were also isolated from master plates.
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2.6.5.2 Isolated mutant screening 
Isolated mutants of interest were revived onto TSA from individual freezer stocks and overnight cultures 
diluted to approximately 106 cfu/ml. 100 µl of the diluted overnight culture was transferred in a staggered 
format to four wells in both columns 1 and 7 of a white 96 well plate; this was carried for six mutants per 
plate (Figure 7). The wells in between the mutants contained 100 µl of TSB-only for normalisation of 
RLU data. To columns 1-6, 100 µl of TSB was added to all wells (control condition) and 100 µl of the 
screening preservative was added to all wells of columns 7-12 (test condition) (Figure 7). After incubation 
in the dark at 30°C for 24-hours, luminescence was measured. The replicate RLU readings were 
normalised to the mean RLU of the blank wells.  
2.6.5.3 Statistical analysis of RLU measurements 
Using R statistical software (v3.3.3), mutant RLU data was analysed by comparing the two means for the 
control and test conditions using a paired two-sample T-test for means; RLU differences with a p-value of 
≤ 0.05 were considered to be significant. Boxplots were generated using BoxPlotR (Spitzer et al., 2014) to 
examine the difference in RLU measurements between the control and test conditions and observe the 
distribution of quantified light emission data.  
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Figure 7. The organisation of luminescent plates when screening master plates and individual 
mutants 
A master plate was replicated into a deep-well plate (A) and sub-cultured into two plates, one 
containing columns 1-6 in both the left and right hand side (B) and the other consisting of columns 
7-12 in both the left and right hand side (C). Screening of a master plate was carried out in triplicate 
resulting in three sets of plates B and C. Mutants of interest were isolated from plate A and six 
individual mutants were screened with both control and test conditions within one plate (D).   
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2.6.6 Sequencing of transposon flanking DNA and bioinformatics analysis 
An inverse PCR technique was used to identify the transposon insertion sites in mutants of interest as 
described by (Lewenza et al., 2005). Genomic DNA was extracted using the automated Maxwell® 16 
system. DNA flanking the left side of the transposon was digested and ligated using a SacII restriction 
enzyme and T4 DNA ligase (NEB, UK) following the manufacturer’s instructions. The ligated product 
was used as template for an inverse PCR reaction using Tn5-SacII primer 1 (5’-
GTCAAAAGGACGATTTCGGTTTGG-3’) and Tn5-SacII primer 2 (5’-GATCCCCGGG 
TACCGAGCTCGAATTC-3’) in a c1000™ Thermal Cycler. The following cycling conditions were used: 
95°C for 3 minutes, 5 cycles of 95°C for 30 seconds, 60°C for 1 minute and 72°C for 3 minutes, followed 
by 30 cycles of 95°C for 30 seconds, 60°C for 1 minute and 72°C for 3 minutes and finishing with a single 
step of 72°C for 5 minutes.  
Each PCR reaction mixture was prepared with an overall volume of 25 µl, with reagents obtained from 
Qiagen, UK. The mixtures contained sterile H2O, 1X PCR buffer, 1X Q-solution, 0.5 mM MgCl2, 200 µM 
of each dNTP, 0.4 pmol/µl of each primer 1U of Taq DNA polymerase and 2.5 µl of the ligated DNA as a 
template. The PCR reaction products were run along with a 2-Log DNA ladder on 1.5% high resolution 
(w/v) agarose-TAE gels stained with Safeview and run at 80V for 8 cm. All samples yielding a single 
major band were purified with the QIAquick PCR purification kit (Qiagen, UK), according to the 
manufacturer’s instructions and quantified using a Qubit. The purified PCR products were forwarded to 
the MWG Eurofins DNA Sanger sequencing service following the sample submission guidelines for 
‘MWG Eurofins Value Read Service in Tubes’. A sequencing primer Tn5-SacII primer 3 (5’-
CCGGGTACCGAGCTCGAATTCG-3’) was sent along with the PCR products to identify the DNA 
flanking the left side of the transposon. Insertion sites were identified using a command line standalone 
NCBI Nucleotide BLAST (BLASTn, v2.2.29+) (Camacho et al., 2009) with a BLAST database of the 
RW109 PacBio genome sequence and an E-Value cut-off of 1E-6 was used. The COG functional 
associations of the transposon insertion sites were identified from the annotation of RW109 in Section 
2.5.5.1. The distribution of the mutant transposon insertion sites within the RW109 genome were mapped 
using CGView, as described in Section 2.5.8.  
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2.7 RNA-Sequencing (RNA-Seq) experiments 
All RNA-Sequencing (RNA-Seq) experiments were carried out using the same P. aeruginosa RW109 
freezer stock prepared in Section 2.5.1 which was used for PacBio sequencing.  
2.7.1 Growth curve analysis of RW109 when exposed to individual preservatives 
To determine the growth dynamics of RW109 with and without preservatives, a Bioscreen C 
Microbiological Growth Analyser (Labsystems, Finland) was used. Within a Bioscreen C microplate, four 
blank control wells contained 200 μl TSB-only and test wells contained  200 μl TSB supplemented with 
preservatives and inoculated with approximately 106 cfu/ml of an overnight culture. The preservatives BIT 
and POE were analysed with a range of 0 – 115% of the MIC value (calculated in Section 2.6.4), going up 
in 5% increments. Growth was monitored for 48 hours at 30°C with turbidity measurements taken at 15-
minute intervals using a wide band filter (450-580 nm), after shaking the microplates for 10 seconds at an 
intermediate intensity. Each experiment contained four technical replicates for the control and test 
conditions and was performed in triplicate with different starting overnight cultures and test condition 
preparations. The data was pooled and analysed in Microsoft Excel with the mean value of the control 
blank wells subtracted from all the test OD data, which was averaged and logarithmically transformed and 
used to produce line graphs. After this initial assessment, another Bioscreen microplate was set up where 
RW109 was exposed to BIT and POE at only 20 and 50% of the MIC for 24 hours for further analysis of 
the growth dynamics at these concentrations.  
2.7.2 Growth curve analysis of RW109 when exposed to BIT and POE in combination 
The growth dynamics of RW109 when exposed to a combination of the preservatives BIT and POE were 
also assessed. The Bioscreen microplate was set up and run as described in Section 2.7.1 and RW109 was 
grown in the presence of the preservatives both in combination at 5, 10, 15 and 20% of the calculated MIC 
values.  
2.7.3 Growth curve analysis of RW109 when exposed to a product formulation with and without the 
presence of a preservative 
The growth dynamics of RW109 when exposed to a product formulation with and without the presence of 
a preservative was also assessed. A liquid laundry detergent product was supplied by Unilever, which did 
not have a preservation system (Section 2.3.1); the laundry detergent was colourless and soluble in H2O. 
The Bioscreen microplate was set up and run as described in Section 2.7.1 and RW109 was grown in the 
presence of the laundry detergent at the following dilutions: 1:10, 1:20, 1:50 and 1:100. The dilutions of 
the laundry detergent were prepared in TSB. After the initial analysis of RW109 grown with only the 
laundry detergent, a Bioscreen experiment was also set up with exposure to the laundry detergent and the 
preservative BIT in combination. 
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2.7.4 RNA-Seq exposure experiments  
The RW109 strain was exposed to eight conditions, which included: 
   Control condition: TSB-only, 
1) BIT at 20% of the MIC (001875% active),
2) BIT at 50% of the MIC (0.00469%),
3) POE at 20% of the MIC (0.1% active)
4) POE at 50% of the MIC (0.25% active),
5) BIT and POE in combination, both at 20% of the MIC (see above for active
concentrations),
6) 1:100 dilution of unpreserved laundry detergent composed of C12-15 Pareth-7 and
Sodium Laureth Sulfate (Section 2.3.1), and
7) 1:100 dilution of the laundry detergent in combination with BIT at 20% of the MIC.
These chosen concentrations were lower than product recommended usage levels of 0.05-0.15% active for 
BIT and 0.5-1.0% active for POE.  
The exposure experiments were carried out using the Bioscreen C instrument and the microplate was set 
up as described in Section 2.7.1 with the control condition and seven test conditions each represented by 
four technical replicates within the plate (Figure 8). RW109 was exposed to the conditions for 24 hours at 
30°C and turbidity measurements were taken every 15 minutes as previously described. After exposure for 
24 hours the cultures in each of the four technical replicate wells for the control and exposure conditions 
were promptly pooled into separate micro-centrifuge tubes, and immediately snap-cooled in an ethanol 
and dry ice bath, before centrifuging at 20,000 x g at 4ºC for 1 minute.        
The supernatant was removed and pellets were immediately snap-frozen and stored at -80ºC until required. 
Exposure experiments were repeated with different starting overnight cultures, and exposure condition 
preparations to obtain four biological replicates for the control and exposure conditions. The mean Log10 
OD value (450-580 nm) of the four biological replicates at 24 hours for each RNA-Seq exposure condition 
were analysed by comparing the two means for the control and test exposure conditions using a paired 
two-sample t-test for means; Log10 OD value differences with a p-value of ≤ 0.05 were considered to be 
significant. 
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Figure 8. The arrangement of a Bioscreen microplate during RNA-Seq exposure experiments 
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A Bioscreen microplate was arranged as follows for each exposure experiment; orange wells were the blanks 
and contained 200 µl of TSB and were not inoculated with RW109, wells coloured in green indicate the 
control condition and contained 200 µl of TSB inoculated with approximately 10
6
 cfu/ml from an overnight 
culture. The white wells numbered 1-7 represent the test exposure conditions which were as follows: 1) BIT at 
20% of the MIC, 2) BIT at 50% of the MIC, 3) POE at 20% of the MIC, 4) POE at 50% of the MIC, 5) BIT 
and POE in combination, both at 20% of the MIC, 6) 1:100 dilution of unpreserved laundry detergent, and 7) 
1:100 dilution of laundry detergent in combination with BIT at 20% of the MIC. Grey wells were empty and 
not used during the exposure experiments.  
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2.7.5 Enumeration of viable bacteria from exposure experiments 
After exposure to the RNA-Seq conditions, the enumeration of viable cells was carried out as described in 
Section 2.2.3. For each serial dilution of the exposure conditions, 100 μl of was spread onto 3 replicate 
TSA agar plates and incubated for 24 hours at 30°C. This was repeated with different starting overnight 
cultures and exposure condition preparations, to obtain three biological replicates for the control and 
exposure conditions.  
2.7.6 Total RNA (toRNA) extraction 
Total RNA was extracted within one week of harvesting cells using the RiboPure™ RNA Purification 
Bacteria Kit (Ambion, Life Technologies Ltd, UK) according to the manufacturer’s instructions. The kit 
uses zirconia beads for cell wall disruption and organic extraction of the lysate, and RNA purification with 
silica spin columns. After the extraction and wash steps, the RNA bound to a silica filter was eluted with 2 
x 30 μl of elution buffer. Each sample was treated to remove any contaminating genomic DNA using the 
Ambion DNA-free™ reagents following the manufacturer’s instructions.  
2.7.7 Total RNA (toRNA) quantification and quality assessment 
A Qubit™ fluorometer system with the broad range RNA kit (Invitrogen, USA) was used to quantify the 
total RNA (toRNA) samples according to the manufacturer’s instructions. An additional RNA 
precipitation step was incorporated for samples with low RNA concentrations (< 100 ng/μl) via addition 
of 0.1 volumes of 3 M sodium acetate, 5 μg of glycogen and 2.5 volumes of 100% ethanol. Mixtures were 
incubated for 30 minutes at -80°C, centrifuged at ≥12,000 x g for 30 minutes at 4°C, and RNA pellets 
washed twice with 70% ethanol and re-suspended in 17 μl of the elution buffer from the RiboPure™ RNA 
Purification Bacteria Kit and re-quantified. The quality of toRNA was assessed with a Bioanalyzer using 
the RNA 6000 Nano kit (Agilent Technologies Ltd, UK), following the manufactures protocol. If the RNA 
Integrity Number (RIN) was ≥ 8 and the ratio of 23S:16S rRNAs was ≥ 1.5, the toRNA samples were used 
for further applications. If the toRNA was found to be of low quality the exposure, experiment and toRNA 
extraction was repeated. 
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2.7.8 Messenger RNA (mRNA) enrichment, quantification and quality assessment 
A MICROBExpress™ bacterial mRNA enrichment kit (Ambion), was used to enrich for messenger RNA 
(mRNA) from the toRNA; samples were added within a concentration range of 1.5 – 3 μg in a maximum 
volume of 15 μl. The kit works by mixing the toRNA with an optimized set of capture oligonucleotides, 
which bind to the bacterial 16S and 23S ribosomal RNA (rRNA). Derivatized magnetic microbeads 
remove the rRNA, which have hybridised to the oligonucleotides hybrids, but leave the mRNA in the 
supernatant, which is retrieved by ethanol precipitation. The resulting enriched mRNA pellets were re-
suspended in 10 μl of nuclease free water and quantified using the Qubit™ fluorometer system, with the 
broad range RNA kit to ensure the concentration was greater than 2 ng/μl for input into the 
complementary DNA (cDNA) library preparation kit. The Bioanalyzer with the RNA 6000 Nano kit was 
used to evaluate the depletion of rRNA by comparing RNA samples before and after MICROBExpress 
mRNA enrichment. Noticeable reduction in the 16S and 23S rRNA peaks were observed on the 
bioanalyzer electropherograms; samples were allowed to continue forward to RNA sequencing even if 
traces of the ribosomal RNA were still present. RIN values and ratios of 23S:16S rRNAs cannot be 
calculated when quality assessing mRNA samples with the Bioanalyzer.  
2.7.9 cDNA library preparations and sequencing 
Complementary DNA (cDNA) library preparations and sequencing were carried out in collaboration with 
the Genomics Research Hub at Cardiff School of Biosciences: 
https://www.cardiff.ac.uk/biosciences/research/technology-research-hubs/genomics-research. 
The Illumina® TruSeq® Stranded mRNA Sample Preparation Kit was used to prepare sequencing 
libraries with the low sample protocol. The manufacturer’s instructions describing the use of the protocol 
with previously isolated mRNA was followed; 5 μl of enriched mRNA within the Illumina recommended 
concentration range of 10 – 400 ng was added to 13 μl of the fragment, prime, finish mix to prepare 
sequencing libraries for each sample. Sample library concentrations were checked with the Qubit™ 
fluorometer system using the broad range DNA kit (Invitrogen) and were between the ranges of 20.0 – 
83.3 ng/μl. The fragment size of each library was evaluated using the Agilent Tape-System 2200, with the 
standard D1000 Screen-Tape and sizes varied between 290-320 bp. The libraries were then normalised to 
approximately 2 nM and pooled in equimolar concentrations with 16 samples pooled for the sequencing 
runs; in total 2 sequencing runs were carried out for the 32 samples. Pooled libraries were checked with 
the Qubit™ fluorometer, using the broad range DNA kit and the Agilent Tape-System 2200, with the High 
Sensitivity D100 Screen-Tape. The overall concentration of the first pooled library was 0.306 ng/μl at 297 
bp, equating to 1.58 nM. For the second library, the overall concentration was 0.317 ng/μl at 276 bp, 
equating to 1.34 nm. The Illumina NextSeq-500 was used to carry out the sequencing. The pooled cDNA 
libraries were loaded into a mid-output cartridge to produce paired-end reads of 75 bp in length, following 
the manufacturer’s instructions. 
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2.7.10 RNA-Seq bioinformatics analysis 
The relevant files and scripts used throughout the bioinformatics analysis of the RNA-Sequencing data are 
provided on within the relevant Chapter folder on the CD-ROM, which accompanies this thesis (folder: 
RNA-Seq_BioinformaticAnalysis_Scripts). All subsequent bioinformatics analysis was carried out using a 
virtual machine, hosted by the CLIMB consortium (Connor et al., 2016). 
2.7.10.1 Quality control and adaptor trimming 
2.7.10.2 Mapping RNA-Seq reads to the RW109 genome 
Alignment of the RNA-Seq reads to the reference RW109 PacBio genome (Section 2.5) was carried out 
via a Burrows-Wheeler Aligner transformation (BWA) with the BWA-MEM algorithm (v0.7.13-r1126) 
(Li, 2013). The algorithm works by seeding alignments with maximal exact matches (MEMs) and then 
extending seeds with the affine-gap Smith-Waterman algorithm (SW), to map low-divergent sequences 
against a large reference genome. The programme is highly recommended for high-quality alignments for 
RNA-Seq experiments due to its accuracy and speed. An index database of the reference genome of 
RW109 nucleotide FASTA file was generated using the BWA index command, and the BWA-MEM 
command was used to run with default settings for the paired-end trimmed RNA-Seq reads. The output 
was a SAM file of aligned sequence reads which were sorted into BAM files using the Sequence 
Alignment/Map (SAM) Tools toolkit (v1.3) (Li et al., 2009).  
2.7.10.3 Counting the number of RNA-Seq reads which map to the RW109 genome 
The Python programme HTSeq-count (v0.6.0) (Anders et al., 2015) was used to count the number of 
sorted aligned RNA-Seq reads which map to the gene features of the RW109 reference genome. The input 
was the sorted alignment BAM files and the Prokka generated RW109 GFF file (parameters set: --
stranded = reverse, --order = pos, -- feature type = gene, --id attribute = locus_tag and --mode = 
interSection-strict). The output was a count matrix file of RNA-Seq reads, which mapped to the RW109 
gene features for each biological replicate for the test and control conditions (4 files for control condition 
and 4 for each test condition = 32 count files in total). 
Quality control and adaptor trimming of the sequencing sample raw reads was carried out using Trim 
Galore for paired-end reads. Default settings were used to remove short low quality reads (< 20 bp), 
predict and trim Illumina adaptor sequences, and eliminate poor-quality bases from the sequences  
(<  Q20).  FastQC  confirmed  that  the  resulting  trimmed  reads  were  of  sufficient  quality  for 
subsequent analysis.  
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2.7.10.4 Differential gene expression analysis 
The Bioconductor programme DESeq2 (v1.14.1) (Love et al., 2014) was used in R to normalise the count 
data and determine differential gene expression between the control and test samples. The HTSeq-count 
matrix files were input into DESeq2, using the DESeqDataSetFromHTSeqCount command and 
differential gene expression calculated using the DESeq command. An example of a DESeq2 script used 
for differential gene expression analysis between the control and exposure to POE at 20% of the MIC can 
be found on CD-ROM (Example_DESeq2_POE20RScript.r). 
DESeq2 has a normalization method built in which uses negative binomial distribution and estimates size 
factors dispersions, to control for differences in the library size of the sequencing experiments. The 
programme then estimates the dispersion for each gene and fits a generalized linear model. Fold change is 
reported on a logarithmic scale to base 2, and indicates how much the expression of a gene changed in the 
test condition when compared to the control.  The p-values were adjusted via the p.adjust function with the 
Benjamini and Hochberg (BH) method. Differentially expressed genes (DEGs) were defined as exhibiting 
a log2-fold change of ≥ 1.5 and an adjusted p-value of ≤ 0.05, when each test condition was compared 
against the control condition.    
2.7.11 Generating heat maps of expression data 
The heatmap.2 function from the R package gplots (v2.3.2) was used to build heat maps. A distance 
matrix was generated with log2-fold changes using the hierarchical cluster analysis ‘hclust’ ‘dist’ 
functions to produce a dendrogram tree. The hierarchical clustered distance matrix was used as an input 
for the heatmap.2 function. To obtain a preliminary overview of the gene expression data, all log-2 fold 
changes generated by DESeq2 for the test conditions when compared to the control were input into 
heatmap.2 regardless of the adjusted p-value.  
2.7.12 Grouping differentially expressed genes into functional categories 
DEGs were grouped based on the KEGG KO number assignment (Section 2.5.5). The KEGG Mapper 
reconstruct pathway tool (v2.8) was used to characterise the pathways of the up and down regulated DEGs 
(Kanehisa et al., 2017). Gene expression analysis of the predicted antimicrobial genes of RW109 (Section 
2.5.5) was carried out in response to the test exposure conditions. The distributions of DEGs across the 
RW109 genome were visualised with some test conditions using CGView as described in Section 2.5.8.  
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2.8 Metabolic modelling reconstruction experiments 
Relevant programming scripts used throughput this section are provided within the relevant Chapter folder 
on the CD-ROM, which accompanies this thesis.  
2.8.1 Updating the PA14 model 
A recently published metabolic model for the P. aeruginosa PA14 strain (Bartell et al., 2017) was used as 
a basis to reconstruct a biochemical network for the RW109 industrial strain. The PA14 model was 
provided in an Excel format, which had two tabs labelled ‘reactions’ and ‘metabolites’.   
The reactions tab had the following headers: 
Column 1: Abbreviation = rxn03253 
Column 2: Name = acyl-CoA dehydrogenase (decanoyl-CoA)        
Column 3: Reaction = cpd00015[c] + cpd03128[c] -> cpd00982[c] + cpd03129[c] 
Column 4: Reactions with MetNames = FAD + Decanoyl-CoA -> FADH2 + (2E)-Decenoyl-CoA 
Column 5: Gene Protein reaction (GPR) = ((PA14_52900) or (PA14_06600) or (PA14_31580)) 
Column 6: Genes = PA14_52900 PA14_06600 PA14_31580   
Column 7: Protein = (optional)          
Column 8: Subsystem = (optional) 
Column 9: KEGG Subsystem = Fatty acid metabolism 
Column 10: Reversible = 0 
Column 11: Lower bound = 0 
Column 12: Upper bound = 1000 
Column 13: Objective = 0 (optional) 
Column 14: Confidence Score = (optional) 
Column 15: Enzyme Commission (EC) Number = 1.1.1.1 (optional) 
Column 16: Notes = N/A (optional) 
Column 17: References = Supporting the inclusion of the reaction (optional) 
The metabolites tab had the following headers: 
Column 1: Abbreviation = cpd00015[c] 
Column 2: Name = FAD 
Column 3: Formula (neutral) = (optional) 
Column 4: Formula (charged) = C27H31N9O15P2 
Column 5: Charge = - 2    
Column 6: Compartment = (optional) 
Column 7: KEGG ID = C00016 
Column 8: PubChem ID = (optional) 
Column 9: ChEBI ID = (optional) 
Column 10: InChI string = (optional) 
Column 11: Smiles = (optional) 
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For the PA14 metabolic reconstruction described by (Bartell et al., 2017), the 
Pseudomonas_aeruginosa_PA14_109.faa annotated amino acid FASTA sequence from the Pseudomonas 
database was used. This file was downloaded and compared against the Prokka annotated amino acid 
sequence of the RW109 strain, using the command line standalone NCBI Protein-Protein BLAST 
(BLASTp, v2.2.29+) (Camacho et al., 2009). Matches between genes in the two strains were determined 
by applying an E-value cut-off of 1E-40, and setting the best-hit filtering algorithm overhang parameter to 
0.25.          
The BLASTp results were used to replace the PA14 locus tags with the matching RW109 locus tags, 
within columns 5 and 6 of the model reactions tab in the Excel format. This was achieved using the Excel 
multi-find and replace function. Column 5 within the reactions tab of the model represents the gene-
protein-reaction (GPR) associations; a reaction can be associated with just one gene, or more than one 
gene can be involved. A protein complex occurs when all the genes are required for a reaction to take 
place, and within the Excel model in column 5 these genes were separated by the word ‘and’. Isozymes 
occur when a reaction is associated with more than one gene, which encodes for the reaction enzyme, but 
not all are required for that reaction to take place and in the model, these genes were separated by the 
word ‘or’. PA14 genes that matched with more than one RW109 gene in the BLASTp search were 
included in column 5, following the rule for isozymes.  
Any PA14 model genes that did not match with genes in the RW109 strain, were manually evaluated by 
reducing the strict BLASTp filtering parameters. The PA14 biomass reaction was also updated to 
represent the industrial strain, by incorporating the RW109 strain specific compositions of DNA, RNA 
and amino acids (see RW109_Biomass Parameters.xlsx on CD-ROM). During the PA14 model 
reconstruction the approach outlined by (Chavali et al., 2008) was used to generate the biomass 
formulation.  
2.8.2 Assigning new reactions to the RW109 metabolic model reconstruction  
RW109 FASTA sequences were run through the modelSEED (Henry et al., 2010) and KEGG (Kanehisa 
et al., 2017) databases to identify additional reactions for the RW109 strain. New reactions were added to 
the model in Excel format following the order for the reactions tab (Section 2.8.1). Reactions were 
classified via their KEGG functional categories and assigned enzyme commission (EC) numbers from the 
ExPASy:SIB bioinformatics resource portal (Artimo et al., 2012). The metabolites of the new reactions, 
not already in the model were added to Excel model format following the order for the metabolites tab 
(Section 2.8.1).   
2.8.3 Loading the model into MATLAB  
MATLAB (v9.1.0.441655, R2016b) was used throughout metabolic modelling experimental analysis, 
along with the COnstraint-Based Reconstruction and Analysis (COBRA) Toolbox (v2.0) (Schellenberger 
et al., 2011). The COBRA toolbox was initiated in MATLAB using the initCobraToolbox function:  
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The changeObjective function was used to designate the RW109_Biomass reaction as the objective 
function for the constraint-based model:  
(https://opencobra.github.io/cobratoolbox/latest/modules/FBA.html). The changeMedia_SEED.m script (CD-
ROM) worked by changing the lower and upper bounds of the RW109 model's exchange reactions to alter 
the in-silico media. LB media was always chosen, and the substrates associated with this media are 
provided within the changeMedia_SEED.m script. LB was chosen as it represented a complete in-silico 
medium. This script is an approximation of LB medium as LB is not well-defined, and the lower and 
upper bounds set within the script allow for a degree of flexibility, in what substrates the model would 
uptake.  
The optimizeCbModel function was used to perform flux balance analysis (FBA) on the model:
(https://opencobra.github.io/cobratoolbox/latest/modules/FBA.html).  
FBA is regularly used as a constraint-based reconstruction and analysis tool to examine the metabolite 
flow through genome-scale metabolic network reconstructions (Orth et al., 2010). FBA enables the 
prediction of an organism’s metabolic capabilities, such as growth, via a mathematical representation of 
the metabolic reactions displayed as stoichiometric matrix, together with a biologically relevant objective 
function (Lee et al., 2006b). A fundamental assumption of FBA is the optimum performance of an 
organism in relation to a specified metabolic reaction, known as the objective function; one commonly 
used objective function is the biomass reaction, which serves as an approximation for growth (Orth et al., 
2010). Upon setting an objective function, subsequent analysis of the network is based on the conservation 
of mass through solving a system of equations. As well as identifying the resulting distribution of 
metabolic fluxes, that lead to optimal flux through an objective function (Raman and Chandra, 2009). 
The output of optimizeCbModel was a solution structure that contained the maximal flux through the 
chosen RW109_Biomass objective function (f, units = hr-1) and was used as a prediction of model growth 
in LB complete media. Additionally, this solution structure included the primal solution (x = the flux 
carried by each reaction within the model), the dual solution (y = metabolite shadow prices; indicates how 
much the addition of a metabolite will increase or decrease the objective value), the reduced cost (w = 
how much each reaction affects the objective) and a universal status flag (stat = solver status which  
(https://opencobra.github.io/cobratoolbox/deprecated/docs/cobra/initCobraToolbox.html). The Gurobi 6 solver 
was used for all COBRA analysis. The RW109 metabolic model in Excel format was loaded into 
MATLAB using a d_xls2model_JAB.m script (CD-ROM). This script writes in a model from an Excel 
spreadsheet and converts it into a COBRA Toolbox model format. Once in MATLAB the following steps 
were always carried out before any model analysis and simulations:  
1) Set objective function:RW109model = changeObjective(RW109model,'RW109_Biomass')
3) Optimise model: optimizeCbModel(RW109_LB)
2) Change media to LB: RW109_LB = changeMedia_SEED(RW109model,1)
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outputs 1 for an optimal solution, 2 for an unbounded solution, 0 if solution is infeasible and -1 if no 
solution is reported).  
2.8.4 Removing PA14 genes with no similarities to RW109 genes  
Once loaded into MATLAB the PA14 model genes with no similarities to any genes within the RW109 
genome sequence, as identified from the BLASTp search, were individually deleted from the RW109 
model using the SingleGeneDeletion COBRA Toolbox function: 
(https://opencobra.github.io/cobratoolbox/latest/modules/deletion.html).  
The function outputs the computed growth-rate ratio between the deletion strain and wild type strain 
(grRatio), the deletion strain growth rate (grRateKO- hr-1), and the wild type growth rate (grRateWT- hr-1). 
The function also demonstrates if the gene deletion results in a reaction being removed from the model 
(hasEffect) and will produce a list of deleted reactions for each gene grRateKO (delRxns) and a list of 
FBA fluxes for KO strains (fluxSolution).  
These outputs were used to determine if the PA14 model genes, which had no similarities to any in the 
RW109 genome sequence were essential for model growth. If they could be deleted without any effect, 
they were removed from Excel version of the model, along with the reactions and metabolites associated 
with them (metabolites were only removed if they were not associated with any reactions remaining in the 
model). Genes that could not be deleted due to their effect on model growth were kept in the model and 
further analysis was carried out using BLAST searches, to determine an alternative RW109 gene 
associated with the essential reaction.  
2.8.5 Integrating RNA-Seq gene expression data into the RW109 model 
Transcriptomic data which profiled gene expression changes when RW109 was exposed to relevant 
industrial conditions (Section 2.7), was integrated into the model using the Metabolic Adjustment by 
Differential Expression (MADE) algorithm (Jensen and Papin, 2011), within the Toolbox for Integrating 
Genome-scale metabolic models, Expression data, and transcriptional Regulatory networks (TIGER) 
(Jensen et al., 2011).  The MADE_Model_integration.m MATLAB script was used for the integration of 
the RNA-Seq data into the RW109 model (CD-ROM).  
To predict which model genes were switched on or off in RW109, the log2-fold changes and 
corresponding adjusted p-values of the test exposure conditions when compared to the control condition, 
were input into the MADE algorithm. A gene was considered switched ‘off’ by MADE in the control 
condition and switched ‘on’ in the test condition, if expression increased significantly between the two. A 
gene would also remain ‘on’ in a model if it had no change in expression, and was considered to be 
necessary for the model to function, as defined by a necessity for the minimal flow of flux through the 
specified objective function.  
When a gene was found to have a significant decrease in expression between the control and test 
conditions, it was considered switched ‘off’ in the test condition if flux was still able to flow through the 
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defined objective function, meaning it was not required for metabolism. In a situation where the integrated 
expression data prevents flux through the objective function, MADE would ensure that the related gene 
remains ‘on’ in the model. The MADE algorithm, with the calculation of a penalty score, maintained 
functionality within condition specific models. This score was sought to be kept at a minimum to limit 
discrepancies with expression data; statistical significance of the log2-fold changes, was also used to 
prioritise inconsistencies in gene states. Integration of gene expression data into the model, results in a 
metabolic representation more consistent with the physiological status of a bacterium when exposed to a 
particular condition.  
The output of the algorithm was a series of eight condition-specific MADE models in the TIGER Toolbox 
format with a constrained set of reactions. These reactions were considered to be either required for a 
functioning model (as specified by the objective function), and/or were verified by the transcriptomic 
integrated data. These MADE models represented the functional gene states and metabolic adjustments of 
the control exposure condition (control model) and the 7-test exposure conditions (models 1-7). The 
models differed in that some of their reactions were ‘turned on’ or ‘turned off’ according to the gene 
expression levels of their corresponding genes. The TIGER MADE models were converted into a COBRA 
format, via the deletion of the model genes from the base RW109 model in COBRA, according to the 
MADE functional gene states output (See MADE_Model_integration.m MATLAB script for more 
details). A COBRA format was necessary for further analysis and simulations of the condition-specific 
models.  
2.8.6 Gene and reaction essentiality predictions from the condition specific MADE models  
The COBRA Toolbox was used to predict gene and reaction essentiality from the 8 MADE models using 
the MATLAB script COBRA_Essentiality_Predictions.m (CD-ROM). This script worked by simulating 
the individual removal of each remaining gene within the condition specific models in COBRA format, 
using the singleGeneDeletion function (https://opencobra.github.io/cobratoolbox/latest/modules/deletion.html).
A reaction that requires a deleted gene to function will have inhibited flux, and if the reaction was 
necessary for the condition specific model to produce biomass, the gene was predicted as essential. These 
genes were identified as resulting in a grRateKO of < 0.0001 hr-1.  
The reactions associated with predicted essential genes for each condition specific model, were 
individually removed using the singleRxnDeletion function 
 (https://opencobra.github.io/cobratoolbox/latest/modules/deletion.html). 
(See MATLAB script COBRA_Essentiality_Predictions.m). The reactions required for the condition 
specific model to produce biomass were identified as those resulting in a grRateKO of < 0.0001hr-1. 
The essential genes and reactions predicted for the control condition were compared to those for each of 
the 7-test exposure conditions; essential reactions for each test condition that were not found within the 
control condition, were grouped according to their KEGG functional category assignment. The JVENN 
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online tool was used to create Edwards-Venn diagrams to determine relationships between the predicted 
essential reactions for each test exposure condition (Bardou et al., 2014).  
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3. Whole genome sequencing and comparative genomics of the industrial
P. aeruginosa strain RW109
3.1 Introduction 
The first complete whole genome sequence of P. aeruginosa was acquired for the clinical strain PAO1 by 
Stover et al., (2000) and at the time was the largest bacterial genome ever to be sequenced using whole-
genome-shotgun-sampling. Analysing the genome in such detail, provided valuable insights into the 
genetic diversity and vast functional characteristics of PAO1, whilst also providing a perspective on the 
association between genome size and genetic complexity (Stover et al., 2000). The PAO1 sequencing 
project also supported the development of the Pseudomonas Genome database (Winsor et al., 2016) which 
currently contains 3,348 annotated genome sequences and provides valuable information on drug targets, 
antibiotic resistance genes and vaccine candidates. The technology of whole genome sequencing has 
advanced considerably since the year 2000 and has evolved at an exponential pace with development of 
new methods which are increasingly accurate and cost-effective (Levy and Myers, 2016, Klemm and 
Dougan, 2016).   
Complete genome sequencing of bacteria is an important analysis tool, which provides the framework for 
understanding the characteristics of a particular bacterial strain. There have also been advancements in the 
development of databases for annotation of genome coding sequences (CDS) such as the Clusters of 
Orthologous Groups (COGs) (Tatusov et al., 2000) and the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) (Kanehisa et al., 2017) which assign information about the strain’s biological functions using a 
complete genome sequence. Antimicrobial resistance and virulence genes can also be characterised using 
databases such as The Comprehensive Antimicrobial Resistance Database (CARD) (McArthur et al., 
2013), BacMet: the biocide and metal resistance database (Pal et al., 2013) and the Virulence Factor Data 
Base (VFDB) (Chen et al., 2016b). Functional annotations are important for assessing the pathogenic 
potential and the environmental adaptability of strains (Stover et al., 2000). For accurate transcriptomic 
profiling analysis techniques such as RNA-Seq, a detailed understanding of biological characteristics of a 
reference strain is also crucial (Conesa et al., 2016).    
There are currently numerous methods available to obtain a bacterial whole genome, and Pacific 
Biosciences (PacBio) single-molecule real-time (SMRT) sequencing technology is one of the most 
accurate methods for an error free complete genome (Rhoads and Au, 2015, Nakano et al., 2017, Quail et 
al., 2012). It is classified as a third generation sequencing technique because unlike second generation 
methods such as Illumina, PacBio is able to provide information on regions difficult to sequence by 
having an unbiased G+C coverage and it generates extra-long multi-kilobase reads (Shin et al., 2013, Chin 
et al., 2013). The technology works by attaining the sequence data during the replication process of the 
DNA in real time (Rhoads and Au, 2015). The equipment uses a SMRTbell template which is loaded into 
the numerous sequencing units of a SMRT cell and the template acts as a closed, single-stranded circular 
DNA which is generated by ligating hairpin adaptors to both ends of the target double-stranded DNA 
molecule to be sequenced (McCarthy, 2010). Each sequencing unit contains an immobilised single 
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polymerase which binds to the hairpin adaptor of the SMRTbell template resulting in a DNA 
polymerase/template complex; this binding initiates the replication of the target DNA molecule (Rhoads 
and Au, 2015). Within the sequencing units are four fluorescently labelled phospholinked-nucleotides 
which each produce unique emission spectrums related to the colour of the fluorophore, when a base is 
detected during the replication if the target DNA (Berlin et al., 2015). The sequencing units are made up 
of zero-mode waveguides (ZMWs) which only permit light to illuminate at the bottom of the sequencing 
unit where the DNA polymerase/template complex is immobilized (Rhoads and Au, 2015, McCarthy, 
2010). Specific light pulses related to the colour of the four different fluorophores are recorded and 
interpreted as a sequence of bases. The ZMWs result in a small detection volume, which provides 1000-
fold enhancement in limiting the amount of background noise during sequencing (McCarthy, 2010, 
English et al., 2012, Rhoads and Au, 2015). This real-time sequencing process occurs in parallel within 
the thousands of SMRT cell sequencing units containing ZMWs (Chin et al., 2013, Rhoads and Au, 2015). 
The end result is a collection of long PacBio reads which can combined using de novo assembly to form a 
high-quality complete whole genome sequence (Chin et al., 2013, Rhoads and Au, 2015); an integral 
component for informative bacterial genomic investigations.   
PacBio sequencing technology was first used to obtain a complete P. aeruginosa genome in 2015 with the 
DSM-50071T strain (Nakano et al., 2015). This analysis resulted in a single circular contig, which 
represented the main P. aeruginosa chromosome. The completeness of the sequence provided a reliable 
reference genome due to the higher-resolution and accuracy of the base order. For bacteria with large 
genomes and high GC content such as Pseudomonas, the reported accuracy of using PacBio SMRT 
technology is very useful for detailed characterisation of the antimicrobial and pathogenic potential of 
different strains. The re-sequencing of the reference PA1 strain using SMRT technology also revealed a 
number of errors in the genome previously obtained using Illumina sequencing by synthesis (SBS) 
technology; errors included nucleotide sequence mutations, inverted regions and contig arrangement error 
(Li et al., 2016). The complete PacBio PA1 genome was used for accurate accurately classification of the 
strain’s virulence factors, regulatory proteins, secretion system proteins, type II toxin–antitoxin pairs and 
genomic islands. The sequence also enabled detailed whole genome comparisons which demonstrated the 
similarity of PA1 to other P. aeruginosa strains and also highlighted the variations in horizontal gene 
transfer characteristics within the genomic islands and prophage regions of the strain (Li et al., 2016).  
Whole genome comparative genomics is an important research tool to determine similarities and 
differences between bacterial strains; it provides detailed analysis on the relatedness of strains and how 
their genomes have evolved (Mathee et al., 2008, Winsor et al., 2016). The P. aeruginosa strains PAO1 
and UCBPP-PA14 (PA14) are classified as universal reference strains in both laboratory experiments and 
genome analysis investigations (Stover et al., 2000, He et al., 2004, Klockgether et al., 2010, Mikkelsen et 
al., 2011a). PAO1 is employed as a reference as it was the first P. aeruginosa strain to be associated with a 
complete whole genome sequence (Stover et al., 2000) and the highly virulent PA14 strain provides an 
informative model for pathogenesis and biofilm formation investigations (Mikkelsen et al., 2011a). These 
reference strains are both clinical isolates and can be used for comparison against P. aeruginosa strains 
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obtained from the environment and industry to determine genomic characteristics, which enable survival 
within niche settings. Another advantageous component of comparative genomics is classifying the pan-
genome of a collection of bacterial sequences to identify the core and accessory genes (Page et al., 2015). 
This analysis determines the network of genes, which are shared between collections of isolates and is 
used to establish the functional features specific to a certain strain type.         
There are currently over 100 complete P. aeruginosa genomes available in the Pseudomonas database 
(and 3000+ draft genomes) which represent clinical and natural environments (Winsor et al., 2016). A 
previous study determined the draft genome sequences for eighteen industrial strains (Weiser, 2015), but 
as far as we are aware, there are no complete genome sequences available for a P. aeruginosa strain 
isolated from industrial contamination.  
3.1.1 Aim and objectives 
The overall aim of this chapter was to characterise the complete genome of an industrial P. aeruginosa 
strain. This was achieved with the following objectives:  
1) Obtain a complete genome of the industrial strain RW109 using PacBio Single Molecule,
Real-Time (SMRT) technology.
2) Identify the basic features of the RW109 genome.
3) Characterise the functional categories of the RW109 coding sequences (CDS).
4) Identify distinctive functional characteristics of the RW109 strain when compared to the
clinical reference strains PA14 and PAO1.
5) Comparison of RW109 with a panel of P. aeruginosa genome sequences representing strains
isolated from clinical, environmental and industrial sources.
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3.2 Results 
3.2.1 Sequence assembly, annotation and basic feature identification 
Genome Features 
P. aeruginosa Strain
RW109 PA14 PA01
Genome size (bp) 7,756,224 6,537,648 6,264,404
Contig numbers 3 1 1
DNA G + C content (%) 65.11 66.29 66.56
Coding sequences (CDS) 7,303 5,901 5,671
Number of hypothetical proteins 2,199 2,026 1,858
rRNA genes 12 12 12
tRNA genes 76 69 73
tmRNA 1 1 1
RW109 was sequenced using PacBio SMRT technology and the FASTQ files were assembled with Canu 
as described in Section 2.5. The total output bases resulting from the two SMRT sequencing cells was 
3,583 Mb with a length distribution that peaked at 10 kb (Figure 9). The assembly generated three contigs 
and annotation with Prokka identified the function of 7,303 CDS with 2,199 of these being hypothetical 
proteins (Table 4). The genome sequence of RW109 relieved a G+C content of 65.11% and a genome size 
of 7.8 Mb with twelve ribosomal RNA (rRNA), seventy-six transfer RNA (tRNA) and one transfer-
messenger RNA (tmRNA) molecules. General features of the Prokka annotated reference strains PA14 
and PAO1 were also shown in Table 4. Both reference strains have one contig and in comparison to 
RW109, their genomes were smaller; PA14 genome was 15.7% smaller and the PAO1 genome 19.2% 
smaller. RW109 had 1,402 more CDS when compared to PA14 and 1,632 more CDS than PAO1. The 
annotated amino acid, nucleotide and general feature format (GFF) files for the RW109 sequence can be 
found in the CD-ROM (RW109.FAA, RW109.FFN and RW109.GFF). The annotated and assembled 
sequence was uploaded onto the European Nucleotide Archive (ENA) under the accession
number SAMEA104432335.
Table 4. The basic genome features of the industrial P. aeruginosa strain RW109 in comparison to 
the reference strains PA14 and PAO1 
CHAPTER 3 - Whole genome sequencing and comparative genomics of the industrial 
P. aeruginosa strain RW109
66 
Figure 9. Read length distributions from PacBio Sequencing of RW109 using SMRT cell 
technology 
Bar chart showing the overview of the length distribution of the reads generated from PacBio 
sequencing of RW109. The total output size of the bases was 3,583 Mb with a length 
distribution that peaked at ~10 kb.    
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3.2.2 Identifying plasmids in the assembled genome 
3.2.2.1 Nucleotide BLAST  
The assembly of the PacBio sequence of RW109 resulted in three contigs with contig 2 being the largest 
with 7,049,347 bp. Contig 1 had 555,265 bp and contig 3 had 151,612 bp. QUAST analysis of the FASTA 
sequence of each RW109 contig was obtained as described in Section 2.5.2. The G+C content of each 
contig was as follows, contig 1 = 58.09%, contig 2 = 65.84% and contig 3 = 57.28%. Due to the smaller 
size of contigs 1 and 3 and the difference observed in G+C content when compared to contig 2, 
comparative analysis was carried out to determine if these contigs were plasmids.  
A BLASTn comparison of the assembled un-annotated RW109 genome was carried out against six 
circular P. aeruginosa complete plasmid sequences (Table 5). Contig 1 was found to have high alignment 
similarities to plasmid pOZ176 with 76 BLASTn hits over the sequence (mean values for percentage ID= 
94.0%, alignment length= 5046.46, E-value= 7.49e-09 and BIT-Score= 8605.57). Contig 1 was also found 
to have high alignment similarities to plasmid pBM413 with 52 BLASTn hits over the sequence (mean 
values for percentage ID= 95.54%, alignment length= 6494.37, E-value= 1.46e-09 and BIT-Score= 
11182.15). The third contig had high alignment similarities to a plasmid from the P. aeruginosa strain S04 
90 with 14 BLASTn hits over the sequence (mean values for percentage ID= 94.72%, alignment length= 
8561.29, E-value= 1.14286e-67and BIT-Score= 11182.15).  
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Table 5. P. aeruginosa plasmid sequence information 
P. aeruginosa strain Plasmid 
Name Isolation source Name
GC 
content 
(%)
Length 
(bp)
Accession 
number 
S04 90 Microbial mat material S04 90 (plasmid un-named) 57.73 159,187 CP011370
BH6 Tissue of patient with lung disease pBH6 55.86 3,652 CM003767
121617 Sputum pBM413 56.41 423,017 CP016215
3448 Bloodstream pPA3448 58.9 49,094 CM007350
7790 Unknown pPA7790 58.9 49,021 CP015000
96 Clinical isolate from Guangzhou, China pOZ176 57.00 500,839 KC543497
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3.2.2.2 Comparison of contig synteny 
ACT comparisons were carried out between contig 1 and plasmids pOZ176 and pBM413 and between 
contig 2 and the plasmid from the P. aeruginosa strain S04 90 (Figure 10 A and B). An ACT comparison 
was also carried out between the whole RW109 genome sequence (all contigs) and the PA14 reference 
strain (Figure 10C). The comparative synteny plot in Figure 10A shows contig 1 of RW109 in the middle 
with pOZ176 at the top and pBM413 at the bottom of the plot. The plot indicates that contig 1 has a high 
degree of similarity with these two plasmids as shown by the red bars, which indicate conserved 
sequences and gene order. A small number of blue lines were present between pOZ176 and contig 1 
suggesting regions of sequence similarity that have been inverted. The gaps between the red bars indicate 
no sequence similarity and these gaps occur in approximately the same positions on the plot for both the 
plasmids when compared to contig 1, suggesting that these regions were only found in RW109 contig 1 
when compared to these plasmids. There was also a high degree of similarity between contig 3 of RW109 
and the plasmid from the P. aeruginosa strain SO4 90 (Figure 10B; see the red bars). However, RW109 
contig 3 had no sequence homology to the end of the SO4 90 plasmid (Figure 10B). Figure 10C illustrates 
a comparative synteny plot for the whole genome sequence of RW109 (including all contigs) and the 
reference P. aeruginosa PA14 strain. Only contig 2 had a high degree of sequence similarity with PA14 
whereas contigs 1 and 3 had limited sequence homology to PA14.  
The comparative analysis of contigs 1 and 3 with the P. aeruginosa plasmid sequences suggest that these 
were plasmids acquired by RW109 and that contig 2 was the main P. aeruginosa chromosome of the 
industrial strain. Throughout the rest of this thesis, contig 1 (554 kb) was referred to as RW109 plasmid 1, 
contig 2 (7,049 kb) as RW109 main chromosome and contig 3 (161 kb) as RW109 plasmid 2.  
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The analysis was carried out using the Artemis Comparison Tool (ACT) with the comparative crunch files generated using BLASTall. The red bars 
indicate regions of similarity, the blue bars show regions oriented in opposite directions and the gaps between bars were regions of non-similarity 
between the sequences. ACT comparisons were carried out between contig 1 and plasmids pOZ176 and pBM413 (A), contig 2 and the plasmid from the 
P. aeruginosa strain S04 90 (B) and between the whole RW109 genome sequence (all contigs) and the PA14 reference strain (C).
Figure 10. Comparative synteny line plots of the RW109 contigs 1 and 2 Vs. plasmid sequences and the RW109 whole genome sequence Vs. PA14 
A) B)
C)
RW109 Contig 1
Plasmid pOZ176
Plasmid pBM413 RW109 Contig 3
P. aeruginosa strain S04 90 Plasmid 
PA14
RW109 whole genome sequence
RW109 Contig 1 RW109 Contig 3RW109 Contig 2
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3.2.3 Assigning functional groups to the RW109 whole genome sequence 
3.2.3.1 COG functional annotation  
3.2.3.1.1 Whole genome COG annotation 
The whole genome sequence of RW109 was categorised using COG functional annotation as described in 
Section 2.5.5.1. Out of the 7,303 CDS in the RW109 genome, 6,220 (85.17%) were assigned to a category 
(Table 6) with 123 CDS being annotated with two or more COG annotations. The percentage of each 
COG category was based on the total number of CDS and COG categories were divided into three well-
characterised functional classes with metabolism having the highest number of CDS (46.01%), followed 
by cellular processes and signalling (22.28%), and information storage and processing (15.34%). A high 
number of CDS in RW109 were assigned to the poorly characterised COG categories with 25.59% being 
termed as function unknown (S). The CDS that were not assigned to a COG category were termed as a 
protein not being similar to any COG in the database and 1,083 RW109 CDS (14.83%) were allocated to 
this group.  
Across the well-characterised functional classes, the top three COG categories with the highest percentage 
CDS totals throughout the whole genome sequence were transcription (K= 7.38%), amino acid transport 
and metabolism (E= 6.82%) and replication, recombination and repair (L= 5.13%). No CDS were 
assigned to the extracellular structures (W), nuclear structure (Y), cytoskeleton (Z) and general function 
prediction only (R) COG categories. The COG categories of the whole genome sequence were also 
divided up to represent the assigned functional annotations for each of the three contigs (Table 6).  
Circular maps of the main chromosome and plasmids 1 and 2 were generated using command line 
CGView as described in Section 2.5.8 (Figure 11). The first two outermost rings on the maps illustrate the 
predicted CDS on the reverse and forward strands respectively and were coloured according to the 
assigned COG categories.  
3.2.3.1.2 RW109 main chromosome COG annotation 
Within in the well-characterised COG functional annotations of the main chromosome the categories with 
the largest percentage of CDS were transcription (K= 7.75%), amino acid transport and metabolism (E= 
7.04%), energy production and conversion (C= 5.44%) and inorganic ion transport and metabolism (P= 
5.31%). Of the poorly characterised COG categories, the main chromosome had 26.46% CDS assigned to 
function unknown (S) and 10.89% which could not be assigned to any COG category (unknown). The 
COG categories which had the least number of CDS within the main chromosome (disregarding those 
with no CDS) were RNA processing and modification (A= 0.05%), chromatin structure and dynamics (B= 
0.05), cell cycle control, cell division, chromosome partitioning (D= 0.55%) cell motility (N= 1.31%), 
defence mechanisms (V= 1.37%) and nucleotide transport and metabolism (F= 1.71%).  
CHAPTER 3 - Whole genome sequencing and comparative genomics of the industrial 
P. aeruginosa strain RW109
72 
3.2.3.1.3 RW109 plasmid 1 COG annotation 
When focusing on the well characterised COG functional annotations of plasmid 1, the replication, 
recombination and repair (L) category represented the largest percentage of CDS (9.00%) and when the 
annotations of these CDS were analysed, 35.85% encoded for transposases. Other COG categories with 
large representations on plasmid 1 were amino acid transport and metabolism (E= 6.11%) and 
transcription (K= 4.92%). When analysing the CDS on plasmid 1 which were assigned to the E COG 
category, seventeen CDS were found to be in close proximity to each other within the genome, and when 
the COG accession numbers were analysed in the STRING protein-protein interaction database, 4 clusters 
were predicted (Figure 12). The cluster represented in red (Figure 12) comprised five CDS which was the 
biggest number of CDS with a high confidence interaction score and was predicted to be a cleavage 
system involved in glycine/serine degradation (RW109_00289, RW109_00290, RW109_00291, 
RW109_00292 and RW109_00293).  The cluster with the greatest interaction confidence score (coloured 
as blue in Figure 12) contained 3 CDS (RW109_00305, RW109_00306 and RW109_00307) which were 
predicted to be involved in an ABC-type amino acid transport system. Two threonine efflux proteins were 
also identified within the E COG category of plasmid 1 (RW109_00569 and RW109_00570).   
When analysing the CDS on plasmid 1 assigned to the K COG category, 58.62% were found to be 
regulatory proteins with 37.93% with a predicted transcriptional regulator function. Out of the total 
number of CDS on plasmid 1, 65.70% where poorly characterised whereas only 37.34% of the CDS on the 
main chromosome fell into this category. The COG categories with the lowest numbers of CDS on 
plasmid 1 were lipid transport and metabolism (I= 0.17%), cell cycle control, cell division, chromosome 
partitioning (D= 0.17%), RNA processing and modification (A= 0.17%), nucleotide transport and 
metabolism (F= 0.34%), secondary metabolites biosynthesis, transport, and catabolism (Q= 0.34%), cell 
motility (N= 0.51%) and defence mechanisms (V= 0.51%). 
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3.2.3.1.4 RW109 plasmid 2 COG annotation 
The replication, recombination and repair (L) COG category also represented the highest number of well-
characterised CDS on plasmid 2 with a percentage total of 14.10%, which was higher than the percentage 
of CDS represented in this category for both plasmid 1 and the main chromosome. These 
replication, recombination and repair CDS were spread out throughout the plasmid sequence (Figure 11; 
see deep pink coloured COG category). When the L COG category CDS of plasmid 2 were analysed, 
27.27% were found to encode for transposases. The intracellular trafficking, secretion, and vesicular 
transport (U) COG category was found to have the second largest representation of CDS in plasmid 2 
with of 5.77% of the total CDS. Plasmid 2 has a greater percentage of CDS represented in COG-category 
U when compared to the main chromosome and plasmid 1 where 0.68% and 2.73% of CDS were 
represented within this COG functional group.  
When the annotated CDS from the plasmid 2 U-COG category were analysed, 8 of the genes were all in 
close proximity to each other and encoded 2 twitching mobility proteins (RW109_07269 and RW109 
_07279), a toxin co-regulated pilus biosynthesis protein E (RW109_07271), a type II secretion system 
protein E (RW109_07272), a pilin accessory protein (pilO) (RW109_07274), an outer membrane 
lipoprotein BfpB precursor (RW109_07275) and 2 hypothetical proteins (RW109_07268 and 
RW109_07270). A toxin co-regulated pilus biosynthesis protein Q (RW109_07276) which was assigned 
to COG functional group unknown (S), was also found in close proximity to these 8 U-COG category 
CDS. The amino acid sequences of these 9 CDS and the RW109_07276 CDS, were formatted into a 
multi-FASTA file and used to conduct a Pseudomonas database DIAMOND BLASTP search (Winsor et 
al., 2016). The resulting output for 8 out of the 9 CDS (excluding RW109_07276) were found to have a 
high degree of sequence similarity to a Section of the P. aeruginosa S04 90 plasmid encoding for a Type 
II secretion system (percentage ID= 100%, alignment length= 3307.00, E-value= 0.0 and BIT-Score= 
6218.20). This further confirms the similarity of the third RW109 contig with the plasmid of the S04 90 
strain. The RW109_07276 CDS was found to have sequence similarity to a plasmid (pND6-2) from the 
Pseudomonas putida strain ND6 (percentage ID= 88.0%, alignment length= 208.00, E-value= 0.0 and 
BIT-Score= 379.00). On the circular map of plasmid 2 in Figure 11, to the right on the second track this 
group of CDS were coloured in green/yellow representing the U COG category and have been labelled as 
an operon with a number of determinants for a Type II secretion system.
74.36% of CDS on plasmid 2 were poorly characterized which was a higher proportion when compared to 
plasmid 1 and the main chromosome. Plasmid 2 also has limited CDS within the metabolism COG 
functional class (1.28%) with only 2 CDS being associated with Lipid transport and metabolism (I), 
whereas the metabolism associated COGs of Plasmid 1 and the main chromosome represent 11.04% and 
25.40% respectively of their total numbers of CDS.    
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  Footnotes: *The percentage of COG categories is based on the total number of CDS. 
Table 6. The Number of RW109 genes associated with general COG functional categories 
COG Category Description
P. aeruginosa strain RW109
Whole Genome Plasmid 1 Main Chromosome Plasmid 2
Value
Percentage 
(%)*
Value
Percentage 
(%)*
Value
Percentage 
(%)*
Value
Percentage 
(%)*
Well characterised categories 
Information storage and processing
A RNA processing and modification 4 0.05 1 0.17 3 0.05 0 0.00
B Chromatin structure and dynamics 3 0.04 0 0.00 3 0.05 0 0.00
J Translation, ribosomal structure and biogenesis 199 2.72 0 0.00 199 3.03 0 0.00
K Transcription 539 7.38 29 4.92 508 7.75 2 1.28
L Replication, recombination and repair 375 5.13 53 9.00 300 4.57 22 14.10
Cellular processes and signalling 
D Cell cycle control, cell division, chromosome partitioning 38 0.52 1 0.17 36 0.55 1 0.64
O Post-translational modification, protein turnover, and chaperones 222 3.04 7 1.19 214 3.26 1 0.64
M Cell wall/membrane/envelope biogenesis 323 4.42 10 1.70 312 4.76 1 0.64
N Cell motility 91 1.25 3 0.51 86 1.31 2 1.28
P Inorganic ion transport and metabolism 363 4.97 15 2.55 348 5.31 0 0.00
T Signal transduction mechanisms 305 4.18 18 3.06 285 4.35 2 1.28
U Intracellular trafficking, secretion, and vesicular transport 192 2.63 4 0.68 179 2.73 9 5.77
V Defence mechanisms 93 1.27 3 0.51 90 1.37 0 0.00
W Extracellular structures 0 0.00 0 0.00 0 0.00 0 0.00
Y Nuclear structure 0 0.00 0 0.00 0 0.00 0 0.00
Z Cytoskeleton 0 0.00 0 0.00 0 0.00 0 0.00
Metabolism 
C Energy production and conversion 371 5.08 14 2.38 357 5.44 0 0.00
G Carbohydrate transport and metabolism 225 3.08 5 0.85 220 3.35 0 0.00
E Amino acid transport and metabolism 498 6.82 36 6.11 462 7.04 0 0.00
F Nucleotide transport and metabolism 114 1.56 2 0.34 112 1.71 0 0.00
H Coenzyme transport and metabolism 172 2.36 5 0.85 167 2.55 0 0.00
I Lipid transport and metabolism 203 2.78 1 0.17 200 3.05 2 1.28
Q Secondary metabolites biosynthesis, transport, and catabolism 150 2.05 2 0.34 148 2.26 0 0.00
Poorly characterised
R General function prediction only 0 0.00 0 0.00 0 0.00 0 0.00
S Function unknown 1869 25.59 101 17.15 1735 26.46 33 21.15
Unknown Protein is not similar to any COG 1083 14.83 286 48.56 714 10.89 83 53.21
Total Number of CDS = 7,303 589 6,558 156
Figure 11. Circular maps of the RW109 main chromosome and plasmids 1 and 2 
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Starting from the outermost circle for each map and moving inwards the following tracks were identified: (1) predicted CDS on forward strand coloured according to COG 
categories, (2) predicted CDS on reverse strand coloured according to COG categories, (3) genomic islands (GIs) coloured green, (4) phages coloured light pink (those labelled with 
* indicate an incomplete phage and those labelled with ** indicate a questionable phage) , (5) GC content (black), (6) positive and negative GC skew (green and purple, respectively)
and (7) genome region by mbp for the main chromosome and kbp for plasmids 1 and 2. The size of the main chromosome and the two plasmids were not drawn to scale.
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The interaction of seventeen CDS within the E COG category were analysed using the STRING 
database. A network of COG accession numbers which were split into 4 groups (A) via kmeans 
clustering as represented with the colour coding. The nodes represent the different COG 
accession numbers and the line thickness between the nodes indicates the strength of data 
support with thicker lines indicating a high confidence level score. B) The table represents the 
CDS and COG accession numbers and were colour coded in relation to A) to represent the 
clusters they fall into.  
Figure 12. STRING network analyses of RW109 Plasmid 1 CDS within the E COG 
category 
Transcript ID CDS function 
COG 
Accession 
(E category)
Interaction  
confidence 
score 
RW109_00279 Spermidine/putrescine import ATP-binding protein PotA COG3842
0.943
RW109_00280 Putrescine-binding periplasmic protein precursor COG0687
RW109_00283 Putrescine importer PuuP COG0531
0.493RW109_00286 putative hydrolase YxeP COG1473
RW109_00288 Lysine/ornithine decarboxylase COG0019
RW109_00289 Glycine cleavage system H protein COG0509
0.985
RW109_00290 Glycine dehydrogenase (decarboxylating)
COG0403 and 
COG1003
RW109_00291 Serine hydroxymethyltransferase 2 COG0112
RW109_00292 L-serine dehydratase 1 COG1760
RW109_00293 Aminomethyltransferase COG0404
RW109_00299 N-carbamoyl-L-amino acid hydrolase COG0624
0.635
RW109_00300 Diaminopropionate ammonia-lyase COG1171
RW109_00301 Aspartate-proton symporter COG0531
RW109_00302 putative hydrolase YxeP COG1473
RW109_00305 Inner membrane amino-acid ABC transporter permease protein YecS COG0765
0.998RW109_00306 putative glutamine ABC transporter permease protein GlnM COG0765
RW109_00307 Octopine permease ATP-binding protein P COG1126
A)
B)
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3.2.3.2 RW109 KEGG functional module assignment and metabolic and physiological potential 
KEGG Orthology (KO) terms were assigned to the main chromosome and the two plasmid amino acid 
sequences using KASS as described in Section 2.5.5.3. Out of the 6,558 CDS in the main chromosome, 
3,381 were annotated with a KO number (51.56%) with six CDS (RW109_01016, RW109_02053, 
RW109_02258, RW109_02260, RW109_04953 and RW109_06543) having two or more KO number 
associations.  Out of the 589 plasmid 1 CDS, 146 were assigned with a KO number (24.79%) with 1 CDS 
(RW109_00245) having 2 more KO number associations and of the 156 CDS of plasmid 2, 28 were 
annotated with a KO number (17.95%). Using the KO-assigned CDS of the RW109 genome, KEGG 
defined modules were mapped using MAPLE, which searched against 279 pathways, 291 complexes, 155 
functions and 40 signatures.  The module completion ratios (MCR) were calculated to determine the 
completeness of the assigned modules. The whole genome of RW109, including the main chromosome 
and two plasmids, encoded for 171 biologically feasible KEGG modules.  
3.2.3.2.1 Biologically feasible KEGG modules identified within the main chromosome  
When KEGG functional modules were mapped to the KO-assigned CDS of the main chromosome 68 
pathways, 59 complexes, 31 functional sets and 7 signatures were identified as biologically feasible 
(MCRs with Q-values of <0.5) (Figure 13). The two-component regulatory system category within the 
functional set group had the greatest number of modules which were biologically feasible across the four 
categories (24 MCRs (all 100%) with Q-values of <0.5) (Table 7). The cofactor and vitamins biosynthesis 
category within the pathways group had the second largest number of modules which were biologically 
feasible (13 MCRs with Q-values of <0.5), and the mineral and organic ion transport system category 
within the complexes group had the third biggest number of biologically feasible modules (11 MCRs with 
Q-values of <0.5).  
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Figure 13. Biologically feasible KEGG functional modules of the RW109 main chromosome 
Bar chart represents the number of KEGG modules mapped to KO-assigned CDS of the RW109 main chromosome which had MCRs with Q-values <0.5. 
Modules were grouped into four categories with pathways in blue, complexes in green, functional sets in red and signatures in purple. The MRC of each module 
and associated Q-value were calculated using the MAPLE system. 
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Module ID Two-component regulatory system
RW109 main chromosome KO 
Terms
RW109 main chromosome CDS*
M00434 PhoR-PhoB (phosphate starvation response) 
K07636 
K07657
RW109_06969 
RW109_06968
M00444 PhoQ-PhoP (magnesium transport) 
K07637 
K07660
RW109_04990 
RW109_04991
M00445 EnvZ-OmpR (osmotic stress response) 
K07638 
K07659
RW109_06800 
RW109_06801
M00446 RstB-RstA
K07639 
K07661
RW109_05012 
RW109_04258
M00449 CreC-CreB (phosphate regulation) 
K07641 
K07663
RW109_01067 
RW109_01066
M00452 CusS-CusR (copper tolerance) 
K07644 
K07665
RW109_03165 
RW109_03166
M00453 QseC-QseB (quorum sensing) 
K07645 
K07666
RW109_06365 
RW109_06364
M00454 KdpD-KdpE (potassium transport) 
K07646 
K07667
RW109_04526 
RW109_04525
M00457 TctE-TctD (tricarboxylic acid transport) 
K07649 
K07774
RW109_05484 
RW109_05485
M00471 NarX-NarL (nitrate respiration) 
K07673 
K07684
RW109_01839 
RW109_01838
M00473 UhpB-UhpA (hexose phosphates uptake) 
K07675 
K07686
RW109_04072 
RW109_04071
M00475 BarA-UvrY (central carbon metabolism) 
K07678 
K07689
RW109_05256 
RW109_03415
M00477 EvgS-EvgA (acid and drug tolerance) 
K07679
K07690
RW109_01768 
RW109_00625
M00493 AlgZ-AlgR (alginate production) 
K08082
K08083
RW109_06867 
RW109_04341
M00497 GlnL-GlnG (nitrogen regulation) 
K07708 
K07712
RW109_06720 
RW109_06721
M00501 PilS-PilR (type 4 fimbriae synthesis) 
K02668 
K02667
RW109_06121 
RW109_06122
M00504 DctB-DctD (C4-dicarboxylate transport) 
K10125 
K10126
RW109_06765
RW109_06766
M00505 KinB-AlgB (alginate production) 
K11383 
K11384
RW109_07101 
RW109_07100
M00507 ChpA-ChpB/PilGH (chemosensory) 
K06596 
K02487 
K02657
K02658 
K06597
RW109_01016 
RW109_03121
RW109_01011
RW109_01012
RW109_01017
M00509 WspE-WspRF (chemosensory) 
K13490
K11444
K13491
RW109_02111
RW109_02113
RW109_02112
M00515 FlrB-FlrC (polar flagellar synthesis) 
K10942 
K10943
RW109_05079
RW109_05078
M00523 RegB-RegA (redox response) 
K15011 
K15012
RW109_05834
RW109_05833
M00653 AauS-AauR (acidic amino acids utilization) 
K17060
K17061
RW109_04685
RW109_04686
M00770 PfeS-PfeR (enterobactin-dependent iron acquisition) 
K19609
K19610
RW109_03310
RW109_03311
Table 7. Biologically feasible two-component regulatory systems on the RW109 main chromosome 
Footnotes: * The order of the CDS matches with the order of the associated KO terms in column 2  
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3.2.3.2.2 Biologically feasible KEGG modules identified within plasmid 1  
When KEGG functional modules were mapped to the KO-assigned CDS of plasmid 1, 3 pathways, 2 
complexes, 0 functional sets and 1 signatures were identified as biologically feasible (MCRs with Q-values 
of <0.5) (Table 8). Within the pathways group, the 3 mapped modules were pyrimidine metabolism 
(Pyrimidine degradation: MRC=100%, Q-value <0.5), serine and threonine metabolism (Betaine 
biosynthesis: MRC=100%, Q-value <0.5) and cofactor and vitamin biosynthesis (C1-unit interconversion: 
MRC= 66.7%, Q-value <0.5). A plasmid 1 CDS (RW109_00291= K00600) which is thought to be involved 
in a glycine/serine cleavage system in Section 3.2.3.1.3 was identified as being part of the cofactor and 
vitamin biosynthesis module (M00140). The complexes group had two mapped modules both involved in 
transport; phosphate and amino acid transport system (Putative polar amino acid transport system: 
MRC=100%, Q-value <0.5) and ABC-2 type transport systems (lipopolysaccharide transport system: 
MRC=100%, Q-value <0.5). The CDS involved in the phosphate and amino acid transport system module 
(M00236) were also predicted by STRING protein-protein network analysis in Section 3.2.3.1.3 as being 
part of an ABC-type amino acid transport system. The complete module within the signature group was 
involved in multidrug resistance (efflux pump BpeEF-OprC: MRC=100%, Q-value <0.5). All of the 
pathway and complex modules identified in plasmid 1 were also found within the main chromosome, except 
for the multidrug resistance efflux pump BpeEF-OprC signature module.  
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              Table 8. The biologically feasible KEGG functional modules of RW109 Plasmid 1 
  
 
Footnotes: * The order of the CDS matches with the order of the associated KO terms in column 2  
Module Module ID Functional Process Plasmid 1 KO Number Plasmid 1 CDS*
Pathways
Pyrimidine metabolism M00046
Pyrimidine degradation, uracil => beta-alanine, thymine => 3-
aminoisobutanoate
K06016 RW109_00299
Serine and threonine metabolism M00555 Betaine biosynthesis, choline => betaine
K00108 RW109_00565 
K00130 RW109_00449
Cofactor and vitamin biosynthesis M00140 C1-unit interconversion
K00600 RW109_00291 
K01491 RW109_00468
Complexes
Phosphate and amino acid 
transport system
M00236 Putative polar amino acid transport system
K02030 RW109_00304 
K02029 RW109_00306
K02028 RW109_00307
ABC-2 type and other transport 
systems
M00250 Lipopolysaccharide transport system
K09690 RW109_00168
K09691 RW109_00169
Signatures
Multidrug resistance, efflux M00698 Multidrug resistance, efflux pump BpeEF-OprC
K18900 RW109_00010 and RW109_00017
K18901 RW109_00012
K18902 RW109_00013
K18903 RW109_00014
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3.2.3.2.3 Biologically feasible KEGG modules identified within plasmid 2 
When KEGG functional modules were mapped to the KO-assigned CDS of plasmid 2, no biologically 
feasible modules were identified and across all the module groups only one had an MCR of greater than 
zero but was associated with a Q-value of greater than 0.5. This module was found within the functional 
set group and was identified as a ChpA-ChpB/PilGH (chemosensory) two-component regulatory system 
(M00507) (MCR = 20% and Q-value =0.968). Plasmid 2 had a CDS associated with 1 of the 5 KO-terms 
required for the M00507 module to be complete; this KO-term was K02487, which was assigned to toxin 
co-regulated pilus biosynthesis protein Q (RW109_07276). This same CDS was found to be in close 
proximity to eight U-COG category genes, which encoded a putative type II secretion system (described in 
Section 3.2.3.1.4).  Two out of the eight U-COG category CDS had KO numbers assigned 
(RW109_07269= K02669 and RW109_07279= K12203); when the KO terms were searched on the 
KEGG database, they correlated to a KEGG type II secretion system twitching motility protein PilT and a 
Icm/Dot secretion system protein, respectively.  
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3.2.3.3 Identifying the antimicrobial resistance and virulence genes in the RW109 genome 
The ABRicate tool was used to identify antimicrobial and virulence genes within the RW109 genome. 
Table 9 shows the antimicrobial genes identified when searched against the CARD, ARG-ANNOT and 
Resfinder databases. Thirty-eight RW109 CDS were classified as having an antimicrobial function with 
three being recognised by all databases and two found by both CARD and Resfinder. One CDS 
(RW109_04031) was found to have percentage coverage and identity scores of greater than 98% for two 
different CARD antimicrobial resistance genes, AmrA and MexX. All predicted antimicrobial resistance 
genes were located on the main chromosome of RW109 and not on the two plasmids. Thirty-one of the 
identified resistance CDS were associated with efflux pump systems, two were beta-lactamase encoding 
CDS, three were antimicrobial target modification proteins, one encoded for an aminoglycoside 
phosphotransferase and there was one chloramphenicol acetyltransferase associated CDS. The assigned 
COG functional annotations of the RW109 antimicrobial CDS were also examined and the three 
categories with the greatest number of CDS were defence mechanisms (V= 36.84%), cell 
wall/membrane/envelope biogenesis (M= 28.95%) and the inorganic ion transport and metabolism (P= 
10.53%). Out of the other CDS identified as being antimicrobial, 5.26% were found within the translation, 
ribosomal structure and biogenesis (J), transcription (K) and function unknown (S) categories and 2.63% 
were situated in signal transduction mechanisms (T), energy production and conversion (C) and amino 
acid transport and metabolism (E) categories.  
When the ABRicate tool was used to identify the virulence genes of the RW109 genome by searching 
against the VFDB database, 239 CDS were classified as being associated with virulence (3.27% of the 
RW109 genome) (Gene annotations provided on the CD-ROM, Predicted virulence and BacMet RW109 
genes.xlsx). Again, all predicted virulence CDS were found on the main chromosome and not on the two 
plasmids. Prokka annotated 25 of these CDS as hypothetical proteins, whereas the VFDB database 
identified a putative virulence function for them. The well-characterised COG functional classes for the 
virulent CDS were examined and the cellular processes and signalling class contained the greatest number 
of CDS (67.78%). Within this functional class 22.59% were assigned to the cell motility (N) category, 
9.67% to the intracellular trafficking, secretion, and vesicular transport (U) category, 10.46% to the cell 
wall/membrane/envelope biogenesis (M) category and 9.62% to the signal transduction mechanisms (T) 
category. The poorly characterised class had 21.34% of the virulence CDS and the metabolism functional 
class had 15.48% and within this class the secondary metabolites biosynthesis, transport, and catabolism 
(Q) category had 7.11% of CDS.
 84 
 
 
Table 9. Antimicrobial resistance genes identified in the RW109 genome 
RW109 CDS 
ID
ABRicate
Antimicrobial Gene 
ABRicate Antimicrobial Gene Function Database Accession Number 
RW109_00759 TriA Membrane protein that is fused to TriB and within the P. aeruginosa efflux complex TriABC-OpmH Card ARO:3003679
RW109_00760 TriB Membrane protein that is fused to TriA and within the P. aeruginosa efflux complex TriABC-OpmH Card ARO:3003680
RW109_00761 TriC RND transporter that is a part of TriABC-OpmH, a triclosan-specific efflux protein Card ARO:3003681
RW109_01029 MexA Membrane fusion protein of the MexAB-OprM multidrug efflux complex Card ARO:3000377
RW109_01030 MexB Inner membrane multidrug exporter of the efflux complex MexAB-OprM Card ARO:3000378
RW109_01031 OprM Outer membrane factor protein part of the MexAB-OprM, MexVW-OprM, MexXY-OprM and the AmrAB-OprM efflux pump complexes Card ARO:3000379
RW109_01466 OpmD Outer membrane channel protein of the efflux complex MexGHI-OpmD Card ARO:3000809
RW109_01467 MexI Inner membrane transporter of the efflux complex MexGHI-OpmD Card ARO:3000808
RW109_01468 MexH Membrane fusion protein of the efflux complex MexGHI-OpmD Card ARO:3000807
RW109_01469 MexG Membrane protein required for MexGHI-OpmD efflux activity Card ARO:3000806
RW109_01555 APH(3')-IIb Chromosomal-encoded aminoglycoside phosphotransferase in P. aeruginosa Card, Resfinder and ARG-ANNOT ARO:3002645
RW109_01564 PDC-1 Beta-lactamase found in P. aeruginosa Card and Resfinder ARO:3002497
RW109_02137 MexL Specific repressor of mexJK efflux transcription Card ARO:3003710
RW109_02138 MexJ Membrane fusion protein of the MexJK multidrug efflux protein Card ARO:3003692
RW109_02139 MexK Inner membrane RND transporter in the MexJK multidrug efflux protein Card ARO:3003693
RW109_02266 ArnA Modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) allowing gram-negative bacteria to resist cationic antimicrobial peptides and polymyxin Card ARO:3002985
RW109_02297 MexP Membrane fusion protein of the MexPQ-OpmE multidrug efflux complex Card ARO:3003698
RW109_02298 MexQ Inner membrane transporter of the multidrug efflux pump MexPQ-OpmE Card ARO:3003699
RW109_02299 OpmE Outer membrane factor protein that is part of the multidrug efflux pump MexPQ-OpmE Card ARO:3003700
RW109_03516 OprN Outer membrane channel component of the MexEF-OprN multidrug efflux complex Card ARO:3000805
RW109_03517 MexF Multidrug inner membrane transporter of the MexEF-OprN efflux complex Card ARO:3000804
RW109_03518 MexE Membrane fusion protein of the MexEF-OprN multidrug efflux complex Card ARO:3000803
RW109_03520 MexS Suppressor of MexT, which is an activator of the multidrug efflux pump MexEF-OprN Card ARO:3000813
RW109_04031
AmrA Efflux pump subunit of the AmrAB-OprM multidrug efflux complex Card ARO:3002982
MexX Membrane fusion protein of the MexXY-OprM multidrug efflux complex. Card ARO:3003034
RW109_04032 AmrB Membrane fusion protein of the AmrAB-OprM multidrug efflux complex Card ARO:3002983
RW109_04814 MexN Inner membrane transporter of the MexMN-OprM multidrug efflux complex Card ARO:3003705
RW109_04815 MexM Membrane fusion protein of the MexMN-OprM multidrug efflux complex Card ARO:3003704
RW109_05044 FosA Confers resistance to fosfomycin via catalyzing the conjugation of glutathione to carbon-1 of fosfomycin Card and Resfinder ARO:3000149
RW109_05523 CatB7 Chromosome-encoded variant of the cat gene (chloramphenicol acetyltransferase gene) Card, Resfinder and ARG-ANNOT ARO:3002679
RW109_05712 MexV Membrane fusion protein of the MexVW-OprM multidrug efflux complex Card ARO:3003030
RW109_05713 MexW RND-type membrane protein of the efflux complex MexVW-OprM Card ARO:3003031
RW109_06173 OprJ Outer membrane channel component of the MexCD-OprJ multidrug efflux complex Card ARO:3000802
RW109_06174 MexD Multidrug inner membrane transporter of the MexCD-OprJ efflux complex Card ARO:3000801
RW109_06175 MexC Membrane fusion protein of the MexCD-OprJ multidrug efflux complex Card ARO:3000800
RW109_06176 NfxB Repressor of the efflux pump mexCD-oprJ Card ARO:3000820
RW109_06365 PmrB Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+) Card ARO:3003583
RW109_06568 OpmH Outer membrane efflux protein required for triclosan-specific efflux pump function Card ARO:3003682
RW109_07131 OXA-50 Beta-lactamase found in P. aeruginosa Card, Resfinder and ARG-ANNOT ARO:3001796
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3.2.3.4  Identifying biocide and metal resistance genes in the RW109 genome 
The BacMet database was used to identify antibacterial biocide and metal resistance genes in the RW109 
genome and a total number of sixty-three CDS were classified (Gene annotations provided on the CD-
ROM = Predicted virulence and BacMet RW109 genes.xlsx). Four CDS from plasmid 1 were identified as 
BacMet resistance genes, 59 CDS identified were from the main chromosome and there were no CDS 
identified by BacMet from plasmid 2. Two plasmid 1 CDS identified by BacMet (RW109_00013 and 
RW109_00014) were previously identified as part of the multidrug resistance efflux pump BpeEF-OprC 
KEGG signature module (Table 8). The other plasmid 1 CDS identified with BacMet were annotated with 
functions in mercury (RW109_00034) and tellurium (RW109_00121) resistance.   
 
The three COG categories with the greatest number of BacMet resistance CDS were inorganic ion 
transport and metabolism (P= 33.33%), defence mechanisms (V= 23.81%) and cell 
wall/membrane/envelope biogenesis (M= 12.70%). Nineteen of the BacMet resistance CDS were 
previously identified as antimicrobial genes using ABRicate in Section 3.2.3.3 and were associated with 
efflux pump systems. One BacMet gene was also classified as virulence CDS (RW109_01453) and was 
annotated as a Fe (3+)-pyochelin receptor-OS by both the BacMet and VFDB databases. The BacMet 
predicted CDS for RW109 are provided on the CD-ROM.  
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3.2.4 Identifying RW109 genomic islands 
Genomic islands (GIs) for the main chromosome and two plasmids were predicted using Island Viewer as 
described in Section 2.5.6. The predicted genomic islands were visualised in the circular replicon maps 
(see Figure 11; highlighted in green on the third track in from the outside of the map). A total of forty-two 
possible GIs were identified within the main chromosome (Table 10), six were found in plasmid 1 and one 
in plasmid 2 (Table 11).  
3.2.4.1 GIs encoded on the main chromosome  
The mean length of the forty-two GIs identified in the main chromosome was 9810 bp and the mean 
number of CDS per GI was ten. GI-8 had the greatest number of CDS with eighteen, and GI-19 and GI-33 
were the second largest with each having 17 genes (Table 10). Every GI contained hypothetical proteins 
(GI-18 and GI-41 only contained hypothetical proteins), 15 had transposase proteins and 9 had phage-
associated proteins. The number of assigned COG categories for the GIs CDS of the main chromosome 
were analysed and the poorly characterised COG categories S and unknown represented the highest 
number of GI CDS (Figure 14). Within the well-characterised COG classes the three categories with the 
greatest number of GI CDS were replication, recombination and repair (L = 70), transcription (K = 26), 
cell wall/membrane/envelope biogenesis (M = 14) and defence mechanisms (V =11). The CDS assigned 
to COG category L and K were well distributed throughout the 42 GIs. Nine out of the fourteen CDS 
assigned to the M category were found within GI-11 and five out of the eleven V category CDS were 
found in GI-16. There were no antimicrobial and/or virulence CDS identified in Section 3.2.4 within the 
forty-two main chromosome GIs. Two main chromosome GI CDS were classified as putative BacMet 
resistance genes (Section 3.2.3.4); a cobalt-zinc-cadmium resistance protein CzcA (RW109_02795) in GI-
12 and a nickel and cobalt resistance protein CnrA (RW109_05607) found in GI-33.  
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Genomic Island Start End Length (bp) Number of CDS Annotation 
GI-1 53593 74190 20597 11 Hypothetical Protein (x5), Transposase IS200 like protein (x3), ParB-like nuclease domain protein, Adenosine monophosphate-protein transferase and cysteine protease IbpA precursor, Transposase DDE domain protein
GI-2 807810 822504 14694 12 Site-specific tyrosine recombinase XerC, Phage integrase family protein, Hypothetical Protein (x5), helix-turn-helix protein, recombination protein F, Transposase, Modification methylase DpnIIB, Type III restriction enzyme, res subunit
GI-3 860197 864197 4000 5 Hypothetical Protein (x4), Mor transcription activator family protein
GI-4 1169714 1179963 10249 12 Hypothetical Protein (x8), ATP-dependent RNA helicase HrpB (x2), helix-turn-helix protein (x2)
GI-5 1186579 1199486 12907 11
Hypothetical Protein (x3), LexA repressor, site-specific tyrosine recombinase XerC, Phage integrase family protein, SdiA-regulated, RNA polymerase-binding transcription factor DksA, Universal stress protein family protein, Bicarbonate 
transporter BicA, DNA polymerase IV
GI-6 1361129 1378932 17803 13 Phage integrase family protein (x2), Hypothetical Protein (x8), ATP-dependent RecD-like DNA helicase, Transposase DDE domain protein, Tyrosine recombinase XerC
GI-7 1392112 1398449 6337 13
Replicative DNA helicase, Hypothetical Protein (x6), Serine/threonine-protein phosphatase 1, Phage regulatory protein Rha (Phage_pRha), Phage holin family (Lysis protein S), Chitinase class I, Phage DNA packaging protein Nu1, Phage 
terminase large subunit (GpA)
GI-8 1407149 1420149 13000 18 Hypothetical Protein (x17), methionine aminopeptidase
GI-9 1478291 1488819 10528 10 Hypothetical Protein (x6), Prophage CP4-57 regulatory protein (AlpA), Chaperone protein HtpG, Competence protein CoiA-like family protein, Sporulation initiation inhibitor protein Soj
GI-10 1490712 1499857 9145 13
IS66 Orf2 like protein, putative Helix-turn-helix domain of transposase IS66, Hypothetical Protein (x6), Antiseptic resistance protein, HTH-type transcriptional regulator YfmP, PAAR motif protein, DNA-binding transcriptional activator AllS, 
Transposase
GI-11 2170714 2184863 14149 14
Hypothetical Protein (x5), lipopolysaccharide biosynthesis protein WzzE, Polysaccharide biosynthesis protein, UDP-glucose 4-epimerase, NAD dependent epimerase/dehydratase family protein, UDP-2, 3-diacetamido-2, 3-dideoxy-D-glucuronate 
2-epimerase, putative glycosyl transferase, 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase, Transposase DDE domain protein, putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
GI-12 2309559 2319897 10338 10
Penicillinase repressor, heat shock protein HtpX, Cobalt-zinc-cadmium resistance protein CzcC precursor, Cobalt-zinc-cadmium resistance protein CzcB, Cobalt-zinc-cadmium resistance protein CzcA, Hypothetical Protein (x4), Hca operon 
transcriptional activator
GI-13 2347603 2354444 6841 6 Hypothetical Protein (x4), Replicase family protein, HTH-type transcriptional regulator SinR
GI-14 2593796 2609655 15859 14
putative deferrochelatase/peroxidase YfeX, DNA-binding transcriptional regulator CynR, Hca operon transcriptional activator, Formaldehyde dismutase, Hypothetical Protein (x3), Integrase core domain protein, Transposase DDE domain protein, 
UvrABC system protein B, HTH-type transcriptional regulator DmlR, SnoaL-like domain protein, 2-oxoglutaramate amidase, Transcriptional repressor FrmR
GI-15 2611449 2616363 4914 4 Hypothetical Protein, S-formylglutathione hydrolase FrmB, NADH dehydrogenase-like protein YjlD, Replication-associated recombination protein A
GI-16 2754265 2772704 18439 12
putative type I restriction enzymeP M protein, EcoKI restriction-modification system protein HsdS, Hypothetical Protein (x3), ATP-dependent helicase HepA, 5-methylcytosine-specific restriction enzyme B, 5-methylcytosine-specific restriction 
enzyme subunit McrC, Type-1 restriction enzyme R protein, Integrase core domain protein, Transposase, Toxic protein SymE
GI-17 2837405 2842473 5068 8 Type II secretion system protein G precursor, Hypothetical Protein (x5), General secretion pathway protein K, General secretion pathway protein M
GI-18 3101647 3112481 10834 5 Hypothetical Protein (x5)
GI-19 3411526 3425833 14307 17 6-aminohexanoate-dimer hydrolase, HTH-type transcriptional regulator VirS, Hypothetical Protein (x13), Phytanoyl-CoA dioxygenase (PhyH), Ycf48-like protein precursor
GI-20 3431903 3438789 6886 6 Hypothetical Protein, Gamma-glutamylputrescine oxidoreductase, Phytanoyl-CoA dioxygenase (PhyH), putative DNA-binding transcriptional regulator, FAD-containing monooxygenase EthA, Putative aminoacrylate hydrolase RutD
GI-21 3579713 3588705 8992 10
Alanine--tRNA ligase, Serine acetyltransferase, Cysteine synthase, putative adenylyltransferase/sulfurtransferase MoeZ, Hypothetical Protein, putative inner membrane transporter YedA, Transposase DDE domain protein, putative HTH-type 
transcriptional regulator YjiR, putative oxidoreductase, Putative acetyl-hydrolase LipR precursor
GI-22 3941539 3954604 13065 13 Hypothetical Protein (x10), Lysozyme RrrD, O-acetyltransferase OatA, Prophage tail length tape measure protein
GI-23 3964377 3968753 4376 11 Phage portal protein, Hypothetical Protein (x7), Phage Terminase, small subunit, HNH endonuclease
GI-24 3988289 3993220 4931 13 Hypothetical Protein (x11), Siphovirus Gp157, LytTr DNA-binding domain protein
GI-25 4300185 4304881 4696 5 Hypothetical Protein (x3), thiamine biosynthesis protein ThiF, Helix-turn-helix domain protein
GI-26 4695760 4700811 5051 6 Pyocin-S2 immunity protein, Pyocin-S1, Hypothetical Protein (x2), Integrase core domain protein, Transposase
GI-27 4873196 4883713 10517 12 Virulence sensor protein BvgS precursor, NADH pyrophosphatase, Hypothetical Protein (x3), 1, 4-dihydroxy-2-naphthoyl-CoA hydrolase, IS2 transposase TnpB, Transposase (x3), Colicin-Ia, DSBA-like thioredoxin domain protein
GI-28 5047600 5055035 7435 6 Prophage CP4-57 integrase, Hypothetical Protein(x4), N-6 DNA Methylase
GI-29 5057139 5063286 6147 6 Hypothetical Protein (x4), T5orf172 domain protein, helix-turn-helix protein
GI-30 5078468 5083193 4725 6 Hypothetical Protein (x3), Transposase, Integrase core domain protein, Histidinol-phosphatase
GI-31 5085496 5105213 19717 14 Hypothetical Protein (x10), Chromosome partition protein Smc, TM2 domain protein, PAAR motif protein, VRR-NUC domain protein
GI-32 5296079 5300880 4801 3 ATP-dependent DNA helicase PcrA, Hypothetical Protein, RNA polymerase sigma factor
GI-33 5318785 5336645 17860 17
Hypothetical Protein (x3), mce related protein, Methionine import ATP-binding protein MetN, putative phospholipid ABC transporter permease protein MlaE, Nickel and cobalt resistance protein CnrA, Multidrug resistance protein MdtE precursor, 
HTH-type transcriptional regulator AcrR, putative efflux pump outer membrane protein TtgC precursor, Hca operon transcriptional activator, Quaternary ammonium compound-resistance protein SugE, HTH-type transcriptional regulator SyrM 1, 
Conjugal transfer protein TraG, Ribbon-helix-helix protein, copG family, Type IV secretion system protein PtlH
GI-34 5632149 5637115 4966 8 Hypothetical Protein (x7), Replicative DNA helicase
GI-35 5677209 5684343 7134 10 Hypothetical Protein (x9), Putative SOS response-associated peptidase YedK
GI-36 5714944 5726091 11147 13 Hypothetical Protein (x6), Antitoxin ParD1, Toxin ParE1, Integrase core domain protein, Transposase, Putative helicase, site-specific tyrosine recombinase XerC, Sporulation initiation inhibitor protein Soj
GI-37 5726582 5731142 4560 7 Hypothetical Protein (x6), Replicative DNA helicase
GI-38 5735127 5745199 10072 13
Nucleoid-associated protein YejK, DNA adenine methylase, Arc-like DNA binding domain protein, ParB-like nuclease domain protein, Hypothetical Protein(x6), Phage regulatory protein Rha (Phage_pRha), Single-stranded DNA-binding protein, 
Helix-turn-helix domain protein
GI-39 5763025 5772960 9935 10 Hypothetical Protein (x3), Twitching mobility protein, PilM, Integrase core domain protein (x2), Transposase, IS66 Orf2 like protein, Transposase IS66 family protein
GI-40 5784090 5793274 9184 9 Hypothetical Protein (x8), Transposase DDE domain protein
GI-41 6658315 6662965 4650 3 Hypothetical Protein (x3)
GI-42 7002470 7013629 11159 12 Hypothetical Protein (4), Putative transposase (4), Hydroxyacylglutathione hydrolasev (x3), 2-hydroxyhexa-2,4-dienoate hydratase
Table 10. Genomic Islands within the P. aeruginosa RW109 main chromosome 
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 Figure 14. The COG categories of the RW109 main chromosome Genomic Island’s CDS 
Bar chart represents the numbers of the GI CDS within each COG category for the main chromosome. The poorly characterised COG categories S and unknown 
represented the highest proportion of GI CDS.  Within the well characterised COG classes the four categories with the greatest number of GI CDS were L (70 CDS), 
K (26 CDS), M (14 CDS) and V (11 CDS).  No GI CDS were found in categories R, Z, Y, W, J, B and A.  
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3.2.4.2 Genomic islands encoded on RW109 plasmid 1 
The mean length of the six GIs identified in plasmid 1 was 14,574 bp and the mean number of CDS per GI 
was 15. GI-5 had a large number of CDS with the other GIs having between 5-19 CDS (Table 11). The 
number of assigned COG functional groups for the GI CDS of plasmid 1 were analysed and the amino 
acid transport and metabolism (E) had the highest number with 19 CDS. The E-COG category CDS were 
found in GIs 2, 4, 5 and 6; GI-4 had four out of its six CDS assigned to this category and GI-5 had the 
highest number of E-COG CDS (9). The poorly categorised COG group S had the second largest number 
with 17 CDS and K category had the third largest number with 13 CDS; both S and K COG CDS were 
distributed throughout the plasmid 1 GIs. Two CDS with efflux pump functions were found in GI-1 and 
these were identified as predicted BacMet resistance genes encoding an efflux pump membrane 
transporter BepE (RW109_00013) and putative efflux pump outer membrane protein TtgC precursor 
(RW109_00014). These two genes were also associated with the KEGG module M00698, the multidrug 
resistance efflux pump BpeEF-OprC (Section 3.2.3.2.2). The other three genes in the M00698 module 
(RW109_00010, RW109_00012 and RW109_00017) (Table 8) were also identified within GI-1 of 
plasmid 1 suggesting this efflux pump is part of a genomic island. No other BacMet resistance genes were 
found in the GI’s of plasmid 1. GI-6 also had two threonine efflux proteins (RW109_00569 and 
RW109_00570) and there were seven CDS with transporter functions were also identified throughout the 
GIs with one in GI-1, and two in GI-2, GI-4 and GI-5.  
3.2.4.3 Genomic islands encoded on plasmid 2 
Plasmid 2 was found to have one GI with a length of 35,019 bp with forty CDS; 55% of the CDS were 
annotated as hypothetical proteins (Table 11). When the COG categories of the GI were analysed the 
majority were within the poorly characterised group (67.50%). 30% were assigned to the replication, 
recombination and repair (L) category and these CDS were annotated as transposase and integrase 
proteins. One CDS was assigned to the lipid transport and metabolism (I) category (2.5% of total number 
of CDS) and was an outer membrane protein P1 precursor.   
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Table 11. Genomic Islands encoded on the RW109 plasmids 
Genomic 
Island 
Start End
Length 
(bp)
Number 
of CDS
Annotation 
Plasmid 1
GI-1 9313 30288 20975 19
Tniq, Bacterial TniB Protein, Transposon Tn7 Transposition Protein Tnsb, Aerotaxis Receptor, HTH-Type Transcriptional Regulator DmlrR(X2), Transposase DDE Domain Protein, 
Multidrug Resistance Protein MdtA Precursor, Efflux Pump Membrane Transporter BepE, Putative Efflux Pump Outer Membrane Protein TtgC Precursor, NADH Oxidase, HTH-Type 
Transcriptional Regulator LeuO, Glutathione S-Transferase GST-6.0, DNA-Invertase Hin, Hypothetical Protein (X2), PIN Domain Protein, Tn3 Transposase DDE Domain Protein, 
Mercuric Transport Protein Periplasmic Component Precursor
GI-2 102388 111297 8909 11
Putative M18 Family Aminopeptidase 2, Phosphoserine Phosphatase, Cytochrome C-552 Precursor (X2), Aralkylamine Dehydrogenase Light Chain Precursor, Methylamine 
Utilization Protein MauD, Methylamine Utilization Protein MauE, Aralkylamine Dehydrogenase Heavy Chain Precursor, Hypothetical Protein, Sulfate Transport System Permease
Protein CysW, Putative 2-Aminoethylphosphonate Transport System Permease Protein PhnV
GI-3 171629 176324 4695 5 Hypothetical Protein(X3), Transposase DDE Domain Protein (X2)
GI-4 328383 332688 4305 6
Leucine-Responsive Regulatory Protein, Cystine-Binding Periplasmic Protein Precursor, Inner Membrane Amino-Acid ABC Transporter Permease Protein YecS, Putative Glutamine 
ABC Transporter Permease Protein GlnM, Octopine Permease ATP-Binding Protein P, Hypothetical Protein
GI-5 425648 461677 36029 36
Hypothetical Protein (X7), HTH-Type Transcriptional Regulator PuuR, Glutamine Synthetase 3, Amidophosphoribosyltransferase Precursor, GXGXG Motif Protein, Glutamate 
Synthase [NADPH] Large Chain, Ammonia Channel Precursor, Phenoxybenzoate Dioxygenase Subunit Beta, Aminomethyltransferase (X2), Quaternary Ammonium Compound-
Resistance Protein SugE, GMP Synthase [Glutamine-Hydrolyzing], Betaine Aldehyde Dehydrogenase, Ammonia Channel, Methyl-Accepting Chemotaxis Protein PctB, HTH-Type 
Transcriptional Regulator LutR, Eama-Like Transporter Family Protein, Sialic Acid TRAP Transporter Permease Protein SiatT, LysR Substrate Binding Domain Protein, Imelysin, 
Cytochrome C, Variant SH3 Domain Protein, Pca Regulon Regulatory Protein, Sarcosine Oxidase, Gamma Subunit Family, Delta Subunit Family, Sarcosine Oxidase Subunit Beta, 
Bifunctional Protein Fold Protein, Formyltetrahydrofolate Deformylase, 4-Methylaminobutanoate Oxidase (Formaldehyde-Forming), Acetate Operon Repressor
GI-6 528619 541150 12531 11
Transcriptional Regulator AcuR, Alcohol Dehydrogenase, Chromosome-Partitioning Protein Spo0J, Hypothetical Protein (X3), Bifunctional Transcriptional Activator/DNA Repair 
Enzyme Ada, Threonine Efflux Protein (X2), Glycine Cleavage System Transcriptional Activator, Putative Prophage CPS-53 Integrase
Plasmid 2 
GI-1 122949 35019 35019 40
Site-Specific Tyrosine Recombinase XerC, Abi-Like Protein, Hypothetical Protein (X22), Transposon Tn7 Transposition Protein TnsA, Transposon Tn7 Transposition Protein TnsB, 
Transposase DDE Domain Protein, Transposon Tn7 Transposition Protein TnsC, Integrase Core Domain Protein(X3), Transposase (X2), ATP-Dependent Helicase HepA, Replicative 
DNA Helicase, Outer Membrane Protein P1 Precursor, Transposase IS66 Family Protein, IS66 Orf2 Like Protein, Antitoxin DinJ, mRNA Interferase YafQ
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3.2.5 Identifying phages in the RW109 genome 
The PHASTER tool was used to identify phage sequences in the RW109 genome (Table 12). Eight phages 
were identified in the main chromosome; five were classified as intact, one was incomplete and two were 
questionable. One phage was identified in each of the two plasmids and these were both characterised as 
incomplete. On the circular replicon maps (Figure 11), the phage sequences were highlighted in light pink 
on the forth track in from the outside of the map. Phage’s 3, 4 and 6 had overlaps with the GIs (see Figure 
11). A similar overlap with annotated GIs was observed for the phage’s identified in plasmids 1 and 2 
(Figure 11). Out of the phages on the main chromosome, six were characterised as Pseudomonas phages, 
phage 5 was classed as a Salmonella phage and phage 8 was an Enterobacteria. The phage sequence in 
plasmid 1 was identified as a Shigella phage and the phage in plasmid 2 was classified as a Pseudomonas 
phage.  
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Table 12. Phages within the RW109 genome 
Phage 
Number 
Region 
Length 
(bp)
Region position
Total number 
CDS in region
GC %
PHASTER
Score
Phage 
Completeness
Phage sequence most similar to Phage NC Number 
Plasmid 1 
1 39600 152692-192335 15 57.25% 60 Incomplete Shigella_Sf6 NC_005344(2)
Main Chromosome 
1 41900 670851-712805 60 63.91% 130 Intact Pseudomonas_vB_PM105 NC_028667(40)
2 18400 724969-743443 25 65.19% 100 Intact Pseudomonas_JBD44 NC_030929(10)
3 66200 802521-868726 65 61.05% 150 Intact Pseudomonas_vB_PaeS NC_028667(42)
4 47800 1371811-1419673 63 61.12% 109 Intact Pseudomonas_F10 NC_007805(46)
5 22800 1464864-1487750 7 61.55% 20 Incomplete Salmonella_SPN1S NC_016761(2)
6 72900 3923988-3996972 96 58.92% 150 Intact Pseudomonas_PMG1 NC_016765(50)
7 18000 4637833-4655921 11 61.20% 85 Questionable Pseudomonas_Pf1 NC_001331(8)
8 12900 5599645-5612594 16 60.32% 70 Questionable Enterobacteria_HK022 NC_002166(3)
Plasmid 2 
1 39300 106946-146332 19 58.27% 50 Incomplete Pseudomonas_F116 NC_006552(2)
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3.2.6 Comparative genomics of the RW109 whole genome sequence 
3.2.6.1 Comparing RW109 annotated functional categories with PA14 and PAO1  
3.2.6.1.1 COG functional annotation comparisons  
The COG functional annotation of predicted CDS of PA14 and PAO1 was carried out and compared to the 
COG assignment of the RW109 whole genome. Figure 15 shows a bar chart of the number of CDS 
assigned to the well characterised COG categories for the three strains. The poorly characterised 
categories were not shown as a high number of CDS for each strain were assigned to this group when 
compared to the well-characterised COG categories. Within the poorly characterised COG functional 
class, RW109 had 2,952 CDS (40.42% of its genome), PA14 1,999 CDS (33.86% of its genome) and 
PAO1 1845 CDS (32.53% of its genome).  
 
Out of the twenty well characterised COG categories (ignoring categories W, Y and Z which had no CDS 
assigned for the three strains), RW109 had a greater number of CDS in seventeen categories when 
compared to PA14 and PAO1. In the replication, recombination and repair category (L) RW109 had 
96.34% more CDS than PA14 and 123.21% more than PAO1. RW109 was also found to have 22.29% 
extra CDS than PA14 and 42.22% more CDS than PAO1 in the intracellular trafficking, secretion, and 
vesicular transport (U). The other categories where RW109 was found to have 10% or more CDS when 
compared to PA14 and PAO1 included cell cycle control, cell division, chromosome partitioning (D), 
defence mechanisms (V) and transcription (K). There was a less than 1% difference in the number of CDS 
for the nucleotide transport and metabolism (F), chromatin structure and dynamics (B) and translation 
ribosomal structure and biogenesis (J) categories when RW109 was compared to PA14 and PAO1. 
 
The percentage of CDS within each COG category for the RW109, PA14 and PAO1 strains were also 
compared and were found to be similar throughout the three genomes (Figure 16); the category where 
there was a noticeable difference in the percentage of CDS was the replication, recombination and repair 
(L) category. RW109 had 5.13% of its total CDS assigned to the L COG category, whereas PA14 had 
3.24% CDS and PAO1 2.96% CDS with L COG annotation. 
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Information storage and processing Cellular processes and signalling Metabolism 
 
The bar chart shows the number of CDS which were assigned to the well characterised COG categories for RW109 (red), PA14 (blue) and PAO1 
(green). The poorly characterised COG categories were not shown as a high number of CDS were assigned to this group.  
Figure 15. Comparison of the number of CDS within the well characterised COG categories for RW109, PA14 and PAO1 
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Figure 16. Percentage number of CDS within each COG category for RW109, PA14 and PAO1 
A B J K L D O M N P T U V C G E F H I Q
% of PAO1 CDS 0.04 0.05 3.53 8.15 2.96 0.56 3.53 5.47 1.48 6.12 4.88 2.38 1.43 6.10 3.86 8.04 2.03 2.93 3.49 2.50
% of PA14 CDS 0.03 0.05 3.41 8.10 3.24 0.56 3.52 5.24 1.44 5.86 4.74 2.66 1.39 5.91 3.66 7.71 1.93 2.76 3.37 2.46
% of RW109 CDS 0.05 0.04 2.72 7.38 5.13 0.52 3.04 4.42 1.25 4.97 4.18 2.63 1.27 5.08 3.08 6.82 1.56 2.36 2.78 2.05
*
The percentage number of CDS within each COG category when compared to the size of the genome was calculated for RW109 (red), UCBPP-PA14 (blue) 
and PAO1 (green). The stacked column graph demonstrates the percentage of CDS for each of the COG categories across the three strains. The asterisk 
above the column for L indicates the COG category where RW109 was found to have a noticeably greater percentage number of CDS when compared to 
PA14 and PAO1.  
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3.2.6.1.2 KEGG functional modules and MAPLE MRCs comparisons  
The KEGG MAPLE MRCs and Q-values for PAO1 and PA14 were calculated and compared against 
those identified as biologically achievable across the whole genome sequence of RW109 (combining the 
annotations of the main chromosome and plasmids 1 and 2) from Section 3.2.3.2.   Table 13 demonstrates 
the KEGG functional modules, which differed when RW109 was compared to PA14 and PAO1. RW109 
contained two modules which were not biologically feasible in both PA14 and PAO1 (MCRs with Q-
values of >0.5). These were a UhpB-UhpA (hexose phosphates uptake) two-component regulatory system 
(M00473) and a multidrug resistance, efflux pump BpeEF-OprC (M00698) which was found on GI-1 of 
plasmid 1. Another two RW109 modules, which were not biologically feasible in PA14 but were in 
PAO1, included a lipopolysaccharide metabolism module (M00064- ADP-L-glycero-D-manno-heptose 
biosynthesis) and an AauS-AauR (acidic amino acids utilisation) two-component regulatory system 
(M00653). In PA14, two modules were found to be not biologically feasible in RW109 and PAO1; these 
were involved in aromatic anthranilate degradation (M00637) and nitrate assimilation (M00615). A 
central carbohydrate metabolism module involved in 5-phospho-α-ribosyl-1-pyrophosphate (PRPP) 
biosynthesis (M00005) was found to be biologically achievable in both PA14 and PAO1 but not in 
RW109. 
 97 
 
 
 
 
 
 
 
 
 
Footnotes: KEGG functional modules were considered biologically achievable when they were assigned a MCR with a Q-value of < 0.05.   
KEGG Functional Module Module Type Module number Module description 
RW109 PA14 PAO1
MRC (%) Q-Value MRC (%) Q-Value MRC (%) Q-Value
Two-component regulatory system Functional M00473 UhpB-UhpA (hexose phosphates uptake) two-component regulatory system 100 0 50 0.667 50 0.667
Drug resistance Signature M00698 Multidrug resistance, efflux pump BpeEF-OprC 100 0 50 0.933 50 0.8
Two-component regulatory system Functional M00653 AauS-AauR (acidic amino acids utilization) two-component regulatory system 100 0 50 0.667 100 0
Lipopolysaccharide metabolism Pathway M00064 ADP-L-glycero-D-manno-heptose biosynthesis 100 0 75 0.533 100 0
Central carbohydrate metabolism Pathway M00005 PRPP biosynthesis, ribose 5P => PRPP 0 1 100 0 100 0
Aromatics degradation Pathway M00637 Anthranilate degradation, anthranilate => catechol 0 0.571 100 0 0 0.571
Metabolic capacity Signature M00615 Nitrate assimilation 33.3 0.545 66.7 0.396 33.3 0.545
Table 13. KEGG functional modules which differ when MCRs and Q-values of RW109 were compared to PA14 and PAO1 
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3.2.6.3.3 Antimicrobial and virulence functional annotation comparisons  
3.2.6.3.3.1 ABRicate analysis of PA14 and PAO1  
The antimicrobial resistance genes of PA14 and PAO1 were identified using ABRicate; thirty-eight CDS 
were associated with antimicrobial resistance in both PA14 and PAO1 which was the same number as 
identified in RW109 (see Section 3.2.3.3). When the resistance associated CDS for the three strains were 
compared, RW109 and PAO1 were found to obtain the same set of ABRicate CDS whereas minor 
differences were seen with PA14. A resistance gene called PDC-1, which is a P. aeruginosa beta-
lactamase (Table 9) was found in RW109 and PAO1 but not in PA14. A resistance gene called PDC-9 
was identified in PA14 but not in RW109 and PAO1, this gene is an extended-spectrum beta-lactamase 
found in P. aeruginosa (McArthur et al., 2013).  
 
PA14 was found to have less predicted virulence genes, 235 CDS, compared to 239 in RW109 (Section 
3.2.3.3). However, more predicted virulence genes were observed in PAO1 246 CDS (Figure 17A). 
RW109 and PAO1 were found to have eleven virulence genes that were not found in PA14 with eight of 
these being associated with Type IV fimbrial biogenesis. Five virulence genes were found in PA14 and 
PAO1 but not in RW109 and their function was related to pyoverdine biosynthesis. Two type III secretion 
system virulence genes were found in PA14, which were not identified in both PAO1 and RW109 (Figure 
17A). In PAO1, lipopolysaccharide biosynthesis virulence genes were observed that were not found in 
RW109 and PA14 (Figure 17A).  
 
3.2.6.3.3.2 BacMet analysis of PA14 and PAO1 
The amino acid sequences of PA14 and PAO1 were searched against the BacMet database; sixty PA14 
CDS and fifty-six PAO1 CDS were identified as being antibacterial biocide and metal resistance genes. 
Figure 17B shows the BacMet resistance genes which differed when the sixty-three predicted RW109 
BacMet CDS where compared to those identified in PA14 and PAO1. RW109 had nine BacMet associated 
genes, which were not found in PA14 and PAO1; four were part of efflux pump systems, two were 
involved in mercury resistance, two had functions in resistance to nickel, zinc, cadmium and cobalt and 
one was a tellurium resistance protein. There were six BacMet CDS which were identified in both RW109 
and PA14 but not in PAO1 and two found in both RW109 and PAO1 but not in PA14 (Figure 17B). PA14 
and PAO1 also both contained a BacMet resistance gene (BAC0513) that was not found in RW109, which 
functioned as multidrug resistance protein (vmeF). Two BacMet resistance genes were also found in PA14 
(BAC0067 and BAC0549) but not in RW109 or PAO1; one was involved in the tolerance to copper and 
the other was a nickel, cobalt and cadmium resistance protein.   
 99 
 
Figure 17. Virulence and BacMet predicted genes which differed between RW109, PA14 and PAO1  
BacMet ID Gene name Experimentally verified BacMet gene information RW109 PA14 PAO1
BAC0015* adeG Part of the AdeFGH efflux system; contributes to resistance of antibacterial biocides such as dyes, anionic detergents
BAC0016* adeH Part of the AdeFGH efflux system; contributes to resistance of antibacterial biocides such as dyes, anionic detergents
BAC0046* bepG Efflux pump membrane transporter BepG; Contributes to resistance of Deoxycholate, Sodium dodecyl sulphate and Nalidixic acid 
BAC0119 czcA Cobalt-zinc-cadmium resistance protein
BAC0203 cnrA Nickel and cobalt resistance protein
BAC0388* terC Tellurium resistance protein; membrane protein which may provide a barrier to Tellurium ion entry
BAC0425 vexD Transporter, AcrBDF efflux system; contributes to resistance of Ethidium bromide and Deoxycholate
BAC0650* merA Mercuric reductase; contributes to resistance of Mercury and Phenylmercury acetate
BAC0653* merA Mercuric ion reductase; contributes to resistance of Mercury
BAC0263 ncrA Part of ncrABCY nickel resistance chromosomal determinant system; encodes a membrane protein that forms an efflux with ncrC
BAC0267 nczA Nickel-cobalt-zinc resistance protein;  part of the nczCBA operon
BAC0526 vmeV
Transporter, AcrBDF efflux system; contributes to resistance of Sodium dodecyl sulphate, Sodium cholate, Sodium deoxycholate,
Sodium glycocholate, Ethidium bromide, Benzylkonium chloride, Chlorhexidine, Acriflavine and Tetraphenylphosphonium  
BAC0570 actP Acetate Permease; contributes to resistance to Tellurium
BAC0652* merA Mercury reductase enzyme; contributes to resistance to Mercury
BAC0698 ncrA Part of the ncrABC determinant system; contributes to Nickel and Cobalt resistance
BAC0044 bepE Efflux pump membrane transporter; involved in resistance to Sodium deoxycholate, Ethidium bromide and Crystal violet
BAC0130 czrA Part of the czrSRCBA resistance operon; contributes to resistance to Zinc and Cadmium
BAC0513 vmeF
Putative multidrug resistance protein; contributes to the resistance of Ethidium bromide, Sodium dodecyl sulphate, Sodium cholate, 
Sodium deoxycholate, Sodium glycocholate and Acriflavine
BAC0067 cinA Copper-containing azurin-like protein; involved in Copper tolerance
BAC0549 nccA Nickel-cobalt-cadmium resistance protein
A Absent 
P Present
VFDB ID Gene name Virulence information from VFDB RW109 PA14 PAO1
NP_248771 fha1 Fha domain-containing protein; type VI secretion system protein, protein secretion/export apparatus
NP_252530 exoS Exoenzyme S; type III Secretion system protein, secreted Factors (toxins, enzymes, alginate)
NP_253217 pilC Pilin biogenesis protein; protein secretion by the type II secretion system, motility and attachment
NP_253239 fimT Type IV fimbrial biogenesis protein; protein secretion, motility and attachment
NP_253240 fimU Type IV fimbrial biogenesis protein; protein secretion, motility and attachment
NP_253241 pilV Type IV fimbrial biogenesis protein;pilus biogenesis, motility and attachment
NP_253242 pilW Type IV fimbrial biogenesis protein;pilus biogenesis, motility and attachment
NP_253243 pilX Type IV fimbrial biogenesis protein;type IV pilus-dependent motility, motility and attachment
NP_253244 pilY1 Type IV fimbrial biogenesis protein;pilus biogenesis, motility and attachment
NP_253245 pilY2 Type IV fimbrial biogenesis protein;pilus biogenesis, motility and attachment
NP_253246 pilE Type IV fimbrial biogenesis protein;type IV pilus-dependent motility, motility and attachment
NP_251092 pvdI Pyoverdine biosynthetic process; pathogensis, regulation of other virulence factors and biofilm formation
NP_251090 pvdJ Pyoverdine biosynthetic process; pathogensis, regulation of other virulence factors and biofilm formation
NP_251089 pvdD Pyoverdine biosynthetic process; pathogensis, regulation of other virulence factors and biofilm formation
NP_251088 fpvA Ferripyoverdine receptor; pyoverdine biosynthetic processl; pathogensis, regulation of other virulence factors and biofilm formation
NP_251087 pvdE Pyoverdine biosynthetic process; pathogensis, regulation of other virulence factors and biofilm formation
NP_250386 pscP Translocation protein in type III secretion; protein secretion/export apparatus
AAC16023 exoU Type III secretory toxin; secreted Factors (toxins, enzymes, alginate)
NP_251844 wzy Lipopolysaccharide biosynthetic process; membrane protein; adherence, endotoxin; 
NP_251850 wzz Lipopolysaccharide biosynthetic process; cell wall, LPS, capsule
A)
B)
Comparison of RW109, UCBPP-PA14 and PAO1 showed differences in the identification of genes associated with virulence (A) and biocide 
and metal resistance (B). The figure shows the presence (dark blue) and absence (light blue) of these genes when the three strains were 
compared. The database accession number, gene name and information about the gene were shown.  In panel B) the * illustrates the BacMet 
associated RW109 CDS which were found on plasmid 1.  
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3.2.6.2 Core-genome comparison of RW109 with 102 P. aeruginosa genome sequences  
Pan-genome (Roary) analysis of 102 P. aeruginosa selected genomes (Chapter 2, Table 3) along with the 
RW109 genome sequence identified 4,009 core genes; a 95% identity cut-off was applied and core genes 
were defined as those in 99-100% of the genome sequences. A further 222 genes were shared by 95-99% 
of isolates and were termed soft-core genes. The genome sequences used in this analysis represented 66 
strains from a clinical setting, 19 environmental strains, 16 industrial strains, one strain classified as both 
clinical and environmental (PA1RG) and one strain with an unknown isolation source (ATCC-13388) 
(Chapter 2, Table 3). The alignment of the core-genes was used to construct a maximum-likelihood tree of 
the 103 P. aeruginosa sequences as shown in Figure 18.
The tree was rooted with the PA7 genome sequence as this strain was highly divergent when compared to 
the other sequences (Figure 18). The P. aeruginosa sequences were colour coded depending on whether 
they were clinical, environmental, industrial strains or unknown and genome sequences for each type of 
strain were distributed relatively equally throughout the tree. The genome sequences of the P. aeruginosa 
were split into 2 major clades, with 13 industrial positioned in clade 1 and 3 located within clade 2 (Figure 
18). The sub-clade which contained RW109 was highlighted by a light purple box; within this sub-clade 
were six industrial strains (including RW109) and six clinical strains; there were no environmental type 
strains identified within this sub-clade. RW109 was found to be most closely related to the industrial 
RW192 strain, which was isolated from a contaminated Unilever surface cleaner product in 2012 (Chapter 
2, Table 3). The other industrial strains in this sub-clade included RW138 (isolated from liquid abrasive 
cleaner product), RW149 (isolated from personal care product), RW176 (isolated from dishwasher liquid) 
and RW200 (isolated from a timber care product); this sub-clade had the highest number of industrially 
isolated strains when compared to others in the tree. The clinical strains within this sub-clade included 
Carb01-63 (isolation unknown), F30658 (isolation unknown), FRD1 (isolated from CF sputum), F23197, 
(isolation unknown), RW27 (isolated from CF sputum) and RW30 (isolated from CF sputum) (Figure 18).  
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The phylogenetic tree was generated based on the Roary core-genome generated from the 103 P. aeruginosa 
genome sequences and RW109. The strain names of the genome sequences were colour coded to indicate if 
the strain was clinical (red, environmental (green) or industrial (blue) (the PA1RG strain was classified as 
both clinical and environmental so was coloured red and green). The strain with an unknown source of 
isolation is shown in grey (ATCC-13388). The numbers on the nodes represent the bootstrap values with 1 
being 100% and the tree was drawn to scale with genetic distances given as the number of base substitutions 
per site as shown by the scale bar. The tree was rooted with the PA7 genome sequence as it was highly 
divergent and was ordered based on the increasing nodes. The sub-clade highlighted by a light purple square 
towards the top of the tree contains the RW109 strain which is in bold and has an asterisks next to it.  
Figure 18. Core-gene phylogenetic tree of 103 P. aeruginosa and RW109 genome sequences
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3.2.6.3 Presence and absence of CARD predicted antibiotic resistance genes in RW109 and the 102 
P. aeruginosa genome sequences
The antibiotic resistance genes present in the 103 P. aeruginosa sequences were determined by CARD and 
visualised as a heat map presence/absence annotation aligned to a core-genome alignment phylogenetic 
tree (Figure 19; the core-genome alignment was not ordered based on increasing nodes as with the tree in 
Figure 18). The antimicrobial resistance genes were grouped according to their predicted function. 
Overall, the clinical, environmental and industrial strain sequence types had similar CARD resistance gene 
profiles.  The mean number of CARD resistance genes was determined as 43 for clinical strains, 41 for 
environmental strains, and 41 for industrial strains (the strain classified as both clinical and environmental 
had 39 resistance genes and the strain with an unknown isolation source had 42). The highest numbers of 
antimicrobial resistance genes were found in the two clinical strains PA121617 (isolated from CF sputum) 
and VRFPA04 (isolated from a corneal button of a patient with corneal keratitis); both strains had 50 
CARD predicted resistance genes. Strains PA1R (a clinical strain isolated from a respiratory tract 
infection) and E2oS (a soil environmental strain) had the lowest number of predicted resistance genes with 
35 identified.   
All 103 genome sequences had the polymixin resistance genes PmrB and ArnA and the aminoglycoside 
resistance gene OXA-50. All but one strain, RW149 (isolated from a personal care product), had the 
chloramphenicol resistance gene catB7 and all strains except for DK2 (isolated from CF sputum) had the 
aminoglycoside APH(3')-IIb gene. The four genes involved in the triclosan specific efflux pump were 
present in all strains except for the environmental strain N002 (isolated from crude oil contaminated soil) 
which did not have TriA and the environmental strain ATCC-700888 (isolated from an industrial water 
system) where the TriC and OpmH genes were not present. An industrial strain RW184 (isolated from 
dishwasher liquid) and two clinical strains VRFPA04 and PA7 (non-respiratory clinical isolate) were the 
only strains not to have the fosfomycin resistance gene FosA.  The majority (101 of 103) P. aeruginosa 
sequences encoded a number of genes predicted to be Mex-type multidrug efflux complexes. Two clinical 
strains NCTC-12903 (an antibiotic efficacy testing reference strain) and ATCC-15692 (isolated from an 
infected wound) were the only two, which did not have the genes for the MexGHI-OpmD efflux pump. 
The clinical strain PA7 was the only strain to encode a predicted oprA gene from the MexXY-OprA efflux 
pump.  
Within the industrial genome sequences, RW109 and RW192 were the only two with the beta-lactamase 
PDC-1 gene; this gene was also found within seven clinical strains (ATCC-15692, H27930, H5708, 
PA121617, PAO1, VA-134, and W16407). The majority of the genes, which encode the Mex-type efflux 
pump systems, were found in all 16 industrial strains. The exceptions were oprA which was not predicted 
in any of the industrial strain genomes, and the mexY gene which was absent in RW109. The sulfonamide 
resistance gene sul2 was found only in the ATCC-13388 genome sequence, which had an unknown 
isolation source and is used in industrial testing. For the industrial strain sequences, CARD did not 
identify any antimicrobial genes within the quinolone, carbapenem, trimethoprim, macrolide and 
tetracycline efflux resistance functional groups, and this was true for the environmental strains.    
103 
See next page for figure legend 
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Figure 19. The presence and absence of CARD antimicrobial genes across 103 P. aeruginosa 
sequences  
The phylogenetic tree on the left of the figure was annotated with a heat map to illustrate the 
presence/absence of antimicrobial resistance genes from the CARD database for a panel of 103                                                    
P. aeruginosa genome sequences of clinical (red), environmental (green) and industrial (blue) 
strains. The strain with an unknown isolation source is shown in grey. The CARD antimicrobial 
genes were grouped via their resistance function on the top of the heat map; light blue shows its 
absence of an antimicrobial genes and dark blue indicates the presence. The sub-clade, which 
contains RW109, is highlighted with a light purple box and RW109 is indicated in bold with an 
asterisk next to it.  
CHAPTER 3 - Whole genome sequencing and comparative genomics of the industrial                
P. aeruginosa strain RW109 
 
105 
 
3.2.6.4 The unique genes of RW109 
The gene presence and absence output from the pan-genome analysis of the 103 P. aeruginosa sequences 
was used to determine genes, which were unique to RW109.  In total, 329 genes were found to be specific 
to RW109 with 105 encoded on plasmid 1, 202 on the main chromosome and 22 encoded on plasmid 2. 
No predicted antimicrobial or virulence genes (Sections 3.2.3.3) were found within the unique subset of 
RW109 genes. The COG annotation assessment identified 51.06% of the RW109 unique genes as poorly 
characterised.                  
The well-characterised COG categories with the highest number of unique RW109 genes were replication, 
recombination and repair (L) with 23.10%, followed by amino acid transport and metabolism (E) with 
7.90%, transcription (K) with 4.86% and energy production and conversion (C) with 4.56%. The KEGG 
modules identified as biologically feasible (Section 3.2.3.2) were analysed and the CDS required for a 
phosphate and amino acid transport system module (M00236: RW109_00304, RW109_00306 and 
RW109_00307) and a pyrimidine metabolism module (M0046: RW109_00299) from plasmid 1 were 
found within the unique genes of RW109 (Table 8). One out of the two genes required for a plasmid 1 
encoded cofactor and vitamin biosynthesis module (M00140- RW109_00291) was also found within the 
unique genes.  
Genomic islands (GI’s) genes (Section 3.2.4) were examined and more than 70% of the genes in GI’s 9, 
10, 13, 28, 29 and 42 of the main chromosome (Table 10) were associated with the unique RW109 genes; 
all of the genes in GI-13 and GI-42 were identified as unique. For plasmid 1, all genes found in GI’s 2 
(RW109_00089 - RW109_00099) and 4 (RW109_00303 - RW109_00308) were also within the unique 
RW109 gene set (Table 11). 16 out of the 40 CDS, which make up the one GI in plasmid 3, were also 
identified as unique RW109 genes. The RW109 PHASTER sequences predicted in Section 3.2.5 (Table 
12) were also examined and seventy-four phage CDS were identified as unique genes; within the main 
chromosome four were identified in phage 1, 28 in phage 3, three in phage 4, two in phage 5, 27 in phage 
6 and one in phage 8. Two unique genes were identified in the one phage sequence identified on plasmid 1 
phage and seven were found within the plasmid 2 phage.   
When analysing the presence and absence output from pan-genome analysis (Roary), the five genes 
associated with the KEGG BpeEF-OprC efflux pump (M00698), were also found in the genome 
sequences for RW130, RW146, RW172, RW176 and RW184, but were not identified in the remaining 97                                      
P. aeruginosa genome sequences. These five genome sequences were all industrial isolates obtained from 
contaminated dishwasher liquids at different time points and in various locations (Chapter 2 Table 3). The 
KEGG BpeEF-OprC efflux pump (M00698) module was considered biologically feasible in all of these 5 
industrial strains when checked with the KEGG MAPLE tool (MCR of 100% and a Q-value of 0). The 
genes, which matched to the M00698 KO numbers within each strain along with the RW109 strain, are 
shown in Table 14. These 6 industrial strains were spread throughput the core genome phylogenetic tree 
(Figure 18) and did not cluster within one sub-clade.   
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Table 14. Industrial isolates with the BpeEF-OprC efflux pump KEGG module (M00698)  
Industrial Isolates 
M00698 BpeEF-OprC efflux pump (KO number)
K18900 K18901 K18902 K18903
RW130 RW130_06334 and RW130_06328 RW130_06329 RW130_06330 RW130_06331
RW146 RW146_05850 and RW146_05844 RW146_05845 RW146_05846 RW146_05847
RW172 RW172_05145 and RW172_05139 RW172_05140 RW172_05141 RW172_05142
RW176 RW176_03984 and RW176_03978 RW176_03979 RW176_03980 RW176_03981
RW184 RW184_02738 and RW184_02744 RW184_02743 RW184_02742 RW184_02741
RW109 RW109_00010 and RW109_00017 RW109_00012 RW109_00013 RW109_00014
Footnotes: Each strain gene ID, which correspond to the KO numbers are shown in the columns.   
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3.2.6.5 Genome size comparison of RW109 with the 102 P. aeruginosa genome sequences   
The number of base pairs for each of the 103 P. aeruginosa sequences (including RW109) were obtained 
from the Prokka summary annotation files and the genome size distribution for all the strains were 
examined (Figure 20A). The median genome size for all 103 sequences was 6,643,410 bp and six strains 
(RW109, RW146, RW130, RW131, Carb01-63 and RW172) were identified as outliers with larger 
genome sizes (Figure 20A). RW109 was found to have the largest genome size with 7,756,224 bp and was 
identified as the top outlier on Figure 20A. Five of the outliers were identified as industrial strains and 
Carb01-63 was a clinical strain with an unknown isolation source. Four of these outlying industrial strains 
(RW109, RW130, RW146 and RW172) had previously been identified as obtaining the 5 genes associated 
with a BpeEF-OprC efflux pump KEGG module (M00698) (Sections 3.2.3.2.2 and 3.2.6.4).       
The distribution of genome sizes were examined for the three different strain isolation sources (Figure 
20B); this comparative analysis excluded PA1RG, which was classified as both clinical and 
environmental, and the ATCC-13388 strain with an unknown source of isolation. The genome sizes of 
those isolated from an industrial setting were found to be larger than strains from a clinical and an 
environmental source (Figure 20 B and C). Strains isolated from an environmental setting were found to 
have the lowest genome size when compared to the other strain types. The mean sizes of the genomes 
were calculated (Figure 20C) and statistical analysis using a two-sample T-test (assuming unequal 
variances, as decided by the F-test), was performed to determine if the mean genome size of strains 
isolated from industry was significantly different to those obtained from a clinical and environmental 
setting. The industrial strains were found to have a significantly larger mean genome size when compared 
to the clinical strains (7,086,444 bp compared to 6,660,367 bp, p-value = 0.0020) and those isolated from 
an environmental setting (7,086,444 bp compared to 6,527,492 bp, p-value = 0.0002). 
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A)
B)
Strain type
Genome size (bp)
Median Mean 
Clinical 6,644,650 6,660,367
Environmental 6,453,808 6,527,492
Industrial 7,082,665 7,086,444
C)
RW109: 7,756,224 bp
RW146: 7,648,339 bp
RW130: 7,627,036 bp
RW131: 7,584,892 bp
Carb01-63: 7,497,593 bp
RW172: 7,448,884 bp
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Figure 20. Genome size distributions of 103 P. aeruginosa sequences of strains isolated from clinical, 
environmental and industrial sources 
 
The distribution of the genome sizes for the 103 P. aeruginosa sequences were visualised using boxplots 
which display the median (black horizontal line), upper quartile, lower quartile, maximum and minimum 
values. The mean values are also represented with a cross. Outliers are shown as open circles outside of the 
boxplots with the strain names and genome sizes indicated. A bloxplot to represent the genome size 
distribution of the 103 sequences combined are shown in A). The sequences were also divided into three 
boxplots (B) to indicate the genome sizes of the clinical strains (red, n = 66), environmental strains (green, n 
=19) and industrial (blue, n = 16).  The values for the median and mean genome sizes (bp) for the clinical, 
environmental and industrial strains are shown in panel C).   
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3.3 Discussion 
3.3.1 Obtaining a complete sequence of the industrial P. aeruginosa strain RW109 
When searching the literature with a combination of the keys words ‘Pseudomonas aeruginosa’, 
‘industrial contamination’, ‘home and personal care products’ and ‘whole genome sequencing’, no studies 
appear to have obtained a whole genome sequence of an industrial P. aeruginosa strain specifically 
isolated from a home and personal care product. In this project PacBio SMRT sequencing technology, was 
successfully used to acquire a complete genome of the industrial RW109 strain, which assembled into 
three contigs. The genome sequence provided a valuable insight into the characteristics of an industrial 
strain and detailed functional annotation was carried out using COG and KEGG. The antimicrobial 
resistance and virulence genes were classified and the genomic islands and phage sequences of the strain 
were identified. Determining these important features of a genome sequence is essential for in-depth 
transcriptomic investigations, which were also carried out with the industrial strain as part of this PhD 
project.  
RW109 was found to have a genome size of 7.8 Mbp, which is larger than the reported P. aeruginosa 
genome size range of 5.2 to 7.0 Mbp (Schmidt et al., 1996, Stover et al., 2000, Juhas et al., 2005, Winsor 
et al., 2016). The RW109 genome comprised a 7,049,347 bp main chromosome and two plasmids; 
555,265 bp were found in plasmid 1 was and plasmid 2 had 151,612 bp. The large genome size and the 
two additional plasmids may contribute to the ability of the RW109 strain to survive in industrial HPC 
products by encoding for additional genes. The genome size of the 103 P. aeruginosa sequences were 
compared and RW109 was found to have the largest number of bp. The mean genome size of the 16 
industrial strains was also found to be significantly higher when compared to those strains obtained from a 
clinical and environmental setting, suggesting larger genome size is indicative of a strain’s ability to reside 
within an industry setting. The numbers of genome sequences examined in this study were not however 
equal for the three different isolations sources; a greater number of industrial and environmental genome 
sequences need to be included in future analysis.  
Plasmid 1 of RW109 was found to have similar sequence similarity with two previously identified P. 
aeruginosa plasmids pOZ176 (Xiong et al., 2013) and pBM413 (Chen et al., 2016a, Botelho et al., 2017). 
The pOZ176 plasmid was identified in the clinical P. aeruginosa strain 96 isolated from a hospital setting 
in China. The pOZ176 plasmid was found to encode genes, which mediate carbapenem resistance, and 
was thought to have originated from an environmental source. The pBM413 plasmid was found in the 
clinical PA121617 strain isolated from CF sputum in China. When the pOZ176 and pBM413 plasmids 
were sequenced, they were described as the largest plasmids which had been isolated from P. aeruginosa 
(Xiong et al., 2013, Botelho et al., 2017). As both these plasmids were from strains isolated in clinical 
settings, it suggests that RW109 may have been acquired from a clinical source, providing the strain with 
plasmid associated antimicrobial resistance genes.  
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Contig 3 had similar sequence homology to the un-named plasmid from the environmental P. aeruginosa 
strain SO4 90 which was isolated from microbial mat material in Rotterdam, the Netherlands (Kraak and 
van der Zee, 2015). This suggests plasmid 3 may have been acquired by RW109 from an environmental 
source. The RW109 plasmids were only compared against P. aeruginosa plasmid sequences in this study; 
these plasmids may have been acquired from other bacterial species. For further classification of the 
plasmids, sequence comparisons need to be carried out against a larger collection of plasmid sequences 
across bacterial genera isolated from various settings. Searching databases such as the plasmid MLST 
collection may also help with characterisation of these industrial strain plasmids 
(https://pubmlst.org/plasmid). Additional work to increase the understanding of these plasmids and their 
importance in RW109’s capabilities as an industrial strain would be to experimentally remove them. This 
would determine the effect the plasmids have on the strain’s ability to grow in preservative formulations 
and HPC products. Additional plasmids in environmental P. aeruginosa isolates are related to heavy metal 
resistance (Raja and Selvam, 2009, Durve et al., 2013) and plasmids also have associations with increased 
tolerance to the industrial antimicrobials chlorhexidine, quaternary ammonium compounds, triclosan and 
formaldehyde (McDonnell and Russell, 1999). However when compared to antibiotic resistance, the role 
of plasmids in delivering increased resistance to industrial preservatives is not well established.   
3.3.2 Functional annotation of a P. aeruginosa strain isolated from an industrial setting 
The CDS of the RW109 genome were annotated with COG categories which provided the ability to 
investigate the functional classifications of the main chromosome and the two plasmids. The highest 
percentage of CDS within the well characterised COG categories of the main chromosome was in 
transcription (K= 7.75%) and the replication, recombination and repair (L) category was found to 
represent 9.00% and 14.00% of the CDS of plasmid 1 and 2 respectively. P. aeruginosa has previously 
been identified as having one of the largest transcriptional regulatory networks of those reported in 
bacteria (Galán-Vásquez et al., 2011, Balasubramanian et al., 2012, Coggan and Wolfgang, 2012); this 
defines P. aeruginosa capabilities as a metabolically versatile and virulent bacterium. The highest 
percentage of PA14 and PAO1 CDS were also found within the K COG category in this study and a large 
portion of genes associated with regulation was reported when the first genome P. aeruginosa genome 
(PAO1) was sequenced by (Stover et al., 2000);  highlighting the importance of the regulatory functional 
characteristic of P. aeruginosa. A substantial number of the L category CDS on plasmids 1 and 2 were 
found to be encoding transposases, a common characteristic of plasmids; presence of these mobile gene 
elements suggests these plasmids are suitable for transposition providing RW109 with the ability to adapt 
to various environments. The poorly characterised COG categories represented the biggest percentage of 
CDS within the main chromosome and the two plasmids. Overall 40.42% of the RW109 CDS were within 
the poorly characterised class whereas PA14 had 33.86% and PAO1 32.53% had CDS within this class; 
this suggests that more of the industrial strain CDS are of unknown function and these uncharacterised 
proteins may have a novel mechanism of action.  
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Due to the large genome size of RW109, the strain was found to have a greater number of CDS in 
seventeen of the twenty well-characterised COG categories when compared to PA14 and PAO1. This 
suggests that RW109 has a broader functional potential than the reference strains. RW109 had over 95% 
more CDS in the L category than the reference strains, which is owing to the large number of CDS on the 
two additional plasmids within this category. RW109 was found to have 20% more CDS in the 
intracellular trafficking, secretion, and vesicular transport (U) category compared to the reference strains. 
The high numbers of CDS found within the L and U COG categories highlights their importance in the 
lifestyle of RW109 industrial strain. A recent study carried out COG comparisons between clinical and 
environmental isolates of Burkholderia by counting the number of CDS per COG category (Peeters et al., 
2017). It demonstrated that isolates obtained from the environment were significantly enriched with the L 
and U COG categories when compared to clinical isolates, suggesting that the isolation source of bacteria 
has an effect on functional characteristics of a genome.   
The percentage distribution of the well characterised COG categories when compared to the genome size 
was also analysed and found to be similar in the three strains, with the K and amino acid transport and 
metabolism (E) categories having greatest percentage of CDS (Figure 16). This illustrates the functional 
importance of the K and E categories in the lifestyle of P. aeruginosa. The energy production and 
conversion (C) category had the third largest percentage of CDS for PA14 and PAO1 and this category 
was ranked fourth for RW109. The L category had the third largest percentage of CDS for RW109 
whereas for the reference strains, this category was ranked eleventh in the percentage distributions of the 
well-characterised COG categories. This difference between the two clinical strains and RW109 suggests 
that the biological functions of the CDS within the L category are important for a strain to adapt and 
endure industrial conditions.   
As a preliminary analysis of the RW109 genome, identifying the COG functional annotations provided a 
valuable insight into the strain’s biological functions and was important for comparative analysis with 
reference strains. The database is a universal tool which is regularly used for genome-scale analysis of 
protein functions and provides a consistent classification of bacterial genomes based on orthologous 
groups (Galperin et al., 2014)  Assigning COG categories also provides a classification method of 
grouping genes of interest identified in transcriptomic analysis. However due to the large size of the COG 
database, it is not regularly updated (Huerta-Cepas et al., 2016) which might explain the high percentage 
of CDS which were placed within the poorly characterised COG classes.                            
The KEGG database offers a larger actively maintained reference system for classifying biological 
systems (Kanehisa et al., 2017). This method of functional annotation was used to interpret the genome 
sequence of RW109 by determining biologically feasible KEGG modules within the strain. Across the 
whole genome, including the main chromosome and two plasmids, 171 biologically achievable KEGG 
modules were identified and found to be involved in a variety of functions; this suggests the strain has a 
high metabolic and physiological potential. The two-component regulatory system group was found to 
contain the greatest number of complete modules, which were all on the main chromosome of RW109. 
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The P. aeruginosa species has previously been reported to encompass a high number of two component 
regulatory systems which facilitate their ability to live in a variety of habitats (Gooderham and Hancock, 
2009, Stover et al., 2000, Rodrigue et al., 2000) and KEGG annotation identified 24 in RW109 (Table 7). 
Two component regulatory systems are used to sense and mediate responses to environmental stimuli by 
regulating target genes which have roles in antimicrobial resistance, virulence, quorum sensing and 
biofilm formation (Gooderham and Hancock, 2009, Stock et al., 2000, Mikkelsen et al., 2011b). When the 
RW109 plasmids were evaluated with KEGG, five out of the six modules identified on plasmid 1 were 
also found on the main chromosome, suggesting the plasmid contains duplicate copies of main 
chromosome genes. A multidrug resistance efflux pump BpeEF-OprC module (M00698) was found only 
in plasmid 1 of RW109 within GI-1 and plasmid 2 was found to have any biologically feasible KEGG 
modules.  
Using the ABRicate tool and BacMet database, RW109 was found to encode a high number of genes with 
predicted associations to antimicrobial resistance and virulence. This is supported by previous research 
demonstrating the ability of P. aeruginosa in producing a wide spectrum of virulence factors and 
antibiotic resistance capabilities (Jácome et al., 2012, Beceiro et al., 2013, Breidenstein et al., 2011). 
However, across all the 103 P. aeruginosa isolates analysed using the CARD database, the number of 
antibiotic genes was broadly equivalent. This suggests the industrial strains do not have additional 
predicted genomic capacity for antibiotic resistance and isolation source has limited impact on 
antimicrobial proficiency. These finding need to be assessed phenotypically with antibiotic susceptibility 
testing.   
Island Viewer predicted that the RW109 strain had 42 GIs on the main chromosome (Table 10), six on 
plasmid 1 and one in plasmid 2 (Table 11). GIs are important regions of interest within strains as they 
frequently contain virulence and antimicrobial resistance genes as well as contributing metabolic fitness 
(Bertelli et al., 2017). A high number of GIs is important for P. aeruginosa to survive and adapt to niche 
environments (Battle et al., 2008, Schmidt et al., 1996); they belong to the accessory genome and up to 
10% of an individual isolate’s genetic material can be made up of GIs (Spencer et al., 2003, Shen et al., 
2006). The high number of GIs identified in RW109 is consistent with other P. aeruginosa strains such as 
PSE9 which has been described as a hyper-virulent strain (Battle et al., 2008).   
The RW109 GIs contained a large amount of hypothetical proteins and the poorly characterised COG 
classes represented the highest number of GI CDS suggesting novel functions. GI-1 within plasmid 1 was 
of interest as it encoded for the KEGG BpeEF-OprC efflux pump module (M00698); this module was also 
biologically feasible in five other industrial contamination strains but was not identified in any of the other 
97 P. aeruginosa sequences examined. Genomic islands and phage sequences may also have a role as 
mobile genetic elements within the accessory genome of P. aeruginosa and are indicative of horizontal 
gene transfer during bacterial evolution (Li et al., 2016, Kung et al., 2010). RW109 was predicted to have 
five intact phage sequence regions which is comparable to other strains such as the clinical PA1 strain (Li 
et al, 2016) and the environmental isolates M18 (Wu et al., 2011) and YL84 (Chan et al., 2014). 
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Characterising the CDS of RW109 associated with antimicrobial resistance, virulence, GIs and phages, 
provides a valuable resource for further comparative genomics and transcriptomics work to distinguish 
genes important for survival within a niche industrial setting. 
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3.3.3 Notable functional annotations of the RW109 strain in comparison to the clinical reference 
strains PA14 and PAO1  
The RW109 whole genome sequence was compared to the annotated genome sequences of PA14 and 
PAO1 which represented well studied P. aeruginosa reference strains. The differences in COG functional 
annotations were previously discussed in Section 3.3.2. The KEGG module MCRs were evaluated, 
RW109 was found to contain 2 modules, which were not biologically feasible in PA14 and PAO1. These 
included the UhpB-UhpA two-component regulatory system (M00473) from the main chromosome and 
the multidrug resistance, efflux pump BpeEF-OprC (M00698) found on GI-1 of plasmid 1. The UhpB-
UhpA system is involved in the UhpT transport system of hexose phosphates and is commonly found in E. 
coli and Vibrio cholera  (V. cholera)  (Moisi et al., 2013, Yamamoto et al., 2005). When searching the 
literature the UhpB-UhpA system was not evidently classified as being a P. aeruginosa two-component 
system.  UhpT transports fosfomycin into the bacterial cell and inactivation of the regulatory genes uhpA 
and uhpB results in the down regulation of uhpT contributing to fosfomycin antibiotic resistance (Kadner 
and Shattuck-Eidens, 1983, Castañeda-García et al., 2013). A study which investigated the transport of 
fosfomycin in P. aeruginosa using a PA14 insertion mutant library identified a permease GlpT protein as 
the only mutational target involved in fosfomycin resistance (Castañeda-García et al., 2009). This suggests 
the UhpB-UhpA two-component regulatory system is not commonly found in P. aeruginosa strains. 
Another study which carried out a pan-genome wide analysis of 181 P. aeruginosa genomes identified one 
gene of the UhpB-UhpA system within the accessory genome (Mosquera-Rendón et al., 2016) further 
confirming the absence of this two competent regulatory system in P. aeruginosa. As UhpB-UhpA system 
was identified in RW109, it suggests this two component regulatory system may provide a functional role 
for survival in diverse environments such as those encountered in industry.  
The RW109 BpeEF-OprC efflux pump identified within GI-1 of plasmid 1, is a multi-drug efflux pump 
found in Burkholderia pseudomallei (B. pseudomallei) (Chan et al., 2004). It is linked to the resistance of 
clinical and environmental B. pseudomallei isolates to chloramphenicol and trimethoprim (Kumar et al., 
2006, Podnecky et al., 2013). This efflux pump was not identified in PA14 and PAO1 and when further 
analysis was carried out on the 102 P. aeruginosa genomes from Section 3.2.6, the genes encoding this 
efflux module were identified in only industrial strains isolated from contaminated dishwasher liquids. 
This suggests the efflux pump may provide protection against the industrial antimicrobials present within 
dishwasher liquids. These industrial P. aeruginosa strains may have acquired the efflux pump genes from 
a Burkholderia species which are also commonly found to contaminate HPC products (Russell, 2003c, 
Jimenez, 2007). Four out of the five industrial strains, which obtained this efflux pump, were also 
identified as having a larger genome sizes when compared to the panel of 103 P. aeruginosa sequences 
(Figure 20). Further work is required to determine if these industrial strains are carrying the BpeEF-OprC 
efflux pump genes on an additional plasmid similar to the one in RW109.   
One KEGG module was found to be biologically achievable in both PA14 and PAO1 but not in RW109 
and this was a central carbohydrate metabolism module involved in 5-phospho-α-ribosyl-1-pyrophosphate 
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(PRPP) biosynthesis (M00005). This metabolic pathway involves the ribose-phosphate diphosphokinase 
enzyme (K00948) which converts ribose 5-phosphate to PRPP, a ribose sugar required for purines and 
pyrimidines synthesis (Hove-Jensen et al., 2003, Kanehisa et al., 2017). This module is important for 
bacterial metabolism, suggesting that RW109 would have an alternative means of encoding for the ribose-
phosphate diphosphokinase enzyme; further interpretation of the genome is required to identify CDS in 
RW109 associated with this enzyme.  
The antimicrobial resistance genes of RW109 were predicted using the ABRicate tool and the BacMet 
database. ABRicate compares genome sequences against four well maintained antimicrobial resistance 
gene databases whereas BacMet has not been updated since 2014 but provides experimentally confirmed 
information about biocide and metal resistance genes. Using ABRicate, little differences were identified in 
the antimicrobial resistance genes between RW109 and the clinical reference strains. The only variation 
observed was with two beta lactamase encoding genes; RW109 and PAO1 were both found to have PCD-
1 and PA14 had the PCD-9 gene. The PCD-9 gene encodes for a beta lactamase which is capable of 
degrading an extended spectrum of antibiotics when compared to PCD-1 (Rodríguez-Martínez et al., 
2009). The BacMet database was used to compare RW109 with PA14 and PAO1 and the industrial strain 
was found to have nine additional genes associated with biocide and metal resistance with multiple 
antimicrobial functions; six of these genes were on plasmid 1. This suggests that the RW109 strain 
encompasses a clinical antimicrobial resistance profile similar to PA14 and PAO1 but also has additional 
genes, which are linked to biocide antimicrobial resistance.  
Comparative genomic analysis to determine differences in functional annotations between strains was a 
useful research method to identify candidate genes for further examination during transcriptomic analysis. 
For example, it would be interesting to establish if the genes encoding for the BpeEF-OprC efflux pump or 
the UhpB-UhpA two component regulatory system were differentially regulated in response to industrially 
relevant conditions.  
3.3.4 Core genome analysis of 103 P. aeruginosa genome sequences isolated from clinical, 
environmental and industrial sources 
The core genome comparison of the 103 P. aeruginosa sequences identified that isolation source had 
limited influence on the distributions of strains throughout the constructed phylogenetic tree as all three 
types of strains were found within the tree clades (Figure 18). This was previously shown in a whole 
genome multi locus sequence typing (MLST) profile analysis where strains isolated from clinical, 
environmental and industrial settings were also dispersed evenly throughout the network (Weiser, 2015). 
These results highlight that at a genomic level, isolation source does not result in specific niche sub-
groups in P. aeruginosa. The core-genome alignment did however identify the highest number of 
industrially isolated strains to fall within the sub-clade, which contained RW109 when compared to the 
others in the tree. This indicates these 6 industrial strains share a comparable core genome and may have 
originated from a similar origin. However, there were also 6 clinical strains within the sub-clade 
suggesting that a related core genome does not necessarily determine strain type. More industrial strains 
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were also were identified within clade 1 of the tree when compared to clade 2 suggesting found in clade 1 
share a similar core genome.  
The accessory genome of these strains may provide the essential genes required for living within either a 
clinical or industrial environment. It has previously been identified that P. aeruginosa strains obtain highly 
diverse genomes, even amongst closely related isolates (Mathee et al., 2008, Jun et al., 2015). The 5 
strains within the RW109 sub-clade may all be capable of living within a clinical or an industrial 
environment; their strain type was determined by their isolation source, but this may not be where they are 
only capable of residing. The numbers of genome sequences from the three isolation sources were not 
equal for the core genome analysis in this study; a higher number of the sequences were from strains 
isolated from a clinical setting (n = 66). This was due to the greater availability of sequenced clinical 
strains when compared to environmental (n = 19) and industrial isolates (n= 16). Potentially, if more 
environmental and industrial sequences were included, clustering within these particular strain types may 
be observed, as strains from the same source are likely to share a similar source of origin.    
The core genome alignment identified 2 major tree clades with the panel of 103 P. aeruginosa genome 
sequences. The tree was rooted with the PA7 genome sequence as its core genome was highly divergent 
when compared to the other sequences. The identification of two major groupings of P. aeruginosa whole 
genome sequences with the contrasting PA7 strain solely being placed into a separate third group, has 
previously been confirmed (Freschi et al., 2015).  
The CARD database was used to predict the presence and absence of antimicrobial genes across the 103 
P. aeruginosa genomes; small differences were observed between the genome sequences of the strains 
isolated from the different sources (Figure 19). When compared to the clinical strains, CARD did not 
identify any antimicrobial resistance genes within the quinolone, carbapenem, trimethoprim, macrolide 
and tetracycline efflux resistance functional groups for the industrial and environmental strain sequences. 
This suggests that these resistance genes may be more specific to survival in clinical settings rather than in 
the environment and industry. This analysis only included one antimicrobial resistance gene database and 
incorporating others may increase the accuracy of the predicted resistance profiles of the genome 
sequences. Further relevant analysis would be to search the genes of the 103 genome sequences using the 
BacMet database to determine if the industrial strains have a different biocide and metal gene resistance 
profile when compared to the clinical and environmental strains. In addition, functional screening for 
resistance traits associated with the predicted genes would be needed for a complete analysis of 
antimicrobial resistance. Interestingly the six industrial strains with the biologically achievable 
antimicrobial BpeEF-OprC efflux pump (M00698) did not all cluster within one sub-clade and were 
dispersed throughout the core-genome phylogenetic tree suggesting different sources of origins for these 
strains.  
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3.4 Conclusions  
 
The main conclusions from this detailed investigation of an industrial P. aeruginosa strain genome were 
as follows:  
 
1) A complete genome of the industrial RW109 strain was successfully obtained using PacBio 
SMRT sequencing technology.  
 
2) RW109 had a larger than average sized genome when compared to a panel of 102  P. aeruginosa 
genome sequences which were isolated from clinical, environmental and industrial sources; the 
7.8 Mbp genome comprised a main chromosome and two plasmids.  
 
3) A thorough functional annotation of RW109 was achieved using COG, KEGG, ABRicate and 
BacMet databases providing an accurate reference sequence for further transcriptomic analysis of 
the industrial strain (see Chapter 5).  
 
4) Comparative analysis with the clinical reference strains along with the pan-genome analysis of 
102 P. aeruginosa genome sequences identified important RW109 genes. Notable genes included 
those from a genomic island on plasmid 1encoding for a BpeEF-OprC efflux pump only identified 
as biologically achievable in industrial strains isolated from contaminated dishwasher liquids. 
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4. Use of an industrial P. aeruginosa mini-Tn5-luxCDABE mutant library to
investigate the genetic basis of preservative resistance
4.1 Introduction
Important research tools such as transposon mutant libraries, have been used to characterise the genetic 
basis of functional traits in P. aeruginosa, such as quorum sensing (Whiteley et al., 1999), swarming 
(Overhage et al., 2007) and antimicrobial resistance (Aires et al., 1999, McPhee et al., 2003, Lewenza et 
al., 2005) (Table 15). Transposition can be achieved by incorporating the reporter gene into transposon 
vectors such as mini-Tn5, and delivering on a pUT suicide plasmid by conjugation; due to the loss of the 
tnp gene after insertion, the transposon is stably integrated into the chromosome and inherited (Winson et 
al., 1998, De Lorenzo et al., 1990, Dehio and Meyer, 1997). The transposon results in knockout polar 
mutations of downstream genes in the same operon, generating a transcriptional fusion with a random 
bacterial gene (Weitz et al., 2001, Lewenza et al., 2005). Mutant libraries can be analysed to identify those 
with altered functional attributes in comparison to the wild-type strain. Key mutants can then be 
characterised to determine the genetic basis for their altered phenotype. A variety of promoterless 
reporters (lux, phoA, lacZ) can also be integrated into the transposon to generate measurable 
transcriptional or translational signals (Winson et al., 1998, Whiteley et al., 1999, Aendekerk et al., 2002).  
The luxCDABE operon developed from Photorhabdus luminescens, incorporates all the necessary genes 
for luminescence and requires only ATP from metabolically active cells for the encoded luciferase to emit 
light (Figure 21) (Winson et al., 1998, Meighen, 1994). Bioluminescent lux reporters provide a method of 
quantifying gene expression through the detection of light emission alterations in response to a particular 
stimuli (Su et al., 2011, Winson et al., 1998). A mini-Tn5-luxCDABE transposon ideally generates 
individual mutants which have the lux reporter infused within different genes (Lewenza et al., 2005). 
The resulting mutants can function as novel whole cell biosensors, allowing the measurement of 
luminescence change in response to environmental changes. This research tool provides a high-throughput 
and highly sensitive way of reporting gene expression. A multi-functional mini-Tn5-luxCDABE mutant 
library using the PAO1 P. aeruginosa strain was successfully constructed, with the resulting transposon 
insertion sites being evenly distributed throughout the genome (Lewenza et al., 2005). P. aeruginosa mini-
Tn5-luxCDABE mutant libraries have effectively been used to identify genes involved in the ability of the 
microorganism to swarm (Overhage et al., 2007) and were exploited in the classification of a PmrA-PmrB 
regulatory system relating to polymyxin resistance (McPhee et al., 2003) (Table 15).  
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Table 15. The use of transposon mutagenesis to identify the genetic basis of functional characteristics in P. aeruginosa   
Transposon mutagenesis Screening using transposon mutagenesis Identification of transposon insertion site Major research findings Reference 
Tn501 random insertion 
mutagenesis of P. aeruginosa 
PAO1. 
Random Tn501 tagging of the P. aeruginosa PAO1 
strain was carried out using a temperature sensitive 
pMT1000 plasmid derived from R68::Tn501. 
Mutants screened for resistance or hyper-
susceptibility to aminoglycosides by individual 
replication on Mueller Hinton agar plates containing 
0.5 or 16 µg of amikacin ml-1. 
A 7-kbp genomic fragment from strain PAO1 which 
contained the Tn501 insertion site from a mutant of 
interest was cloned into E. coli and the fragment was 
sequenced to identify insertion site.   
Identification of a mutant hyper-susceptible to 
aminoglycosides, tetracycline and 
erythromycin. Mutant of interest found to be 
deficient in the MexXY active efflux pump 
system.  
(Aires et al., 
1999) 
Tn5-B22 promoterless lacZ 
random transposon insertion 
mutagenesis in the chromosome 
of a                          P. 
aeruginosa (PAO-MW1) 
quorum sensing acyl-acyl-
homoserine lactone (HSL) 
synthesis mutant. 
Library constructed was screened to identify mutants 
showing acyl-HSL-dependent β-galactosidase 
expression using the lacZ reporter. Transcription of 
the Tn5-B22 lacZ within a quorum-sensing gene 
responds to an acyl-HSL signal as the transposon 
contains a promoterless lacZ and PAO-MW1 is a 
lasI, rhlI null mutant that does not make acyl-HSL 
signals.  
Arbitrary PCR was used to identify DNA sequences 
flanking Tn5-B22 insertions. Sequences that could not 
be identified by using this method were cloned into E. 
coli and sequenced.  
Identification of 39 quorum sensing-regulated 
genes, which code for putative virulence 
factors or production of secondary metabolites. 
(Whiteley et al., 
1999) 
Random Mini-Tn-phoA3 
transposon mutagenesis of P. 
aeruginosa strain PA59.20, a 
type III pyoverdine-producing 
strain. 
Mutants were screened by replica-plating on 
Casamino acid medium containing VOSO4 for the 
detection of Vanadium-sensitive mutants.  
An inverse PCR  was used to identify insertion sites, 
the method involved:   
 The isolation of genomic DNA,  
 Digestion with restriction enzymes (SmaI digestion) that 
cut once within the transposon but numerous times 
within the Pseudomonas genome.  
 Ligation to circularise all linear genomic fragments.  
 Ligated products amplified via PCR, which was 
followed by a nested PCR reaction.  
 Products of inverse PCR were sequenced.   
Identification of one mutant, which could not 
grow in the presence of VOSO4 and the 
transposon had inserted in a non-coding region 
upstream of a 4 gene cluster: mexGHI-opmD. 
This cluster is associated with a P. aeruginosa 
antibiotic efflux pump systems.  
(Aendekerk et 
al., 2002) 
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Bank of bioluminescent Mini-
Tn5 luxCDABE fusion strains in 
various P. aeruginosa strains.  
Constructed bioluminescent bank was screened for 
mutants with differential light emission expressions 
in response to high or low MgSO4 concentrations. 
This was used to identify regulatory systems in P. 
aeruginosa, which respond to varying MgSO4 levels.  
Interrupted genes were identified by two step 
arbitrarily primed PCR. In first round used a primer 
specific for the mini-Tn5 luxCDABE transposon and 
an ARB1 primer. Products from this PCR reaction 
were then used as the template in second round PCR, 
which used an ARB2 primer and same mini-Tn5 
luxCDABE primer from first round PCR.  
Screening for Mg2+ responsive promoters 
using the library of mini-Tn5 luxCDABE 
mutants identified a two-component regulatory 
system, PmrA-PmrB. This system regulates 
resistance to polymyxin B and cationic 
antimicrobial peptides.  
(McPhee et al., 
2003) 
pBTK30 mariner C9 mini-
transposon insertions in                 
P. aeruginosa retS null mutants.  
Mutants were used to screen for suppressors of 
distinct RetS-dependent phenotypes such as 
decreased hyper-adhesion and repression of the type 
III secretion system (TTSS) when grown on minimal 
and TTSS-inducing culture medium.  
Insertion sites were identified using two round 
arbitrary PCR and the amplified transposon-
chromosome junctions were sequenced using BTK30-
Seq. 
In suppressors of distinct RetS-dependent 
phenotypes, a high number of transposon 
insertions were found in the genes of the 
GacS/GacA/rsmZ regulatory pathway. This 
pathway functions as a multicomponent switch 
for the transition from acute colonisation to 
chronic infection.  
(Goodman et 
al., 2004) 
Whole genome random 
mutagenesis of PA01 using a 
bioluminescent Mini-Tn5 
luxCDABE reporter.  
  
The mini Tn5-luxCDABE-Tc transposon was 
exploited to create a multi-functional mutant library 
using the PAO1 P. aeruginosa strain. Differentially 
regulated novel genes were identified when exposed 
to magnesium and phosphate-limiting conditions.  
Insertion sites were mapped via a high-throughput 
inverse PCR similar to the one used by Aendekerk et 
al., 2002. Differences included using NarI restriction 
enzymes which cut once within the transposon but 
numerous times within the PA01 genome. Products of 
ligation were amplified using a PCR, which 
incorporated two outward-facing, transposon-specific 
primers. 
The genes identified through screening were 
mapped to wild-type genome and found to be 
involved in bacterial resistance to cationic 
antimicrobial peptides.  
(Lewenza et al., 
2005) 
Mini-Tn5-luxCDABE 
transposon PA01 mutant 
Library 
Use of library constructed by Lewenza et al., (2005) 
to screen for alterations in swarming motility. 5,000 
mutants were tested by growing on brain heart 
infusion agar plates containing 0.5% (wt/vol) Difco 
agar. Phenotypic screening was carried out on 36 
swarming-deficient mutants by analysing the 
swimming and twitching motility.  
Same inverse PCR used by Lewenza et al., (2005).  Tn5 insertions identified a variety of genes 
involved in P. aeruginosa swarming. The 
genes were found to be involved in the 
synthesis or function of flagellin, type IV 
pilus, in genes for the Xcp-related type II 
secretion system, and in regulatory, metabolic, 
chemosensory, and hypothetical genes with 
unknown functions. A high number of 
swarming-negative mutants also showed 
impairment in biofilm formation.  
(Overhage et 
al., 2007) 
Figure 21. A bioluminescent mini-Tn5-luxCDABE-Tc transposon 
The promoterless mini-Tn5-luxCDABE-Tc transposon can be exploited to identify mutants which respond to preservative exposure by monitoring changes in 
light emission over a set time period. The transposon used in this study contains a tetracycline (Tc) resistance cassette flanked by transcriptional and 
translational termination signals and a promoterless luxCDABE operon. All the genes required for bacterial bioluminescence are found within the operon so 
there is no requirement to add an exogenous substrate (Winson et al., 1998, Meighen, 1994). The luxAB genes encode the heterodimeric subunits of bacterial 
luciferase, whilst luxCDE encode proteins that make up a fatty acid reductase enzyme complex for synthesis of the long-chain fatty aldehyde luciferin 
substrate (Meighen, 1994). Bacterial luciferases emit light at 490 nm by catalysing the oxidation of reduced flavin mononucleotide (FMNH2) and the long-
chain aldehyde.  
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4.1.1 Aim and objectives 
 
The overall aim of this chapter was to investigate the genetic basis of industrial P. aeruginosa 
preservative resistance. This was achieved with the following objectives:  
 
1) Construct a mini-Tn5-luxCDABE mutant library within the industrially isolated RW109 P. 
aeruginosa strain. 
 
2) Develop a screening method to identify mutants with altered light emission responses when 
exposed to sub-lethal concentrations of industry relevant preservatives.   
 
3) Determine the putative gene function in mutants of interest.  
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4.2 Results  
4.2.1 Construction of a mini-Tn5-luxCDABE mutant library using an industrial P. aeruginosa 
strain 
 
4.2.1.1 Transconjugant selective media  
A broth assay was used to determine the MIC of the donor and recipient with the antibiotic Tc before 
further assessment with an agar dilution assay. The lowest Tc concentration which resulted in a >80% 
reduction when compared to growth in the control wells, was 25 µg/ml for the donor and 100 µg/ml for 
the recipient strain. The wells, which corresponded to the MIC values, demonstrated no signs of visible 
growth in the 96 well plates, supporting the MICs determined by the absorbance readings.                                                                               
An agar assay was used to evaluate concentrations and combinations of Tc and Pmx within TSA, in order 
to prevent growth of the donor and recipient strains, whilst allowing growth of the transconjugants. 
Selective plates, which contained Tc only at 150 µg/ml and Tc at 125 µg/ml, along with Pmx at 120 
units/ml, prevented the growth of both the donor and recipient. These selective TSA plates were then 
further assessed by plating 50 µl of re-suspended mating mixture at 10-0 – 10-3 dilution onto triplicate 
plates. The plates containing Tc only at 150 µg/ml with 10-1 dilution of the mating mixture resulted in 
around 50 and to 150 individual, evenly spread colonies, allowing for ease of transconjugant collection. 
As Tc only at 150 µg/ml prevents growth of both donor and recipient, this concentration was used within 
selective media during mutant bank construction. 
4.2.1.2 The RW109 lux tagged bioluminescent mutant bank  
An industrial P. aeruginosa strain RW109, was used to construct a mini-Tn5-luxCDABE mutant library by 
performing a bi-parental mating with an E. coli donor carrying the mini-Tn5 on the S17-1 λpir suicide 
plasmid pUT. In total 3,760 mutants were generated and stored in 96-well master plates (n=40 plates) at -
80 ºC. Each mutant was categorised based on the RLU measurements and mutants with light emission 
readings above 499 RLU represented 52.82% of the library. The transposon mutant library bioluminescent 
light emission categories, as described in Section 2.6.1.2, were represented as follows: category 1 (≥ 
1.00E+06 RLU) = 0.03% (1 mutant), category 2 (≥ 1.00E+05 RLU) = 11.81%, category 3 (≥ 1.00E+04 
RLU) = 15.05%, category 4 (≥ 1.00E+03 RLU) = 18.94%, category 5 (≥ 5.00E+02 RLU) = 6.99% and 
category 6 (≤ 4.99E+02 RLU) = 47.18%. A luxA PCR, as described in Section 2.6.2, was used to 
determine if mutants within the lowest light emission category 6 contained the luxCDABE transposon. Out 
of the 20 mutants tested across the library, 13 had a positive result and exhibited a light emission reading 
of ≥ 227 RLU. There were 2,272 mutants identified which had a light emission of ≥ 227 RLU with the 
following statistical characteristics, a mean of 45,184 RLU, a lower quartile of 1,092 and an upper quartile 
of 63,106 RLU.   
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RAPD PCR typing was also used to ensure the picked mutants from the transconjugant selective media, 
had the same genotype as the recipient RW109 strain and not the donor. Eighteen of the 2,272 mutants 
from various light emission categories were selected at random and run through a RAPD typing PCR. 
RAPD PCR banding patterns for the mutants and were compared against the lanes representing the 
recipient, donor and a negative control (Figure 22). All mutants analysed demonstrated a comparable 
banding pattern to the recipient strain, except for the one in lane 6, where no bands were visible (Figure 
22). This suggests that the selected mutants, with a comparable banding pattern to the positive control, had 
the same genotype as the wild type RW109 strain. No mutants evaluated had a banding pattern similar to 
donor strain, indicating the mutants did not have the genotype of the E.coli lux strain used in the bi-
parental mating procedure.  
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donor) and lane 21 the negative control. No bands were observed in lane 6.  
Figure 22. RAPD PCR gel for selected RW109 transposon mutants 
The lanes were arranged as follows; M represents the 2-Log DNA ladder (0.1-10.0 kb), 1 
contains the wild type RW109 (recipient strain), 2-18 show RW109 lux mutants arranged 
in order of increasing light emission category, lane 20 contains the E. coli (lux tagged 
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4.2.2 Optimising the preservative screening method to identify responding mutants 
Twelve mutants from across the mutant bank from light emission categories 1 – 5 were randomly selected, 
to choose an appropriate preservative concentration for identifying the maximum number of responding 
mutants during screening experiments. The preservatives BIT and POE were used to screen the mutant 
bank and the MICs for wild-type RW109 strain were determined as 0.00938% active for BIT and 0.5% 
active for POE using a broth doubling dilution assay, as described in Section 2.6.4. Each mutant was 
isolated from the master plates and screened as previously described in Section 2.6.5.2 with BIT and POE 
at 10%, 20%, 30%, 40% and 50% of the calculated MIC. Screening experiments were carried out twice 
using different mutant starting cultures and preservative stock solutions to obtain biological replicates, 
with each repeat having four technical replicates.  
4.2.2.1 Screening with BIT  
Screening with BIT at 20% of the calculated MIC resulted in the greatest number of mutants with a RLU-
fold increase or decrease in response to BIT. Figure 23 demonstrates mutants 8:E2, 15:D4 and 30:C5 
which had an increase (+1.29 fold), decrease (-0.59 fold) and minimal (-0.13 fold) RLU change 
respectively, when screened with 20% of the calculated BIT MIC. Screening with 10% of the calculated 
MIC resulted in the least change in RLU, whereas concentrations of 30%, 40% and 50% of the MIC 
resulted in an overall RLU-fold decrease. BIT at 20% of the MIC was chosen as an appropriate 
concentration to identify the maximum number of responding mutants during screening of the constructed 
master plates.  
4.2.2.2 Screening with POE  
POE exposure with all five screening concentrations resulted in an overall RLU fold decrease for the 
twelve mutants investigated. The mean RLU fold values for POE at 10%, 20%, 30%, 40% and 50% of the 
calculated MIC were -0.63, -0.68, -0.80, -0.83 and -0.87 respectively. It may have been possible that the 
12 mutants selected to optimise the screening concentration, did not represent genes up-regulated in 
response to POE exposure. It was decided to include POE in master plate screens at 20% of the calculated 
MIC to determine if a varied RLU response was observed when more mutants were exposed to POE. The 
concentration of 20% of the MIC was chosen for comparison with the screening concentration selected for 
BIT exposure. Eight master plates were screened with POE, (approximately 752 mutants) and a mean -
0.75-fold decrease was observed (data not shown), with not one mutant demonstrating an increase in RLU 
in response to POE exposure. It was decided to not include POE in further screening experiments as the 
results implied that the preservative was impairing the activity of the luxCDABE operon.  
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The box plots illustrate the light emission response of mutants 8:E2 (A), 15:D4 (B) and 30:C5 
(C) when exposed to BIT at 0%, 10%, 20%, 30%, 40% and 50% of the calculated MIC for 24 
hour. Centre lines show the medians; box limits indicate the 25th and 75th percentiles as 
determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 
75th percentiles, outliers are represented by dots. n = 8 sample points. The RLU fold change 
between readings taken for control (0% BIT) and BIT screening concentrations (% MIC) are 
also shown for each mutant.   
A)
B)
C)
Figure 23. Effect of BIT concentration on the RLU response of three mutants 
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4.2.3 Screening of the constructed mini-Tn5-luxCDABE mutant library to identify preservative 
responding mutants 
The 40 master plates in the transposon library were screened in triplicate with the preservative BIT at 20% 
of the calculated MIC for 24 hours, as previously described in section 2.6.5.1. The genes interrupted by 
the lux transposon were then identified in mutants isolated from the master plates to test for randomness of 
transposon insertion sites before embarking on individual mutant screens. In total 404 mutants of interest 
were isolated and -80ºC freezer stocks prepared. This included 204 with increased RLU measurements 
(≥0.4-fold RLU increase with a p-value ≤ 0.05; BIT positive responding mutants), 97 with decreased light 
emission (≥0.3-fold RLU decrease with a p-value ≤ 0.05; BIT negative responding mutants) and 103 with 
minimal change in light emission (fold change between -0.05 to +0.05 with a p-value ≥0.05; no significant 
RLU change mutants) when exposed to BIT for 24 hours. The fold RLU selection criteria used in this 
study may not represent true preservative responding mutants. However, it allowed isolation of a wide 
range of transconjugants that demonstrated various responses to BIT exposure.  
Out of the 204 BIT positive responding mutants, Figure 24 indicates the top ten with a significant RLU 
fold increase (p-value ≤ 0.05) during master plate screening. Mutant 33:F4 had the greatest RLU fold 
increase of +2.53 (p-value=0.0209) when exposed to BIT at 20% of the MIC for 24 hours. This suggests 
the transposon-disrupted gene was up-regulated in response to BIT exposure. BIT negative responding 
mutants represented 24.0% of those isolated from master plate screening, whereas 50.5% of the mutants 
isolated were BIT positive responders. Therefore, when identifying BIT negative mutants from the 
libraries, the threshold was lowered from ≥0.4-fold to a ≥0.3-fold RLU decrease, in order to isolate more 
with a decreased RLU response with BIT. Figure 25 illustrates the top ten mutants selected from the BIT 
master plate screen with a significant RLU fold decrease (p-value ≤ 0.05). Mutant 28:H11 had the greatest 
fold decrease of -0.98 (p=0.0088) when exposed to BIT for 24 hours. This suggests that the transposon-
disrupted gene was down-regulated in response to BIT exposure. When compared to the BIT positive 
mutants (Figure 24), the overall fold difference for BIT negative responding mutants was lower (Figure 
25).  
Mutants demonstrating minimal RLU fold changes when exposed to BIT for 24 hours were also isolated 
from master plate screening. These mutants were of interest to provide information regarding the RW109 
genes not differently regulated when exposed to the preservative. Minimal change mutants had a RLU fold 
changes between –0.05 to +0.05 and represented 25.5% of those isolated. Figure 26 illustrates the mutants 
with the minimal amount of RLU fold change when exposed to BIT for 24hours (p-value ≥0.05 – no 
significant RLU change). Mutant 9:B7 had the least change in light emission with a RLU fold change of -
0.0002 (p=0.9921), suggesting the transposon insertion gene did not have an altered gene expression in 
response to the preservative BIT.  
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Mutants were exposed to BIT at 20% of the calculated MIC within a master plate screen 
for 24 hours and RLU measurements taken. The top 3 mutants with a significant RLU 
fold increase were 33:E6 (A), 33:F4 (B) and 33:C7 (C). On the boxplots the centre lines 
show the medians and crosses represent the sample means; box limits indicate the 25th 
and 75th percentiles as determined by R software; whiskers extend 1.5 times the 
interquartile range from the 25th and 75th percentiles. n = 3 sample points. Panel D 
demonstrates the RLU fold change and p-values for the top ten BIT positive responding 
mutants.  
Figure 24. Box plots of mutants with a significant RLU fold increase when exposed to BIT 
for 24hours 
Mutant Identity Fold change p-value
33:E6 +2.53 0.0209
33:F4 +2.23 0.0135
33:C7 +2.10 0.0479
33:B7 +1.96 0.0446
33:D5 +1.79 0.0068
8:B11 +1.78 0.0019
4:B3 +1.63 0.0166
17:B11 +1.61 0.0407
17:D12 +1.49 0.0126
16:G4 +1.49 0.0076R
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Mutants were exposed to BIT at 20% of the calculated MIC within a master plate screen 
for 24 hours and RLU measurements taken. The top 3 mutants with a significant RLU fold 
decrease were 28:H11 (A), 28:C6 (B) and 8:E12 (C). On the box plots the centre lines 
show the medians and crosses represent the sample means; box limits indicate the 25th and 
75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile 
range from the 25th and 75th percentiles. n = 3 sample points. Panel D demonstrates the 
RLU fold change and p-values for the top ten BIT negative responding mutants.  
Mutant Identity Fold change p-value
28:H11 -0.98 0.0088
28:C6 -0.71 0.011
8:E12 -0.69 0.0145
39:H10 -0.66 0.0344
20:A7 -0.63 0.0048
4:E5 -0.60 0.0009
37:H9 -0.59 0.0092
27:H11 -0.58 0.0107
24:E10 -0.57 0.0007
17:E4 -0.53 0.0343
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Figure 25. Box plots of mutants with a significant RLU fold decrease when exposed to BIT 
for 24hours 
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Mutants were exposed to BIT at 20% of the calculated MIC within a master plate screen for 24 
hours and RLU measurements taken.  Three mutants with the least amount of RLU fold change 
were 9:B7 (A), 7:D7 (B) and 27:A6 (C). On the box plots the centre lines show the medians and 
crosses represent the sample means; box limits indicate the 25th and 75th percentiles as 
determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 
75th percentiles. n = 3 sample points. Panel D demonstrates the RLU fold change and p-values 
for mutants with the least amount of light emission alterations when exposed to BIT.  
Mutant Identity Fold change p-value
9:B7 -0.0002 0.9921
7:D7 +0.0013 0.9909
27:A6 +0.0005 0.9817
36:E1 -0.0008 0.9949
23:H11 -0.0010 0.9922
27:B9 +0.0021 0.8345
25:A6 +0.0023 0.9150
36:B10 -0.0048 0.9696
21:F7 +0.0043 0.9334
17:C2 +0.0052 0.9543R
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Figure 26. Box plots of mutants with no significant RLU fold change when exposed to BIT 
for 24hours 
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4.2.4 Identifying transposon insertion sites in isolated mutants of interest  
The most successful method for identifying transposon insertion sites in isolated mutants was the 
amplification and sequencing of the DNA flanking the left side of the transposon, as described in Section 
2.6.6. Lewenza et al. (2005) illustrates a method for amplifying and sequencing from the right side of the 
transposon when the left side fails to amplify and was described in Table 15. However when this PCR was 
adapted for this study, it proved unsuccessful and inconsistent. An arbitrary primed PCR as described by 
McPhee et al., (2003) and shown in Table 15, was also modified and tested with the RW109 lux mutants, 
but failed to work correctly.   
Out of the 404 mutants isolated, 157 demonstrated successful amplification with the transposon insertion 
site identification method (Section 2.6.6). The inverse PCR method, which focuses on the left side of the 
transposon, failed to work with the remaining 247 isolated mutants. The PCR conditions were further 
evaluated by altering the annealing temperatures and magnesium ion concentrations. However, no PCR 
products were identified, resulting in the insertion sites not being identified for these mutants.  
The resulting PCR products, which successfully amplified using the insertion identification method, were 
purified and sent away for sequencing. These represented 85 BIT positive mutants, 36 BIT negative 
mutants and 36 mutants with minimal RLU change in response to BIT. In total 53 distinct insertion sites 
were identified (Table 16, Table 17 and Table 18). Out of these mutants, 19 were classified only within 
BIT positive responding mutants, 16 represented only BIT negative responders and 14 were only 
identified within mutants with minimal RLU change when exposed to BIT.  
Four RW109 genes were identified as insertion sites in mutants from different BIT response categories 
and all encoded for hypothetical proteins. RW109_06287 was identified in 3 BIT positive mutants and 1 
minimal RLU change mutant (Table 16 and Table 18), RW109_04396 was found in 1 BIT positive mutant 
and 1 minimal RLU change mutant (Table 16 and Table 18) and RW109_05920 was identified in 1 BIT 
negative and 3 minimal RLU change mutants (Table 17 and Table 18). The RW109_07253 gene was 
identified in all 3 BIT response categories; in BIT positive and negative mutants it was found twice and in 
the minimal RLU change mutants it was identified nine times (Table 16, Table 17 and Table 18). 
Interestingly, the sequence obtained for the BIT negative mutant 25:H3 returned no significant hits when 
compared against the RW109 genome (Table 17).  
Table 16. Transposon-interrupted genes found in BIT positive mutants 
Footnotes: *Mutants with the highest RLU fold increase with identified transposon insertion sites; £ Insertion site RW109_01055 was found in 40 BIT positive mutants; # indicates mutant 
insertion sites identified in two different BIT response categories; ~ RW109_07253 encodes a hypothetical protein which was identified as an insertion site in BIT positive, negative and no 
change mutants.  
COG Category Mutant ID
Bioluminescence 
category
Master plate screening  
RLU Fold Change
Gene ID Gene annotation
Cell wall/membrane/envelope biogenesis (M) 31:B3 3 +0.46 RW109_06517 Small-conductance mechanosensitive channel
Energy production and conversion (C)
8:E2 3 +0.93
RW109_04996 Periplasmic nitrate reductase precursor
8:B11* 3 +1.78
Inorganic ion transport and metabolism (P)
32:G7 2 +1.23 RW109_05781 Bifunctional enzyme CysN/CysC
37:C5 3 +0.73 RW109_01716 Ferrous-iron efflux pump FieF
Amino acid transport and metabolism (E)
28:B12 3 +0.49 RW109_00596 D-glycero-beta-D-manno-heptose-1,7-bisphosphate 7-phosphatase
4:B3* (40 mutants in total) All category 4 +1.63  (Mean RLU fold change = +0.86) RW109_01055£ Bacterial extracellular solute-binding proteins, family 3
Post-translational modification, protein turnover, and chaperones (O)
3:B3 4 +0.63
RW109_01054 Modulator of FtsH protease HflK
3:B4 4 +0.8
28:G6 4 +0.52
RW109_04951 Quercetin 2,3-dioxygenase32:C10 2 +0.72
33:F2 3 +0.65
Transcription (K) 14:C4 2 +0.64 RW109_04041 Transcriptional regulator KdgR
Replication, recombination and repair (L) 37:D10 3 +0.77 RW109_06956 DNA-binding protein HU-beta
Function unknown (S)
26:F11 2 +0.58
RW109_06287 Hypothetical protein27:C9 2 +0.48
28:A12 2 +0.53
31:C5 2 +0.45
RW109_07276 Toxin co-regulated pilus biosynthesis protein Q37:A7 2 +0.6
27:E4 2 +0.58
11:E12 5 +0.99
RW109_07095 Hypothetical protein
13:C9 4 +0.86
13:G9 4 +0.9
13:F12 5 +0.87
16:F4 5 +1.03
16:G4 5 +1.49
16:F5 5 +1.15
16:G6 5 +1.12
37:D1 2 +0.83
RW109_05921 Hypothetical protein
37:B3 2 +0.7
37:E9 4 +1.00
37:G9 2 +0.47
38:G6 3 +0.47
38:C2 5 +0.6
RW109_07026 Hypothetical protein
38:E2 5 +0.45
38:G2 5 +0.55
38:A6 3 +0.56
10:F4 4 +0.64 RW109_04396# Hypothetical protein
24:H2 4 +0.45
RW109_00597 Hypothetical protein
29:A10 4 +0.53
8:D3 4 +0.75 RW109_05512 Hypothetical protein
9:C10 4 +0.71 RW109_06265 Hypothetical protein
12:A2 3 +0.42 RW109_07105 Endonuclease/Exonuclease/phosphatase family protein
22:C6 4 +0.45 RW109_00433 Fic/DOC family protein
Not similar to any COG
28:D10 2 +0.67
RW109_07253~ Hypothetical protein
28:F12 2 +0.68
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Table 17. Transposon-interrupted genes found in BIT negative mutants 
Footnotes: *Mutants with the highest RLU fold decrease with identified transposon insertion sites; # indicates mutant insertion sites identified in two different BIT response categories; 
~ RW109_07253 encodes a hypothetical protein which was identified as an insertion site in BIT positive, negative and no change mutants.  
COG Category Mutant ID
Bioluminescence 
category
Master plate screening 
RLU Fold Change
Gene ID Gene annotation
Carbohydrate transport and metabolism (G)
12:D11 3 -0.5
RW109_02629 Phosphogluconate dehydratase
14:C2 4 -0.33
8:E12* 2 -0.69 RW109_06768 Tripartite ATP-independent periplasmic transporters, DctQ component
Amino acid transport and metabolism (E) 12:B3 3 -0.41 RW109_06692 Glycine betaine transporter periplasmic subunit
Intracellular trafficking, secretion, and vesicular transport (U) 13:D11 3 -0.38 RW109_04175 Type I secretion system membrane fusion protein PrsE
Cell wall/membrane/envelope biogenesis (M) 13:A12 2 -0.48 RW109_05246 Cryptic autophosphorylating protein tyrosine kinase Etk
Inorganic ion transport and metabolism (P)
27:B2 3 -0.39
RW109_02452 Acid-activated urea channel
27:B7 3 -0.36
27:H8 3 -0.37
27:E11 3 -0.36
28:D2 3 -0.41
31:F2 3 -0.39
33:B8 3 -0.35
37:H9* 3 -0.59
Energy production and conversion (C) 18:A3 3 -0.47 RW109_04704 Cytochrome bo(3) ubiquinol oxidase subunit 1
Transcription (K) 38:A8 2 -0.48 RW109_06908 HTH-type transcriptional regulator PuuR
Function unknown (S)
22:C7 2 -0.34 RW109_05170 Putative metallo-hydrolase YycJ
27:F9 4 -0.54
RW109_00750 2-oxoglutarate-dependent ethylene/succinate-forming enzyme27:H11* 3 -0.58
31:H4 4 -0.47
24:E11 3 -0.42
RW109_00047 PhoD-like phosphatase24:F11 3 -0.42
24:F12 2 -0.39
15:H1 2 -0.44
RW109_04388 Phosphoenolpyruvate synthase regulatory protein
16:C10 2 -0.5
No COG
15:D4 4 -0.45 RW109_03550 Hemolysin precursor
28:H12 2 -0.98
RW109_07253~ Hypothetical protein
36:D12 2 -0.33
30:A11 4 -0.38 RW109_05920# Hypothetical protein
4:E5* 3 -0.6 RW109_00153 Cyclic AMP receptor-like protein
37:D12 3 -0.52
RW109_00117 Hypothetical protein38:A2 3 -0.48
38:H3 4 -0.53
38:D7 3 -0.37
RW109_02284 Hypothetical protein
38:C9 3 -0.43
N/A 25:H3 4 -0.48 No Significat hits No Significant hits 
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 Table 18. Transposon-interrupted genes found in mutants with minimal RLU change in response to BIT  
Footnotes: # indicates mutant insertion sites identified in two different BIT response categories; ~ RW109_07253 encodes a hypothetical protein which was identified as an insertion site in 
BIT positive, negative and no change mutants.  
COG Category Mutant ID
Bioluminescence 
category
Master plate screening          
RLU Fold Change
Gene ID Gene annotation
Amino acid transport and metabolism (E) 37:F6 1 +0.0539 RW109_05316 Phenylalanine-4-hydroxylase
Intracellular trafficking, secretion, and vesicular transport (U) 2:A2 5 +0.018 RW109_07271 Toxin coregulated pilus biosynthesis protein E
Defense mechanisms (V) 1:E6 4 +0.0077 RW109_04032 Multidrug efflux pump subunit AcrB
Nucleotide transport and metabolism (F)
26:D11 3 +0.0318
RW109_06702 8-oxoguanine deaminase28:D5 3 +0.0229
31:F3 3 +0.0299
Replication, recombination and repair (L)
29:F7 4 -0.0127
RW109_06040 DNA topoisomerase 1
34:A11 4 +0.0093
Post-translational modification, protein turnover, and chaperones (O) 39:C12 3 +0.0108 RW109_00874 Metalloprotease LoiP precursor
Transcription (K)
37:F8 4 -0.0119 RW109_05312 HTH-type transcriptional regulator DmlR
7:E7 2 +0.02 RW109_06238 HTH-type transcriptional repressor YcgE
38:B3 2 +0.0251 RW109_02216 Oxygen regulatory protein NreC
Function unknown (S)
27:G6 4 +0.0383
RW109_03466 Translocation and assembly module TamB
28:D4 4 +0.0103
28:H9 4 +0.0213
29:A11 4 +0.024
32:D8 4 +0.055
28:C11 3 +0.0201
RW109_02100 Hypothetical protein
29:E11 3 +0.0315
30:A11 4 +0.0422
RW109_05920# Hypothetical protein31:C4 3 +0.0232
32:G12 4 +0.0495
9:B7 4 -0.0002 RW109_04396# Hypothetical protein
28:G5 4 +0.0379 RW109_06261 Hypothetical protein
31:B8 4 +0.0307 RW109_00038 Hypothetical protein
39:D8 3 -0.0142 RW109_06955 Hypothetical protein
27:C7 4 +0.0161 RW109_06287# Hypothetical protein
No COG
23:H11 2 -0.001
RW109_07253~ Hypothetical protein
24:A11 2 +0.0243
27:B9 2 +0.0021
29:C11 2 +0.0501
29:G6 2 -0.0372
30:G5 2 -0.0222
31:B6 2 +0.0417
31:D11 2 +0.047
37:C7 2 +0.0274
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4.2.5 The COG category distributions of identified transposon interrupted genes 
The transposon insertion site genes were categorised based on the Clusters of Orthologous Groups (COGs) 
annotation of the RW109 strain (Chapter 3, Section 3.2.3.1) and 13 COG clusters were determined (Figure 
27). Out of the 53 distinct insertion sites, 49.06% were represented by the poorly characterised COG 
category (S and No COG), with 16 out of 26 encoding for hypothetical proteins. The other 10 poorly 
characterised insertion sites had predicted Prokka annotations as illustrated in Table 16, Table 17 and 
Table 18. COG category distribution comparisons of mutant insertion sites, did not include the 4 
hypothetical protein encoding genes identified in more than one BIT response group (Section 4.2.4). BIT 
positive responding mutants represented the highest number of poorly characterised (S and No COG) 
insertions sites (n=9), followed by BIT negative mutants (n=8) and mutants with minimal RLU change 
(n=5).  
Within the well-characterised COG groups, BIT positive mutants were associated with 7 categories 
(Figure 27). These included, inorganic ion transport and metabolism (n=2), amino acid transport and 
metabolism (n=2), post-translational modification, protein turnover, and chaperones (n=2), cell 
wall/membrane/envelope biogenesis (n=1), energy production and conversion (n=1), transcription (n=1), 
replication, recombination and repair (n=1). Seven COG categories were also identified in BIT negative 
mutants (Figure 27) and these included, carbohydrate transport and metabolism (n=2), intracellular 
trafficking, secretion, and vesicular transport (n=1), cell wall/membrane/envelope biogenesis (n=1), 
energy production and conversion (n=1), transcription (n=1), inorganic ion transport and metabolism 
(n=1) and amino acid transport and metabolism (n=1). Mutants with minimal RLU change when exposed 
to BIT were also linked to 7 COG categories (Figure 27). These included transcription (n=3), defence 
mechanisms (n=1), nucleotide transport and metabolism (n=1), replication, recombination and repair 
(n=1), post-translational modification, protein turnover, and chaperones (n=1), intracellular trafficking, 
secretion, and vesicular transport (n=1) and amino acid transport and metabolism (n=1).  
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Figure 27. The distribution of identified transposon interrupted genes based on COG categories 
COG Category
0 2 4 6 8 10 12 14 16 18
Defense mechanisms
Nucleotide transport and metabolism
Replication, recombination and repair
Post-translational modification, protein turnover, and chaperones
Intracellular trafficking, secretion, and vesicular transport
Cell wall/membrane/envelope biogenesis
Energy production and conversion
Transcription
Inorganic ion transport and metabolism
Amino acid transport and metabolism
Carbohydrate transport and metabolism
No COG
Function unknown
Number of mutants insertion sites
BIT Positive BIT Negative Minimal RLU Change
The green bars r
Section 4.2.4 wh
epresent transposon interrupted genes from mutants with a RLU fold increase (BIT positive), blue bars correspond to genes where a RLU fold decrease was 
observed (BIT negative) and yellow bars show genes from mutants with minimal RLU change in response to BIT. This analysis does not include the 4 insertion sites 
highlighted in ich were classified in mutants from different BIT response categories. 
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4.2.6 Distribution of the distinct transposon insertion sites throughout the RW109 whole 
genome 
Out of the 53 distinct insertion sites, 45 were identified on the main chromosome.  With the exception of a 
large region between ~2.2 and 2.9 Mbp, the 45 insertion sites were evenly distributed throughout the 
RW109 main chromosome (Figure 28). Mutant insertion sites were also found on the plasmids, with 5 on 
plasmid 1 and 3 on plasmid 2.  
The 3 insertion sites identified on plasmid 2, encoded for a hypothetical protein (RW109_07253) and the 
toxin co-regulated pilus biosynthesis proteins E and Q (RW109_07271 and RW109_07276, respectively). 
RW109_07253 and RW109_07276 were classified within the poorly characterised COG category and 
RW109_07271 was annotated within the intracellular trafficking, secretion and vesicular transport (U) 
COG category. The RW109_07253 gene, was a previously noted insertion site, identified in mutants from 
three different BIT response categories (Section 4.2.4). The genes encoding for the two toxin co-regulated 
pilus biosynthesis proteins were not classified within the same BIT response group. The RW109_07271 
gene was identified in a mutant with minimal RLU change in response to BIT ( Table 18) and 3 BIT 
positive mutants were identified with insertion sites in the RW109_07276 gene (Table 16). The 
RW109_07271 gene was identified within a predicted operon on RW109 plasmid 2. This operon had high 
sequence similarity to a P. aeruginosa S04 90 plasmid type II secretion system and RW109_07276 was 
also found in close proximity to this operon (Chapter 3, Section 3.2.3.1.4).   
 
On plasmid 1, the 5 insertion sites genes encoded 2 hypothetical proteins (RW109_00038 and 
RW109_00117), a PhoD-like phosphatase (RW109_00047), a Cyclic AMP receptor-like protein 
(RW109_00153) and a Fic/DOC family protein (RW109_00433). All plasmid 1 transposon insertion 
genes were classified within the poorly characterised COG categories. The RW109_00047 and 
RW109_00117 genes were both identified within 3 BIT negative mutants and RW109_00153 was found 
within 1 BIT negative mutant (Table 17). RW109_00433 was classified within 1 BIT positive mutant 
(Table 16) and RW109_00038 was found in a mutant with minimal RLU change in response to BIT   
 ( Table 18).                               
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Figure 28. Distribution of the distinct lux transposon insertion sites throughput the main chromosome of RW109 
On the main chromosome of RW109, 45 distinct transposon insertion sites were identified. On the map from the outermost circle and moving inwards the following 
tracks were identified: (1) predicted CDS on forward strand coloured according to COG categories, (2) predicted CDS on reverse strand coloured according to COG 
categories, (3) transposon insertion sites indicated by blue arrows, (4) GC content (black), (5) positive and negative GC skew (green and purple, respectively) and (6) 
genome region by mbp. The size of the main chromosome was not drawn to scale. 
*2 indicates two genes in close proximity 
with lux insertions
*4 indicates four genes in close proximity 
with lux insertions
*2
*2
*4
*2
*2
*2
*2
*2
*2
Main Chromosome
7,049,347 bp
RW109_01054-01055: Modulator of  FtsH protease Hf lK and 
bacterial extracellular solute binding proteins f amily  3
Low density  insertion site region
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4.2.7 Key insertion sites of BIT positive responding mutants 
 
Out of the 85 BIT positive mutants which had successful inverse PCR amplification, 40 had transposon 
insertion sites in a gene encoding for the bacterial extracellular solute binding proteins family 3 (gene 
locus: RW109_01055). This protein has multiple functions which include chemoreceptors, components of 
molecular transport systems and initiators of signal transduction pathways (Tam and Saier, 1993, Sauer 
and Camper, 2001). The location of this insertion site in RW109 was also indicated in Figure 28. A mean 
RLU fold increase of +0.86 was observed for the 40 mutants, which were all from bioluminescence 
category 4. Of the mutants identified with this insertion site, 4:B3 had the greatest RLU increase of +1.63-
fold (p-value ≤ 0.05) (Table 16). Mutant 4:B3 was also screened with BIT individually, as previously 
described in Section 2.6.5.2, to ensure a reproducible RLU response and a +1.79-RLU fold increase was 
observed (p-value ≤ 0.05) (Figure 29). In this study gene operons were predicted using the Pseudomonas 
database DIAMOND BLASTP tool (Winsor et al., 2016). 
Two BIT positive mutants 3:B3 and 3:B4, were found to have transposon insertion sites in the gene locus 
RW109_01054, which encodes a modulator of FtsH protease HflK. This gene was located within the same 
three-gene operon as the bacterial extracellular solute binding proteins family 3 (Figure 29). The position 
for this gene within RW109 was also indicated in Figure 28. When mutants 3:B3 and 3:B4 were exposed 
to BIT for 24 hours in a master plate, a +0.63 and +0.80 fold RLU increase was observed respectively (p-
value ≤ 0.05) (Table 16). The RLU response of 3:B4 when exposed to BIT was found to be reproducible 
when the mutant was screened individually (Figure 29). The gene product HflK has previously been 
associated with tobramycin antibiotic resistance in P. aeruginosa (Hinz et al., 2011). Results observed 
from the mutants suggest the genes encoding for the bacterial extracellular solute binding proteins family 
3 and modulator of FtsH protease (HflK) were up-regulated when exposed to BIT at 20% of the MIC.  
 Figure 29. The luxCDABE transposon mutation of genes encoding a bacterial extracellular solute-binding transport system operon and their RLU 
responses when exposed to BIT for 24 hours 
The schematic (A) shows the arrangement of three genes within an operon encoding proteins of a bacterial extracellular solute-binding transport system 
(loci: RW109_01052-01056). Each gene is drawn to the scale given by the 1 kb bar. The putative products of the genes are shown by the colour coded 
key, and the site of transposon-insertion for mutants 4:B4 and 3:B4 are labelled; both these mutants were found to be BIT positive.  
Box plots of mutants 4:B4 (B) and 3:B4 (C) indicates the change in light emission when exposed to BIT for 24 hours. Centre lines show the medians 
and crosses represent the sample means; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the 
interquartile range from the 25th and 75th percentiles (n= 4 sample points). The RLU fold changes and corresponding p-values are indicated next to the 
box plots.  
4:B3
Fold change: +1.79 
(p-value = 0.0183)
3:B4
Fold change: +0.80 
(p-value = 0.0043)
A)
B)
RW109_01054 Modulator of FtsH protease HflK
RW109_01055 Bacterial extracellular solute-binding proteins family 3
RW109_01053 Hypothetical protein
1 kb
4:B3 luxCDABE transposon mutation
3:B4 luxCDABE transposon mutation
RW109_01052 Low-affinity inorganic phosphate transporter 1
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Mutant 14:C4 when exposed to BIT in a master plate screen demonstrated a +0.64-fold RLU increase (p-
value ≤ 0.05) (Table 16). When 14:C4 was isolated and revived on TSA an overproduction of a red/brown 
pigment was observed which was not detected with the wild-type strain and other isolated mutants (Figure 
30). P. aeruginosa produces a red/brown pigment called pyorubin when under oxidative stress conditions 
(Ferguson et al., 2007) and this pigment is produced by highly virulent clinical strains (Kaleli et al., 2007, 
Rajyaguru et al., 2014). The transposon insertion site was identified in a gene encoding for a 
transcriptional regulator (KdgR) (gene locus: RW109_04041) and was directly located next to the 
gnyRDBHAL gene operon (loci: RW109_04035-04040) (Figure 31). This gene operon is involved in 
acyclic isoprenoid degradation (Diaz-Perez et al., 2004, Förster-Fromme et al., 2006) and isoprenoids have 
previously been associated with bacterial pigment production (Cañizares-Villanueva et al., 1997, Saha et 
al., 2008). When 14:C4 was screened with BIT as an individual mutant, a greater RLU fold increase of 
+1.78-fold RLU was observed (p-value ≤ 0.05) when compared to the result obtained from master plate
screening (Figure 31 and Table 16). The increased light emission demonstrated with this mutant, suggests 
the transposon insertion gene was up-regulated in response to BIT at 20% of the MIC.  
Another mutant of interest identified from the BIT master plate screening was 8:B11, where a +1.78-fold 
RLU was observed (p-value ≤ 0.05). This was the largest RLU fold increase observed during master plate 
screening with a BIT positive mutant (Table 16). The transposon insertion site was identified in the 
periplasmic nitrate reductase precursor, napA gene (RW109_04996) of the napEFDABC operon (loci: 
RW109_04993-04998) (Figure 32). This operon functions in the anaerobic regulatory network for P. 
aeruginosa nitrate respiration under anoxic conditions (Schreiber et al., 2007, Van Alst et al., 2009). 
Growth conditions within a biofilm are characterised as anoxic especially within the cystic fibrosis lung 
(Van Alst et al., 2007). When this mutant was screened individually with BIT, a +2.33-fold RLU increase 
was observed (p-value ≤ 0.05), which was a greater fold change when compared to the master plate 
screening result (Figure 32 and Table 16). The RLU-fold increase observed with 8:B11 suggests the napA 
gene, within the napEFDABC operon, was up-regulated during exposure to the preservative BIT at 20% of 
the MIC.  
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A) B)
Figure 30. The overproduction of a brown/red pigment by the BIT positive mutant 
14:C4 
The wild-type RW109 strain (A) and a BIT positive transposon mutant 14:C4 (B) were 
both grown for 24 hours at 30°C on TSA. When compared to A, the mutant shown in B 
was found to overproduce a brown/red pigment.  
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The schematic shows the site of transposon-insertion for the BIT positive mutant 14:C4 (A). The transposon mutation gene is located directly next to 
the gnyRDBHAL gene operon (loci: RW109_04035-04040) which is involved in acyclic isoprenoid degradation. Each gene is drawn to the scale given 
by the 1 kb bar and the putative products are shown by the colour coded key. A box plot of 14:C4 (B) indicates the change in light emission when 
exposed to BIT for 24 hours. Centre lines show the medians and crosses represent the sample means; box limits indicate the 25th and 75th percentiles 
as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles (n= 4 sample points). The RLU fold 
change and corresponding p-value is shown next to the box plot.   
14:C4
Fold change: +1.78
(p-value = 0.0003) 
A) B)
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14:C4 luxCDABE transposon mutation
RW109_04035 Regulatory gene of the gnyRDBHAL cluster, GnyR
RW109_04036-04040 gnyDBHAL operon
RW109_04041 Transcriptional regulator, KdgR
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Figure 31. The luxCDABE transposon mutation of the gene encoding a KdgR transcriptional regulator 
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  The schematic shows the site of transposon-insertion for mutant 8:B11 (A) which was found to be BIT positive. The transposon mutation gene is located 
in the napA gene of the napEFDABC operon (loci: RW109_04993-04998) which is part of the anaerobic regulatory network for P. aeruginosa nitrate 
respiration. Each gene is drawn to the scale given by the 1 kb bar and the putative products are shown by the colour coded key. A box plot of 8:B11 (B) 
indicates the change in light emission when exposed to BIT for 24 hours. Centre lines show the medians and crosses represent the sample means; box 
limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th 
percentiles (n= 4 sample points). The RLU fold change and corresponding p-value is shown next to the box plot.   
Figure 32. The luxCDABE transposon mutation of the gene within the napEFDABC operon 
RW109_04999 Membrane-bound lytic murein transglycosylase B precursor
1 kb
8:B11 luxCDABE transposon mutation
RW109_04993-04998 napEFDABC gene operon 
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A transposon insertion site in a gene encoding for an efflux pump was also identified during master plate 
screening with BIT. The mutant 37:C5 was found to increase RLU by +0.73-fold (p-value ≤ 0.05) (Table 
16) and its insertion site was found within a ferrous-iron efflux pump, FieF (loci RW109_01716) (Figure 
33). FieF is an iron-efflux transporter, which is responsible for iron detoxification (Grass et al., 2005). 
When 37:C5 was screened individually with BIT, a +2.09-fold RLU increase was observed (p-value ≤ 
0.05), which was a greater fold change when compared to the master plate screening result (Figure 33 and 
Table 16). The RLU-fold induction observed with this mutant, suggests the FieF efflux pump was up-
regulated during exposure to the preservative BIT at 20% of the MIC.   
A gene encoding for a bi-functional enzyme CysN, (RW109_05781) was identified as the insertion site for 
the BIT positive mutant 32:G7. A RLU fold increase of +1.23 (p-value ≤ 0.05) was observed when the 
mutant was screened within a master plate (Table 16). The enzyme encoded by this gene functions in the 
metabolism of sulphur in P. aeruginosa within the cysND operon (Hummerjohann et al., 1998). When 
screened individually, a +1.70-fold RLU increase was observed (p-value ≤ 0.05) (Figure 34), suggesting 
that this insertion site gene was up-regulated in response to the preservative BIT at 20% of the MIC.   
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The schematic shows the site of transposon-insertion for mutant 37:C5 (A) which was found to be BIT positive. The transposon mutation is located in a 
gene encoding a ferrous-iron efflux pump FieF (loci: RW109_01716) which is involved in metal cation transportation. Each gene is drawn to the scale 
given by the 1 kb bar and the putative products are shown by the colour coded key. A box plot of 37:C5 (B) indicates the change in light emission when 
exposed to BIT for 24 hours. Centre lines show the medians and crosses represent the sample means; box limits indicate the 25th and 75th percentiles as 
determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles (n= 4 sample points). The RLU fold 
change and corresponding p-value is shown next to the box plot.   
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Fold change: +2.09 
P-value (0.0064)
A)
B)
1 kb
37:C5 luxCDABE transposon mutation
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Figure 33. The luxCDABE transposon mutation of a gene encoding a ferrous-iron efflux pump 
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32:G7
Fold change: +1.70
(p-value = 0.0037)  
A) B)
R
e
la
ti
v
e
 L
ig
h
t 
U
n
it
s
 (
R
L
U
)
1 kb
32:G7 luxCDABE transposon mutation
RW109_05781-05782 cysND gene operon 
RW109_05783 Membrane-bound lytic murein transglycosylase B precursor
RW109_05780 Hypothetical protein
The schematic shows the site of transposon-insertion for mutant 32:G7 (A) which was found to be BIT positive. The transposon mutation is located in a 
gene encoding a bifunctional enzyme CysN within a cysND gene operon (loci: RW109_05781-05782), involved in sulphur metabolism. Each gene is 
drawn to the scale given by the 1 kb bar and the putative products are shown by the colour coded key. A box plot of 32:G7 (B) indicates the change in light 
emission when exposed to BIT for 24 hours. Centre lines show the medians and crosses represent the sample means; box limits indicate the 25th and 75th 
percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles (n= 4 sample points). The 
RLU fold change and corresponding p-value is shown next to the box plot.   
Figure 34. The luxCDABE transposon mutation of gene encoding a bifunctional enzyme CysN 
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4.2.8 Key insertion sites of BIT negative mutants and mutants with minimal RLU change in 
response to BIT 
Eight BIT negative mutants had a transposon insertion site identified within a gene encoding an acid 
activated urea channel (gene locus RW109_02452) which was located next to the amiEBCR gene operon 
(Figure 35). Acid activated urea channels are involved in the transport of urea across the cytoplasmic 
membrane (Sangari et al., 2010) and the amiEBCR gene operon produces the amidase enzyme in response 
to short chain aliphatic amides, such as acetamide (Kelly and Clarke, 1962, Wilson et al., 1995). A mean 
RLU fold decrease of -0.40 (p-value ≤ 0.05) was identified for the 8 mutants which were all from 
bioluminescence category 3. Mutant 37:H9 had the greatest RLU fold decrease of -0.59 (p-value ≤ 0.05) 
(Table 17); when this mutant was screened with BIT individually, a -0.80-fold decrease in RLU was 
observed (p-value ≤ 0.05) (Figure 35). This suggests the gene encoding for the acid activated urea 
channel, was down-regulated in response to exposure with the preservative BIT at 20% of the MIC.  
Mutant 8:E12 had the third greatest RLU-fold decrease when exposed to BIT during master plate 
screening, with a -0.69-fold RLU reduction observed (p-value ≤ 0.05) (Table 17). The transposon insertion 
site gene within this mutant encoded for a tripartite ATP-independent periplasmic (TRAP) transporters 
DctQ component (gene locus RW109_06768) (Figure 36). TRAP transporters are substrate-binding, 
protein-dependent secondary transporters (Mulligan et al., 2011) and DctQ component is essential for 
transport of C4-dicarboxylates such as malate, succinate, and fumarate (Kelly and Thomas, 2001, Forward 
et al., 1997). When 8:E12 was screened individually with BIT, a -0.62 RLU fold decrease was observed 
(p-value ≤ 0.05) (Figure 36), suggesting the gene encoding the DctQ component of the TRAP operon was 
down-regulated in response to BIT exposure. 
Mutant 1:E6 had no significant RLU fold change when exposed to BIT within a master plate screen 
(+0.0077 fold change, p-value ≥ 0.05) ( Table 18) and the transposon insertion site gene encoded for an 
AcrB efflux pump subunit (gene locus: RW109_04032) of a multidrug efflux pump  (Figure 37). The gene 
was identified within the multidrug efflux pump acrEB operon (gene loci RW109_04031-04032) which is 
part of the Resistance-Nodulation-Division (RND) superfamily of efflux pumps (Nikaido and Takatsuka, 
2009). The AcrB subunit acts as an efflux transporter located within the inner membrane (Poole, 2004, 
Poole, 2005b). When this mutant was screened individually, no significant RLU fold change was observed 
(+0.0379 RLU fold, p-value ≥ 0.05) (Figure 37). This suggests that the gene insertion site within the AcrB 
efflux pump sub-unit had no change in expression during exposure to the preservative BIT at 20% of the 
MIC.    
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The schematic shows the site of transposon-insertion for mutant 37:H9 (A) which was found to be BIT negative. The transposon mutation gene was 
annotated as an acid active urea channel (loci: RW109_02452). This gene was located next to the amiEBCR gene operon (loci: RW109_02448-
02451). Each gene is drawn to the scale given by the 1 kb bar and the putative products are shown by the colour coded key. A box plot of 37:H9 (B) 
indicates the change in light emission when exposed to BIT for 24 hours. Centre lines show the medians and crosses represent the sample means; box 
limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th 
percentiles (n= 4 sample points). The RLU fold change and corresponding p-value is shown next to the box plot.   
Figure 35. The luxCDABE transposon mutation of a gene encoding for an acid-activated urea channel 
37:H9
Fold change: -0.80 
P-value (0.0021)
A) B)
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37:H9 luxCDABE transposon mutation
RW109_02448-02451  amiEBCR gene operon 
RW109_02453 Fucose-binding lectin II PA-IIL
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8:E12 luxCDABE transposon mutation
RW109_06767-06769 Tripartite ATP-independent periplasmic transporter (TRAP) operon
RW109_06770  Arginine-ornithine antiporter 
RW109_06766 C4-dicarboxylate transport transcriptional regulatory protein DctD
Figure 36. The luxCDABE transposon mutation of a gene encoding a tripartite ATP-independent periplasmic (TRAP) transporters DctQ component 
The schematic shows the site of transposon-insertion for mutant 8:E12 (A) which was found to be BIT negative. The transposon mutation gene is 
located within the tripartite ATP-independent periplasmic transporters DctQ component (loci: RW109_06768) of the TRAP operon (loci: 
RW109_06767-06769). Each gene is drawn to the scale given by the 1 kb bar and the putative products are shown by the colour coded key. Box plots of 
8:E12 (B) indicates the change in light emission when exposed to BIT for 24 hours. Centre lines show the medians and crosses represent the sample 
means; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th 
and 75th percentiles (n= 4 sample points). The RLU fold change and corresponding p-value is shown next to the box plot.   
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The schematic shows the site of transposon-insertion for mutant 1:E6 (A) which was found to have minimal RLU change when exposed to BIT.  
The transposon mutation gene is located within the multidrug efflux pump subunit AcrB (loci: RW109_04032). Each gene is drawn to the scale 
given by the 1 kb bar and the putative products are shown by the colour coded key. A box plot of 1:E6 (B) indicates the change in light emission 
when exposed to BIT for 24 hours. Centre lines show the medians and crosses represent the sample means; box limits indicate the 25th and 75th 
percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles (n= 4 sample 
points). The RLU fold change and corresponding p-value is shown next to the box plot.   
1:E6
Fold change: +0.0379 
(p-value = 0.4672)
1 kb
RW109_04031-04032 operon: Multidrug export protein AcrE precursor and Multidrug efflux pump subunit AcrB
RW109_04030 HTH-type transcriptional regulator TtgR
RW109_04033 Hypothetical protein
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Figure 37. The luxCDABE transposon mutation of a gene encoding for the multidrug efflux pump subunit AcrB 
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4.3 Discussion 
4.3.1 The industrial RW109 mini-Tn5-luxCDABE mutant library 
This study demonstrated the successful construction of a P. aeruginosa mini-Tn5-luxCDABE transposon 
mutant library using the industrial RW109 strain. The mutants with distinct insertion sites were evenly 
dispersed throughout chromosome of the RW109 strain, with the exception of the region between ~2.2 and 
2.9 Mbp (Figure 28). There were also 5 mutants with insertions on plasmid 1 and 3 mutant insertions on 
plasmid 2; this uniform distribution indicates the transposon was not likely to insert into only one area of 
the genome. Even though a low number of insertion sites were identified, their dissemination throughout 
the RW109 genome enabled the representation of genes from different areas. The mutants with distinct 
insertion sites were also characterised with a wide range of well characterised COG categories; this 
suggests the genes were involved in a variety of biological functions within the RW109 strain. A large 
number were also assigned to the poorly characterised COG categories.  This may be due to these 
categories representing biggest percentage of genes within RW109 genome (Chapter 3, Section 3.2.3.1.1); 
increasing the likelihood of a transposon mutation occurring within poorly characterised genes.   
The low insertion site density region identified between ~2.2-2.9 Mbp, was previously reported in the 
mini-Tn5-lux PAO1 transposon mutant bank (Lewenza et al., 2005). The region was predicted to be the 
terminus of replication in the P. aeruginosa genome (Song et al., 2003, Hallin and Ussery, 2004). This led 
to (Lewenza et al., 2005) suggesting that the low number of insertion sites identified was due to the 
reduced number of target-gene replicates within this region. The predicted essential genes of P. 
aeruginosa are also recognised as spread randomly throughout the genome (Jacobs et al., 2003, Lewenza 
et al., 2005, Stover et al., 2000, Liberati et al., 2006). Thus, indicating the region between 2.2-2.9 Mbp 
would not necessary result in a number of lethal mutations.  
The constructed library was used to classify key mutants with an altered light emission response when 
screened with the isothiazolinone preservative BIT, at 20% of the calculated MIC. Mutants of interest 
identified from master plate screening were isolated and the genetic basis of the mutation was determined 
via comparison against the RW109 PacBio reference genome. The characterisation of insertion site genes 
within the BIT responding mutants identified key putative determinants, which may be involved in the 
resistance of RW109 to the isothiazolinone preservative. A number of mutants of interest where the 
transposon insertion site was successfully identified, also had reproducible RLU responses when screened 
individually. The mutants from the master plate screen where the transposon insertion sites was known 
(Table 16, Table 17 and Table 18), should also be screened individually with BIT to ensure reproducible 
RLU responses in comparison to master plate screening. The transposon insertion sites identified in key 
mutants within this study were only predictions with results requiring validation by quantitative real-time 
PCR (qRT-PCR) and via the generation of site-directed/non-polar mutants. The RW109 transposon 
mutant bank could also be used to identify mutants, which were susceptible or more tolerant to 
preservatives in comparison to the wild-type strain. This analyse could be used to further classify the 
genetic basis for industrial preservative resistance.  
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More insertion sites also need to be classified in the mutants identified from mutant bank screening to 
further identify key genetic determinants. This could be carried out with further optimisation of the inverse 
PCR technique used or by the whole genome sequencing of selected mutants. Transposon Directed 
Insertion Sequencing (TraDIS) could also be used for the generation of a greater density of RW109 
mutants with characterised insertion sites. TraDIS involves the construction of a large mutant bank 
followed by the fragmentation of mutant DNA and selective enrichment for transposon-flanking 
sequences via PCR amplification (Langridge et al., 2009, Barquist et al., 2015). The technique enables the 
classification of the frequency of mutations within the population and can be applied to Tn5-based mutant 
libraries (Barquist et al., 2015). TraDIS has successfully been used to construct characterised mutation 
libraries with a wide-ranging genome coverage in numerous bacteria, including in E. coli (Dziva et al., 
2013), Salmonella Typhi (Langridge et al., 2009), Clostridium difficile (Dembek et al., 2015), 
Mycobacterium marinum (Weerdenburg et al., 2015) and Pseudomonas syringae (Mesarich et al., 2017).  
This study also recognised that the mini-Tn5-luxCDABE transposon was not an appropriate reporter for 
gene expression with all preservative groups. When master plates were screened with POE, mutants 
demonstrated an overall decrease in light emission, suggesting this type of preservative was impairing 
luxCDABE operon activity. Higher concentrations of BIT also had the effect of diminishing light 
emission. Therefore, to fully characterise genetic pathways involved in resistance to the preservative POE, 
as well as increased concentrations of BIT, there is a requirement to use alternative forms of 
transcriptomic analysis, such as RNA-Seq. This method would enable the investigation of the whole 
RW109 transcriptome in response to industry relevant conditions (Wang et al., 2009). Applying RNA-Seq 
would also remove the requirement for construction, characterisation and screening of a large mutant 
library, which is necessary for sufficient genome coverage with transposon mutagenesis. Consequently, 
RNA-Seq would be a more efficient method to determine the genetic basis of preservative resistance.  
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4.3.2 The key genetic determinants associated with BIT positive mutants 
Screening the mini-Tn5-luxCDABE RW109 mutant bank with BIT, identified 204 mutants with a RLU-
fold increase and transposon insertion sites were successfully identified in 85 mutants. Out of these 
mutants, 40 were found to have insertion sites within the bacterial extracellular solute binding proteins 
family 3 (gene locus: RW109_01055). The high number of mutants with this insertion site suggests it was 
a possible hotspot for the Tn5-luxCDABE transposon in RW109. However, the Tn5 inserts at a 9 bp 
degenerate and uneven sequence (Kang et al., 2004) and past studies using this transposon have not 
reported an incidence of hotspots. Lewenza et al., (2005) found the 9 bp Tn5 insertion site sequence to be 
randomly distributed throughout the PAO1 genome; indicating regions of hotspots were not likely in P. 
aeruginosa. The large number of insertions within the RW109_01055 gene may have occurred due to the 
method used for picking individual mutants during library construction.  
All 40 mutants with an insertion in the gene encoding for bacterial extracellular solute binding proteins 
family 3, demonstrated a RLU-fold increase in response to BIT and were from the same bioluminescence 
category (Table 16). The gene product is involved in the active transport of solutes across the cytoplasmic 
membrane (Tam and Saier, 1993, Sauer et al., 2002) and the role of transport systems for removing 
antimicrobials from bacterial cells is a well characterised mechanism of resistance. Class 3 solute binding 
proteins have also been linked with roles in adhesion (Sauer et al., 2002) and the ability of P. aeruginosa 
to adhere has been associated with biofilm-mediated industrial antimicrobial resistance (Brown et al., 
1995, Cochran et al., 2000). The mutant RLU result suggest the gene encoding bacterial extracellular 
solute binding proteins family 3, was up-regulated when exposed to BIT. Increased expression could be to 
actively remove the preservative from the cell or to initiate increased adhesion for a biofilm-mediated 
resistance response. Two additional BIT positive mutants had transposon insertion sites in RW109_01054, 
which encodes an HflK protein. This gene was located within the same operon as the bacterial 
extracellular solute binding proteins family 3 (Figure 29). The increased RLU observation, suggests the 
insertion site operon genes were important to RW109 in response to the preservative BIT. HflK regulates 
the specificity of FtsH membrane protease (Ito and Akiyama, 2005) and inactivation of this protein results 
in increased sensitivity to the aminoglycoside antibiotic tobramycin in P. aeruginosa (Hinz et al., 2011). 
Increased expression of the gene encoding HflK has also been observed in response to aminoglycoside 
treatment (Kohanski et al., 2008). The suggested up-regulation of the gene encoding HflK in this study 
could be associated with decreasing RW109 susceptibility to BIT.               
The BIT positive mutant 14:C4 was phenotypically different from the wild type RW109 strain as it over-
produced a red/brown pigment, possibly pyorubin, when grown on TSA only (Figure 30). The transposon 
insertion site was identified within the RW109_04041 gene that encodes the transcriptional regulator 
KdgR and was located directly next to the gnyRDBHAL gene operon (loci RW109_04035-04040) (Figure 
31). This operon is involved in acyclic isoprenoid degradation (Diaz-Perez et al., 2004, Förster-Fromme et 
al., 2006) and isoprenoids are implicated in bacterial pigment production (Cañizares-Villanueva et al., 
1997, Saha et al., 2008). The overproduction of a pigment in this mutant suggests the insertion site gene 
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encoding KdgR, may have a role in the regulation of the gnyRDBHAL gene operon. The KdgR is a 
member of the IclR family of bacterial transcriptional regulators and functions as a repressor of gene 
expression (Molina-Henares et al., 2006).  KdgR regulates the RsmA-rsmB system, which is involved in 
quorum sensing and in the synthesis of numerous secondary metabolites and virulence factors such as 
protease, elastase, staphylolytic enzymes, hydrogen cyanide and pyocyanin (Hyytiäinen et al., 2001, Pessi 
et al., 2001, Burrowes et al., 2005). The increased RLU observed when mutant 14:C4 was exposed to BIT, 
suggests the transcriptional regulator KdgR was important when RW109 in response to the industrial 
preservative.      
A transposon insertion site was also identified in the periplasmic nitrate reductase napA gene of the 
napEFDABC operon (loci RW109_04993-04998) in mutant 8:B11 (Figure 32). The napEFDABC operon 
is associated with biofilm-mediated antimicrobial resistance and increased expression of the operon allows 
P. aeruginosa to proliferate under aerobic and anaerobic conditions (Schreiber et al., 2007, Van Alst et al., 
2009, Van Alst et al., 2007). The result from mutant screening with BIT at 20% of the MIC, suggests the 
up-regulation of the napA gene within the napEFDABC operon and indicates its importance in RW109’s 
response to the preservative. The BIT positive 37:C5 had an insertion site gene RW109_01716 that 
encoded for a ferrous-iron efflux pump, FieF (Figure 33). Ferrous iron transport systems are associated 
with increased virulence and biofilm development in P. aeruginosa (Marshall et al., 2009, 
Seyedmohammad et al., 2014). The screening results of mutant 37:C5 suggest the ferrous-iron efflux 
pump, FieF is up-regulated when the RW109 strain was exposed to the preservative BIT.  This response 
could be to remove BIT from within the cell or to initiate biofilm formation. 
Another BIT positive mutant of interest was 32:G7 where the insertion site gene encoded for the bi-
functional enzyme CysN within a cysND gene operon (loci: RW109_05781-05782) (Figure 34). The gene 
operon has previously been observed as up-regulated in P. aeruginosa during conditions of oxidative 
stress (Goldová et al., 2011) and has a role in the metabolism of sulphur in P. aeruginosa (Hummerjohann 
et al., 1998). The preservative BIT causes an oxidative response (Collier et al., 1990) as it’s able to act on 
thiol containing cytoplasmic and membrane bound enzymes (Denyer, 1995). As the mutant had increased 
RLU when exposed to BIT, it suggests cysN was up-regulated to combat adverse oxidative stress effects. 
It may also have an increased expression in order to expand sulphur availability, which is required for 
repairing disrupted thiol groups (Ezraty et al., 2017).  
4.3.3 The key genetic determinants associated with BIT negative mutants  
Screening the mini-Tn5-luxCDABE mutant bank with BIT identified 97 mutants, which had an RLU-fold 
decrease, and transposon insertion sites were successfully identified in 36 of these mutants. Eight key BIT 
negative mutants had transposon insertion sites, which encoded an acid, activated urea channel (gene locus 
RW109_02452). Acid activated urea channels are involved in the transport of urea across the cytoplasmic 
membrane (Sangari et al., 2010) (Figure 35). Gram-negative membrane channels and porins can be used to 
influx various chemicals including antimicrobials, and adaptations to reduce entry via this process 
decreases antimicrobial susceptibility (Pagès et al., 2008, Low et al., 2001). Potentially, acid activated 
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urea channels also allow BIT to enter the cell. RW109 could be down-regulating the gene encoding the 
activated urea channel to prevent the resulting adverse effects of preservative build-up. Another BIT 
negative mutant 8:E12, with a reproducible RLU response, also had a transposon insertion site involved in 
membrane transport (Figure 36). The gene encoded for the DctQ component of a TRAP transporter, which 
act as periplasmic importers of a diverse range of solutes into the cytoplasm (Brautigam et al., 2012, 
Mulligan et al., 2011, Kelly and Thomas, 2001). Again, this could be used as a possible method of BIT 
entry and the gene encoding the import transporter protein may be down-regulated by RW109 as a 
resistance mechanism.  
From master plate screening, 103 mutants were isolated, which demonstrated minimal change when 
exposed to BIT and transposon insertion sites were identified in 36. The genes represented by this 
response category suggest there was no altered expression when RW109 was exposed to the preservative 
BIT. An example of a minimal RLU change mutant which had a reproducible RLU response when 
screened individually was 1:E6. The transposon insertion site was identified in a gene encoding for an 
AcrB efflux pump subunit, which formed an operon with an AcrE export protein (Figure 37). These two 
proteins have reported similarities with those involved in the E.coli AcrAB–TolC efflux pump (Smith and 
Blair, 2013) which is able to export multiple antibiotics including tetracycline, chloramphenicol and 
fluoroquinolones (Edward et al., 2003). The results from the mutant screening suggest this efflux system 
did not have an altered expression in response to BIT, indicating it may not be important the resistance to 
this preservative.  
CHAPTER 4 – Use of an industrial P. aeruginosa mini-Tn5-luxCDABE mutant library to 
investigate the genetic basis of preservative resistance 
 
158 
 
4.4 Conclusions  
The main conclusions from this chapter were as follows: 
1) The industrially isolated strain RW109 strain was successfully used to construct a mini-Tn5-
luxCDABE mutant library. The distinct transposon insertion sites were evenly distributed 
throughout the whole genome and identified on the two plasmids.  
2) The mutant bank was screened with the industry relevant preservative BIT at 20% of the MIC 
and mutants with either an increased, decreased or an unchanged RLU response, were 
identified and isolated for further analysis. The RLU light emission response observed within 
a master plate was also reproducible when selected mutants were screened individually.       
                         
3) The mutant library was not suitable for screening with the preservative POE and increased 
concentrations of BIT, as an overall fold decrease in light emission was observed.                         
This suggests the activity of the luxCDABE operon was being diminished.  
 
4) The putative gene function in mutants with a reproducible RLU response were determined and 
linked to gene pathways of the RW109 PacBio reference genome. The mutants of interest had 
insertions in genes encoding solute binding proteins, transcriptional regulators, efflux pumps 
and proteins associated with biofilm formation and oxidative stress responses. These finding 
provide an insight into the genetic basis of BIT preservative resistance in the industrial 
RW109 strain.  
 
5) Out of the 7,303 predicted CDS of the RW109 genome, 53 distinct transposon insertion sites 
were identified using the mini-Tn5-luxCDABE mutant library preservative screening 
approach. This indicates the requirement for an alternative and more enhanced method to 
identify the genetic basis of preservative resistance in the RW109 strain.    
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5. RNA-Seq gene expression analysis of RW109 in response to preservatives 
and product formulations 
 
5.1 Introduction 
The transcriptome profiling technique RNA-Seq, utilises high-throughput next generation sequencing to 
map and quantify gene expression across a genome (Wang et al., 2009). This technique can be used to 
investigate the frequency with which genes are activated or repressed when a bacterium is subjected to 
different conditions. RNA-Seq is the successor of microarray technology and in comparison, provides a 
more holistic method of analysing gene expression without the reliance on hybridisation techniques 
(Wang et al., 2009, Mäder et al., 2011). RNA-Seq demonstrates an extensive dynamic range of expression 
levels, whereas hybridisation techniques are not as efficient at detecting and quantifying expression of 
genes at low or very high levels. Hybridisation techniques are also limited by the occurrence of cross 
hybridisation signal interference and have a limited ability to generate in-depth, high quality detection of 
transcripts (Wang et al., 2009, Mantione et al., 2014, Croucher and Thomson, 2010). RNA-Seq is also not 
dependent on the range of target gene probes present on a hybridisation array, and has been particularly 
useful for the detection of intergenic non-coding regulatory RNAs (Miyakoshi et al., 2015, Saliba et al., 
2017).  
Overall RNA-Seq enables a wide-ranging analysis of transcriptomic changes and produces high-resolution 
results, thus enhancing the reliability and accuracy when quantifying gene expression in response to a 
specified condition. RNA-Seq works via the extraction of RNA from bacterial cells which were exposed 
to either control conditions or test conditions and the enrichment of mRNA via the removal of rRNA 
(Figure 38) (Wang et al., 2009, Levin et al., 2010). The mRNA is converted into cDNA libraries, which 
are sequenced and resulting reads aligned to a reference genome. The number of reads which map to each 
gene feature of the genome are quantified and differential gene expression determined by comparing test 
conditions with a control (Figure 38) (Wang et al., 2009, Levin et al., 2010).                                 
This transcriptomic sequencing technology is advantageous in understanding how bacteria interact with 
their environment. RNA-Seq has been successfully implemented to determine genetic pathways involved 
in multiple bacterial functions such as antimicrobial resistance, biofilm development and pathogenicity 
(Khaledi et al., 2016, Jones et al., 2014, Maura et al., 2016). The use of RN-Seq to investigate 
antimicrobial gene expression responses, identified dominant genetic resistance traits when 135 clinical P. 
aeruginosa isolates were exposed to different antibiotics (Khaledi et al., 2016); an example was the up-
regulation of a sensor kinase-encoding gene cbrA in response to polymyxins, tobramycin, and 
ciprofloxacin (Khaledi et al., 2016). These types of findings can be used to develop targeted treatment 
approaches. RNA-Seq will enable the investigation of global gene expression of the industrial P. 
aeruginosa RW109 when exposed to industry-relevant conditions, thus enabling the detailed analysis of 
genetic pathways, which allow the industrial strain to survive the presence of preservatives and HPC 
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products. A better understanding of common genetic resistant traits used in response to industrial 
antimicrobials, could also enable the development of targeted HPC preservation systems.   
 
5.1.1 Aims and objectives 
The overall aim of this chapter was to investigate the global gene expression response of P. aeruginosa 
RW109 when it was exposed to industry-relevant conditions. This was achieved by carrying out the 
following objectives: 
 
1) Identify appropriate industrial exposure and growth conditions, which enable the extraction of 
good quality RNA for subsequent transcriptomic investigations of the RW109 strain.  
 
2) Carry out RNA-Seq analysis following exposure of RW109 to the individual preservatives BIT 
and POE, a combination of these two preservatives and a laundry detergent with and without the 
addition of the preservative BIT.  
 
3) Analyse differentially regulated genes with significant increases and decreases in expression when 
exposed to the industry relevant conditions.  
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The schematic gives an overview of the RNA-Seq protocol used in this study. The process can be divided into three stages which involve 1) exposing the bacterial strain to 
relevant conditions, extracting the toRNA, mRNA enrichment and quality assurance checking. 2) Converting the mRNA to cDNA and preparing libraries to carry out 
sequencing. 3) Bioinformatics analysis to determine differentially expressed genes. This step includes aligning the sequence reads to a reference genome, counting the number 
of reads which map to the CDS features and determining significant log2-fold changes when comparing test conditions with a control.   
d) Sequencing carried out with the Illumina NextSeq
500 to produce paired-end reads of 75 bp
3) Determining log-2-fold changes and adjusted p-values when test conditions were 
compared to the control
1) Industrial P. aeruginosa strain was grown in the presence of test 
and control conditions for 24-hours:
Four biological replicates 
obtained for each 
exposure condition
Quantification and QC 
assessment with Quibit
fluorometer and Agilent 
Bioanalyzer
a) Quality control and adaptor trimming followed by aligning the sequence 
reads to the reference genome. 
b) Quantify the number of reads mapped to each reference genome CDS  
a) mRNA was 
purified and 
fragmented
b) mRNA fragments 
were put through 
two rounds of cDNA 
synthesis
c) Sequencing 
adaptors were ligated 
onto each cDNA 
fragment and 
amplified via PCR
2) mRNA converted into cDNA and prepared 
into sequencing libraries 
3) Differential gene expression  
Figure 38. Overview of stages involved RNA-Seq transcriptomic analysis 
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5.2 Results  
5.2.1 Growth of P. aeruginosa RW109 in the presence of preservatives BIT and POE at various 
concentrations 
To analyse the growth dynamics of RW109 in the presence of increasing concentrations of BIT and POE, 
the strain was grown for 48 hours in TSB supplemented with the preservatives at concentrations between 0 
– 115% of the MIC. The MIC values were previously calculated as 0.00938% active for BIT and 0.5% 
active for POE (Chapter 4, Section 4.2.2). When deciding on RNA-Seq exposure conditions, BIT at 20% 
of the MIC was of interest to compare with the screening condition for identifying mini-Tn5-luxCDABE 
responding mutants (Chapter 4, Section 4.2.2). An exposure to POE at 20% of the MIC was relevant to 
relate gene expression results with those obtained with BIT at 20% of the MIC. Test conditions with 
increased concentrations for both BIT and POE were also sought, and half the MIC (50%) was seen as a 
possible concentration of interest. 
The growth dynamics of RW109 in the presence of BIT (A) and POE (B) at increasing concentrations 
altered over 48-hours (Figure 39). An extension of the lag phase was observed when RW109 was exposed 
to increasing concentrations of BIT when compared to growth in TSB-only (Figure 39A). RW109 was 
able to grow in concentrations of up to 80% of the MIC with BIT, and reached an OD close to the 
maximum observed in TSB-only, at approximately 46-hours. Growth was also observed with BIT up to 
90% of the calculated MIC, with the OD starting to increase at approximately 38-40 hours at 85% and 
90% of the MIC. When exposed to increasing concentrations of POE for 48-hours, the effect was an 
overall reduction of growth; RW109 was not able to achieve an OD close to the maximum reached in 
TSB-only (Figure 39B). Growth was observed up to 90% of the MIC, with the OD starting to increase at 
around 30-35 hours for 85% and 90% of the MIC (Figure 39B).  
It was decided to repeat the growth of RW109 in the presence of BIT and POE both at 20% and 50% of 
the MIC, and carry out OD measurements for 24-hours (Figure 39C). The mean Log10 OD was 0.421 
(450-480 nm) at 24-hours when grown in just TSB; this value was used as a comparison to calculate the 
percentage difference in mean Log10 OD for the other exposure conditions (Figure 39D). BIT at 20% and 
50% of the MIC had a percentage reduction of -1.21% and -11.41% respectively at 24-hours. POE at 20% 
and 50% of the MIC had a greater effect on growth and resulted in a percentage decrease of -27.16% and -
67.96% respectively. RW109 was at different growth stages after 24-hours exposure to these preservative 
conditions. However, rather than concentrate on harvesting cells at a particular growth stage, the initial 
RNA-Seq experiment aimed to investigate the gene expression response after 24-hours of exposure to 
draw greater correlation to the transposon mutagenesis and lux-reported gene expression (Chapter 4). The 
next step in deciding on appropriate test conditions was to assess the quality of extracted RNA from 
RW109 after exposure to these conditions. 
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Line graphs A and B demonstrate the growth dynamics of the RW109 strain when exposed to the individual preservatives BIT (A) and POE (B) at the concentration 
rage of 0 – 115% of the calculated MICs for 48 hours at 30°C. On the line graphs A and B the * highlights growth at 20% of the MIC and the + shows growth at 50% 
of the MIC. Growth analysis of RW109 at 20% and 50% of the MIC for both BIT and POE was repeated and shown in C). Panel D demonstrates the Log10 OD values 
at 24 hours and the percentage difference in OD when compared to TSB-only for each of the exposure conditions shown in C).   
Figure 39. The effect of the individual preservatives BIT and POE at different concentrations on the growth of RW109 
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5.2.2 Initial total RNA extractions and mRNA enrichment 
Total RNA (toRNA) extractions from RW109 were carried out after growth for 24-hours at 30°C in TSB-
only and POE at 50% of the MIC. These conditions were chosen for assessment of RNA quality as they 
represented the highest and the lowest OD values after 24 hours exposure (Figure 39D). Both toRNA 
samples passed quality analysis with RNA integrity Numbers (RINs) of ≥ 8 and 23S:16S rRNAs ratios of 
≥1.5 (Figure 40). The concentrations were checked with the Qubit and were both above the required value 
of 100 ng/μl (Figure 40). This suggests good quality RNA can be extracted when the OD at 24-hours is 
reduced by more than 50% when compared to RW109 grown in TSB-only. Messenger RNA (mRNA) 
enrichment was then carried out and quality assessment showed a noticeable reduction in the 16S and 23S 
rRNA bands for both samples when compared to the toRNA (Figure 40). The concentration of the mRNA-
enriched samples was 22 ng/μl for the TSB-only treated sample and 28 ng/μl when exposed to POE at 
50% MIC.  These concentrations were within the required range of 10 – 400 ng per 5 μl, for input into the 
Illumina cDNA library preparation kit.   
When choosing further RNA-Seq test conditions, it was decided the mean log10 OD (450-580 nm) should 
not result in a percentage reduction of more than -67.96% when compared to RW109 grown in TSB for 24 
hours. This parameter was used in an attempt to ensure the extraction of good quality RNA that had 
previously been achieved when this percentage reduction in OD was observed. For the RNA-Seq 
experiment, BIT and POE both at 20% and 50% of the MIC were chosen as test conditions to represent 
individual preservatives.  
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Figure 40.  Bioanalyzer electropherograms of extracted total RNA and enriched mRNA  
RNA extracted from RW109 grown in TSB-only (A) and in the presence of POE at 50% of the 
MIC (B) were analysed with the Bioanalyzer to produce electropherograms. Total RNA (toRNA) 
was quality assessed using the RIN value and 23S:16S ribosomal RNA (rRNA) ratio and 
concentrations analysed with the Qubit. Messenger RNA (mRNA) which had been enriched from 
the toRNA was also checked with the Bioanalyzer to determine if the 16S and 23S rRNA peaks 
had been reduced and concentration was again analysed with the Qubit. Both RNA samples 
shown in A and B passed quality assessment checks and were above required concentration 
values.  
16S
23S
F
lu
o
re
s
c
e
n
c
e
Marker
RNA 6000 Nano ladder
Possible genomic DNA 
contamination
Small RNAs
16S
23S
F
lu
o
re
s
c
e
n
c
e
RNA 6000 Nano ladder
Marker
Small RNAs
16S
23S
F
lu
o
re
s
c
e
n
c
e
Marker
RNA 6000 Nano ladder
Possible genomic DNA 
contamination
Small RNAs
16S
23S
F
lu
o
re
s
c
e
n
c
e
RNA 6000 Nano ladder
Marker
Small RNAs
RIN =9.4
23S:16S rRNAs ratio: 1.6
Concentration: 298 ng/μl
RIN =9.6
23S:16S rRNAs ratio: 1.7
Concentration: 165 ng/μl
Concentration: 22 ng/μl
Concentration: 28 ng/μl
After toRNA extraction After mRNA enrichment
After toRNA extraction After mRNA enrichment
A)
B)
CHAPTER 5 – RNA-Seq gene expression analysis of RW109 in response to preservatives and 
product formulations 
          166 
 
5.2.3 Growth of P. aeruginosa RW109 when exposed to BIT and POE in combination  
RW109 was grown in the presence of BIT and POE both in combination at 5%, 10%, 15% and 20% of the 
MIC. This analysis was used for growth dynamics and to calculate the percentage reduction in OD when 
compared to TSB-only. Exposure to the individual preservatives BIT and POE at 20% of the MIC were 
chosen as test conditions, and consequently it would be appropriate to expose the industrial strain to a 
combination of preservatives both at 20% of the MIC. A combination of both preservatives at 50% of the 
MIC was not desirable, due to the large growth reduction observed with POE at this concentration (Figure 
39). Lower combination concentrations were also assessed in the event that percentage reduction in OD 
was more than 67.96%. Increasing the concentration of the preservatives in combination had the effect of 
extending the lag phase, when compared to growth in TSB-only (Figure 41A). A percentage reduction of -
35.15% when compared to growth in TSB-only was observed following exposure of RW109 to BIT and 
POE in combination both at 20% for 24 hours (Figure 41B). Therefore, it was decided the preservatives 
together at this concentration would be suitable for good quality RNA extractions.   
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Figure 41. The effect of BIT and POE in combination on the growth of RW109 
Line graphs demonstrate the growth of the RW109 strain in the presence of BIT and POE in 
combination both at 5, 10, 15 and 20% of their calculated MIC values for 24 hours at 30°C 
(A). Growth was also observed for the preservatives individually at these concentrations 
within the same graph (A). The Log10 OD values at 24 hours for each exposure condition and 
the percentage difference in OD when compared to TSB-only are shown in B). 
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5.2.4 Growth of P. aeruginosa RW109 when exposed to unpreserved laundry detergent and laundry 
detergent with the presence of the preservative BIT  
The growth dynamics of RW109 when exposed to unpreserved laundry detergent and laundry detergent in 
combination with the preservative BIT were assessed for 24-hours. The different dilutions of laundry 
detergent analysed included 1:10, 1:20, 1:50 and 1:100 and when compared to growth of RW109 in TSB, 
similar lag and exponential phases were observed up to the 8-10 hour point (Figure 42A). A reduction in 
growth was seen after 8-10 hours with the laundry detergent dilutions. The 1:10 and 1:20 dilutions 
resulted in an early stationary phase, whereas growth increased slowly with dilutions 1:50 and 1:100.  
Unpreserved laundry detergents at these concentrations for 24-hours, did not result in a mean OD 
percentage reduction of above 67.96% (Figure 42B); dilutions 1:10 and 1:20 were however difficult to 
prepare due to the thickness of the laundry detergent and presence of bubbles during mixing. A small 
amount of foaming was observed during mixing of 1:50 dilutions, but no foam was noted with the 1:100 
dilution. It was decided that dilutions 1:50 and 1:100 would be used to assess the growth dynamics of 
laundry detergent in combination with BIT at 20% of the MIC.  
When RW109 was grown with the laundry detergent dilutions in combination with BIT at 20% of the 
MIC, the effect was an extension in the lag phase and overall slower growth (Figure 42C). A reduction in 
the mean OD was observed in comparison to growth in TSB-only (Figure 42D), however the percentage 
differences observed did not fall below the chosen -67.96% cut off. It was decided to proceed with the 
laundry detergent dilution of 1:100 due to small amount of bubbling observed when mixing with dilutions 
1:50.      
  
Line graphs demonstrate the growth of RW109 for 24 hours at 30°C in the presence of an unpreserved laundry detergent at different dilutions (A) and 
laundry detergent with the preservative BIT (C). The Log10 OD values at 24 hours for each exposure condition and the percentage difference in OD when 
compared to TSB-only are shown in B) for laundry detergent only and in D) for laundry detergent in combination with the preservative BIT. 
Figure 42. The effect of unpreserved laundry detergent and laundry detergent with the preservative BIT on the growth of RW109  
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5.2.5 RNA-Seq exposure conditions  
From the growth analysis investigations, the following exposure conditions were selected to investigate 
gene expression changes in RW109 using RNA-Seq:    
   
                               Control condition: TSB-only  
1) BIT at 20% of the MIC (001875% active) 
2) BIT at 50% of the MIC (0.00469%) 
3) POE at 20% of the MIC (0.1% active) 
4) POE at 50% of the MIC (0.25% active) 
5) POE and BIT in combination at 20% of the MIC 
6) Unpreserved laundry detergent at 1:100 dilution only  
7) Laundry at 1:100 dilution in combination with BIT at 20% of the MIC 
 
RW109 was grown in the presence of the control condition and test exposure conditions for 24 hours at 
30°C and toRNA was extracted. Experiments were repeated with different starting overnight cultures and 
exposure condition preparations, to obtain four biological replicates for the control and test exposure 
conditions. Figure 43 demonstrates the growth of RW109 in response to the control and test conditions, 
with growth curves for the 4 biological replicates of each condition shown. The Log10 OD values were 
consistent during the 4 replications of each exposure condition, as demonstrated by the tight groupings of 
the replicate data points (Figure 43). BIT at 20% of the MIC (1) resulted in the smallest difference in mean 
Log10 OD when compared to the control with a percentage reduction of -2.73% observed. A minimum 
difference in mean viable cell counts (CFU/ml) when compared to the control was also observed with test 
condition 1 with a percentage reduction of -21.50% observed (Figure 43 B and C). POE at 50% of the 
MIC had the greatest effect of the RW109 growth when compared to the control condition. A -68.46% 
reduction in mean Log10 OD and a -100% reduction in mean viable cell counts (CFU/ml) were observed 
in comparison to the control condition (Figure 43 B and C).   
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The growth dynamics of RW109 when exposed to the RNA-Seq control and test conditions (1-7) for 24 hours at 30°C are represented by the line graph in panel 
A). The four biological replicates of each exposure condition are plotted individually on the graph and the numbers represent the test exposure conditions which 
are described in the key. The mean Log10 OD (450-580 nm) at 24 hours for each condition is shown in panel B) along with the percentage difference in OD when 
test conditions were compared to the control condition. The mean viable cell count (CFU/mL) for each condition and the percentage difference when the test 
conditions were compared the control are shown in panel C).   
Exposure condition Mean Log10 OD Percentage difference when compared to condition 1 P-value 
Control- TSB Only 0.417
1) BIT at 20% MIC 0.405 -2.73% 0.0070
2) BIT at 50% MIC 0.370 -11.17% 0.0088
3) POE at 20% MIC 0.308 -26.06% 6.58E-07
4) POE at 50% MIC 0.131 -68.46% 3.78E-06
5) BIT and POE in combination 0.282 -32.23% 5.64E-06
6) Laundry detergent only 0.284 -31.86% 5.30E-07
7) Laundry detergent and BIT 0.212 -49.08% 1.22E-06
Exposure condition Mean viable cell count (CFU/mL)
Percentage difference when compared to condition 1 P-value 
Control- TSB only 1.19E+10
1) BIT at 20% MIC 9.32E+09 -21.50% 0.0004
2) BIT at 50% MIC 4.94E+09 -58.39% 0.0049
3) POE at 20% MIC 3.84E+09 -67.69% 0.00686
4) POE at 50% MIC 7.93E+08 -100.00% 5.96E-05
5) BIT and POE in combination 2.60E+09 -77.78% 0.01846
6) Laundry detergent only 1.81E+09 -84.77% 0.00026
7) Laundry detergent and BIT 9.59E+08 -91.93% 6.10E-05
A)
B) C)
Control- TSB only (orange)
1) BIT at 20% of the MIC (blue)
2) BIT at 50% of the MIC (red)
3) POE at 20% of the MIC (purple)
5) BIT and POE in combination (green)
6) Laundry detergent with no 
preservative (grey)
7) Laundry detergent with BIT 
at 20% of the MIC (pink)
4) POE at 50% of the MIC (brown)
Figure 43. Growth dynamics of RW109 when exposed to the chosen RNA-Seq control and test conditions 
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5.2.6 toRNA and mRNA quantification, quality assessment and sequencing outputs  
The 32 toRNA extractions and mRNA enrichments, obtained after RW109 was exposed to the control and 
test conditions, were quantified, and quality assessed. The toRNA extractions used in this study were 
analysed and the RINs were all ≥ 8 and the rRNAs (23S:16S) ratios were all ≥1.5 (Table 19).                                       
The concentrations were checked with the Qubit to ensure they were above 100 ng/μl; 2 samples were 
below this value after an additional RNA precipitation step as indicated in Table 19. These 2 samples were 
allowed to continue to the mRNA stage, as they were considered close enough to 100 ng/μl and passed 
quality assurance checks; the lower concentrations also did not result in the enriched mRNA having a low 
concentration. The enriched mRNA concentrations were all above the required concentration of 2 ng/μl 
for subsequent cDNA sequence library preparations (Table 19). The mRNA samples were also assessed to 
ensure the sufficient depletion of the 23S and 16S Ribosomal RNA peaks (Figure 44).  
After sequencing the resulting number of paired-end reads for all of the 32 samples ranged from 6.07E+06 
to 2.62E+07. The reads were aligned to the sequenced RW109 genome and a mean percentage number of 
97.87% were found to align (range of 91.32%- 99.03%). From these aligned reads, the mean percentage 
number which mapped to a gene feature, was calculated as 98.56% (range of 96.74%- 99.23%). The full 
details of the number of sequence reads, the number of reads aligned with BWA-MEM and the feature 
mapping with HTSeq-count are provided on the CD-ROM in the corresponding Chapter and Section 
folder (SequenceReads_BWA_HTSeq_Stats.xlsx). The raw RNA-Seq reads are available in the 
ArrayExpress database (http://www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-6344.                                         
Overall, the sequencing analysis demonstrated the achievement of representative global profiling of gene 
expression across all the industrially relevant growth conditions assessed (Figure 43).  
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Footnotes: The numbers in brackets next to the exposure conditions indicates the test exposure condition number. * indicates toRNA concentrations below the required concentration of 100 
ng/μl. These 2 toRNA samples were allowed to continue forward to mRNA enrichment as they were of high quality and considered close enough to the required concentration. The lower 
concentration did not result in the enriched mRNA having a low concentration.  
Biological Replicate Number Exposure Condition
toRNA Extractions mRNA Enrichment
Qubit toRNA
Concentration (ng/ul)
toRNA 
rRNA Ratio 
(23s / 16s)
toRNA 
RNA Integrity Number (RIN)
Qubit mRNA 
Concentration (ng/ul)
1
TSB Only (Control) 357.0 1.7 9.9 27.4
BIT at 20% MIC (1) 343.0 1.6 10.0 23.2
BIT at 50% MIC (2) 328.0 1.6 10.0 21.6
POE at 20% MIC (3) 100.0 1.6 10.0 23.8
POE at 50% MIC (4) 113.0 1.9 9.6 28.4
BIT at 20% MIC + POE at 20% MIC (5) 234.0 1.6 10.0 23.0
1:100 dilution of laundry detergent (6) 172.0 1.5 10.0 27.2
1:100 dilution of laundry detergent + BIT at 20% MIC (7) 103.0 1.5 10.0 20.8
2
TSB Only (Control) 323.0 1.7 10.0 27.0
BIT at 20% MIC (1) 401.0 1.6 10.0 24.8
BIT at 50% MIC (2) 400.0 1.5 10.0 22.6
POE at 20% MIC (3) 141.0 1.5 10.0 18.3
POE at 50% MIC (4) 408.0 1.6 10.0 21.8
BIT at 20% MIC + POE at 20% MIC (5) 112.0 1.5 10.0 18.6
1:100 dilution of laundry detergent (6) 88.6* 1.5 10.0 38.6
1:100 dilution of laundry detergent + BIT at 20% MIC (7) 532.0 1.6 9.9 35.2
3
TSB Only (Control) 233.0 1.6 10.0 23.8
BIT at 20% MIC (1) 374.0 1.5 9.7 19.4
BIT at 50% MIC (2) 376.0 1.7 9.8 18.4
POE at 20% MIC (3) 132.0 1.6 10.0 17.4
POE at 50% MIC (4) 180.0 1.6 10.0 30.2
BIT at 20% MIC + POE at 20% MIC (5) 125.0 1.7 10.0 22.0
1:100 dilution of laundry detergent (6) 249.0 1.7 10.0 19.0
1:100 dilution of laundry detergent + BIT at 20% MIC (7) 97.7* 2.3 10.0 17.0
4
TSB Only (Control) 178.0 1.5 10.0 26.4
BIT at 20% MIC (1) 323.0 1.5 9.9 19.0
BIT at 50% MIC (2) 240.0 1.6 10.0 17.8
POE at 20% MIC (3) 153.0 1.7 10.0 25.6
POE at 50% MIC (4) 196.2 1.6 9.0 23.2
BIT at 20% MIC + POE at 20% MIC (5) 106.0 1.6 9.8 25.4
1:100 dilution of laundry detergent (6) 190.0 1.7 10.0 33.4
1:100 dilution of laundry detergent + BIT at 20% MIC (7) 103.0 1.7 10.0 20.8
Table 19. Total RNA and messenger RNA quantification and quality assessment 
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Figure 44.  Bioanalyzer electropherograms of total RNA extractions and enriched messenger RNA samples 
 The toRNA extracted when RW109 was exposed to the control condition (TSB only) for 24 hours (replicate 1) was quality assessed with the Bioanalyzer to 
produce an electropherogram (A). The RIN and 23S:16S rRNAs ratio for this toRNA sample are shown in A) and both were above the recommended values. The 
concentration of toRNA was checked with the qubit to ensure it was above 100 ng/μl. The mRNA was enriched from this toRNA sample and was also analysed 
with the Bioanalyzer to produce an electropherogram (B). This analysis was used to ensure sufficient depletion of the 23S and 16S ribosomal peaks when compared 
to the toRNA sample and this was observed in B). The Qubit was used to ensure the mRNA concentration was above 2 ng/μl. This analysis was carried out for all 
the 32 RNA extractions used in this study.   
A) B)After toRNA extraction
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5.2.7 RNA-Seq data analysis  
5.2.7.1 Overview of gene expression analysis 
To summarise the gene expression data of RW109 when exposed to the test exposure conditions, all log2-
fold changes obtained in comparison to the control, were used to generate a heat map (Figure 45A).                          
The preservative BIT at 20% of the MIC (test condition 1) resulted in the least amount of gene expression 
changes when compared to the other conditions. Laundry detergent in combination with BIT at 20% of the 
MIC (test condition 7) had the greatest number of gene expression alterations. Within the heat map, the 
test exposure conditions were grouped according to their gene expression similarities via the top 
dendrogram. This resulted in three global gene expression groups comprising of test conditions 1 and 2, 
associated with the presence of BIT, test conditions 3, 4 and 5, linked to the presence POE and test 
conditions 6 and 7, correlating to the presence of laundry detergent (Figure 45A).                                                             
A differentially expressed gene (DEG) was defined as exhibiting a log2-fold change of ≥ 1.5 and an 
adjusted p-value of ≤ 0.05 when the test conditions 1-7 were compared against the control condition. 
Figure 45B illustrates the numbers of genes for each condition, which were either up or down regulated in 
response to the test conditions. Again the test exposure condition with the least amount of DEGs was BIT 
at 20% of the MIC; 1 gene was up-regulated and 1 gene was down-regulated. Condition 7, laundry 
detergent in combination with BIT at 20% of the MIC, had the greatest number of DEGs with 714 up-
regulated and 773 down-regulated. Excel spreadsheets of all the identified DEGs with each tab 
representing a test condition can be found on the CD-ROM provided with this thesis in the corresponding 
folder (Significantly_Down_Regulated_DEGs.xlsx and Significantly_Up_Regulated_DEGs.xlsx).  
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A heat map was generated (A) to show the overview of gene expression data for all the RNA-Seq test exposure conditions when compared to the control. The numbers below 
the heat map represent the test conditions as shown by the test exposure conditions, blue indicates genes which are up-regulated and red represents genes which are down-
regulated and the more in10se the colours the greater the gene expression (see color key). The top dendrogram displays the test exposure conditions which have been grouped 
together via hierarchical cluster analysis and the dendrogram to the left of the heat map represents the gene clusters which are grouped according to their log2-fold change 
values across all the conditions. The Table (B) represents the number of genes which were differentially regulated for each test exposure condition for the whole genome 
sequence of RW109 (main chromosome and 2 plasmids). Differentially expressed genes were defined as exhibiting a log2-fold change of ≥ 1.5 and an adjusted p-value of                     
≤ 0.05 when the test conditions were compared against the control condition.  
Figure 45. Overview of RNA-Seq gene expression data 
Test exposure 
Condition 
No. of up-
regulated genes
No. of  down-
regulated genes 
1 1 1
2 63 50
3 183 310
4 346 514
5 279 307
6 594 670
7 714 773
Cut off values: ≥ 1.5 log2 fold change and adjusted p-value= ≤ 0.05 
(All test exposure conditions compared to the control condition)
A)
B)
Test exposure conditions key: 
1: BIT at 20% of the MIC
2: BIT at 50% of the MIC
3: POE at 20% of the MIC
4: POE at 50% of the MIC
5: POE and BIT in combination at 20% of the MIC
6: Laundry detergent at 1:100 dilution only 
7: Laundry at 1:100 dilution in combination with BIT at 20% of the MIC
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5.2.7.2 Classification of DEGs based on KEGG pathway annotations 
The DEGs from each test exposure condition were grouped based on KEGG Orthology (KO) numbers and 
the KEGG pathways characterised. The percentage of DEGs for each KEGG pathway was based on the 
total number of up or down regulated DEGs with an assigned KO number for each of the test exposure 
conditions (Table 20). DEGs identified with BIT at 20% of the MIC were excluded due to the low number 
identified. DEGs without a KO number were also not included in the analysis. A high number of DEGs 
were assigned to the carbohydrate metabolism pathway for each test condition. A greater percentage were 
up-regulated for test conditions 2-5 whereas more carbohydrate pathways were down-regulated in 
conditions 6 and 7 associated with the presence of laundry detergent.  
Amino acid metabolism pathways also had a high percentage of DEGs for each test condition. Condition 
2, BIT at 50% MIC, had a greater percentage of down-regulated DEGs whereas a higher percentage of up-
regulated genes was observed with condition 3. Limited differences were observed between the percentage 
numbers of up and down regulated DEGs within the amino acid metabolism category with other test 
conditions. A prominent difference in the percentage of up-regulated DEGs was observed for all test 
conditions in the energy metabolism pathway group, and this was especially true for test conditions 2 
(BIT-associated), 6 and 7 (laundry detergent associated). A greater percentage of membrane transport 
pathways were identified as down-regulated in conditions 3, 4 and 5 (POE associated); contrastingly more 
were up-regulated in conditions 2 (BIT-associated) and 6 (laundry detergent associated). An equal 
percentage of up and down regulated DEGs were observed in condition 7 (laundry detergent associated) 
for membrane transport (Table 20).   
Within biofilm pathways a greater percentage of down-regulated DEGs were observed in all test 
conditions, except for test condition 3 (POE at 20% MIC) and prominent differences between up and 
down regulated DEGs were identified in conditions 6 and 7(laundry detergent associated) (Table 20). All 
test exposure conditions had a higher percentage of down-regulated DEGs within the quorum-sensing 
pathway, which was especially true for test condition, 2 (BIT at 50% MIC). The xenobiotics and 
metabolism pathway had a higher percentage of up-regulated DEGs with test conditions 2, 3, 4 and 5, 
associated with presence of either BIT or/and POE, whereas a limited difference was observed with 
conditions 6 and 7 where laundry detergent was present. Test exposure condition 5 had the greatest 
percentage of up-regulated DEGs within the xenobiotics pathway group followed by condition 4, both 
linked to the presence of POE. Other notable observations with KEGG pathway analysis included test 
condition 3, POE at 20% MIC, having the highest percentage of up-regulated genes assigned to the cell 
motility and signal transduction: two-component system pathways (Table 2). The genes of two RW109 
KEGG modules of interest, the BpeEF-OprC efflux pump (M00698) (Chapter 3, Section3.2.3.2.2) and the 
UhpB-UhpA two-component regulatory system (M00473) (Chapter 3, Section 3.2.3.2.1), were not 
identified as significantly up or down regulated in response to the test exposure conditions used within this 
study.  
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Table 20. KEGG pathway classifications of the up and down-regulated DEGs for each test exposure condition 
Footnotes: The numbers in each column correspond to the percentage of DEGs for each KEGG pathway in relation to the total number of up or down regulated DEGs with an assigned KO 
number. The colour intensities decrease with the decreasing percentage of DEGs.  
KEGG Pathways
Test condition 2: 
BIT at 50% of the MIC
Test condition 3: 
POE at 20% of the MIC
Test condition 4: 
POE at 50% of the MIC
Test condition 5: 
BIT and POE at 20% of the MIC
Test condition 6: 
LD Only
Test condition 7:
LD and BIT at 20% of the MIC KEGG Pathways
Up-regulated 
DEGs (%)
Down-regulated 
DEGs (%)
Up-regulated 
DEGs (%)
Down-regulated 
DEGs (%)
Up-regulated 
DEGs (%)
Down-regulated 
DEGs (%)
Up-regulated 
DEGs (%)
Down-regulated 
DEGs (%)
Up-regulated 
DEGs (%)
Down-regulated 
DEGs (%)
Up-regulated
DEGs (%)
Down-regulated
DEGs (%)
Carbohydrate metabolism 22 12 17 15 25 11 19 8 15 20 16 20 Carbohydrate metabolism
Energy metabolism 10 0 8 6 12 9 6 4 13 7 12 6 Energy metabolism
Amino acid metabolism 17 24 21 16 13 17 19 16 11 16 12 15 Amino acid metabolism
Membrane transport 11 4 0 4 5 8 4 8 10 6 9 9 Membrane transport
Translation 1 4 1 14 1 6 1 8 8 1 8 1 Translation
Metabolism of cofactors and vitamins 3 0 3 4 2 6 2 6 5 4 6 5 Metabolism of cofactors and vitamins
Nucleotide metabolism 6 0 0 7 1 7 1 7 5 3 6 3 Nucleotide metabolism
Signal transduction: Two-component system 4 8 12 2 5 4 6 2 7 7 6 7 Signal transduction-Two-component system
Lipid metabolism 7 4 9 2 6 2 8 3 4 3 4 3 Lipid metabolism
Glycan biosynthesis and metabolism 0 0 1 0 0 1 1 1 3 0 4 0 Glycan biosynthesis and metabolism
Cellular community: Biofilm formation 1 12 5 4 4 5 5 7 4 10 3 9 Cellular community - Biofilm formation
Folding, sorting and degradation 0 0 0 2 0 2 0 3 3 0 3 0 Folding, sorting and degradation
Replication and repair 0 4 0 0 0 0 0 2 2 1 2 1 Replication and repair
Metabolism of other amino acids 4 0 3 2 4 3 5 3 2 3 2 3 Metabolism of other amino acids
Cellular community: Quorum sensing 0 20 0 4 0 3 0 9 2 7 2 7 Cellular community - Quorum sensing
Biosynthesis of other secondary metabolites 2 8 0 5 1 6 1 8 1 3 2 3 Biosynthesis of other secondary metabolites
Metabolism of terpenoids and polyketides 2 0 1 4 2 3 3 3 1 1 1 1 Metabolism of terpenoids and polyketides
Xenobiotics biodegradation and metabolism 8 0 9 4 13 4 18 4 2 3 1 2 Xenobiotics biodegradation and metabolism
Cell motility 1 0 9 2 3 2 2 1 1 6 1 5 Cell motility
Transcription 0 0 0 1 0 1 0 0 1 0 1 0 Transcription
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5.2.7.3 Key differentially regulated genes identified following exposure of P. aeruginosa RW109 to 
single preservatives  
5.2.7.3.1 Gene expression analysis following exposure to BIT at 20% of the MIC 
Gene expression analysis of the RW109 strain when exposed to BIT at 20% of the MIC (test condition 1), 
identified two significant DEGs. One gene was up-regulated and the other down-regulated and both were 
on the main chromosome (Table 21). No differentially regulated genes were observed on the two plasmids 
in response to this test condition. The up-regulated gene was RW109_02248, which was annotated as 3-
hydroxyisobutyrate dehydrogenase I and a 1.5 log2 fold change increase in expression was observed 
(adjusted p-value ≤ 0.05). RW109_02248 was also up-regulated in response to BIT at 50% of the MIC 
with a 1.8 log2-fold increase (adjusted p-value ≤ 0.05). This gene was characterised with a KO number 
involved in valine degradation (K00020) within the amino acid metabolism KEGG pathway.  
The one down-regulated gene identified after exposure to BIT at 20% of the MIC encoded a hypothetical 
protein (RW109_05945) and expression decreased with a -1.6 log2-fold change (adjusted p-value ≤ 0.05). 
This hypothetical annotated gene was also down-regulated in response to BIT at 50% of the MIC, where a 
-2.6 log2-fold change was observed (adjusted p-value ≤ 0.05). No KO numbers were assigned to this 
hypothetical protein. In response to BIT at 50% of the MIC, 5 other hypothetical protein encoding genes 
within close proximity to RW109_05945 included RW109_05942-05943 and RW109_05947-
RW109_05949 were all down-regulated ≥ 1.7 log2-fold in response to 50% of the MIC. 
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Footnotes: The percentages represent the proportion of DEGs in relation to the size of each replicon. In the total columns the percentages represent the proportion of DEGs in relation and to the 
genome as a whole.  * total number of up and down regulated DEGs 
Test exposure condition
Up-regulated genes Down-regulated genes Overall 
proportions of 
DEGs* Plasmid 1 Main Chromosome Plasmid 2 Total Plasmid 1 Main Chromosome Plasmid 2 Total
Number
Percentage
(%)
Number
Percentage
(%)
Number
Percentage
(%)
Number
Percentage
(%)
Number
Percentage
(%)
Number
Percentage
(%)
Number
Percentage
(%)
Number
Percentage
(%)
Number
Percentage
(%)
1) BIT at 20% of the MIC 0 0 1 0.02 0 0 1 0.01 0 0 1 0.02 0 0 1 0.01 2 0.03
2) BIT at 50% of the MIC 0 0 63 0.96 0 0 63 0.086 0 0 50 0.76 0 0 50 0.68 113 1.55
3) POE at 20% of the MIC 13 2.21 160 2.44 10 6.41 183 2.51 4 0.68 306 4.67 0 0 310 4.24 493 6.75
4) POE at 50% of the MIC 10 1.70 320 4.88 16 10.26 346 4.74 6 1.02 507 7.73 1 0.64 514 7.04 860 11.78
5) BIT and POE in combination 20 3.40 248 3.78 11 7.05 279 3.82 5 0.85 301 4.59 1 0.64 307 4.20 586 8.02
6) LD with no preservative 7 1.19 581 8.86 6 3.85 594 8.13 32 5.43 627 9.56 11 7.05 670 9.17 1264 17.31
7) LD with BIT 23 3.90 678 10.34 13 8.33 714 9.78 35 5.94 724 11.04 14 8.97 773 10.58 1487 20.36
Table 21. The number of genes differentially regulated in the main chromosome and two plasmids after exposure to the test exposure conditions
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5.2.7.3.2 Gene expression analysis following exposure to BIT at 50% of the MIC 
Gene expression analysis of the RW109 strain when exposed to BIT at 50% of the MIC (test condition 2), 
identified 113 significant DEGs (Table 21); 63 were up-regulated and 50 were down-regulated. All the 
DEGs identified in response to condition 2 were on the main chromosome.  
Within the top 10 up-regulated DEGs, an anthranilate 1,2-dioxygenase large subunit, antA 
(RW109_03497) and an anthranilate 1,2-dioxygenase small subunit antB (RW109_03496) were identified 
(Table 22). These genes are predicted to be involved in the first step of a sub-pathway, which synthesises 
catechol, during the degradation of anthranilate via hydroxylation. Another gene associated with this sub-
pathway, anthranilate 1,2-dioxygenase electron transfer component, antC (RW109_03495), was also 
significantly up-regulated in response to BIT at 50% of the MIC, with a 2.0 log2-fold change. These three 
genes were assigned KO numbers, which mapped to the KEGG xenobiotic biodegradation and metabolism 
pathways. RW109_03496 was associated with benzoate, fluorobenzoate and xylene degradation, and 
RW109_03497 and RW109_03495 were linked to aminobenzoate degradation.  
Genes RW109_02633, RW109_02635 and RW109_02636 were also within the top ten up-regulated genes 
(Table 22) and all had KO numbers associated with a glucose/mannose ABC transport system. The 
RW109_02634 gene was also associated with this transport system and in response to BIT at 50% of the 
MIC, a 2.4 log2-fold increase was observed. Furthermore, genes encoding for a putative sialic acid 
transporter (RW109_03936) and a porin B precursor (RW109_02637) were identified in the top ten up-
regulated genes (Table 22).  
Other up-regulated DEGs of interest included RW109_04035-04040, which were all co-located on the 
main chromosome. The genes were involved in leucine degradation and all had an increased expression of 
between 1.5 - 2.6 log2-fold. The amino acid sequences were analysed using the Pseudomonas database 
DIAMOND BLASTP search (Winsor et al., 2016) and a high degree of sequence similarity was identified 
with the PA14 gnyRDBHAL gene cluster (mean BLASTP scores: percentage ID= 98.27%, alignment 
length=  379, E-value= 0.0 and BIT Score= 734). Other genes also involved in leucine degradation 
encoded for an acetyl-CoA acetyltransferase (RW109_04050, 1.5log2-fold), and subunits A and B of a 
putative succinyl-CoA:3-ketoacid coenzyme A transferase (RW109_04051, 2.2 log2-fold and 
RW109_04052, 2.0 log2-fold).   
In response to BIT at 50% of the MIC, 5 up-regulated genes involved in sulphur metabolism were 
identified. These included a sulfite reductase [ferredoxin] (RW109_04218, 1.9 log2-fold), a bi-functional 
enzyme CysN/CysC (RW109_05781, 1.7 log2-fold), a sulfate adenylyl-transferase subunit II 
(RW109_05782, 1.6 log2-fold), a cytochrome c-551 precursor (RW109_01122, 1.7log2-fold) and a 
sulfate-binding protein precursor, which was identified within the top 10 up-regulated DEGs 
(RW109_00880,) (Table 22). Genes involved in nitrogen metabolism were also up-regulated and encoded 
for a carbamate kinase 1 (RW109_06773, 1.9 log2-fold) and a nitrite reductase precursor (RW109_01123, 
2.0 log2-fold). A high number of up-regulated DEGs in response to BIT at 50% of the MIC were 
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characterised within the KEGG energy metabolism category (Table 20) which includes sulphur and 
nitrogen metabolism sub-pathways.    
Within the top ten down-regulated genes in response to BIT at 50% of the MIC, included 6 within close 
proximity to each other in the RW109 genome, (Table 23). A gene annotated as a PQB biosynthetic 3-
oxoacyl-[acyl-carrier-protein] synthase III, (RW109_05184) had decreased expression with a 2.0 log2-fold 
change and was in close proximity to those identified in Table 23. From the Pseudomonas database 
analysis, the RW109_05181-05187 had a high degree of sequence similarity was identified with the PA14 
quorum sensing operons phnAB and pqsABCDE (mean BLASTP scores: percentage ID= 99.51%, 
alignment length= 358, E-value= 0.0 and BIT Score= 723).  
Out of the DEGs down-regulated in response to BIT at 50% of the MIC, 24% were classified within the 
amino acid metabolism pathway (Table 20). Further analysis revealed these genes were involved with 
leucine biosynthesis, inversely correlating to the up-regulation of leucine degradation genes, 
(RW109_04035-04040) as noted above. These encoded a 3-isopropylmalate dehydrogenase 
(RW109_02705, -1.7 log2-fold), a 2-isopropylmalate synthase (RW109_01995, -1.5 log2-fold) and a 3-
isopropylmalate dehydratase small subunit I (RW109_02703, -1.5 log2-fold). An asparagine synthase 
annotated gene involved in aspartate metabolism was also down-regulated in response to BIT at 50% of 
the MIC (RW109_00655, -1.6 log2-fold).  
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Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Main Chromosome 
RW109_03497 Anthranilate 1,2-dioxygenase large subunit Q 3.9 1.24E-13
RW109_02636 sn-glycerol-3-phosphate import ATP-binding protein UgpC G 3.5 7.26E-16
RW109_03936 Putative sialic acid transporter G 3.4 7.10E-10
RW109_02633 Putative sugar-binding periplasmic protein precursor G 3.4 2.60E-20
RW109_02637 Porin B precursor M 3.2 2.49E-13
RW109_00880 Sulfate-binding protein precursor P 2.8 4.25E-07
RW109_03496 Anthranilate 1,2-dioxygenase small subunit Q 2.7 0.000032
RW109_02628 D-erythrose-4-phosphate dehydrogenase G 2.7 2.89E-08
RW109_02635 L-arabinose transport system permease protein AraQ P 2.7 0.0000105
RW109_04038 1,4-Dihydroxy-2-naphthoyl-CoA synthase I 2.6 1.27E-06
Table 22. Top 10 up-regulated genes in response to BIT at 50% of the MIC 
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Table 23. Top 10 down-regulated genes in response to BIT at 50% of the MIC 
Footnotes: *indicates genes in close proximity to each other within the RW109 genome  
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Main chromosome
RW109_05182 Anthranilate synthase component II, pyocyanine specific* E -3.0 5.87E-09
RW109_05185 3-oxoacyl-(acyl carrier protein) synthase III* I -2.8 1.81E-09
RW109_05945 Hypothetical protein S -2.6 1.77E-20
RW109_05186 3-oxoacyl-(acyl carrier protein) synthase III* Unknown -2.6 6.08E-09
RW109_05183 Putative diflavin flavoprotein-A III* S -2.4 0.00000341
RW109_05181 Anthranilate synthase component II, pyocyanine specific* E -2.4 0.0000971
RW109_05187 Anthranilate-CoA ligase* I -2.3 5.02E-08
RW109_07078 Hypothetical protein Unknown -2.3 2.82E-10
RW109_05948 Hypothetical protein S -2.3 0.0000448
RW109_04992 Hypothetical protein M -2.2 0.00000338
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5.2.7.3.3 Gene expression analysis following exposure to POE at 20% of the MIC 
Gene expression analysis of the RW109 strain when exposed to POE at 20% of the MIC (test condition 3), 
identified 493 significant DEGs (Table 21). On the main chromosome, 160 genes were up-regulated and 
306 were down-regulated. On plasmid 1, 13 genes were up-regulated and 4 genes were down-regulated. 
Within plasmid 2, 10 genes were up-regulated and no genes were identified as down-regulated (Table 21).  
Within the top 10 up-regulated main chromosome genes, RW109_02297 and RW109_02298 were 
identified and formed part of a MexPQ-OprM efflux pump system (Table 24). The gene annotated as the 
outer membrane OprM protein (RW109_02299) was not included in the top ten up-regulated genes, but 
did have an increased expression of 3.1 log2-fold.  Also recognised were 3 genes in close proximity to 
each other on the main chromosome with one having the greatest log2-fold change and encoded for a 
hypothetical protein (RW109_01137). The other 2 genes were annotated as a gamma-glutamylputrescine 
oxidoreductase, PuuB (RW109_01139) and a HTH-type transcriptional regulator PuuR (RW109_01140) 
and both had a log2-fold increase of ≥ 4.7. These genes were involved in Gamma-aminobutyric acid 
(GABA) biosynthesis from putrescine within the amino acid metabolism KEGG pathway. PuuB 
functioned in the breakdown of putrescine via the oxidation of L-glutamylputrescin and PuuR regulates 
the putrescine utilisation pathway.  
Out of the up-regulated genes characterised in the KEGG signal transduction, 12% were assigned to the 
two-component system pathway (Table 20). Two genes, RW109_05645 and RW109_05646, both encoded 
for the PctA and PctB methyl-accepting chemotaxis proteins and were up-regulated by 1.7 and 1.8 log2-
fold respectively. The genes, RW109_01838 and RW109_01839, were previously identified as encoding 
for a NarX-NarL (nitrate respiration) two-component regulatory system (Chapter 3, Section 3.2.3.2).                   
These had an increased expression of 2.1 and 1.7 log2-fold respectively in response to POE at 20% of the 
MIC. Two other up-regulated genes identified were RW109_04786 and RW109_04787, which both 
encode for the chemotaxis protein CheW.  
Up-regulated genes of interested classified within the cell motility pathway, had functions in flagella 
assembly and encoded for an FlgN protein (RW109_02463, 1.7log2-fold) and an anti-sigma-28 factor, 
FlgM (RW109_02462, 2.3log2-fold). Two other notable genes were annotated as Flagellar protein FliS 
(RW109_05082, 1.8log2-fold) and a B-type flagellin (RW109_05085, 2.2log2-fold). Within the 
xenobiotics and biodegradation pathway, noticeable up-regulated genes included RW109_01049 (2.2 
log2-fold) and RW109_04050 (2.4 log2-fold) which encoded for acyl-CoA dehydrogenase and acetyl-
CoA acetyltransferase respectively; both enzymes were involved in benzoate degradation. Two genes 
involved in caprolactam degradation encoded for the alkane 1-monooxygenase I and II enzymes 
(RW109_03429, 1.8 log2-fold and RW109_04639, 2.0 log2-fold). A gene annotated as an alcohol 
dehydrogenase, RW109_07041, was up-regulated in response to POE at 20% of the MIC with a 2.5 log2-
fold. The RW109_04035-04039 genes, identified as part of the gnyRDBHAL gene cluster, also had an 
increased expression of between 1.8 – 4.2 log2-fold with this test condition.   
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Within the top 10 genes up-regulated on plasmid 1 in response to POE, a mercuric transport protein 
periplasmic component precursor (RW109_00024) had the greatest increase in expression (Table 24).                  
This was also the only up-regulated plasmid 1 gene assigned with a KO number and was characterised as a 
pores ion channel. Seven out of the 10 up-regulated plasmid 2 genes were annotated as hypothetical 
proteins. Three genes of interest encoded for an antitoxin DinJ (RW109_07361), an mRNA interferase 
YafQ (RW109_07362) and an antitoxin ChpS (RW109_07367). The genes encoding DinJ and YafQ, 
work together as a toxin-antitoxin (TA) system. The YafQ toxin is an RNase enzyme which interferes 
with translation and the DinJ is an antitoxin which counteracts the effects of YafQ toxicity (Armalytė et 
al., 2012). ChpS was also part of a TA-System involving ChpB and RW109 was found to encode for 
ChpB on plasmid 2. However, no gene expression changes in response to the industrial conditions were 
observed for this gene.  
The main chromosome genes within the top 10 POE down-regulated genes are shown in Table 25. Of 
these, RW109_03624, which encoded an L-ornithine 5-monooxygenase, had the largest fold change 
(Table 25). The RW109_03625 and RW109_03626 (not included in the top 10 down-regulated genes) 
were of interest due to their close proximity to RW109_03624. These encoded for an acyl-homoserine 
lactone acylase PvdQ (RW109_03625) and a ferric uptake regulation protein (RW109_03626) and were 
down-regulated ≥ 2.9 log2-fold. The enzymes encoded by RW109_03624 and RW109_03625 were 
involved in quorum sensing and the RW109_03626 was involved in the regulation of iron-uptake. Other 
genes of note in the top 10 down-regulated genes were RW109_05337 encoding a GlcNAc-binding 
protein A precursor, and RW109_02092 which encodes for a pseudolysin precursor. A RW109_03982 
gene encoding for a decarbamoylnovobiocin carbamoyltransferase (K00612) was also identified. 
Siderophore biosynthesis genes RW109_01443-01450 which had decreased expression between the 
ranges of 1.6 – 3.6 log2-fold in response to POE at 20% of the MIC, were also notable. The genes 
RW109_05182-05187, previously identified as part of phnAB and pqsABCDE operons, were also down-
regulated in response to test condition 3 and a decrease of between 1.6 – 2.2 log2-fold was observed. The 
plasmid 1 gene with the greatest decrease in expression was RW109_00284 and encoded for a taurine-
pyruvate aminotransferase (Table 25).  
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Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1 
RW109_00024 Mercuric transport protein periplasmic component precursor P 2.5 0.033044
RW109_00588 Chromosome partition protein Smc S 1.8 6.79E-15
RW109_00303 Leucine-responsive regulatory protein K 1.7 5.24E-08
RW109_00516 Hypothetical protein Unknown 1.7 0.02571
RW109_00367 Arc-like DNA binding domain protein Unknown 1.6 0.010028
RW109_00019 DNA-invertase hin L 1.6 3.24E-11
RW109_00048 Hypothetical protein S 1.6 0.00000119
RW109_00101 Hypothetical protein S 1.6 0.00000873
RW109_00562 HTH-type transcriptional regulator DmlR K 1.6 0.00000831
RW109_00020 Hypothetical protein S 1.6 0.0000403
Main chromosome 
RW109_01137 Hypothetical protein Unknown 6.7 7.00E-34
RW109_02297 Membrane fusion protein MexP V 5.5 6.94E-15
RW109_02298 Efflux pump membrane transporter MexQ V 5.0 3.65E-14
RW109_01140 HTH-type transcriptional regulator PuuR K 4.9 1.82E-14
RW109_01139 Gamma-glutamylputrescine oxidoreductase E 4.7 5.28E-69
RW109_02242 Copper chaperone CopZ P 4.5 8.99E-23
RW109_04035 HTH-type transcriptional regulator CueR K 4.2 8.05E-28
RW109_05611 Hca operon transcriptional activator K 4.0 5.01E-52
RW109_05610 Putative efflux pump outer membrane protein TtgC precursor M 3.9 1.90E-75
RW109_06470 Multidrug-efflux transporter 1 regulator K 3.9 1.05E-32
Plasmid 2
RW109_07319 Hypothetical protein Unknown 2.3 4.37E-21
RW109_07282 Hypothetical protein S 2.3 2.67E-34
RW109_07367 Antitoxin ChpS Unknown 2.2 0.0000634
RW109_07253 Hypothetical protein Unknown 2.1 2.14E-18
RW109_07362 mRNA interferase YafQ S 2.1 1.12E-09
RW109_07255 Hypothetical protein Unknown 2.0 5.85E-19
RW109_07254 Hypothetical protein Unknown 2.0 8.10E-09
RW109_07330 Hypothetical protein Unknown 1.7 0.00614
RW109_07361 Antitoxin DinJ L 1.7 1.35E-08
RW109_07256 Hypothetical protein Unknown 1.6 0.00000989
Table 24. Top 10 up-regulated genes in response to POE at 20% of the MIC 
Footnotes = Top 10 genes from the main chromosome and the two plasmids are shown 
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Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00284 Taurine-pyruvate aminotransferase H -2.2 0.012463
RW109_00047 PhoD-like phosphatase S -1.7 1.58E-09
RW109_00460 Imelysin S -1.7 0.016447
RW109_00125 Hypothetical protein E -1.6 0.006475
Main chromosome
RW109_03624 L-ornithine 5-monooxygenase Q -5.2 1.56E-16
RW109_05337 GlcNAc-binding protein A precursor G -4.8 4.75E-37
RW109_03982 Decarbamoylnovobiocin carbamoyltransferase O -4.7 5.28E-13
RW109_03587 Linear gramicidin synthase subunit B Q -4.6 3.90E-09
RW109_07078 Hypothetical protein Unknown -4.6 1.20E-10
RW109_04157 Hypothetical protein S -4.5 0.000000301
RW109_03598 Diaminobutyrate--2-oxoglutarate aminotransferase E -4.2 0.000000365
RW109_02092 Pseudolysin precursor E -4.2 1.26E-101
RW109_02394 Hemophore HasA S -4.1 0.00000159
RW109_03645 Hypothetical protein S -4.0 7.88E-13
Table 25. Top 10 down-regulated genes in response to POE at 20% of the MIC 
Footnotes = Top 10 genes from the main chromosome are shown as well as and the total 4 down-regulated from 
plasmid 1.   
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5.2.7.3.4 Gene expression analysis following exposure to POE at 50% of the MIC 
Gene expression analysis of the RW109 strain when exposed to POE at 50% of the MIC (test condition 4) 
identified 860 significant DEGs (Table 21). On the main chromosome, 320 were up-regulated and 507 
were down-regulated. Ten genes were up-regulated on plasmid 1 and 6 genes were down-regulated and on 
plasmid 2, 16 were up-regulated and one gene was down-regulated.  
Within the top 10 up-regulated on the main chromosome, the gene with the greatest fold change encoded 
for a hypothetical protein RW109_01137 (Table 26), which was also had the highest increase in gene 
expression in response to POE at 20% of the MIC (5.2.7.3.3). A putative sialic acid transporter associated 
with RW109_03936 had the second greatest log2-fold increase. The antA RW109_03497 gene was 
identified as the third gene most up-regulated on the main chromosome. The antB RW109_03496 gene 
and antC RW109_03495 gene also both had increases in expression with 4.7 log2-fold and 3.3 log2-fold 
changes observed respectively (Table 26). These three genes were previously identified with BIT at 50% 
of the MIC (Section 5.2.7.3.2).  
The efflux pump membrane transporter MexQ (RW109_02298), was also identified within the top up-
regulated main chromosome genes (Table 26). The membrane fusion protein MexP (RW109_02297, 
4.9log2-fold) and outer membrane protein OpmE precursor (RW109_02299, 3.2log2-fold) were 
significantly up-regulated but not included within the top ten. Other genes of interest were the putative 
tartrate transporter (RW109_03749) and a bacterioferritin encoding gene (RW109_02289) (Table 26).The 
RW109_04035-04040 genes which form the gnyRDBHAL gene cluster were also up-regulated in response 
to POE at 50% of the MIC with increases observed between 3.6 – 5.5 log2-fold. A transcriptional 
regulator, KdgR (RW109_04041) was also significantly up-regulated with a 2.6 log2-fold change. The 
RW109_01139 and RW109_01140 genes involved in GABA biosynthesis from putrescine were up-
regulated by 2.3 and 3.8 log2-fold respectively, and were identified with increased expression in response 
to POE at 20% of the MIC (Section 5.2.7.3.3).  
Within the xenobiotics biodegradation and metabolism KEGG pathway, 4 genes were identified as up-
regulated in response to POE at 50% of the MIC and were involved in benzoate degradation. These were 
annotated as a muconolactone delta-isomerase (RW109_03501, 3.8 log2-fold), a catechol 1,2-dioxygenase 
(RW109_03502, 4.8 log-2fold), an acyl-CoA dehydrogenase (RW109_01049, 1.9 log2-fold) and an 
acetyl-CoA acetyltransferase (RW109_04050, 1.8 log2-fold). The RW100_07041 and RW109_02105 
genes were up-regulated in response to POE at 50% of the MIC by 2.0 and 1.7 log2-fold respectively and 
encoded for alcohol dehydrogenases. The RW100_07041 gene was also up-regulated with POE at 20% of 
the MIC by 2.5 log2-fold. POE is an alcohol based preservative making genes encoding putative alcohol 
dehydrogenases of interest.   
The gene with the highest increase in expression on plasmid 1 in response to POE at 50% of the MIC 
encoded a glutathione S-transferase GST (RW109_00018) (Table 26). This gene was characterised as part 
of the KEGG xenobiotics by cytochrome P450 pathway. The majority of the genes with increased 
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expression on plasmid 2 encoded for hypothetical proteins (Table 26). The genes encoding for the TA-
System antitoxin ChpS (RW109_07367) and mRNA interferase YafQ (RW109_07362) that increased 
expression in response to POE at 20% of the MIC (Section 5.2.7.3.3) were also up-regulated in response 
to POE at 50% of the MIC.  
On the main chromosome, a hypothetical protein encoded gene (RW109_05811) had the greatest log2-
fold change within the top ten down-regulated genes (Table 27). The RW109_05337 gene involved in 
chitin-binding, a pseudolysin precursor gene RW109_02092 and a decarbamoylnovobiocin 
carbamoyltransferase encoding RW109_03982 gene were down-regulated in response to POE at 50% of 
the MIC and were identified in Table 27. These three genes were also down-regulated in response to POE 
at 20% of the MIC. Other notable genes identified on the main chromosome were RW109_01443-
RW109_01450, which had a decrease in expression within the range of 2.7 – 6.0 log2-fold. These genes 
were also down-regulated in response to POE at 20% of the MIC and functioned in the biosynthesis of 
siderophores (Section 5.2.7.3.3). The down-regulation of these 8 genes together was only observed with 
POE at 20% and 50% of the MIC. The RW109_05181-05187 genes previously identified as part of the 
phnAB and pqsABCDE operons (Section 5.2.7.3.2), were also down-regulated in response to POE at 50% 
of the MIC, with a decrease of between 1.8 – 4.4 log2-fold.  
A Cytochrome c encoding gene RW109_00461 had the greatest decrease in expression on plasmid 1. The 
taurine-pyruvate aminotransferase encoding gene RW109_00284 previously identified with POE at 20% 
of the MIC was also down-regulated with 50% of the MIC (Table 27). Other plasmid 1 genes of interest 
were an acrylyl-CoA reductase AcuI (RW109_00560) and a formyltetrahydrofolate deformylase 
(RW109_00469). RW109_07290 encoding for a hypothetical protein was the only plasmid 2 down-
regulated gene identified.  
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Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Table 26. Top 10 up-regulated genes in response to POE at 50% of the MIC 
Footnotes = Top 10 genes from the main chromosome and the two plasmids are shown  
Plasmid 1 
RW109_00018 Glutathione S-transferase GST-6.0 O 2.3 0.000578
RW109_00576 Hypothetical protein Unknown 2.0 7.96E-11
RW109_00005 DNA-invertase hin L 1.9 4.72E-13
RW109_00180 Hypothetical protein Unknown 1.9 0.014388
RW109_00516 Hypothetical protein Unknown 1.9 0.001518
RW109_00386 Hypothetical protein Unknown 1.7 0.031553
RW109_00068 Bifunctional (p)ppGpp synthase/hydrolase RelA S 1.7 0.00093
RW109_00589 Site-specific tyrosine recombinase XerD L 1.5 4.66E-13
RW109_00170 Putative S-adenosylmethionine-dependent methyltransferase/MSMEI_2290 Q 1.5 2.92E-08
RW109_00588 Chromosome partition protein Smc S 1.5 6.24E-08
Main chromosome 
RW109_01137 Hypothetical protein Unknown 6.3 5.87E-21
RW109_03936 Putative sialic acid transporter G 6.0 7.97E-15
RW109_03497 Anthranilate 1,2-dioxygenase large subunit Q 5.7 9.42E-13
RW109_02298 Efflux pump membrane transporter MexQ V 5.5 2.02E-14
RW109_03749 Putative tartrate transporter G 5.5 4.79E-12
RW109_04035 HTH-type transcriptional regulator CueR K 5.5 5.00E-49
RW109_02628 D-erythrose-4-phosphate dehydrogenase G 5.5 1.74E-29
RW109_02289 Bacterioferritin P 5.3 3.76E-70
RW109_04036 Acyl-CoA dehydrogenase I 5.3 6.68E-70
RW109_03934 Hypothetical protein S 5.2 9.79E-09
Plasmid 2
RW109_07256 Hypothetical protein Unknown 2.5 5.22E-18
RW109_07367 Antitoxin ChpS Unknown 2.2 0.00000611
RW109_07352 Hypothetical protein Unknown 2.0 0.021039
RW109_07312 Hypothetical protein Unknown 1.9 0.006913
RW109_07362 mRNA interferase YafQ S 1.9 0.000000105
RW109_07382 Hypothetical protein Unknown 1.9 1.69E-08
RW109_07266 Transposase DDE domain protein L 1.9 9.24E-11
RW109_07365 Hypothetical protein Unknown 1.8 0.0000792
RW109_07254 Hypothetical protein Unknown 1.8 0.00000758
RW109_07250 Hypothetical protein Unknown 1.8 5.11E-18
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Table 27. Top 10 down-regulated genes in response to POE at 50% of the MIC 
Footnotes = Top 10 genes from the main chromosome are shown as well as the total 6 down-regulated on 
plasmid 1 and the one from plasmid 2  
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00461 Cytochrome c C -2.7 0.01304
RW109_00269 Hypothetical protein S -1.8 0.0000424
RW109_00284 Taurine-pyruvate aminotransferase H -1.7 0.009095
RW109_00135 Hypothetical protein S -1.6 2.98E-08
RW109_00560 Acrylyl-CoA reductase AcuI C -1.6 0.000279
RW109_00469 Formyltetrahydrofolate deformylase F -1.6 0.000918
Main chromosome
RW109_05811 Hypothetical protein S -7.9 5.85E-23
RW109_03585 Putative RNA polymerase sigma factor FecI K -7.7 1.73E-17
RW109_02092 Pseudolysin precursor E -7.2 1.48E-226
RW109_05337 GlcNAc-binding protein A precursor G -6.9 2.41E-51
RW109_01518 Pesticin receptor precursor P -6.8 1.82E-23
RW109_05808 Superoxide dismutase [Mn/Fe] P -6.8 2.65E-27
RW109_03711 Chitinase D precursor G -6.7 3.84E-18
RW109_03982 Decarbamoylnovobiocin carbamoyltransferase O -6.6 3.32E-18
RW109_05809 Hypothetical protein S -6.5 2.14E-17
RW109_05840 Periplasmic dipeptide transport protein precursor E -6.5 3.20E-37
Plasmid 2
RW109_07290 Hypothetical protein Unknown -2.0 0.007861
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5.2.7.4 Key differentially regulated genes identified following exposure of RW109 to a combination of 
preservatives  
5.2.7.4.1 Gene expression analysis following exposure to a combination of BIT and POE both at 
20% of the MIC 
Gene expression analysis of the RW109 strain when exposed to BIT and POE in combination at 20% of 
the MIC (test condition 5) identified 586 significant DEGs (Table 21). On the main chromosome, 248 
were up-regulated and 301 genes were down-regulated and on plasmid 1, 20 genes were up-regulated and 
5 genes were down-regulated. Eleven genes had increased in expression on plasmid 2, and one gene was 
down-regulated. 
Within the top ten up-regulated genes on the main chromosome, the antA RW109_03497 gene had the 
greatest log2-fold change (Table 28). The antB RW109_03496 gene had the forth greatest increase in 
expression and the antC RW109_03495 gene was also identified as up-regulated in response to POE and 
BIT in combination with a 3.4 log2-fold increase (not included within the top ten unregulated). These 
three genes were involved in the degradation of anthranilate via hydroxylation and previously observed 
had an increased expression with test conditions 2 and 4 (Sections 5.2.7.3.2 and 5.2.7.3.4). The genes 
encoding MexQ (RW109_02298) and MexP (RW109_02298) had the second and third biggest increases 
in expression when exposed to BIT and POE in combination (Table 28). Also up-regulated by 3.1 log2-
fold was the RW109_ 02299 gene annotated as the OprM outer membrane protein was encoded in close 
proximity to the latter efflux genes, although its fold increase was not within the top 10 up-regulated 
genes. Other genes of interest up-regulated in response to BIT and POE in combination, were a putative 
sialic acid transporter encoding gene (RW109_03936), a gene annotated as a copper chaperone CopZ 
(RW109_02242) and a citrate transporter encoding gene (RW109_04047) (Table 28).  
Out of the genes up-regulated in response to BIT and POE in combination, 18% were characterised as part 
of the xenobiotics metabolism and degradation KEGG pathway (Table 20). Within this pathway three 
genes involved in benzoate degradation were found in close proximity to each other on the RW109 
genome and encoded for a muconate cycloisomerase 1 (RW109_03500, 2.5 log2-fold), a muconolactone 
delta-isomerase Q (RW109_03501, 3.1 log2-fold) and a catechol 1,2-dioxygenase Q (RW109_03502, 4.3 
log2-fold). Other up-regulated genes also involved in benzoate degradation encoded an acetyl-CoA 
acetyltransferase (RW109_04050, 2.5 log2-fold) and a carboxymuconolactone decarboxylase family 
protein (RW109_00826, 1.6 log2-fold). A gene on plasmid 1, RW109_00018 encoded a glutathione S-
transferase, was up-regulated by 2.2 log2-fold (Table 28) and characterised as part of the metabolism of 
xenobiotics by cytochrome P450. RW109_00018 was also up-regulated with POE at 50% of the MIC. 
Three genes encoding for alcohol dehydrogenases were also identified with increased expression in 
response to BIT and POE in combination and these included RW109_07041 (2.6 log2-fold), 
RW109_02105 (1.5 log2-fold) and RW109_06146 (2.2 log2-fold). The RW109_04035-04040 genes, 
which form the gnyRDBHAL gene cluster, were also up-regulated in response to BIT and POE with 
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increased expression observed between 3.0 – 4.2 log2-fold. The RW109_04041 gene, which encodes for 
the transcriptional regulator, KdgR was also significantly up-regulated with a 2.2 log2-fold change. 
On plasmid 1 in response to BIT and POE, a gene encoding for a hypothetical protein had the greatest 
increase in expression with a 2.3 log2-fold change. Five other genes annotated as hypothetical proteins 
were also identified within the top ten up-regulated on plasmid 1 (Table 28). This was also the case with 
plasmid 2 where 8 hypothetical encoding genes had increased expression in response to BIT and POE in 
combination (Table 28).  
The gene with the greatest fold decrease on the main chromosome in response to the combined 
preservatives encoded a pesticin receptor precursor (RW109_01518) (Table 29). Four genes within close 
proximity on the main chromosome encoded a superoxide dismutase (RW109_05808), two hypothetical 
proteins (RW109_05809 and RW109_05811) and a fumarate hydratase class II (RW109_05810) (Table 
29). The RW109_05181-05187 genes, which encode for the quorum sensing phnAB and pqsABCDE 
operons, were also all down-regulated after combined preservative exposure, with a fold decrease of 2.4 – 
3.6 log2-fold observed. The genes RW109_01443-01450 which functioned in the biosynthesis of 
siderophores were all down-regulated in response to the BIT-POE combination with a decrease of ≥ 2.2 
log2-fold. These genes were also down-regulated in response to POE at 20% and 50% of the MIC.  
Four down-regulated genes encoded in close proximity to each other on plasmid 1 were identified 
(RW109_00464-00469; Table 29) and 3 had been assigned to KEGG pathways. RW109_00469 was 
characterised in the glyoxylate and dicarboxylate metabolism pathway and RW109_00464-00465 were 
involved in glycine, serine and threonine metabolism. The one gene down-regulated on plasmid 2 was 
annotated as a hypothetical protein (RW109_07290) and had decreased expression in response to POE at 
50% of the MIC.   
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Table 28. Top 10 up-regulated genes in response to BIT and POE in combination at 20% 
of the MIC 
Footnotes = Top 10 genes from the main chromosome and plasmid 1 are shown, as well as the total 11 
genes down regulated from plasmid 2  
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00266 Hypothetical protein Unknown 2.3 0.0000241
RW109_00018 Glutathione S-transferase GST-6.0 O 2.2 0.000127
RW109_00576 Hypothetical protein Unknown 2.2 2.23E-12
RW109_00324 Recombination-associated protein RdgC L 2.1 4.51E-11
RW109_00180 Hypothetical protein Unknown 1.9 0.005873
RW109_00375 Hypothetical protein S 1.9 0.017366
RW109_00516 Hypothetical protein Unknown 1.9 0.001297
RW109_00194 Hypothetical protein Unknown 1.8 0.027186
RW109_00049 Hypothetical protein S 1.7 0.003275
RW109_00367 Arc-like DNA binding domain protein Unknown 1.7 0.000387
Main chromosome 
RW109_03497 Anthranilate 1,2-dioxygenase large subunit Q 6.1 2.25E-20
RW109_02298 Efflux pump membrane transporter MexQ V 5.3 5.05E-17
RW109_02297 Membrane fusion protein MexP V 5.2 1.54E-13
RW109_03496 Anthranilate 1,2-dioxygenase small subunit Q 4.9 7.83E-09
RW109_04047 Citrate transporter E, G 4.5 9.93E-09
RW109_02242 Copper chaperone CopZ P 4.5 9.54E-26
RW109_03936 Putative sialic acid transporter G 4.4 2.97E-08
RW109_03502 Catechol 1,2-dioxygenase Q 4.3 0.000000209
RW109_04037 Methylmalonyl-CoA carboxyltransferase 12S subunit I 4.2 9.88E-30
RW109_01137 Hypothetical protein Unknown 4.2 9.46E-10
Plasmid 2
RW109_07266 Transposase DDE domain protein L 2.1 1.33E-15
RW109_07345 Hypothetical protein Unknown 2.0 0.024347
RW109_07352 Hypothetical protein Unknown 2.0 0.005691
RW109_07250 Hypothetical protein Unknown 2.0 9.41E-18
RW109_07342 Transposase L 1.7 0.009392
RW109_07282 Hypothetical protein S 1.7 1.60E-17
RW109_07376 DNA-binding protein HRL53 L 1.7 1.70E-13
RW109_07297 Hypothetical protein S 1.7 0.000398
RW109_07382 Hypothetical protein Unknown 1.6 0.000000133
RW109_07256 Hypothetical protein Unknown 1.6 0.00000144
RW109_07312 Hypothetical protein Unknown 1.5 0.027199
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Table 29. The top ten down-regulated genes in response to BIT and POE in combination 
at 20% of the MIC 
Footnotes = Top 10 genes from the main chromosome are shown as well as the total 5 genes from 
plasmid 1 and the one gene from plasmid 2. The* indicates those genes within close proximity on the 
main chromosome. The ~ illustrates plasmid 1 genes in close proximity.   
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00464 Sarcosine oxidase, gamma subunit family~ E -2.9 0.010672
RW109_00461 Cytochrome c~ C -2.2 0.00854
RW109_00469 Formyltetrahydrofolate deformylase~ F -1.9 0.00000628
RW109_00465 Aminomethyltransferase~ E -1.8 0.017953
RW109_00423 Hypothetical protein Unknown -1.5 0.046256
Main chromosome
RW109_01518 Pesticin receptor precursor P -6.4 3.44E-36
RW109_05811 Hypothetical protein* S -6.3 3.40E-45
RW109_03585 Putative RNA polymerase sigma factor FecI K -5.8 1.82E-31
RW109_02394 Hemophore HasA S -5.7 3.52E-14
RW109_03624 L-ornithine 5-monooxygenase Q -5.5 4.82E-41
RW109_05808 Superoxide dismutase [Mn/Fe]* P -5.3 1.53E-48
RW109_05809 Hypothetical protein* S -5.2 1.09E-28
RW109_03982 Decarbamoylnovobiocin carbamoyltransferase O -4.9 3.70E-31
RW109_06145 Hypothetical protein Unknown -4.9 6.94E-21
RW109_05810 Fumarate hydratase class II* C -4.8 1.13E-84
Plasmid 2
RW109_07290 Hypothetical protein Unknown -1.5 0.00024
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5.2.7.5 Key differentially regulated genes identified following exposure of RW109 to a laundry detergent 
with and without the addition of the preservative BIT 
5.2.7.5.1 Gene expression analysis following exposure to laundry detergent at 1:100 dilution with 
no preservative added  
Gene expression analysis of the RW109 strain when exposed to laundry detergent with no preservative 
added (LD-only, test condition 6), identified 1,264 significant DEGs (Table 21). On the main 
chromosome, 581 were up-regulated and 627 genes were down-regulated and on plasmid 1, 7 genes were 
up-regulated and 32 genes were down-regulated. Six genes had increased expression on plasmid 2 and 11 
were down-regulated.                  
A gene encoding a putative sialic acid transporter RW109_03936, had the greatest fold increase within the 
top ten up-regulated genes on the main chromosome (Table 30). Four other genes within close proximity 
to RW109_03936 were also identified in Table 30. These genes encoded a hypothetical protein 
(RW109_03934), a porin-like protein NicP precursor (RW109_03937), a LamB/YcsF family protein 
(RW109_03938) and a kinase-A inhibitor (RW109_03939). The putative KipI antagonist (RW109_03940) 
and a HTH-type transcriptional regulator GltR (RW109_03935), were also up-regulated in response to 
LD-only by 4.4 and 1.5 log2-fold respectively. The amino acid sequences of these 7 genes were searched 
using DIAMOND BLASTP on the Pseudomonas database. The genes RW109_03936-03940 had high 
sequence homology to four genes within a predicted PA14 membrane transport operon (mean BLASTP 
scores: percentage ID= 99.2%, alignment length= 329, E-value= 0.0 and BIT Score= 650). Another gene 
of interested, up-regulated in response to the laundry detergent was RW109_05501 (Table 30), which 
encoded a metallo-beta-lactamase superfamily protein and was not observed in conditions 2-5.  
Outside of the top 10 up-regulated genes, a notable observation was the increased expression of the 
syntenic genes RW109_01012 – 01017 ranging between 1.8 – 3.9 log2-fold in response to LD-only. The 
genes had high homology to those within the PA14 pilin biogenesis operons pilGHI and pilJK-chpA-E 
when analysed using the Pseudomonas database (mean BLASTP scores: percentage ID= 99.6%, 
alignment length= 682, E-value= 0.0 and BIT Score= 1171). These genes encode chemotaxis-like 
chemosensory signal transduction systems for regulation of type IV pili production and twitching motility 
in P. aeruginosa (Mattick, 2002).  
Out of the genes up-regulated in response to LD-only, 12% were characterised within the energy 
metabolism KEGG pathways (Table 20). Notable genes RW109_07219-07226 were associated with 
oxidative phosphorylation and had increased expression between 1.5 – 2.6 log2 fold; the genes were part 
of the atpCDGAHFEBI operon.  The genes RW109_00877-00880 functioned in sulphur metabolism and 
increased their expression between 3.0 – 4.2 log2-fold. RW109_00880 encoded for a sulphate-binding 
protein, and the RW109_00877-00879 genes were associated with a sulphate transport operon cysAWT. A 
large cluster of genes (RW109_01333-01370), were up-regulated between 1.9 – 3.7 log2-fold in response 
to LD-only. These genes encoded for 32 ribosomal proteins, 3 DNA-directed RNA polymerases, 2 
elongation factors and 1 preprotein translocase.  
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Genes up-regulated in response to LD-only were also represented by membrane transport pathways (10%) 
(Table 20). RW109_02634-02637 encoded for an ABC sugar transporter operon and RW109_02635 and 
RW109_02636 were within the top ten up-regulated main chromosome genes (Table 30). RW109_02634 
encoded for a glycerol-3-phosphate transport system permease protein and was up-regulated by 4.1 log2-
fold. RW109_02637 was annotated as a porin B precursor and had a 4.6 log2-fold increase in expression. 
The genes encoding the MexP and MexQ proteins of the MexPQ-OpmE efflux pump were up-regulated 
by 4.2 and 4.5 log2-fold respectively in response to LD-only; these genes had previously been identified 
with test conditions 3-5.  
The genes within the gnyDBHAL operon (RW109_04036-04040) and the KdgR transcriptional regulator, 
encoding gene (RW109_04041) had log2-fold increases of ≥ 2.0 in response to LD-only. These genes 
were also up-regulated with test conditions 2-5. Seven plasmid 1 genes were up-regulated in response to 
LD-only and a hypothetical protein encoding gene RW109_00524 had the greatest increase with 3.0 log2-
fold (Table 30). A hypothetical protein encoding gene RW108_07297 also had the greatest fold increase 
out of the 6 genes up-regulated on plasmid 2.  
Within the top ten down-regulated chromosome genes identified in response to LD-only, RW109_05642 
annotated as an Flp/Fap pilin component had the greatest fold decrease (Table 31). RW109_05181 was the 
second-most downregulated chromosomal gene (Table 31) and was associated with the quorum sensing 
operon phnAB. The RW109_05182 gene associated with the same quorum sensing operon phnAB was also 
down-regulated in response to LD-only by 4.2 log2-fold. The genes, which form the pqsABCDE operon 
RW109_05183-05187, also had a decreased expression with this test condition of between 4.0 – 5.3 log2-
fold (Table 31). Genes RW109_06227 and RW109_06228 (Table 31) encoded two spore Coat Protein U 
domain proteins and were both highly down-regulated by 6.0 log2-fold. An outer membrane channel 
protein, LapE (RW109_04177) and a cna B-type domain protein (RW109_04178) were identified in the 
top ten down-regulated DEGs. Two other genes in close proximity were also down-regulated and encoded 
a type I secretion system membrane fusion protein LapC (RW109_04175, -4.3 log2-fold) and a toxin 
RTX-I translocation ATP-binding protein LapB (RW109_04176, -4.5 log-fold). RW109_04176-04177 
were characterised by KEGG as a lapBCE adhesin protein transport system operon. Two genes of interest 
with decreased expression with LD-only encoded for two bacterial type II secretion system proteins 
(RW109_05636, -3.6 log2-fold and RW109_05637, -2.4 log2-fold). Out of the genes down-regulated in 
response to LD-only, 20% were associated with carbohydrate metabolism (Table 20). Notable genes 
RW109_02383-02385 within this KEGG pathway formed a pyruvate dehydrogenase complex and had a 
decreased expression of between 2.5 – 3.6 log2-fold.   
The gene with the greatest fold decrease on plasmid 1 in response to LD-only was annotated as a 
hypothetical protein (RW109_00135) (Table 31). Other notable genes down-regulated on the plasmid 
included RW109_00469 and RW109_00464 which also had decreased expression in response to BIT and 
POE in combination (Section 5.2.7.4.1). A plasmid 1 aerotaxis receptor annotated gene (RW109_00009) 
had the third greatest log2-fold decrease in response to LD-only and was part of a KEGG bacterial 
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chemotaxis two-component system. Two other notable down-regulated plasmid 1 genes encoded 
transposition TniQ and TniB proteins (RW109_00006, -1.9 log2-fold and RW109_00007, -2.1 log2-fold). 
On plasmid 2, a down-regulated gene of interest encoded for an antitoxin DinJ protein (RW109_ 07361); 
the majority of plasmid 2 genes with decreased expression were annotated as hypothetical proteins (Table 
31).   
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Table 30. The top ten up-regulated genes in response to LD with no preservative added 
Footnotes = Top 10 genes from the main chromosome as well as the 7 genes from plasmid 1 and the 6 
genes from plasmid 2. The * indicates genes within close proximity on the RW109 genome.  
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00524 Hypothetical protein Unknown 3.0 0.000877
RW109_00459 Hypothetical protein S 2.6 0.000000509
RW109_00174 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase M 1.9 1.15E-12
RW109_00057 Site-specific tyrosine recombinase XerC L 1.8 2.73E-08
RW109_00460 Imelysin S 1.6 1.77E-09
RW109_00225 Hypothetical protein Unknown 1.5 0.000000256
RW109_00198 Anaerobic sulfatase-maturating enzyme S 1.5 0.002315
Main chromosome 
RW109_03936 Putative sialic acid transporter* G 6.9 1.20E-21
RW109_03934 Hypothetical protein* S 5.3 9.89E-10
RW109_05501 Metallo-beta-lactamase superfamily protein Q 5.1 4.70E-11
RW109_03937 Porin-like protein NicP precursor* M 5.0 1.12E-12
RW109_02635 L-arabinose transport system permease protein AraQ P 5.0 1.44E-12
RW109_03939 Kinase A inhibitor* E 4.9 3.11E-08
RW109_03690 High-affinity gluconate transporter E, G 4.8 5.26E-08
RW109_06963 Putative FAD-linked oxidoreductase C 4.7 5.82E-09
RW109_03938 LamB/YcsF family protein* E 4.6 0.00000202
RW109_02636 sn-glycerol-3-phosphate import ATP-binding protein UgpC G 4.6 1.73E-24
Plasmid 2
RW109_07297 Hypothetical protein S 2.0 0.0000024
RW109_07302 Hypothetical protein Unknown 1.9 0.000268
RW109_07275 Outer membrane lipoprotein BfpB precursor U 1.8 9.94E-10
RW109_07312 Hypothetical protein Unknown 1.7 0.005522
RW109_07299 Hypothetical protein Unknown 1.6 0.004189
RW109_07267 O-acetyltransferase OatA I 1.5 0.0000075
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Table 31. The top ten down-regulated genes in response to LD with no preservative added 
Footnotes = Top 10 genes from the main chromosome and plasmid 1 are shown as well as the total 11 
genes from plasmid 2  
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00135 Hypothetical protein S -3.7 3.52E-34
RW109_00469 Formyltetrahydrofolate deformylase F -3.6 3.08E-22
RW109_00009 Aerotaxis receptor T -3.4 4.13E-34
RW109_00303 Leucine-responsive regulatory protein K -3.3 1.34E-21
RW109_00081 Hypothetical protein Unknown -3.2 0.017561
RW109_00269 Hypothetical protein S -2.9 6.38E-13
RW109_00231 Hypothetical protein Unknown -2.8 0.00016
RW109_00464 Sarcosine oxidase, gamma subunit family E -2.7 0.008721
RW109_00446 Aminomethyltransferase E -2.7 0.002159
RW109_00566 Chromosome-partitioning protein Spo0J K -2.6 0.015754
Main chromosome
RW109_05642 Flp/Fap pilin component Unknown -6.9 3.96E-38
RW109_05181 Anthranilate synthase component 2, pyocyanine specific E -6.4 4.68E-13
RW109_04178 Cna protein B-type domain protein O -6.1 2.22E-163
RW109_06227 Spore Coat Protein U domain protein S -6.0 2.78E-45
RW109_06228 Spore Coat Protein U domain protein S -6.0 4.32E-11
RW109_04177 outer membrane channel protein M -5.9 4.22E-48
RW109_05641 SAF domain protein U -5.8 2.36E-15
RW109_03434 PA-I galactophilic lectin S -5.7 4.60E-32
RW109_00725 Aegerolysin Unknown -5.5 1.29E-126
RW109_01791 Hypothetical protein S -5.4 1.23E-197
Plasmid 2
RW109_07281 Hypothetical protein S -2.3 0.028305
RW109_07290 Hypothetical protein Unknown -2.3 0.000000173
RW109_07361 Antitoxin DinJ L -1.8 7.81E-10
RW109_07316 Hypothetical protein Unknown -1.8 9.4E-13
RW109_07384 Hypothetical protein Unknown -1.7 0.0000139
RW109_07253 Hypothetical protein Unknown -1.6 2.69E-08
RW109_07238 Transglycosylase SLT domain protein M -1.6 0.02264
RW109_07257 Hypothetical protein Unknown -1.5 0.00149
RW109_07280 Hypothetical protein S -1.5 0.035025
RW109_07268 Hypothetical protein U -1.5 2.97E-08
RW109_07293 Initiator Replication protein L -1.5 0.000000098
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5.2.7.5.2 Gene expression analysis following exposure to a combination of laundry detergent at 
1:100 dilution and BIT at 20% of the MIC 
Gene expression analysis of the RW109 strain when exposed to a combination of laundry detergent at a 
1:100 dilution and BIT at 20% of the MIC (test condition 7) identified 1,487 significant DEGs   (Table 
21). On the main chromosome, 678 were up-regulated and 724 genes were down-regulated. On plasmid 1, 
23 genes were up-regulated and 35 genes were down-regulated and on plasmid 2, 13 genes had increased 
expression and 14 were down-regulated.  
Due to the large number of DEGs identified with this test condition, it was decided to illustrate those with 
increased and decreased expression on circular maps representing the main chromosome and two plasmids 
(Figure 46, Figure 47 and Figure 48). Both the up-regulated and down-regulated genes were dispersed 
throughout the main chromosome. A large grouping of the up-regulated RW109_01333-01370 genes were 
observed on main chromosome which encoded for ribosomal proteins (Figure 46) and were also identified 
as up-regulated during exposure to laundry detergent only (Section 5.2.7.5.1). An increase in ribosomal 
protein gene expression suggests the repair and replacement of ribosomes is required by the RW109 strain 
when exposed to LD with and without BIT.  On plasmid 1, greater co-localisation of up-regulated genes 
was observed, whereas the down-regulated genes were spread throughout the plasmid (Figure 47). 
Interestingly, a similar split and co-localisation of up-regulated genes on plasmid 2 was also observed 
(Figure 48). The down-regulated genes were also more dispersed throughout plasmid 2 when compared to 
the up-regulated genes (Figure 48).  
On the main chromosome, the most up-regulated gene in response to LD with BIT was the putative sialic 
acid transporter encoding gene RW109_03936 (Table 32); this gene was also up-regulated in response to 
multiple test conditions (2, 4, 5 and 6) as indicated by Figure 49. RW109_03936 was characterised within 
a predicted membrane transport operon, which included RW109_03937-03940 and a transcriptional 
regulator GltR, encoded by RW109_03935 (Figure 49). All genes associated with this operon were up-
regulated in response to LD with BIT, and RW109_03937 and RW109_03939 were within the top 10 up-
regulated main chromosome DEGs (Table 32).   
The RW109_05501 gene encoding a metallo-beta-lactamase superfamily protein had the second highest 
log2-fold change in response to LD with BIT (Table 32); this gene was also up-regulated with LD-only. 
The MexPQ-OpmE RND efflux system encoding genes RW109_02297-02299 were up-regulated with LD 
with BIT, and the gene RW109_02298 was the third gene within the top ten up-regulated main 
chromosome DEGs (Table 32). The RW109_04035-04040 gnyRDBHAL operon and the RW109_04041 
gene encoding the KdgR transcriptional regulator, previously identified with conditions 2-6, were also up-
regulated with LD and BIT with an expression increase of ≥ 1.9 log2-fold.   
A notable observation was the up-regulation of the genes RW109_01012 – 01017, that ranged between 1.7 
– 3.7 log2-fold. These genes were associated with the pilin biogenesis operons pilGHI and pilJK-chpA-E 
(Section 5.2.7.5.1) and increased expression with LD-only (Figure 50). All the genes of the pilGHI operon 
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were identified as up-regulated in response to test condition 5 as indicated in Figure 50. In response to LD 
with BIT, 4 up-regulated genes were identified which were not observed together in any other test 
condition. These included RW109_04463 (pscN, 2.4 log2-fold), RW109_04466 (pscQ, 2.9 log2-fold), 
RW109_04467 (pscR 3.0 log2-fold) and RW109_04470 (pscU, 3.0 log2-fold). These genes formed part of 
the pscNOPQRTU operon of a KEGG type III section system.  Four genes associated with a 
glucose/mannose membrane ABC transport system (RW109_02633-02636) were up-regulated in response 
to LD and BIT with a ≥ 3.4 log2-fold increase. These genes were also all up-regulated together in response 
to BIT at 50% of the MIC.  
On plasmid 1, within the top ten up-regulated genes, 7 encoded for hypothetical proteins which was also 
observed with plasmid 2 (Table 32). A gene of interest on plasmid 1 was RW109_00174, which encoded 
an N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase WbbL, and functioned in cell 
wall peptidoglycan biosynthesis (Figure 47). On plasmid 2 a notable gene, RW109_07269, encoded for a 
twitching mobility protein as indicated in Figure 48.  
On the main chromosome, a gene encoding for decarbamoylnovobiocin carbamoyltransferase 
(RW109_03982) had the greatest fold decrease in response to LD with BIT (Table 33). This gene was 
previously identified as down-regulated in response to POE at 20% and 50% of the MIC. Also within the 
top ten down-regulated genes were RW109_05186 and RW109_05187, which formed part of the 
RW109_05183-05187 quorum sensing pqsABCDE operon. The other genes associated with this operon 
and the RW109_05181-05182 phnAB operon all had decreased expression in response to LD with BIT. 
The genes encoding a Flp/Fap pilin component (RW109_05642), an outer membrane channel protein 
(RW109_04177) and a Cna B-type domain protein (RW109_04178) were identified in Table 33 and also 
had a decreased expression with LD-only. Two down-regulated DEGs previously identified with LD-only 
encoded for bacterial type II secretion system proteins (RW109_05636, -4.1 log2-fold and RW109_05367, 
-2.2 log2-fold); these genes were only observed after exposure to LD with and without BIT. The genes 
encoding for a KEGG iron complex transport system were only observed in response to LD with BIT and 
these included RW109_01515 and RW109_01516 which had 3.5 and 3.2 log2-fold decreases respectively. 
A KEGG glycine betaine/proline membrane transport system was also only down-regulated with this test 
exposure condition and was encoded for by RW109_06690 (-2.1 log2-fold) and RW109_06691 (-1.8 
log2-fold).   
Hypothetical protein encoded genes were repressed on both plasmid 1 and 2, with 7 being within the top 
10 down-regulated genes on each replicon (Table 33). On plasmid 1, the greatest fold decrease was 
observed with the hypothetical protein encoding gene RW109_00135 (Table 33). The RW109_00464 and 
RW109_00469 plasmid 2 genes (Table 33) were also identified with BIT-POE and LD-only test 
conditions and encoded for a sarcosine oxidase and formyltetrahydrofolate deformylase respectively. The 
aerotaxis receptor encoding gene (RW109_00009) which had decreased expression with LD-only, was 
also observed within the top ten down-regulated plasmid 1 genes, in response to LD with BIT (Table 33). 
A down-regulated gene of interest on plasmid 2 encoded for an antitoxin DinJ protein (RW109_ 07361) 
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which had previously been identified as up-regulated in response to POE at 20% of the MIC (Section 
5.2.7.3.3). A large number of genes with decreased expression were annotated as hypothetical proteins 
(Table 33) and this was true during exposure to LD-only.   
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Figure 46. The differentially regulated genes identified on the main chromosome in response to laundry detergent in combination with BIT 
Significant up-regulated DEGs 
Significant down-regulated DEGs 
COG categories 
GC content features 
Main Chromosome
7,049,347 bp
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
RW109_01333 50S ribosomal protein L11 J 1.8 2.61E-16
RW109_01334 50S ribosomal protein L1 J 2.9 7.49E-35
RW109_01335 50S ribosomal protein L10 J 3.9 1.09E-65
RW109_01336 50S ribosomal protein L7/L12 J 3.3 1.44E-39
RW109_01337 DNA-directed RNA polymerase subunit beta K 1.9 5.10E-28
RW109_01338 DNA-directed RNA polymerase subunit beta' K 2.1 8.63E-34
RW109_01339 30S ribosomal protein S12 J 2.4 2.31E-30
RW109_01340 30S ribosomal protein S7 J 3.2 1.99E-46
RW109_01341 Elongation factor G 1 J 3.4 1.42E-58
RW109_01342 Elongation factor Tu J 2.6 6.22E-43
RW109_01343 30S ribosomal protein S10 J 3.0 9.46E-23
RW109_01344 50S ribosomal protein L3 J 3.0 1.24E-33
RW109_01345 50S ribosomal protein L4 J 3.4 1.64E-45
RW109_01346 50S ribosomal protein L23 J 3.3 3.28E-26
RW109_01347 50S ribosomal protein L2 J 3.3 1.13E-44
RW109_01348 30S ribosomal protein S19 J 2.7 4.41E-24
RW109_01349 50S ribosomal protein L22 J 3.0 1.83E-19
RW109_01350 30S ribosomal protein S3 J 2.8 4.26E-31
RW109_01351 50S ribosomal protein L16 J 2.5 5.02E-27
RW109_01352 50S ribosomal protein L29 J 3.0 5.99E-14
RW109_01353 30S ribosomal protein S17 J 2.6 2.43E-28
RW109_01354 50S ribosomal protein L14 J 2.4 3.92E-26
RW109_01355 50S ribosomal protein L24 J 3.5 2.03E-42
RW109_01356 50S ribosomal protein L5 J 3.2 8.83E-43
RW109_01357 30S ribosomal protein S14 J 3.1 3.02E-26
RW109_01358 30S ribosomal protein S8 J 3.3 1.03E-25
RW109_01359 50S ribosomal protein L6 J 3.4 3.23E-42
RW109_01360 50S ribosomal protein L18 J 3.4 3.71E-31
RW109_01361 30S ribosomal protein S5 J 2.6 1.03E-36
RW109_01362 50S ribosomal protein L30 J 2.7 1.01E-22
RW109_01363 50S ribosomal protein L15 J 2.6 1.22E-28
RW109_01364 preprotein translocase subunit SecY U 3.4 1.44E-61
RW109_01365 50S ribosomal protein L36 Unknown 3.0 0.004535
RW109_01366 30S ribosomal protein S13 J 3.6 5.06E-28
RW109_01367 30S ribosomal protein S11 J 2.3 1.31E-12
RW109_01368 30S ribosomal protein S4 J 2.5 3.89E-18
RW109_01369 DNA-directed RNA polymerase subunit alpha K 2.5 5.46E-39
RW109_01370 50S ribosomal protein L17 J 2.4 1.19E-31
RW109_03936-03940 
Predicted membrane transport operon with 
sialic acid transporter  
RW109_05181-05182 phnBA operon and 
RW109_05183-05187 pqsEDCBA operon
RW109_01333-01370 Genes encoding for ribosomal  proteins
Starting from the outermost circle for each map and moving inwards the following tracks were identified: (1) predicted CDS on forward strand coloured according to COG 
categories, (2) predicted CDS on reverse strand coloured according to COG categories, (3) significantly up-regulated DEGs coloured green, (4) significantly down-regulated 
DEGs coloured light pink, (5) GC content (black), (6) positive and negative GC skew (green and purple, respectively) and (7) genome region by Mbp.  The size of the main 
chromosome was not drawn to scale. Notable up-regulated genes were labelled in green and down-regulated genes of interest were labelled in pink.  
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Figure 47. The differentially regulated genes identified on plasmid 1 in response to laundry detergent and BIT in combination 
Plasmid 1
555,265 bp
Significant up-regulated DEGs 
Significant down-regulated DEGs 
COG categories 
GC content features 
RW109_00174 N-acetylglucosaminyl-diphospho-decaprenol
L-rhamnosyltransferase
RW109_00180
Hypothetical protein
RW109_00201
Hypothetical protein
RW109_00293 
Aminomethyltransferase
RW109_00353
Hypothetical protein
RW109_00459
Hypothetical protein
RW109_00477
Hypothetical protein
RW109_00524-00525
Hypothetical proteins
RW109_00103 Type II secretion
system protein G precursor*
RW109_00009
Aerotaxis receptor
RW109_00081
Hypothetical protein
RW109_00135
Hypothetical protein
RW109_00230
Hypothetical protein
RW109_00269
Hypothetical protein
RW109_00303 Leucine-responsive
regulatory protein
Starting from the outermost circle for each map and moving inwards the following tracks were identified: (1) predicted CDS on forward strand coloured according to COG 
categories, (2) predicted CDS on reverse strand coloured according to COG categories, (3) significantly up-regulated DEGs coloured green, (4) significantly down-regulated 
DEGs coloured light pink, (5) GC content (black), (6) positive and negative GC skew (green and purple, respectively) and (7) genome region by kbp.  The size of plasmid 1 
was not drawn to scale. The top ten up-regulated genes were labelled in green and the top ten down-regulated were labelled in pink (the * on RW109_00103, indicates a gene 
of interest not included within the top 10 down-regulated).  
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Figure 48. The differentially regulated genes identified on plasmid 2 in response to laundry detergent and BIT in combination 
Significant up-regulated DEGs 
Significant down-regulated DEGs 
COG categories 
GC content features 
Plasmid 2
151,612 bp
RW109_07266 
Transposase DDE domain protein
RW109_07267
O-acetyltransferase OatA
RW109_07269
Twitching mobility protein
RW109_07277
Plasmid segregation 
protein ParM
RW109_07293
Initiator Replication protein
RW109_07325
site-specific tyrosine 
recombinase XerC
RW109_07361
Antitoxin DinJ
RW109_07377
SprT-like family protein
Starting from the outermost circle for each map and moving inwards the following tracks were identified: (1) predicted CDS on forward strand coloured according to COG 
categories, (2) predicted CDS on reverse strand coloured according to COG categories, (3) significantly up-regulated DEGs coloured green, (4) significantly down-
regulated DEGs coloured light pink, (5) GC content (black), (6) positive and negative GC skew (green and purple, respectively) and (7) genome region by kbp.  The size of 
plasmid 2 was not drawn to scale. All the up-regulated genes not encoding hypothetical proteins were labelled in green and all the down-regulated genes without a 
hypothetical protein annotation were labelled in pink.  
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Table 32. The top ten up-regulated genes in response to laundry detergent in combination with BIT 
at 20% of the MIC  
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00524 Hypothetical protein Unknown 3.4 0.000187
RW109_00174 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase M 2.3 4.26E-21
RW109_00477 Hypothetical protein Unknown 2.3 0.028076
RW109_00057 Site-specific tyrosine recombinase XerC L 2.2 7.27E-14
RW109_00459 Hypothetical protein S 2.2 0.000157
RW109_00353 Hypothetical protein Unknown 2.0 0.030427
RW109_00201 Hypothetical protein Unknown 2.0 0.035608
RW109_00293 Aminomethyltransferase E 1.9 0.003284
RW109_00180 Hypothetical protein Unknown 1.7 0.008859
RW109_00525 Hypothetical protein Unknown 1.7 0.0000212
Main chromosome 
RW109_03936 Putative sialic acid transporter G 6.8 4.72E-20
RW109_05501 Metallo-beta-lactamase superfamily protein Q 5.9 3.78E-14
RW109_02298 Efflux pump membrane transporter MexQ V 5.5 1.19E-14
RW109_03934 Hypothetical protein S 5.3 1.58E-09
RW109_03690 High-affinity gluconate transporter E, G 5.2 7.79E-09
RW109_06963 Putative FAD-linked oxidoreductase C 5.1 2.65E-10
RW109_03937 Porin-like protein NicP precursor M 5.0 8.07E-12
RW109_02635 L-arabinose transport system permease protein AraQ P 5.0 1.14E-10
RW109_03939 Kinase A inhibitor E 4.9 8.43E-08
RW109_02640 Glucose-6-phosphate 1-dehydrogenase G 4.9 1.33E-53
Plasmid 2
RW109_07303 Hypothetical protein Unknown 2.9 0.014245
RW109_07302 Hypothetical protein Unknown 2.3 0.00000496
RW109_07312 Hypothetical protein Unknown 2.0 0.0000876
RW109_07267 O-acetyltransferase OatA I 1.9 0.000000281
RW109_07299 Hypothetical protein Unknown 1.9 0.0000628
RW109_07288 Hypothetical protein Unknown 1.7 2.08E-11
RW109_07297 Hypothetical protein S 1.6 0.0000369
RW109_07277 Plasmid segregation protein ParM S 1.5 0.042658
RW109_07388 Hypothetical protein Unknown 1.5 0.000000259
RW109_07269 Twitching mobility protein N, U 1.5 0.001901
Footnotes = Top 10 genes from the main chromosome and the two plasmids are shown.  
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Figure 49. Gene expression analysis the RW109_03936-03940 predicted membrane transport operon and a transcriptional regulator GItR 
when exposed to test conditions 2-7 
 
Gene ID
Test exposure conditions
BIT 
at 50% of the MIC (2)
POE 
at 50% of the MIC (4)
BIT and POE
in combination (5)
LD only (6)
LD and BIT
at 20% of the MIC (7)
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
RW109_03935 NA NA NA NA NA NA 1.5 0.034038 1.8 0.005044
RW109_03936 3.4 7.10E-10 6.0 7.97E-15 4.4 2.97E-08 6.9 1.20E-21 6.8 4.72E-20
RW109_03937 NA NA 3.0 0.002298 2.8 0.000815 5.0 1.12E-12 5.0 8.07E-12
RW109_03938 NA NA NA NA NA NA 4.6 2.02E-06 4.6 3.55E-06
RW109_03939 NA NA NA NA 2.6 0.014728 4.9 3.11E-08 4.9 8.43E-08
RW109_03940 NA NA NA NA 2.3 0.04825 4.4 1.26E-05 4.6 3.05E-06
RW109_03935 HTH-type transcriptional regulator GltR
RW109_03936-03940 Predicted membrane transport operon  
Sialic acid 
transporter 
Porin LamB/YcsF kinase-A 
inhibitor
KipI
antagonist
1 kb
B)
A)
Panel A shows the transcriptional regulator GItR in blue (RW109_03935) and the predicted membrane transport operon in pink (RW109_03936-
03940).   The log2-fold changes and adjusted p-values for these genes are shown in panel B for conditions 2-7. All the genes of the predicted 
operon were up-regulated with conditions 6 and 7 as well as the gItR annotated gene. The RW109_03936 gene encoding for a sialic acid 
transporter had increased expression in conditions 2, 4, 5, 6 and 7. In condition 4 and 5 the porin annotated gene RW109_03937 was up-regulated 
and the genes RW109_03939-03940 also had increased expression in condition 5.  
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Figure 50. Gene expression analysis of the pilGHI and pilJK-chpA-E operons when exposed to test conditions 5, 6 and 7 
 
Gene ID
Test exposure conditions
BIT and POE
in combination (5)
LD only (6)
LD and BIT
at 20% of the MIC (7)
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
RW109_01011 1.8 2.03E-19 NA NA NA NA
RW109_01012 2.1 1.39E-11 2.3 1.95E-18 1.9 1.34E-10
RW109_01013 2.8 1.96E-05 3.9 4.08E-10 3.7 9.08E-10
RW109_01014 NA NA 2.8 1.60E-34 2.7 7.43E-38
RW109_01015 NA NA 1.8 1.31E-05 1.7 3.78E-06
RW109_01016 NA NA 2.2 1.64E-16 NA NA
RW109_01017 NA NA 2.5 4.49E-05 2.3 1.25E-04
1 kb
RW109_01013-01017 pilJK-chpA-E operon
RW109_01011-01012 pilGHI operon
B)
A)
Panel A shows the pilGHI operon in green (RW109_01011-01012) and the pilJK-chpA-E operon in yellow (RW109_01013-01017). The log2-fold 
changes and adjusted p-values for these genes are shown in panel B. All three genes of the pilGHI operon were up-regulated after exposure to condition 5 
and the pilH and pilI genes had increased expression with 6 and 7. All genes in the pilJK-chpA-E operon were up-regulated in response to conditions 6 
and 7.  
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Table 33. The top ten genes down-regulated in response to laundry detergent in combination with 
BIT at 20% of the MIC 
 
 
Footnotes = Top 10 genes from the main chromosome and plasmid 1 are shown as well as the total 11 
down-regulated genes from plasmid 2  
Transcript ID Prokka putative gene function Cog category Log2 fold change Adjusted P-value
Plasmid 1
RW109_00135 Hypothetical protein S -3.9 1.88E-52
RW109_00469 Formyltetrahydrofolate deformylase F -3.7 2.48E-22
RW109_00269 Hypothetical protein S -3.6 6.34E-25
RW109_00303 Leucine-responsive regulatory protein K -3.6 1.15E-26
RW109_00009 Aerotaxis receptor T -3.6 2.18E-50
RW109_00081 Hypothetical protein Unknown -2.9 0.033649
RW109_00230 Hypothetical protein Unknown -2.7 0.006339
RW109_00446 Aminomethyltransferase E -2.7 0.001958
RW109_00085 Hypothetical protein Unknown -2.6 9.60E-12
RW109_00464 Sarcosine oxidase, gamma subunit family E -2.4 0.009834
Main chromosome
RW109_03982 Decarbamoylnovobiocin carbamoyltransferase O -7.6 3.32E-42
RW109_06227 Spore Coat Protein U domain protein S -6.9 5.42E-42
RW109_03434 PA-I galactophilic lectin S -6.8 2.63E-29
RW109_05642 Flp/Fap pilin component Unknown -6.7 4.01E-41
RW109_05186 3-oxoacyl-(acyl carrier protein) synthase III Unknown -6.6 1.63E-29
RW109_00725 Aegerolysin Unknown -6.5 1.43E-178
RW109_05187 Anthranilate--CoA ligase I -6.3 9.72E-27
RW109_04177 outer membrane channel protein M -6.3 6.99E-53
RW109_05811 Hypothetical protein S -6.2 3.66E-71
RW109_04178 Cna protein B-type domain protein O -6.2 1.00E-171
Plasmid 2
RW109_07290 Hypothetical protein Unknown -2.8 4.97E-15
RW109_07253 Hypothetical protein Unknown -2.8 1.80E-25
RW109_07384 Hypothetical protein Unknown -2.4 2.41E-19
RW109_07263 Hypothetical protein S -1.8 1.29E-14
RW109_07316 Hypothetical protein Unknown -1.8 1.04E-14
RW109_07264 Hypothetical protein Unknown -1.7 1.85E-11
RW109_07347 Hypothetical protein Unknown -1.6 0.015387
RW109_07380 Hypothetical protein S -1.6 7.71E-13
RW109_07361 Antitoxin DinJ L -1.6 7.52E-09
RW109_07293 Initiator Replication protein L -1.5 3.90E-10
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5.2.7.6 Gene expression analysis of RW109 antimicrobial predicted genes 
The output from ABRicate and BacMet (Chapter 3, Sections 3.2.3.3 and 3.2.3.4), were used to investigate 
the expression of known and predicted antimicrobial resistance genes in response to the industry relevant 
conditions. The analysis revealed 34 genes differentially regulated in at least one of the test exposure 
conditions (not including BIT at 20% of the MIC due to the minimal genes regulated) (Figure 51 and 
Table 34). The highest number of differentially regulated antimicrobial DEGs was identified after 
exposure to LD in combination with BIT at 20% of the MIC, with 18 up-regulated and 7 down-regulated 
(Table 34). The least number of antimicrobial DEGs were identified with BIT at 50%, where 
RW109_06416 encoding for magnesium-transport protein MgtA, was up-regulated. The mgtA gene also 
had increased expression after exposure to conditions 6, LD-only, and 7, LD with BIT, whereas it was 
down-regulated in response to condition 4, POE at 50% MIC (Table 34).  
A notable observation was the increased expression of the genes encoding for a MexPQ-OpmE efflux 
pump system (RW109_02297-02299) in response to a broad range of POE and LD associated conditions 
(3-7; opmE gene RW109_02299 not identified with condition 6) (Figure 52). The genes linked to the 
MexPQ proteins of this efflux pump had the greatest expression increases within the predicted 
antimicrobial genes (Table 34). A gene encoding for a copper transporter, CueA, RW109_01794 was up-
regulated in response to multiple POE and LD associated conditions (3-7; Table 34). In contrast, the 
RW109_05808 gene annotated as a superoxide dismutase, SodA protein, was down-regulated after 
exposure to the same five conditions (Table 34).  
The RW109_02137 gene encoding for a MexL protein was classified as a repressor of the MexJK efflux 
pump and was up-regulated in response to multiple POE and LD-associated conditions (4, 5, 6 and 7; 
Table 34).The RW109_02139 gene associated with MexK was up-regulated only in conditions associated 
with laundry detergent (6 and 7; Table 34). The RW109_05607 gene associated with a transporter protein 
VmeV, also had increased expression after exposure to multiple conditions (4, 5, 6 and 7; Table 34). The 
genes encoding for the MexA and MexB proteins of a MexAB-OprM efflux pump (RW109_01029 and 
RW109_01030), were identified as up-regulated in response to LD-associated conditions (6 and 7; Table 
34). The RW109_06268 gene, which encoded an FbpB2, Fe-transport system, also demonstrated increased 
expression in response to these LD associated conditions (Figure 51 and Table 34).  
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Figure 51. Differentially regulated RW109 antimicrobial genes when exposed to test conditions 2-7 
4         5          3         2         7         6 
Test exposure conditions key: 
2: BIT at 50% of the MIC
3: POE at 20% of the MIC
4: POE at 50% of the MIC
5: POE and BIT in combination at 20% of the MIC
6: Laundry detergent at 1:100 dilution only 
7: Laundry at 1:100 dilution in combination with BIT at 20% of the MIC
Heat map representing the hierarchical distance cluster analysis of the log-2 fold changes of 34 RW109 antimicrobial genes. The numbers below the heat map 
represent the test conditions as shown by the test exposure conditions key, blue indicates genes which are up-regulated and red represents genes which are down-
regulated and the more in10se the colours the greater the gene expression (see color key). The top dendrogram displays the test exposure conditions which have been 
grouped together via hierarchical cluster analysis and the dendrogram to the left of the heat map represents the gene clusters which are grouped according to their log2-
fold change values across all the conditions. 
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Test 
exposure 
Antimicrobial 
gene database
CDS ID CDS Function
Log-2 Fold 
Change 
Adjusted
P-value 
Condition 2: BIT at 50% of the MIC 
BacMet RW109_06416 MgtA,Magnesium-transport 2.2 4.17E-07
Condition 3: POE at 20% of the MIC
ABRicate RW109_02297 MexP,MexPQ-OpmE efflux 5.5 6.94E-15
ABRicate and BacMet RW109_02298 MexQ,MexPQ-OpmE efflux 5.0 3.65E-14
BacMet RW109_01794 Copper transporter,CueA 3.7 6.91E-12
ABRicate RW109_02299 OpmE,MexPQ-OpmE efflux 2.5 0.040597
ABRicate RW109_06176 NfxB,Repressor ofMexCD-OprJ efflux 1.8 0.00231
BacMet RW109_01506 FpvA,Ferripyoverdine receptor -2.2 0.007294
BacMet RW109_05808 SodA,Superoxide dismutase -1.9 1.67E-10
ABRicate RW109_06568 OpmH,Triclosan efflux -1.8 0.000729
ABRicate and BacMet RW109_00761 TriC,Triclosan efflux -1.6 0.002666
Condition 4: POE at 50% of the MIC
ABRicate and BacMet RW109_02298 MexQ,MexPQ-OpmE efflux 5.5 2.02E-14
ABRicate RW109_02297 MexP,MexPQ-OpmE efflux 4.9 4.60E-09
BacMet RW109_01794 Copper transporter,CueA 3.8 1.50E-28
ABRicate RW109_02299 OpmE,MexPQ-OpmE efflux 3.2 0.011837
BacMet RW109_05444 Acn,Aconitate hydratase 2.2 6.67E-08
BacMet RW109_02594 SmrA,ABC-type efflux 2.0 7.38E-06
BacMet RW109_05607 VmeV,Transporter AcrB/D/F 1.9 1.39E-09
BacMet RW109_02587 ActP/YjcG_1,Cation/acetate symporter 1.7 8.15E-15
ABRicate RW109_02137 MexL,Repressor of MexJK efflux 1.6 0.002156
BacMet RW109_05808 SodA,Superoxide dismutase -6.8 2.65E-27
BacMet RW109_02125 PbrA,Pb(II) resistance -3.9 1.91E-21
BacMet and VFDB RW109_01453 FptA,Fe-pyochelin receptor -3.9 1.78E-55
BacMet RW109_01506 FpvA,Ferripyoverdine receptor -3.5 0.00000245
BacMet RW109_03986 CopA,Copper resistance protein A -3.1 0.027726
BacMet RW109_06416 MgtA,Magnesium-transport -2.8 0.002518
ABRicate RW109_06568 OpmH,Triclosan efflux -2.7 6.06E-09
BacMet RW109_03482 MdtC/YegO,Multidrug resistance protein -2.2 0.045269
BacMet RW109_06781 YdeP Protein -1.9 0.0000216
Condition 5: BIT and POE in combination at 20% of the MIC
ABRicate and BacMet RW109_02298 MexQ,MexPQ-OpmE efflux 5.3 5.05E-17
ABRicate RW109_02297 MexP,MexPQ-OpmE efflux 5.2 1.54E-13
BacMet RW109_01794 Copper transporter,CueA 4.1 2.12E-30
ABRicate RW109_02299 OpmE,MexPQ-OpmE efflux 3.1 0.002978
BacMet RW109_02594 SmrA,ABC-type efflux 1.8 0.0000441
BacMet RW109_05607 VmeV,Transporter AcrB/D/F 1.7 3.12E-10
BacMet RW109_05444 Acn,Aconitate hydratase 1.6 0.0000499
ABRicate RW109_02137 MexL,Repressor of MexJK efflux 1.5 0.00128
BacMet RW109_02587 ActP/YjcG_1,Cation/acetate symporter 1.5 2.37E-11
BacMet RW109_05808 SodA,Superoxide dismutase -5.3 1.53E-48
BacMet RW109_02125 PbrA,Pb(II) resistance -3.2 1.88E-23
BacMet RW109_01506 FpvA,Ferripyoverdine receptor -3.1 0.000000224
BacMet and VFDB RW109_01453 FptA,Fe-pyochelin receptor -2.9 7.73E-47
ABRicate and BacMet RW109_02138 MexJ,MexJK efflux -2.1 0.014979
ABRicate RW109_06568 OpmH,Triclosan efflux -1.8 0.000000735
Condition 6: Laundry detergent unpreserved 
ABRicate and BacMet RW109_02298 MexQ,MexPQ-OpmE efflux 4.5 1.77E-09
ABRicate RW109_02297 MexP,MexPQ-OpmE efflux 4.2 0.000000267
BacMet RW109_06268 FbpB2,Fe-transport system 3.7 0.0000027
BacMet RW109_01794 Copper transporter,CueA 3.0 1E-16
BacMet RW109_06416 MgtA,Magnesium-transport 2.8 4.55E-18
BacMet RW109_06758 EmrAsm,Multidrug resistance protein A 2.3 0.027519
ABRicate RW109_02137 MexL,Repressor of MexJK efflux 2.1 0.000000179
ABRicate and BacMet RW109_02139 MexK,MexJK efflux 1.9 0.000000611
ABRicate and BacMet RW109_01030 MexB,MexAB-OprM efflux 1.8 1.82E-32
BacMet RW109_06642 RuvB,Malic protein 1.8 4.48E-10
BacMet RW109_05607 VmeV,Transporter AcrB/D/F 1.7 3.96E-12
BacMet RW109_05577 PitA,Phosphate transporter 1.6 0.00059
ABRicate and BacMet RW109_01029 MexA,MexAB-OprM efflux 1.5 5.01E-11
BacMet RW109_02587 ActP/YjcG_1,Cation/acetate symporter -2.7 4.78E-32
BacMet RW109_05808 SodA,Superoxide dismutase -2.5 2.03E-34
BacMet RW109_02193 RpoS,RNA polymerase sigma factor -2.4 4.76E-30
BacMet RW109_03816 ActP/YjcG_2,Cation/acetate symporter -2.0 0.032927
BacMet RW109_03986 CopA,Copper resistance protein A -2.0 0.049462
BacMet RW109_06781 YdeP Protein -1.8 5.92E-10
Condition 7: Laundry detergent with BIT at 20% of the MIC
ABRicate and BacMet RW109_02298 MexQ,MexPQ-OpmE efflux 5.5 1.19E-14
ABRicate RW109_02297 MexP,MexPQ-OpmE efflux 4.3 0.000000572
ABRicate RW109_02299 OpmE,MexPQ-OpmE efflux 3.4 0.001503
BacMet RW109_01794 Copper transporter,CueA 3.0 6.27E-24
BacMet RW109_06268 FbpB2,Fe-transport system 2.5 0.003991
BacMet RW109_06416 MgtA,Magnesium-transport 2.4 4.11E-11
BacMet RW109_05577 PitA,Phosphate transporter 2.3 0.000000529
ABRicate and BacMet RW109_02139 MexK,MexJK efflux 2.1 2.65E-08
BacMet RW109_05607 VmeV,Transporter AcrB/D/F 2.1 4.67E-18
ABRicate and BacMet RW109_01030 MexB,MexAB-OprM efflux 2.0 9.15E-39
BacMet RW109_06642 RuvB,Malic protein 2.0 6.67E-13
BacMet RW109_05704 SodB,Superoxide dismutase 1.8 2.93E-16
ABRicate RW109_02137 MexL,Repressor of MexJK efflux 1.7 0.0000926
ABRicate and BacMet RW109_03517 MexF,MexEF-OprN efflux pump 1.7 0.037303
ABRicate and BacMet RW109_01029 MexA,MexAB-OprM efflux 1.6 4.81E-15
BacMet RW109_02594 SmrA,ABC-type efflux 1.6 0.00000853
BacMet RW109_03481 MdtB,Multidrug resistance protein 1.6 0.002274
BacMet RW109_02932 FabV,Putative reductase 1.5 1.37E-08
BacMet RW109_02125 PbrA,Pb(II) resistance -3.9 1.64E-45
BacMet RW109_05808 SodA,Superoxide dismutase -3.9 3.57E-35
BacMet RW109_03986 CopA,Copper resistance protein A -3.0 0.001242
BacMet RW109_02587 ActP/YjcG_1,Cation/acetate symporter -3.0 2.01E-27
BacMet RW109_02193 RpoS,RNA polymerase sigma factor -2.8 8.33E-59
BacMet and VFDB RW109_01453 FptA,Fe-pyochelin receptor -2.7 3.04E-32
BacMet RW109_06781 YdeP Protein -2.6 1.56E-17
Table 34. Differentially expressed antimicrobial resistance genes identified when RW109 
was exposed to test conditions 2-7 
Footnotes: Genes indicated in blue were up-regulated and those in red were down-regulated. 
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Panel A shows the MexPQ-OpmE RNA efflux pump operon genes coloured in green (RW109_02297-02299) along with an associated heavy metal domain 
protein in blue (RW109_02300) and a hypothetical protein in orange (RW109_02301). The log2-fold changes and adjusted p-values for these genes are shown 
in panel B. The efflux pump operon genes and the gene encoding the hypothetical protein next to the operon were all up-regulated in conditions 3-7 and the 
heavy metal domain protein gene was up-regulated in conditions 3, 4 and 5.  
1 kb
RW109_02300 Heavy-metal-domain protein
RW109_02301 Hypothetical protein
RW109_02297-02299 MexPQ-OpmE RND efflux system
Gene ID and annotation
Test exposure conditions
POE 
at 20% of the MIC (3)
POE 
at 50% of the MIC (4)
BIT and POE 
in combination (5)
LD Only (6)
LD and BIT 
at 20% of the MIC (7)
Fold 
Change 
Adjusted 
p-value
Fold 
Change 
Adjusted
p-value
Fold 
Change 
Adjusted
p-value
Fold 
Change 
Adjusted
p-value
Fold 
Change 
Adjusted 
p-value
RW109_02297 5.5 6.94E-15 5.0 4.60E-09 5.2 1.54E-13 4.2 2.67E-07 4.3 5.72E-07
RW109_02298 5.0 3.65E-14 5.5 2.02E-14 5.3 5.05E-17 4.5 1.77E-09 5.5 1.19E-14
RW109_02299 2.5 4.06E-02 3.2 1.18E-02 3.1 2.98E-03 NA NA 3.4 1.50E-03
RW109_02300 2.8 1.68E-10 2.4 1.90E-07 3.1 3.14E-18 NA NA NA NA
RW109_02301 3.3 6.85E-13 2.0 2.04E-04 2.8 9.56E-12 2.2 1.23E-06 2.5 3.41E-07
A)
B)
Figure 52. The MexPQ-OpmE RND efflux system identified as up-regulated when exposed to POE- and LD-associated test conditions (3-7) 
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5.2.7.7 Differentially regulated genes commonly identified during exposure to the industry relevant 
conditions 
Several DEGs were frequently identified when RW109 was exposed to different industrial test conditions. 
A prominent observation was the up-regulation of all the genes encoding the MexPQ-OpmE efflux pump 
system in response to test conditions where POE or laundry detergent was present (3-5 and 7; Figure 52). 
The genes encoding MexP and MexQ were up-regulated with condition 6, laundry detergent with BIT, but 
there was no increased expression of the opmE gene (Figure 52). Both the MexP and MexQ encoding 
genes were identified within the top 10 up-regulated with conditions 3 and 5, both POE-associated (Table 
24 and Table 28) and the MexQ gene was observed within the top ten up-regulated in conditions 4 and 7, 
POE and LD-associated respectively (Table 26 and Table 32). Interestingly, the hypothetical protein 
encoded by RW109_02301 next to the efflux system, increased in expression in multiple conditions 3-7. A 
heavy metal domain protein annotated gene RW109_02300, was up-regulated in conditions 3, 4 and 5 
(Figure 52).                       
A notable gene, which encoded a putative sialic acid transporter, RW109_03936, was always present in 
the top 10 up-regulated genes in response to multiple test conditions 2, 4, 5, 6 and 7. This gene was 
identified within a predicted membrane transporter operon (RW109_03936-03940) and when exposed to 
LD with and without the addition of BIT, all the operon genes were up-regulated (Figure 49). The 
RW109_04035-04041 genes were also of interest due to the increased expression observed in response to 
the industrial exposure conditions 2-7 (Figure 53). The RW109_04040 gene was not up-regulated in 
response to condition 3 and the RW109_04041 gene did not have increased expression with conditions 2 
and 3. These genes RW109_04035-04040, encoded for a gnyRDBHAL gene cluster and RW109_04041 
was annotated as a transcriptional regulator, KdgR (Figure 53). Another gene of interest annotated as a 
copper transporter, CueA (RW109_01794), was up-regulated in response to test conditions 3-7 (Table 34).  
An anthranilate 1,2-dioxygenase small subunit antB gene (RW109_03496), an anthranilate 1,2-
dioxygenase large subunit,  gene (RW109_03497) and an anthranilate 1,2-dioxygenase electron transfer 
component, antC gene (RW109_03495) were of relevance due to the up-regulation observed in response 
to test conditions 2, 4 and 5. Within the up-regulated genes of condition 6, the antA had an increased 
expression but antB and antC were not observed.  In response to the industry relevant conditions 2-7, an 
interesting observation was the common down-regulation of the RW109_05181-05187 genes 
(RW109_05181 did not decrease expression with condition 3). These were identified as the quorum 
sensing operons phnAB and pqsABCDE involved in the production of the Pseudomonas Quinolone Signal 
(PQS) (Wade et al., 2005) (Figure 54).  
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Gene ID
Test exposure conditions
BIT 
at 50% of the MIC (2)
POE 
at 20% of the MIC (3)
POE 
at 50% of the MIC (4)
BIT and POE
in combination (5)
LD only (6)
LD and BIT
at 20% of the MIC (7)
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
RW109_04035 1.5 4.61E-03 4.2 8.05E-28 5.5 5.00E-49 3.6 6.24E-22 NA NA 1.9 9.95E-06
RW109_04036 2.2 4.80E-09 2.8 7.77E-15 5.3 6.68E-70 4.0 3.96E-45 2.0 1.69E-09 2.4 2.17E-13
RW109_04037 2.3 1.57E-06 2.4 1.56E-05 5.0 2.72E-35 4.2 9.88E-30 2.4 3.42E-08 2.9 9.14E-12
RW109_04038 2.6 1.27E-06 2.9 6.24E-05 4.1 8.93E-11 3.8 8.98E-11 2.5 1.20E-04 2.5 3.59E-05
RW109_04039 2.4 2.34E-08 1.8 2.81E-03 3.6 1.77E-16 3.1 1.06E-14 2.2 7.42E-08 2.4 9.44E-11
RW109_04040 1.7 1.09E-02 NA NA 3.6 1.17E-09 3.0 5.75E-08 2.5 3.64E-05 2.7 2.46E-06
RW109_04041 NA NA NA NA 2.6 1.69E-02 2.2 2.68E-02 2.3 1.41E-02 2.4 7.28E-03
RW109_04041 Transcriptional regulator, KdgR
1 kb
RW109_04036-04040 gnyDBHAL operon
RW109_04035 Regulatory gene of the gnyRDBHAL cluster, GnyR
A)
B)
Figure 53. The up-regulated response of the gnyRDBHAL gene cluster and KdgR transcriptional regulator during exposure to multiple test exposure 
conditions  
Panel A shows the gnyDBHAL operon (RW109_04036-04040) in purple, the gene encoding GnyR (RW109_04035) in green and the KdgR transcriptional regulator 
gene (RW109_04041) in blue. The log2-fold changes and adjusted p-values for these genes are shown in panel B. The gnyRDBHAL gene cluster and kdgR gene were 
up-regulated in response to conditions 4-7. In condition 2 the operon and gnyR gene were up-regulated but the kdgR gene was not and in condition 3 the expression 
of the RW109_04035-04039 genes were increased.  
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Figure 54. The down-regulated response of the phnAB and pqsABCDE operon during exposure to multiple test exposure conditions  
Panel A shows the phnAB operon (RW109_05181-05182) in red and the pqsABCDE operon (RW109_05183-05187) in blue. The log2-fold changes 
and adjusted p-values for these genes are shown in panel B. In conditions 2-7 both operons were down-regulated, except for the RW109_05181 gene 
in the phnAB operon which was not differentially regulated in response to condition 3.  
Gene ID
Test exposure conditions
BIT 
at 50% of the MIC (2)
POE 
at 20% of the MIC (3)
POE 
at 50% of the MIC (4)
BIT and POE
in combination (5)
LD only (6)
LD and BIT
at 20% of the MIC (7)
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
Fold 
change
Adjusted 
p-value
RW109_05181 -2.4 9.71E-05 NA NA -3.5 3.52E-05 -3.6 3.40E-07 -6.4 4.68E-13 -5.3 5.70E-14
RW109_05182 -3.0 5.87E-09 -2.2 1.47E-03 -4.4 2.03E-09 -3.0 1.67E-09 -4.2 7.80E-18 -5.1 5.20E-22
RW109_05183 -2.4 3.41E-06 -1.6 2.22E-02 -2.2 1.75E-04 -3.4 3.68E-09 -4.8 2.16E-18 -4.9 1.10E-19
RW109_05184 -2.0 2.47E-05 -1.9 2.14E-03 -2.4 1.67E-06 -2.4 1.48E-07 -4.3 1.63E-20 -5.2 1.98E-24
RW109_05185 -2.8 1.81E-09 -1.8 8.20E-04 -2.3 2.59E-07 -2.9 9.56E-12 -4.4 5.80E-31 -5.5 1.01E-31
RW109_05186 -2.6 6.08E-09 -1.6 0.002589 -3.0 1.39E-09 -2.9 1.07E-10 -5.3 1.61E-30 -6.6 1.63E-29
RW109_05187 -2.3 5.02E-08 -1.9 0.001108 -1.8 4.83E-05 -2.6 2.84E-10 -4.0 1.29E-21 -6.3 9.72E-27
B)
A)
1 kb
RW109_05183-05187 pqsABCDE operon
RW109_05181-05182 phnAB operon
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5.3 Discussion 
5.3.1 RNA-Seq analysis of the RW109 following exposure to industry relevant conditions 
RNA-Seq analysis was successfully used to investigate the transcriptome of the RW109 strain in response 
to industry relevant conditions. Analysis of the gene expression data revealed numerous genetic pathways 
putatively utilised by the industrial strain, for survival in the presence of HPC preservatives and product 
formulations. The test conditions involved exposure to the preservatives BIT and POE individually and in 
combination with each other. Also investigated was the response to laundry detergent with and without the 
addition of the preservative BIT. The selected conditions were used as a primarily investigation of the 
gene expression response after 24 hours of exposure, regardless of the growth stage of RW109. This was 
due to the differences in growth dynamics observed when the strain was in the presence of the industrial 
conditions. This investigation provides a novel insight into the genetic pathways associated with exposure 
to preservative formulations and HPC products. However, the results from this study require further 
validation with quantitative RT-PCR on select genes to confirm the transcriptomic responses observed.  
The exposure experiments and RNA extractions procedures generated good quality toRNA and mRNA for 
incorporation into cDNA library preparations and sequencing protocols. The bioinformatics pipeline 
resulted in a high number of reads aligning and mapping to the gene features of the RW109 PacBio 
sequence. This study utilised 4 biological replicates to determine log2-fold changes in gene expression 
when the test exposure conditions were compared to the control. There is no absolute consensus for 
classifying a differentially expressed gene and in this study DEGs were defined as exhibiting a log2-fold 
change of ≥ 1.5 as described previously (Rushton et al., 2013, Sass et al., 2011) along with an adjusted p-
value of ≤ 0.05. These cut off values were used for initial analysis and the log2-fold threshold could be 
increased to 2.0 due to the high number of DEGs identified with conditions 2-7.  However the strict cut-
off for the adjusted p-value, controls for a false discovery rate when identifying DEGs (Love et al., 2014).  
The number of biological replicates necessary for a successful RNA-Seq experiment remains unclear in 
the literature. A study which investigated the best RNA-Seq analysis tools using 48 biological replicates 
concluded at least 12 are required (Schurch et al., 2016). However, it was acknowledged that less than 12 
replicates were commonly used in RNA-Seq experiments, due to the cost and time incurred in preparing 
samples. A consensus on the leading tools for accurate differential gene expression analysis with lower 
biological replicates, includes the DESeq2 and edgeR R tools (Schurch et al., 2016, Tang et al., 2015, 
Seyednasrollah et al., 2013). With the 4 biological replicates generated for each exposure condition in this 
study, DESeq2 was successfully implemented to identify the DEGs log2-fold changes and adjusted p-
values. For further validation of the results, another analysis tool could also be applied. The edgeR tool, 
which is part of the R Bioconductor package (Robinson et al., 2010), was also used to compare the BIT at 
50% of the MIC test condition with the control condition. A comparable number of genes were up and 
down regulated as identified with DESeq2 (data not shown). However, the tool should also be used to 
validate the gene expression results obtained with the other test exposure conditions. Another 
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consideration for future work would be to select less exposure conditions and include more replicates to 
enable increased accuracy and more detailed analysis of the gene expression data.  
5.3.2 Overview of the transcriptomic analysis when RW109 was exposed to industry relevant 
conditions 
When exposed to BIT at 20% of the MIC the lowest number of DEGs were identified (0.03% of the whole 
genome) whereas laundry detergent in combination with BIT at 20% of the MIC, resulted in the greatest 
number of up and down regulated genes observed in this study (Figure 45). The up and down regulated 
genes identified in response to LD with BIT were also distributed evenly throughout the RW109 genome 
(Figure 46, Figure 47 and Figure 48). This indicates a large global gene expression effort was necessary 
for RW109 to survive, with 20.36% of the whole genome differently expressed in the presence this HPC 
product in combination with BIT (Table 21).   
The RW109 main chromosome had the greatest number of DEGs in response to the test conditions (Table 
21). This is understandable due to the higher number of genes on the main chromosome when compared to 
the two plasmids. Up and down regulated genes were also observed on plasmid 1 and 2 in all test 
conditions except for BIT at 20% and 50% of the MIC; the number of identified DEGs on plasmids 1 and 
2 were generally comparable. Multiple plasmid DEGs encoding for hypothetical proteins were identified, 
suggesting the uncharacterised plasmid genes play an important role in RW109’s provenance as an 
industrial strain. On plasmid 1, the highest number of DEGs were observed in response to LD with BIT 
(up-regulated n = 23 and down-regulated n= 35;Table 21). Within the top ten up-regulated plasmid 1 
genes, a DEG of interest encoded for N-acetylglucosaminyl-diphospho-decaprenol L-
rhamnosyltransferase WbbL, and was proposed to be involved in the biosynthesis of peptidoglycan and 
LPS O-antigen production (Crick et al., 2001, McNeil, 1999). The upregulation of this gene suggests a 
role in cell wall maintenance of plasmid 1 when RW109 was exposed to laundry detergent in combination 
with BIT. The greatest number of DEGs identified on plasmid 2 were in response to POE at 50% of the 
MIC and two up-regulated genes of interest encoded for a YafQ and DinJ. These function as a Toxin-
antitoxin (TA) system, which are mechanisms for responding appropriately to harsh environments and 
enabling the multidrug tolerance of biofilms (Harrison et al., 2009). TA-systems also function in 
stabilising bacterial plasmids by destroying daughter cells not encompassing the plasmid (Gerdes et al., 
1986, Pal et al., 2015). The up-regulation of the TA-system in response to POE indicates its role for 
survival of RW109 in the presence of the preservative and signifies the value of plasmid 2 in response to 
the industrial conditions.  
The limited number of significant up and down regulated genes identified following exposure to BIT at 
20% of the MIC, suggests that the RW109 P. aeruginosa strain was well adapted to survival in the 
presence of low concentrations of this preservative. This condition was chosen to determine if genes of 
interest identified from screening the mini-Tn5-luxCDABE mutant library (Chapter 4), were differentially 
expressed during RNA-Seq analysis. However, only a minimal number of genes could be compared across 
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the mutagenesis and global gene expression approaches, with the two genes identified from RNA-Seq not 
being observed in the mutant library analysis.  
On the other hand, the same genes recognised with 20% of the MIC in this chapter were also found with 
BIT at 50% of the MIC, suggesting their importance when RW109 was exposed to this preservative. The 
up-regulated gene encoded for 3-hydroxyisobutyrate dehydrogenase I and in the Gram-negative Ralstonia 
pickettii bacterium, a gene mutation encoding for this enzyme revealed an inability to neutralise the 
adverse effects of oxidative stress (Takanashi et al., 2009). A BIT mechanism of action involves the 
oxidation of thiol groups, resulting in the generation of free radicals and damage to the cell (Collier et al., 
1990). The up-regulation of a gene, which encodes an enzyme linked to neutralising oxidative stress, 
suggests its use in minimising the adverse effects of the preservative BIT. The down-regulated gene 
identified with exposure to both 20% and 50% of the BIT MIC was annotated as a hypothetical protein.  
Interestingly a gene involved in sulphur metabolism was up-regulated in response to BIT at 50% of the 
MIC and was also identified as an insertion site of a BIT positive lux transposon mutant (Chapter 4, Table 
2). This gene encoded for a bi-functional enzyme CysN/CysC (RW109_05781) and an adjacent gene 
annotated as a sulfate adenylyl-transferase subunit II CysD (RW109_05782), also had increased 
expression in response to BIT at 50% of the MIC. The cysND operon has been associated with an 
increased expression in P. aeruginosa in response to oxidative stress (Goldová et al., 2011). This suggests 
the oxidation effect of the preservative BIT results in RW109 up-regulating the cysND operon. Another 
interesting observation with BIT at 50% of the MIC was the increased expression of genes encoding 
carbamate kinase 1 and a nitrite reductase precursor, which are involved in nitrogen metabolism. This 
suggest that up-regulation of nitrogen metabolism-related enzymes enhances the ability of RW109 to 
survive the presence of BIT. A previous study on a P. aeruginosa strain resistant to isothiazolinones 
demonstrated a significant number of DEGs involved in nitrogen metabolism when exposed to a Kathon 
preservative formulation (Zhou et al., 2016). This illustrates the importance of nitrogen metabolism when 
P. aeruginosa strains are exposed to isothiazolinone preservatives.  
This investigation also identified 34 differentially expressed RW109 predicted antimicrobial resistance 
genes (Figure 51). This illustrates the importance of several previously characterised antimicrobial 
resistance mechanisms for the survival in the presence of industry relevant conditions. Numerous reports 
indicate that increased resistance to biocides also decreases susceptibility to antibiotics (McBain et al., 
2002, Pal et al., 2015, Russell, 2003a). However, it may also be the case that a strain encompassing 
antibiotic resistance capabilities such as RW109, already has the inherent structural and functional 
characteristics to be resistant to industrial biocides. Proving direct associations between biocides and 
antibiotic resistance is a point of much debate and only a few specific mechanisms of co-resistance have 
been defined. For example with Burkholderia lata, exposure to isothiazolone preservatives resulted in the 
up-regulation of an efflux pump which was also directly involved in fluoroquinolone antibiotic resistance 
(Rushton et al., 2013). The Burkholderia strain involved did not gain multiple antibiotic resistances and 
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overall was less tolerant of antibiotics, but just more resistant to fluoroquinolones as a direct correlation to 
the efflux pump up-regulation (Rushton et al., 2013).  
5.3.3 Prevalent RW109 genes differentially expressed in response to multiple industry relevant 
conditions 
An interesting observation of this study was the frequent up-regulation of the same genetic pathways in 
response to different test conditions. This identified common resistance mechanisms used by RW109 
when exposed to industrial preservatives and product formulations. The genes associated with the 
predicted antimicrobial resistance MexPQ-OpmE RND efflux pump system, were up-regulated in 
response to POE at both 20% and 50% of the MIC, BIT and POE in combination and laundry detergent 
with BIT (Figure 52). The genes encoding MexP and MexQ were up-regulated with the LD-only condition 
but an increased expression with the OpmE gene was not observed. The MexP and MexQ were also 
commonly identified within the top ten up-regulated in response to these industrial conditions. This efflux 
pump system is used by P. aeruginosa to export a variety of antibiotics such as fluoroquinolones, 
tetracycline, chloramphenicol and macrolides (Lister et al., 2009, Mima et al., 2005). This efflux system 
also functions as a metal ion exporter and knocking out the mexP or mexQ genes elevates P. aeruginosa 
susceptibility to copper (Thaden et al., 2010).                                     
The common up-regulation of the efflux pump in response to industry conditions, suggests it could also be 
used to pump out preservatives. In particular, the efflux pump genes had increased expression when 
exposed to POE at 20% and 50% of the MIC, signifying its use as a resistance mechanism in the presence 
of this preservative. When exposed to BIT at these concentrations, the efflux pump genes were not up-
regulated indicating it was not used with this preservative. In response to BIT and POE in combination 
both at 20% of the MIC, all the efflux pump genes demonstrated an increased expression. This suggests 
the efflux pump may be used as a resistance mechanism is response to preservative combinations. The 
efflux pump was linked with the presence of POE within a formulation, as a limited number of genes were 
up-regulated when exposed to just BIT at 20% of the MIC. Consequently, the increased expression of all 
the efflux pump genes was observed with LD in combination with BIT, whereas in response to LD 
without BIT, the OpmE encoding gene was not up-regulated. This indicates the addition of BIT to the 
laundry detergent results in RW109 utilising the MexPQ-OpmE RND efflux pump system as a resistance 
mechanism.  
Follow-up research aimed at knocking out the efflux pump system genes in the RW109 strain and 
investigating changes in susceptibility to industry relevant conditions should be carried out. As noted 
above the role of efflux as an important industrial preservative resistance mechanism was previously 
demonstrated with the up-regulation of a B. Lata RND-type efflux system in response to isothiazolone 
preservatives (Rushton et al., 2013). Examples of P. aeruginosa efflux pump-mediated biocide resistance 
include the MexJK and MexAB-OprM efflux systems which export the biocide triclosan (Chuanchuen et 
al., 2002, Chuanchuen et al., 2001, Schweizer, 1998) and the MexCD-OprJ efflux pump which is induced 
by disinfectants such as benzalkonium chloride, chlorhexidine and ethidium bromide (Morita et al., 2003). 
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This highlights the versatility of multidrug efflux pumps in response to agents other than antibiotics. The 
consistent up-regulation of the P. aeruginosa MexPQ-OpmE RND efflux system genes in response to the 
industry relevant conditions used in this study, emphasises the approach to target efflux pumps in 
preservation strategies. Chemicals which act as efflux pump inhibitors (Stavri et al., 2006, Lomovskaya et 
al., 2001) could be used in combination with industrial preservatives to potentiate their activity and 
enhance HPC preservation systems.  
Another gene, which frequently had increased expression when RW109 was exposed to the industry 
relevant conditions, was a putative sialic acid transporter. This gene was continuously present within the 
top ten up-regulated genes in response to multiple test conditions associated with all preservatives as well 
as laundry detergent, 2, 4, 5, 6 and 7 (Figure 49), signifying its importance as a potential mechanism of 
survival in the presence of industry preservatives and HPC products. The sialic acid transporter encoding 
gene was identified within a predicted membrane transporter operon (RW109_03936-03940) and in 
response to LD with and without the addition of BIT, all the genes within this operon were up-regulated 
(Figure 49). Sialic acids incorporate more than 50 naturally occurring nine-carbon amino sugars, which 
can be used by bacteria as sole carbon sources and are imported via sialic acid transporters (Vimr et al., 
2004, Almagro-Moreno and Boyd, 2009). Sialic acid is commonly found in mucus rich environments 
(Vimr, 2013) and has been linked to P. aeruginosa pathogenicity in immunocompromised patients 
(Khatua et al., 2010). It is proposed acquiring and assembling sialic acids on the surface mediates 
enhanced binding to host cells, confers resistance to complement-mediated killing and facilitates the 
establishment of persistent infection (Khatua et al., 2010, Greiner et al., 2004).  
Salic acid uptake has also been linked to biofilm formation in the Gram-negative bacterium Haemophilus 
influenzae (H. influenza); sialic acid was identified as an important biofilm matrix component during 
persistent respiratory tract infections (Jurcisek et al., 2005, Greiner et al., 2004). The P. aeruginosa 
RW109 strain may increase the expression of genes involved in the sialic acid transport system in order to 
uptake the molecule for enhanced survival in industrial conditions. Sialic acid may be required for the 
RW109 to adhere and form a biofilm to permit viability when exposed to preservative formulations and 
HPC products. The increased expression of the transport system could also be for use as an antimicrobial 
export mechanism of the preservative formulations and HPC products. Since the global gene expression 
was performed under planktonic conditions with limited potential for biofilm formation, this functional 
role would appear more likely. The sialic acid transport system is clearly important during exposure to 
industry related conditions and targeting its components in preservation strategies could be beneficial. A 
patent for an agent which specifically inhibits sialic acid transporters in numerous pathogens, including P. 
aeruginosa, has been filed and reports a reduction in bacterial growth upon exposure (Gibson et al., 2006). 
Agents, which specifically target common resistance mechanisms, could be incorporated into HPC 
preservative formulations to minimise proliferation of contaminants.  
Genes within the isoprenoid degradation associated gnyRDBHAL operon were commonly up-regulated 
when exposed to the industrial test conditions (not including BIT at 20% of the MIC) (Figure 53).  The 
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adjacent transcriptional regulator KdgR, had increased expression in response to conditions 4-7 and was 
characterised in a transposon mutant with an increased light emission in response to BIT at 20% of the 
MIC (BIT positive) (Chapter 4, Table 16). However, during RNA-Seq analysis the associated gene was 
not up-regulated when exposed to the preservative BIT individually. The gnyRDBHAL gene cluster 
encodes enzymes which function in P. aeruginosa acyclic isoprenoid degradation (Diaz-Perez et al., 
2004). The frequent up-regulation of these genes suggests a potential role of the gnyRDBHAL operon in 
the survival of RW109 when exposed to industry relevant conditions. The gene cluster has previously 
been identified as up-regulated during transcriptomic analysis of developing P. aeruginosa biofilms 
(Waite et al., 2006). Increased transcript levels of the gny genes were also observed during growth of P. 
aeruginosa in mucus when compared to cultivation in minimal media (Cattoir et al., 2012). Therefore the 
gnyRDBHAL operon may have a role in the biofilm and virulence capabilities of P. aeruginosa and the up-
regulation of the operon, suggests its use as a survival mechanism when RW109 was exposed to industrial 
conditions.  
A gene characterised via the BacMet biocide resistance database encoded for a copper transporter, CueA 
and was up-regulated in response to the industrial conditions (not including BIT at 20% and 50% of the 
MIC) (Table 34). In P. aeruginosa, the cueA gene has a role in copper tolerance, with mutations in the 
gene resulting in increased sensitivity to the heavy metal (Thaden et al., 2010). P. aeruginosa strains with 
a cueA mutation also demonstrated a 20-fold attenuation in the spleens of mice when compared to the 
wild-type (Schwan et al., 2005), highlighting the involvement of the gene in virulence.  There are various 
reports of bacterial strains resistant to heavy metals that also have decreased susceptibility to antibiotics 
(Yazdankhah et al., 2014, Seiler and Berendonk, 2012, Berg et al., 2010), and it may be the case that 
mechanisms of copper tolerance could also be used for survival in the presence of industrial preservative 
formulations. This is supported by the up-regulation of the cueA gene in response to the majority of 
preservative formulations and HPC products used in this study (excluding BIT).  
The antABC genes had increased expression when RW109 was exposed to BIT and POE individually at 
50% of the MIC and in response to BIT in combination with POE both at 20% of the MIC. The antA and 
antB genes were also observed within ten up-regulated in response to these conditions. The antABC 
operon functions in the first stage of anthranilate degradation and the ability of P. aeruginosa to form 
biofilms has been identified as partly reliant on this degradative pathway (Costaglioli et al., 2012). 
Transcriptomic analysis of P. aeruginosa biofilm sessile cells identified an increased expression of the 
antA, antB, and antC genes and mutations in these genes, significantly reduced adhesion and biofilm 
forming abilities (Costaglioli et al., 2012). The formation of biofilms especially with sessile cells, is a 
recognised resistance mechanism, often associated with a reduced susceptibility to antimicrobials (Donlan 
and Costerton, 2002). This link between anthranilate degradation and biofilm formation, suggests the 
RW109 strain may be transitioning to a biofilm state in order to survive exposure to the preservatives BIT 
and POE at 50% of the MIC and when in combination with each other at 20% of the MIC.  
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The recurrent down-regulation of the same genes in response to different test conditions signifies 
commonly supressed mechanisms. Two operons phnAB and pqsABCDE were frequently identified with 
decreased expression in response to the industrial test conditions (not including BIT at 20% of the MIC) 
(Figure 54). These operons were adjacent to each other within the RW109 genome and encode enzymes 
necessary for the biosynthesis of PQS (Wade et al., 2005). The pqsABCDE operon encodes enzymes that 
catalyse production of five different types of the PQS molecule 4-hydroxy-2-alkylquinolines (HAQs) 
(Déziel et al., 2004). The operon phnAB is involved in the conversion of the central metabolite chorismate 
to anthranilate by anthranilate synthase, which is an essential precursor pathway in the biosynthesis of 
HAQs (Essar et al., 1990, Déziel et al., 2004).  
PQS are cell to cell signalling molecules involved in quorum sensing enabling the development of multi-
cellular processes for survival purposes such as biofilm formation (Diggle et al., 2007). These molecules 
are generally produced in response to harsh environments and involve substantial investment of bacterial 
reserves (Häussler and Becker, 2008). After an extensive exposure to rate limiting conditions such as 
preservative formulations and HPC products, PQS production may not be sustainable. The phnAB and 
pqsABCDE operons were possibly beneficial during initial exposure to the industrial test conditions, 
however after 24 hours PQS biosynthesis may not have been viable for RW109. Further work could 
involve exposing the strain to the same test conditions for a shorter amount of time to determine 
alterations in the expression of these operons. It is also proposed that under increased exogenous stresses, 
the overproduction of PQS becomes harmful to P. aeruginosa (D'Argenio et al., 2002, Heurlier et al., 
2005).   
Down-regulation of the PQS genes in response to industrial preservatives may also be a mechanism, 
which allows the RW109 strain to persist in the presence of these antimicrobials and harsh conditions. 
Excessive PQS disrupts electron flow through the respiratory chain which releases reactive oxygen 
species, this impairs membrane integrity inducing bacterial cell autolysis and the release of DNA (Hazan 
et al., 2016). A P. aeruginosa mutant deficient in the pqsA gene was grown in the presence of the 
antibiotics ciprofloxacin, imipenem and gentamicin, and killing was found to be significantly delayed in 
comparison to the wild-type and a mutant which over produced PQS (Häussler and Becker, 2008). The 
pqsA mutant also demonstrated an enhanced resistance when exposed to hydrogen peroxide in relation to 
the wild-type and the PQS overproducing mutant (Häussler and Becker, 2008). Again, the operons may 
have been advantageous as an initial response to the test conditions used in this study. However after 
prolonged exposure, PQS biosynthesis may have become detrimental to RW109, resulting in the down-
regulation of phnAB and pqsABCDE.  
The transcriptomic analysis performed in this study generated a vast amount of data. Consequently, it was 
decided to mainly focus the discussion on the genetic pathways commonly identified as differently 
expressed when exposed to industry relevant conditions. This interpretation has highlighted central 
resistance mechanisms utilised by RW109, with many of the genes and operons discussed being found 
within the top ten up and down regulated DEGs in response to each test condition. This signifies the 
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importance of these recognised mechanisms in the ability of RW109 to survive the presence of 
preservative formulations and HPC products. This study has also highlighted a variety of genetic pathways 
with differential regulation in response to preservatives and product formulations. This indicates the 
resistance mechanisms used by P. aeruginosa to survive in an industrial environment are complex and 
may involve more than one genetic pathway. Further interpretation of the findings from this study would 
enable a comprehensive characterisation of the resistance mechanisms utilised in response to each of the 
industry relevant conditions.  
5.4 Conclusions  
 
The main conclusions from this chapter were as follows:  
 
1) Good quality RNA for use in RNA-Seq analysis was extracted from P. aeruginosa RW109 
following exposure to conditions which resulted in a OD percentage reduction of up to 68%, when 
compared to growth in TSB for 24 hours.   
 
2) When exposed to industry relevant conditions, RNA-Seq transcriptomic analysis was successfully 
applied to investigate the gene expression response of P. aeruginosa RW109.  The exposure 
conditions included the individual preservatives BIT and POE at different concentrations, a 
combination of these two preservatives and laundry detergent with and without the addition of the 
preservative BIT.   
 
3) Exposure of P. aeruginosa RW109 to BIT at 20% of the calculated MIC resulted in the least 
number of differentially regulated genes, with 0.03% of DEGs in relation to the whole genome. In 
response to laundry detergent in combination with BIT, the greatest proportion of up and down 
regulated genes (20.36%) within the RW109 genome was observed.  
 
4) The consistent up-regulation of the same genetic pathways when exposed to the different test 
conditions identified common resistance mechanisms used by P. aeruginosa RW109 in response 
to industrial preservatives and product formulations. These included a MexPQ-OpmE RND efflux 
pump system, a putative sialic acid transporter and a gnyRDBHAL operon. These frequently used 
resistant mechanisms can be targeted during the development of HPC preservation strategies.   
 
5) The repeated decreased expression of certain genetic pathways in response to different test 
conditions signifies commonly supressed P. aeruginosa mechanisms. Two operons phnBA and 
pqsEDCBA involved in PQS production and quorum-sensing, were repeatedly down-regulated 
when exposed to industry relevant conditions after 24 hours.  
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6.1 Introduction  
Genome-scale metabolic network reconstructions provide a comprehensive overview of bacterial 
biochemical networks and can be analysed to predict the essentiality of genes and reactions when a 
bacterium is exposed to various environmental conditions (Thiele and Palsson, 2010). Information from a 
well-annotated whole-genome sequence, together with databases and relevant literature searching, enables 
the gene-protein-reaction relationship to be determined for characterisation of the network of reactions 
involved in bacterial metabolism. Updating a previously developed metabolic model with the use of 
genetic information is a useful starting point during model reconstruction to better represent a specific 
bacterial strain (Rocha et al., 2008). The metabolic potential of an organism under various conditions can 
be simulated using a constraint-based modelling approach called flux balance analysis (FBA) to further 
understand the biological system of interest (Thiele and Palsson, 2010). Constraint-based reconstruction 
and analysis (COBRA) methods are widely used; they are built on three fundamental concepts which 
include the constraints of a microorganism based on its genome and biochemical networks, the objective 
function which accounts for the necessary components for growth and the association of gene-protein-
reaction relationships (Lewis et al., 2012). A COBRA model is represented mathematically enabling the 
computational interpretation of genome-encoded reactions and a better understanding of the metabolism of 
a microorganism.  FBA is commonly used in conjunction with COBRA when investigating the metabolite 
flow through genome-scale metabolic network reconstructions (Orth et al., 2010). The rapid increase in 
the availability of high-throughput genomic, proteomic and metabolomics data has advanced the 
capabilities of genome-scale metabolic models as investigative tools (Lewis et al., 2012). As an advanced 
research technique, metabolic models are valuable when examining the virulence or antimicrobial 
resistance capabilities of a microorganism.  
The recently published metabolic model for the P. aeruginosa strain PA14 evaluated the interrelationships 
between growth and virulence-linked pathways using an in silico media to mimic the lung of a CF patient 
(Bartell et al., 2017). The results enabled the prediction of 46 essential genes, which were involved in 
growth inhibition and virulence reactions, with a high representation of fatty acid and phospholipid 
metabolism pathways. The findings provide information to enhance the design of effective CF 
antimicrobial treatments which have a wide-impact on P. aeruginosa metabolism (Bartell et al., 2017). 
The reconstruction and biological interpretation of the PA14 metabolic model demonstrates how 
computational screening can be a useful tool in understanding how bacteria respond to their environments.    
There is currently motivation in the field of modelling for the development of condition-specific models, 
which represent the metabolic state of a bacterium when exposed to a particular environmental condition 
(Schmidt et al., 2013, Hyduke et al., 2013, Ebrahim et al., 2016). Various methods have been developed 
which enable transcriptomic data to be integrated into a genome-scale model (Blazier and Papin, 2012, 
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Lewis et al., 2012, Vivek-Ananth and Samal, 2016). The integration applies further constraints on a 
model, allowing for an accurate representation of gene expression dynamics and resulting condition-
specific models can be used to predict the essentiality of genes and reactions. Hypotheses can then 
formulated regarding the importance of specific metabolic pathways during exposure to relevant 
conditions, which can then be validated. This offers a streamlined hypothesis-driven approach for 
experimentally investigating the genetic and metabolic determinants of antimicrobial resistance, by 
initially focusing on predicted genes and enzymes of interest. Metabolic modelling can examine the genes 
deemed necessary for a bacterium to survive within harsh environments and draw attention to potential 
novel antimicrobial targets to combat the increasing problem of resistance development. Putative targets to 
combat the resistance with the antibiotic colistin have recently been identified using a constraint-based 
approach with an Acinetobacter baumannii (A. baumannii) genome-scale metabolic model, combined with 
gene expression data (Presta et al., 2017). A set of novel genes were identified using in silico gene 
essentiality predictions when the bacteria was exposed to colistin. The study identified essential reaction 
targets for development of new drugs against resistant A. baumannii. This work highlights the use of 
genome-scale models along with transcriptomic data in understanding the response of bacteria to stressful 
conditions.  
There are over 100 published and experimentally validated metabolic models which represent various 
microorganisms (Broddrick, 2017). Genome-scale metabolic models serve as prominent resources in 
understanding how bacteria respond to various environmental conditions, and enable the testing and 
generation of relevant hypotheses. As far as we know, no genome-scale metabolic models exist, which 
represent an industrial P. aeruginosa strain; this would be useful to determine the metabolic requirements 
for survival in home and personal care products (HPC) products and in the presence of industrial 
preservatives.   
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6.1.2 Aim and objectives   
The overall aim of this chapter was to reconstruct and utilise a genome-scale metabolic model specific to 
an industrial P. aeruginosa strain and this was achieved by carrying out the following objectives:  
 
1) Up-date a recently published PA14 metabolic model to represent the industrial RW109 strain 
using the PacBio genome sequence (Chapter 3).  
 
2) Integrate the RNA-Seq transcriptomic gene expression data (Chapter 5) with the reconstructed 
model and generate condition-specific models that represent RW109 when exposed to industrial 
conditions.  
 
3) Predict the essentiality of model reactions when RW109 was exposed to industry relevant 
conditions.  
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6.2 Results 
6.2.2 Updating the PA14 model  
The recently published and validated PA14 model was updated to represent an industrial P. aeruginosa 
strain by using the complete RW109 genome sequence (Chapter 3). Updating was initially carried out by 
replacing the PA14 model gene locus tags with RW109 orthologs identified from a BLASTp search 
between the two strains. Out of the 1,129 genes in the PA14 model, 7 did not match to any RW109 genes 
even when the BLASTp filtering parameters were reduced. The remaining 1,122 PA14 model genes 
matched to 1,185 RW109 genes using the set BLASTp filtering parameters.  
6.2.3 Classifying the additional reactions of the RW109 metabolic model 
When the FASTA sequences were run through the modelSEED (Henry et al., 2010) and KEGG databases 
(Kanehisa et al., 2017), 166 additional reactions were identified and included in the updated model. 114 
genes were associated with these additional reactions as follows: 38 were unique to RW109 when 
compared to PA14 (there was no match during a BLASTp search to any PA14 genome genes); 54 were 
RW109 genes which had similarity to PA14 genes not included in the original model; and 22 were 
RW109 genes which corresponded to PA14 genes already in the original model and associated with other 
reactions. Running the RW109 FASTA sequences through the modelSEED database also identified 
existing reactions within the PA14 model, which were associated with 7 unique RW109 genes and an 
additional 45 RW109 genes, which had similarity to PA14 genes not in the original model.  
 
KEGG functional categories were assigned to the 166 additional reactions of the RW109 model and the 
xenobiotic biodegradation and metabolism category was found to be the most represented, with 33 
reactions (Figure 55). Out of the 33 reactions in this category, 31 were linked to genes from plasmid 1. 
Within this functional category, 60% of the reactions were associated with the metabolism of xenobiotics 
by cytochrome P450 sub-category (Figure 56A). The original PA14 model had 11 reactions within the 
xenobiotic biodegradation and metabolism category; 1 reaction was associated with aminobenzoate 
degradation and 10 with benzoate degradation; the additional reactions of the RW109 model were not 
associated with the benzoate degradation group. The second functional category with the greatest number 
of reactions was amino acid metabolism, which had 30 reactions (Figure 55). Within this functional 
category, 43% of the reactions were associated with the glycine, serine and threonine metabolism sub-
category (Figure 56B). When analysing the genes associated with this sub-category, two genes 
(RW109_00449 and RW109_00565) from plasmid 1 were previously described as being part of the serine 
and threonine metabolism pathway KEGG module (M00555) (Chapter 3, Table 8; Section 3.2.3.2.2). 
Within the glycine, serine and threonine metabolism sub-category in the RW109 model, RW109_00449 
was associated with 7 reactions and RW109_00565 was found within 2 reactions.  
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When examining the location of the genes associated with the 166 additional reactions of the RW109 
model, 33 genes were from plasmid 1, 78 from the main chromosome and 3 genes were from plasmid 2. 
Plasmid 1 genes were associated with 97 additional reactions and the xenobiotics biodegradation and 
metabolism functional category represented the highest number of reactions (31.96%) linked to plasmid 1 
genes, followed by amino acid metabolism (18.56%), nucleotide metabolism (10.31%), glycan 
biosynthesis and metabolism (9.28%), and carbohydrate metabolism (9.28 %). The 3 genes from plasmid 
2 were linked to 5 additional reactions; 3 were involved in membrane transport, 1 with replication and 
repair and the other in nucleotide metabolism.  
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Figure 55. KEGG functional categories of the additional RW109 model reactions 
The bar-chart shows the functional categories of the 166 additional reactions included within the RW109 metabolic model. The functional categories were assigned 
to the reactions via the KEGG database and the xenobiotics biodegradation and metabolism category had the greatest number of the additional reactions associated 
with it, followed by amino acid and metabolism.  
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Figure 56. Breakdown of the key reactions in the two major functional categories associated with the RW109 additional model reactions 
The pie charts represent the percentage of reactions assigned to the sub-categories of A) xenobiotics biodegradation and metabolism and B) amino acids metabolism 
KEGG functional categories. Within A) the metabolism of xenobiotics by cytochrome P450 was found to have the greatest number of reactions assigned to it with 
60% and in B) the glycine, serine and threonine metabolism sub-category had the greatest number of reactions (43%) within the amino acid metabolism category.  
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6.2.4 The RW109 model in COBRA format 
The RW109 model in Excel format was loaded into MATLAB and converted into a COBRA toolbox 
model as described in Section 2.8.3. The model was optimised with FBA, once the model objective was 
set to the RW109_Biomass reaction, which serves as an approximation of growth and the in silico media 
was changed to LB complete media. This media was chosen as it represented the complete in silico media 
available on the change media script (see changeMedia_SEED.m script on CD-ROM Chapter 2 folder). 
The output of FBA was an objective function value of 17.45 hr-1, indicating that the model was able to 
grow and an optimal flux balance analysis solution for the model was found in silico.  
6.2.5 Removing PA14 genes with no similarities to RW109 genes  
The 7 genes from the PA14 model with no similarity to any RW109 genes were individually deleted from 
the model and this resulted in the removal of 5 non-essential reactions (Figure 57). Out of these non-
essential reactions, 4 were within the glycan biosynthesis and metabolism category and functioned in 
lipopolysaccharide biosynthesis of B-band O antigen; within the model, 38 remaining reactions were 
associated with lipopolysaccharide biosynthesis. The other non-essential reaction removed from the model 
was associated with lipid metabolism and had a function in glycerophospholipid metabolism; however, 56 
model reactions remained which were also involved in glycerophospholipid metabolism. The 
PA14_60120 gene, which did not match to any within RW109, was also deleted from the model and its 
removal did not result in any loss of reactions. The PA14_60120 gene was associated with the rxn01672 
reaction and the enzyme associated could be encoded for by more than one gene within the PA14 model. 
The other gene associated with the rxn01672 reaction was PA14_19090 and this was matched to the 
RW109_02319 gene allowing the reaction to remain within the RW109 model reconstruction.   
When the PA14_61770 gene was removed from the model, it resulted in a biomass objective function 
value of 0, indicating that this gene is essential for biomass production. Indeed, this gene was associated 
with the essential reaction ATP: D-ribose-5-phosphate pyrophospho-transferase (rxn00770), which 
produces 5-Phospho-alpha-D-ribose 1-diphosphate. Reducing the strict BLASTp filtering parameters did 
not identify any match for the PA14_61770 gene within the RW109 genome. Within the KEGG database 
this reaction is termed R01049 and the functional units of this reaction (KEGG module M00005; Chapter 
3, Section 3.2.6.1.2) were identified as biologically achievable for the PA14 and PAO1 strains, but was 
not for RW109. The enzyme involved in the reaction rxn00770, ATP:ribose-1,5-bisphosphate 
phosphotransferase, was searched on the Uni-Prot database (Consortium, 2017) and 203 amino acid 
sequences from different bacterial species encoding the enzyme retrieved. These were compiled into a 
multi-FASTA file and a local BLASTp search was carried out against the RW109 genome. This 
comparison loosely matched the RW109_04621 gene with a Sulfolobus solfataricus gene encoding the 
ribose-phosphate pyrophosphokinase enzyme (percentage identity= 38.03%, e-Value: 3e-07, BIT-Score = 
47.4). This indicates that the RW109_04621 gene may be linked to the rxn00770 reaction. The 
RW109_04621 gene had already been found in the model and was associated with the adenine 
phosphoribosyltransferase rxn00139 reaction. Overall, the rxn00770 reaction was kept in the updated 
RW109 model and a note made about the more weakly associated RW109_04621 gene.  
 235 
 
Figure 57. Flow diagram of reactions removed from the RW109 metabolic model 
The flow diagram demonstrates the 5 PA14 model reactions which were removed from the model as they were found to be non-essential when the five PA14 genes 
associated with them were deleted. These genes were deleted as no similarities were found when compared to the RW109 strain during a BLASTp search. Within 
the flow diagrams the first box represents the KEGG functional category, the second the sub-system of the functional category, the third is the model reaction and 
the forth column corresponds to the PA14 gene that was deleted from the model.   
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6.2.6 The overall key features of the RW109 metabolic model 
The reconstructed model of P. aeruginosa RW109 accounts for the predicted function of 1,329 genes, 
1,656 reactions and 1,465 metabolites (Table 35) (See relevant folder on the CD-ROM: 
RW109_Model_23March_UPtoDate.xlsx). The RW109 model had more predicted reactions, genes and 
metabolites when compared to the original PA14 metabolic model (Table 35), consistent with having a 
larger genome. The biomass production was predicted to be higher for the RW109 model when simulating 
growth in LB complete media, compared to simulations with the PA14 model, as indicated by the 
objective function value (Table 35). The locations of all the RW109 model genes on the genome were 
examined and 1,266 were from the main chromosome, 59 from plasmid 1 and 4 genes were from plasmid 
2.  
A diverse distribution of biological functions for the RW109 model reconstruction was observed when the 
reactions were grouped using KEGG functional categories; a total number of 19 KEGG categories were 
represented in the model (Figure 58). The lipid metabolism category had the greatest number of reactions 
associated with it (18.36%), followed by membrane transport (14.55%) and amino acid metabolism 
(13.41%). The KEGG functional categories, which had the least representation within the model, were 
replication and repair (0.06%), biosynthesis of amino acids (0.18%) and biosynthesis of other secondary 
metabolites (0.36%).   
 
Footnotes: *When simulating growth in LB complete media using the FBA optimised model solution  
Table 35. The key features of the RW109 and PA14 metabolic models 
Features RW109 PA14 
Number of 
genes 
1,329 
(18.2% of the genome=7,304 genes) 
1,129 
(18.9% of the genome= 5,978 genes)
Number of 
reactions  
1,656 
(1,223 metabolic, 241 membrane transport,              
172 exchange and 20 unknown)
1,495
(1,070 metabolic, 238 membrane transport, 
172 exchange and 15 unknown)
Number of 
metabolites
1,465 1,286
Objective 
function value*
17.45 hr-1 15.73 hr-1
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Figure 58. KEGG functional categories of the RW109 metabolic model reconstruction
The bar-chart shows the numbers of reactions within each KEGG functional category for the RW109 metabolic model’s 1,656 the reactions. The functional 
categories were assigned via the KEGG database. The percentage representations of each functional category are indicated next to the bars and are based on the total 
number of reactions within the model. The lipid metabolism category had the greatest number of reactions associated with it, followed by membrane transport and 
amino acid metabolism.   
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6.2.7 Transcriptomic data integration to constrain the RW109 metabolic model and predict 
reaction essentiality during exposure to industry relevant conditions 
To generate condition-specific models of RW109 metabolism, gene expression data from exposure of the 
strain to industry relevant conditions (Chapter 5; log2-fold changes and adjusted p-values) were integrated 
following the computational pipeline as shown in Figure 59. The exposure conditions transcriptomically 
evaluated were (abbreviations used throughout this analysis are shown in brackets after the test condition 
number): TSB-Only (control condition), BIT at 20% of the MIC (test condition 1, BIT20), BIT at 50% of 
the MIC (test condition 2, BIT50), POE at 20% of the MIC (test condition 3, POE20), POE at 50% of the 
MIC (test condition 4, POE50), BIT and  POE in combination at 20% of the MIC (test condition 5, 
BIT+POE), unpreserved laundry detergent only (test condition 6, LDOnly) and unpreserved laundry 
detergent in combination with BIT at 20% of the MIC (test condition 7, LD+BIT). The MADE algorithm 
(as described in detail in Section 2.8.5) was used to integrate statistically significant gene expression 
changes into the RW109 metabolic model. This method does not require a predefined threshold to be set 
and generates functioning condition-specific metabolic models, which accurately represent gene 
expression dynamics.   
The outputs from the integration produced 8 separate models, which represented the functional gene states 
and metabolic adjustments of the control exposure condition (TSB-only, control model), and each of the 7 
test exposure conditions (models 1-7).  The MATLAB versions of these 8 models can be found in the 
relevant folder on the CD-ROM supplied with this thesis. The initial results from the integration were as 
follows (Table 36); the models, which represented the test conditions, each had different objective flux 
values, except for the BIT20 model, which had the same value as the control model. The greatest objective 
flux value of 7.46 hr-1 was observed for the control model and the BIT20 model. The lowest objective flux 
value of 5.28 hr-1 was observed for the BIT+POE model. The objective flux indicates the maximum 
amount of flux permitted to flow through the defined objective biomass function after the models were 
constrained with the gene expression data. When no constraints were placed on the RW109 base model, 
the objective flux value was 17.45 hr-1 (Table 35). The number of functional genes (i.e., those not removed 
by the MADE algorithm) within each constrained model were also identified in Table 36.  
The essentiality of the remaining functional genes for each model were predicted by performing 
computational knock-outs; if the resulting flux through the objective biomass function was < 0.0001 hr-1  
after performing the knock-out, that gene was predicted as essential. The reactions associated with the 
essential genes were also deleted and predicted to be essential if the flux through the objective biomass 
function was < 0.0001 hr-1 after a deletion. The 140 genes and 165 reactions predicted to be essential in the 
control condition model were used as a comparison against those identified with the test conditions.                        
For each test condition, the predicted essential reactions not found within the control condition were 
recognised (Table 36) and grouped according to their KEGG functional category assignment (Figure 60).  
This resulted in the classification of reactions for each test condition, which were projected to be essential 
for survival of RW109 within each industrial exposure condition. Spreadsheets of the model essential 
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reactions and genes for each test condition can be found in the relevant folder on the CD-ROM supplied 
with this thesis (TestConditions_Essential_Genes_and_Reactions.xlsx).  
The BIT20 model had 1 gene and 1 reaction predicted to be essential, which was the least number of 
essential genes and reactions identified. The POE50 model had the highest quantities predicted with 38 
essential genes and 53 essential reactions. KEGG categories were used to group the essential reactions of 
the test conditions to understand their biological functions and 9 categories were found to represent the 
essential reactions of the test condition models (Figure 60). Lipid metabolism had the greatest number of 
overall essential reactions with 49, followed by nucleotide metabolism with 42 and membrane transport 
with 39. The fatty acid metabolism and energy metabolism were the least represented functional 
categories for the test conditions (Figure 60). There were also KEGG functional categories of the RW109 
model reconstruction, which had no representation within the predicted essential reactions. These included 
metabolism of other amino acids, glycan biosynthesis and metabolism, carbon metabolism, translation, 
biosynthesis of amino acids, biosynthesis of secondary metabolites and replication and repair.  
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Figure 59. Computational pipeline of transcriptomic data integration into the RW109 metabolic model 
The pipeline illustrates the steps used to integrate the transcriptomic data from Chapter 5 into the RW109 metabolic model reconstruction. The output from the MADE 
algorithm was a series of 8 condition-specific models which represent the functional gene states and metabolic adjustments of the control condition and the 7 test 
exposure conditions. The model names correspond to the exposure conditions: TSB-Only (control condition), BIT20(1) (BIT at 20% of the MIC), BIT50(2) (BIT at 
50% of the MIC), POE20(3) (POE at 20% of the MIC), POE50(4) (POE at 50% of the MIC), BIT+POE(5) (BIT and POE in combination at 20% of the MIC),  
LDOnly(6) (unpreserved laundry detergent only) and LD+BIT(7) (unpreserved laundry detergent in combination with BIT at 20% of the MIC). These models were then 
used to predict the essentiality of genes and reactions when RW109 was exposed to industry relevant conditions.   
Reconstruction of a metabolic model 
specific to the industrial RW109 strain 
using the PA14 model (Bartell et al. 2017)
Transcriptomic gene 
expression analysis of 
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to industry relevant 
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log-2-fold changes and 
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test models with the 
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Table 36. Results of transcriptomic gene expression data integration into the RW109 model reconstruction 
Footnotes: The * in columns 5 and 6 indicates the number of essential genes and reactions which were not identified in the control condition.  
Condition Objective flux(hr-1) 
Number of 
functional genes
Number of  
essential genes
Number of  
essential reactions
Control: TSB only 7.46 739 140 165
Test conditions:
(1) BIT20 7.46 742 1* 1*
(2) BIT50  6.51 723 8* 10*
(3) POE20 5.74 563 35* 45*
(4) POE50 5.89 552 38* 53*
(5) BIT+POE 5.28 590 33* 37*
(6) LD Only 5.57 621 26* 34*
(7) LD+BIT 5.59 629 29* 47*
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Figure 60. KEGG functional categories of the predicted essential reactions for each RNA-Seq exposure condition 
The stacked bar chart demonstrates the number of predicted essential reactions within each test condition grouped via the KEGG functional category.                                     
BIT20(1) is shown in grey, BIT50 (2) is in blue, POE20 (3) is in purple, POE50 (4) is in red, BIT+POE (5) is shown in green, LDOnly (6) is in orange and LD+BIT (7) is 
shown in pink. The lipid metabolism functional category had the greatest number of genes associated with predicted essential reactions.  
 
The stacked bar chart demonstrates the number of predicted essential reactions within each test condition grouped via the KEGG functional category.                                     
BIT20(1) is shown in grey, BIT50 (2) is in blue, POE20 (3) is in purple, POE50 (4) is in red, BIT+POE (5) is shown in green, LDOnly (6) is in orange and LD+BIT (7) is shown in 
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6.2.7.1 Predicted essential reactions involved in lipid metabolism 
The greatest numbers of predicted essential reactions, 49, were associated with lipid metabolism when 
compared to the other KEGG functional categories (Figure 60). All test exposure conditions except for 
BIT20 and BIT50, were predicted to have essential reactions within this category; LD+BIT and POE50 
had the most with 16 and 15 predicted respectively. The groupings between the exposure conditions of the 
lipid metabolism essential reactions are shown in Figure 61 and described in detail in Table 37. A notable 
observation were the 5 predicted reactions only identified as essential after exposure to POE50 (Figure 
61);  these reactions were all found to be associated with CDP-diacylglycerol synthetase (CDP-DAG-
synthetase) and were encoded by the same gene RW109_02164 within the model (Table 37). Six 
cardiolipin synthase reactions were predicted to be essential when RW109 was exposed to POE20, POE50 
and LD+BIT (Figure 61 and Table 37); these reactions were all associated with the essential model gene 
RW109_03891. During exposure to LDOnly and LD+BIT, 6 reactions were predicted as essential which 
were all linked to (3R)-3-Hydroxypalmitoyl-[acyl-carrier-protein]:NADP+ oxidoreductase and were 
encoded for by the RW109_02915 FabG model gene (Table 37). Two reactions related to glycerolipid 
metabolism were also found to only be essential during exposure to POE20 (rxn00763) and BIT+POE 
(rxn01102).   
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Figure 61. Grouping of the lipid metabolism predicted essential reactions 
The Edwards-Venn diagram (A) represents the number of lipid metabolism essential reactions 
(numbers in black) which either overlapped or were found only in the test conditions POE20(3) 
in purple, POE50(4) in red, BITandPOE(5) in green, LDOnly(6) in orange and LD and BIT(7) 
in pink. The bar chart (B) is used to clearly show the numbers of essential reactions within each 
of the test conditions which are coloured the same as in A).     
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Table 37. Predicted essential reactions for the lipid metabolism KEGG functional category 
Footnotes:  
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column, e.g. RW109_02915 
was essential for both LDOnly(6) and LD+BIT(7).                            
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential e.g. RW109_00595(4) was found to be only 
essential in test condition POE50(4).  
Test exposure condition
Essential 
Reaction
Reaction Name Reaction Function Reaction formula EC number Essential genes
POE20(3) rxn00763 Alcohol dehydrogenase (glycerol) Glycerolipid metabolism NAD + Glycerol  <=> NADH + H+ + D-Glyceraldehyde 1.1.1.1,1.1.1.2,1.1.1.21,1.1.1.72 RW109_03810
POE50(4)
rPY00163 CDP-diacylglycerol synthetase (n-C16:0 16:1) Fatty acid biosynthesis H+ + pa160161 + CTP ->  PPi + CDP-pa160161 2.7.7.41 RW109_02164
rPY00168 CDP-diacylglycerol synthetase (n-C18:0 18:1) Fatty acid biosynthesis H+ + CTP + pa180181 + PPi + CDP-pa180181 2.7.7.41 RW109_02164
rxn08310 CDP-diacylglycerol synthetase (n-C161) Glycerolipid and Glycerophospholipid Metabolism in Bacteria
CTP + 1,2-dihexadec-9-enoyl-sn-glycerol_3-phosphate  <=> PPi + CDP-1,2-dihexadec-9-
enoylglycerol 
2.7.7.41 RW109_02164
rxn08311 CDP-diacylglycerol synthetase (n-C180) Glycerolipid and Glycerophospholipid Metabolism in Bacteria
CTP + 1,2-dioctadecanoyl-sn-glycerol_3-phosphate  <=> PPi + CDP-1,2-
dioctadecanoylglycerol 
2.7.7.41 RW109_02164
rxn08312 CDP-diacylglycerol synthetase (n-C181) Glycerolipid and Glycerophospholipid Metabolism in Bacteria
CTP + 1,2-dioctadec-11-enoyl-sn-glycerol_3-phosphate  <=> PPi + CDP-1,2-dioctadec-11-
enoylglycerol 
2.7.7.41 RW109_02164
BIT+POE(5) rxn01102 glycerate kinase Glycerolipid metabolism ATP + Glycerate <=> ADP + 3-Phosphoglycerate 2.7.1.31 RW109_05126
LDOnly(6) & LD+BIT(7)
rxn05336
(3R)-3-Hydroxypalmitoyl-[acyl-carrier-protein]:NADP+ 
oxidoreductase
Fatty acid biosynthesis
NADP + R-3-hydroxypalmitoyl-acyl-carrierprotein- <=> H+ + NADPH + 3-oxohexadecanoyl-
acp 
1.1.1.100,2.3.1.85,2.3.1.86 RW109_02915
rxn05337
(3R)-3-Hydroxyhexanoyl-[acyl-carrier-protein]:NADP+ 
oxidoreductase
Fatty acid biosynthesis NADP + D-3-Hydroxyhexanoyl-[acp]  <=> H+ + NADPH + 3-Oxohexanoyl-[acp] 1.1.1.100,2.3.1.85,2.3.1.86 RW109_02915
rxn05339
(3R)-3-Hydroxybutanoyl-[acyl-carrier protein]:NADP+ 
oxidoreductase
Fatty acid biosynthesis NADP + (R)-3-Hydroxybutanoyl-[acyl-carrier protein]  <=> H+ + NADPH + Acetoacetyl-ACP 1.1.1.100,2.3.1.85,2.3.1.86 RW109_02915
rxn05340
3R)-3-Hydroxydodecanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase
Fatty acid biosynthesis NADP + D-3-Hydroxydodecanoyl-[acp]  <=> H+ + NADPH + 3-oxododecanoyl-acp 1.1.1.100,2.3.1.85,2.3.1.86 RW109_02915
rxn05341
(3R)-3-Hydroxyoctanoyl-[acyl-carrier-protein]:NADP+ 
oxidoreductase
Fatty acid biosynthesis NADP + (R)-3-Hydroxyoctanoyl-[acyl-carrier protein]  <=> H+ + NADPH + 3-oxooctanoyl-acp 1.1.1.100,2.3.1.85,2.3.1.86 RW109_02915
rxn05342
3R)-3-Hydroxytetradecanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase
Fatty acid biosynthesis NADP + HMA  <=> H+ + NADPH + 3-oxotetradecanoyl-acp 1.1.1.100,2.3.1.85,2.3.1.86 RW109_02915
POE20(3) & POE50(4) & LD+BIT(7
rPY00183 Cardiolipin synthase (n-C18:0 18:1) Glycerophospholipid metabolism 2 pg180181 -> Glycerol + clpn180181 2.7.8.- RW109_03891
rPY00184 Cardiolipin synthase (n-C16:0 16:1) Glycerophospholipid metabolism 2 pg160161 -> Glycerol + clpn160161 2.7.8.- RW109_03891
rxn08229 Cardiolipin synthase (n-C16:0) Glycerolipid and Glycerophospholipid Metabolism in Bacteria 2 Phosphatidylglycerol_dihexadecanoyl <=> Glycerol + clpn160 2.7.8.- RW109_03891
rxn08230 Cardiolipin synthase (n-C16:1) Glycerolipid and Glycerophospholipid Metabolism in Bacteria 2 Phosphatidylglycerol_dihexadec-9-enoyl <=> Glycerol + clpn161 2.7.8.- RW109_03891
rxn08231 Cardiolipin synthase (n-C18:0) Glycerolipid and Glycerophospholipid Metabolism in Bacteria 2 Phosphatidylglycerol_dioctadecanoyl <=> Glycerol + clpn180 2.7.8.- RW109_03891
rxn08232 Cardiolipin synthase (n-C18:1) Glycerolipid and Glycerophospholipid Metabolism in Bacteria 2 Phosphatidylglycerol_dioctadec-11-enoyl <=> Glycerol + clpn181 2.7.8.- RW109_03891
POE50(4) & LDOnly(6) & LD+BIT(7)
rPY00162 PA160161S Fatty acid biosynthesis Hexadecenoyl-ACP + 1-hexadecanoyl-sn-glycerol_3-phosphate -> ACP + pa160161 2.3.1.51
RW109_00595(4), 
RW109_03471(6 and 7)
rPY00167 PA180181S Fatty acid biosynthesis Octadecenoyl-ACP + 1-octadecanoyl-sn-glycerol_3-phosphate -> ACP + pa180181 2.3.1.51
RW109_00595(4), 
RW109_03471(6 and 7)
rxn08087
1-hexadec-7-enoyl-sn-glycerol 3-phosphate O-
acyltransferase (n-C161)
Phosphate metabolism|Glycerolipid and Glycerophospholipid
Metabolism in Bacteria
Hexadecenoyl-ACP + 1-hexadec-9-enoyl-sn-glycerol_3-phosphate  -> ACP + 1,2-dihexadec-9-
enoyl-sn-glycerol_3-phosphate 
2.3.1.51
RW109_00595(4), 
RW109_03471(6 and 7)
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6.2.7.2 Predicted essential reactions involved in nucleotide metabolism 
Two groupings of essential reactions within the nucleotide metabolism category were observed (Table 38). 
All exposure conditions were predicted to have essential reactions within this KEGG functional category 
except for BIT20. The greatest numbers of nucleotide metabolism essential reactions were predicted in 
POE20, POE50 and BIT+POE with 9 predicted in each test condition. Three essential reactions identified 
in the 6 exposure conditions were all involved in the salvage pathway nucleoside-diphosphate kinase 
(Ndk) and encoded by the RW109_01980 model gene (Table 38). Six essential reactions were predicted 
when RW109 was exposed to POE20, POE50, BIT+POE and LD+BIT (not identified with BIT50); two 
were involved in the salvage pathways cytidylate kinase (rxn00364) and another with the Ndk enzyme 
(rxn00409). The other 4 reactions had a function in purine and pyrimidine metabolism and biosynthesis 
and 3 were identified as reactions which were additional to the RW109 model (Section 6.2.3); rxn05816, 
rxn05817 and rxn05818.   
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Table 38. Predicted essential reactions for the nucleotide metabolism KEGG functional category 
Test exposure condition
Essential 
Reaction
Reaction name Reaction function Reaction formula EC number Essential genes
POE20(3) & POE50(4) & BIT+POE(5) & LD+BIT(7)
rxn00364 Cytidylate kinase (CMP) Salvage Pathways ATP + CMP  <=> ADP + CDP 2.7.4.14 RW109_02660
rxn00409 Nucleoside-diphosphate kinase (ATP:CDP) Salvage Pathways ATP + CDP  <=> ADP + CTP 2.7.4.6 RW109_01980
rxn00917 GMP synthase (glutamine-hydrolysing)
Purine and Pyrimidine 
Biosynthesis
H2O + ATP + L-Glutamine + XMP  -> H+ + L-Glutamate + 
PPi + AMP + GMP 
6.3.5.2 RW109_00448
rxn05816
Deoxyadenosine 5'-triphosphate:DNA 
deoxynucleotidyltransferase (DNA-directed)
Purine metabolism dATP <=>  PPi 2.7.7.7
RW109_00252 (3,4,5), 
RW109_00592 (7)
rxn05817
Deoxyguanosine 5'-triphosphate:DNA 
deoxynucleotidyltransferase (DNA-directed)
Purine metabolism dGTP <=>  PPi 2.7.7.7
RW109_00252 (3,4,5), 
RW109_00592 (7)
rxn05818
Deoxycytidine triphosphate:DNA deoxynucleotidyltransferase 
(DNA-directed)
Pyrimidine metabolism dCTP <=>  PPi 2.7.7.7
RW109_00252 (3,4,5), 
RW109_00592 (7)
BIT50(2) & POE20(3) & POE50(4) & BIT+POE(5) & LDOnly(6) & LD+BIT(7)
rxn00839 Nucleoside-diphosphate kinase (ATP:dADP) Salvage Pathways ATP + dADP <=> ADP + dATP 2.7.4.6 RW109_01980
rxn01353 Nucleoside-diphosphate kinase (ATP:dGDP) Salvage Pathways ATP + dGDP <=> ADP + dGTP 2.7.4.6 RW109_01980
rxn01673 Nucleoside-diphosphate kinase (ATP:dCDP) Salvage Pathways ATP + dCDP <=> ADP + dCTP 2.7.4.6 RW109_01980
Footnotes:  
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.                             
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.    
 
 
Footnotes:  
4) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
5) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.                             
6) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.    
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6.2.7.3 Predicted essential reactions involved in membrane transport 
Numerous groupings of the essential reactions involved in membrane transport metabolism were noted. To 
enable display of the data, the analysis was divided into comparisons of the essential reactions between the 
test conditions: (i) BIT20(1), BIT50(2), POE20(3), POE50(4) and BIT+POE(5) (Figure 62 and Table 39) 
and (ii) BIT20(1), BIT50(2), LDOnly(6) and LD+BIT(7) (Figure 63 and Table 40). Test conditions 1, 2, 3, 
4 and 5 were analysed together as these conditions represented the preservatives BIT and POE both 
individually and in combination; POE50 had the greatest number of essential reactions with twelve 
predicted. The test conditions 1, 2, 6 and 7 were examined collectively as these conditions represented the 
preservative BIT and laundry detergent separately and in combination; the greatest number of essential 
reactions identified was during LD+BIT exposure with six predicted.  
  
Eight groupings of the essential reactions were observed for test conditions BIT20(1), BIT50(2), 
POE20(3), POE50(4) and BIT+POE(5) (Figure 62 and Table 39). An L-phenylalanine transport reaction 
(rxn05306) was only predicted to be essential with POE20 and 5 membrane transport reactions with 
various functions were identified during exposure to POE50. Three reactions were predicted as essential 
during exposure to the test conditions POE20 and POE50, and these had functions in transporting urea, L-
histidine and L-proline (rxn05164, rxn05165 and rxn09653). A FeoB iron (II) transporter reaction 
(rxn10963) encoded by the RW109_05695 model gene was identified during exposure to the test 
conditions POE50 and BIT+POE and an L-lysine ABC system transport reaction (rxn05151) was 
predicted as essential in both POE50 and BIT+POE and was encoded by RW109_02958. An L-
methionine transport via ABC system (rxn05219) was classified as essential in all of the test conditions 
and was the only reaction predicted for the BIT20 exposure condition. With BIT20 and BIT50, the 
essentiality of rxn05219 was associated with the RW109_07122 model gene and in conditions POE20, 
POE50 and BIT+POE, 3 genes RW109_03660, RW109_03661 and RW109_03662 were linked to the 
reaction.  
 
Seven groupings of essential reactions were recognised when the test conditions BIT20(1), BIT50(2), 
LDOnly(6) and LD+BIT(7) were compared (Figure 63 and Table 40). A L-proline transport reaction 
(rxn05638) was predicted as essential only during exposure to LDOnly, and 2 reactions involved in the 
transport of L-arginine and acetate were only classified as essential with LD+BIT (rxn05154 and 
rxn05488). Exposure to the test conditions LDOnly and LD+BIT classified the essentiality of 2 reactions, 
which transported L-histidine and adenosine (rxn05164 and rxn05318). The L-methionine transport via 
ABC system (rxn05219) was predicted as essential during exposure to BIT20, BIT50 and LD+BIT and the 
FeoB iron (II) transporter was essential during exposure to BIT50, LDOnly and LD+BIT.  
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Figure 62. Grouping of the membrane transport predicted essential reactions for 
the test conditions 1, 2, 3, 4 and 5 
A)
Membrane transport: 
test conditions 1, 2, 3, 4 and 5 
B)
The Edwards-Venn diagram (A) represents the number of membrane transport essential 
reactions (numbers in black) which either overlapped or were found only in the test conditions 
BIT20(1) in grey, BIT50(2) in blue, POE20(3) in purple, POE50(4) in red and BITandPOE(5) 
in green. The bar chart (B) is used to clearly show the numbers of essential reactions within 
each of the test conditions which are coloured the same as in A).  
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Table 39. Predicted essential reactions for the membrane transport category for test conditions 1, 2, 3, 4 and 5 
Test exposure condition
Essential 
Reaction
Reaction function Reaction formula EC number Essential genes
POE20(3) rxn05306
L-phenylalanine transport in/out via proton 
symport
H+ + L-Phenylalanine  <=> H+ + L-Phenylalanine TC-2.A.3.1,2.A.3.1 RW109_02881
POE50(4)
rJB00225 D-Fructose transport via PEP:Pyr PTS Phosphoenolpyruvate + D-Fructose  -> Pyruvate + D-fructose-6-phosphate -
RW109_02260
RW109_02259 
RW109_02258
rxn05161 L-leucine transport via ABC system H2O + ATP + L-Leucine  -> H+ + ADP + Phosphate + L-Leucine -
RW109_05103
RW109_05104
rxn05168 L-valine transport via ABC system H2O + ATP + L-Valine  -> H+ + ADP + Phosphate + L-Valine -
RW109_05103 
RW109_05104
rxn05179 L-isoleucine transport via ABC system H2O + ATP + L-Isoleucine  -> H+ + ADP + Phosphate + L-Isoleucine - RW109_06504
rxn05560 D-fructose transport via PEP:Pyr PTS Phosphoenolpyruvate + D-Fructose  <=> Pyruvate + D-fructose-1-phosphate -
RW109_02260 
RW109_02258
BIT50(2) & POE20(3) rxn10963 FeoB iron (II) transporter Fe2+ <=> Fe2+ - RW109_05695
POE20(3) & POE50(4)
rxn05164 L-histidine transport via ABC system H2O + ATP + L-Histidine  -> H+ + ADP + Phosphate + L-Histidine - RW109_02958
rxn05165 L-proline transport via ABC system H2O + ATP + L-Proline  -> H+ + ADP + Phosphate + L-Proline - RW109_01824
rxn09653
urea reversible transport via proton symport
(2 H+)
2 H+ + Urea  <=> 2 H+ + Urea - RW109_04753
POE50(4) & BIT+POE(5) rxn05151 L-lysine transport via ABC system
cpd00001 + cpd00002 + cpd00039[e]  -> cpd00067 + cpd00008 + cpd00009 
+ cpd00039 
- RW109_02958
BIT50(2) & POE50(4) & BIT+POE(5)
rxn05663 L-tryptophan transport in via proton symport H+ + L-Tryptophan  <=> H+ + L-Tryptophan TC-2.A.3.1,2.A.3.1
RW109_05322(2 and 5) 
RW109_02881(4)
BIT50(2) & POE20(3) & POE50(4) & BIT+POE(5)
rxn05169 L-threonine transport via ABC system H2O + ATP + L-Threonine  -> H+ + ADP + Phosphate + L-Threonine -
RW109_06501(2,3 and 5)                                                          
RW109_05103(4),
RW109_05104(4)
BIT20(1) & BIT50(2) & POE20(3) & POE50(4) & BIT+POE(5)
rxn05219 L-methionine transport via ABC system H2O + ATP + L-Methionine  -> H+ + ADP + Phosphate + L-Methionine -
RW109_07122(1 and 2),                                         
RW109_03660(3, 4 and 5), 
RW109_03661(3, 4,and 5), 
RW109_03662(3, 4 and 5)
Footnotes:  
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.                             
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.    
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A)
Membrane transport: 
test conditions 1, 2, 6 and 7
B)
Figure 63. Grouping of the membrane transport predicted essential reactions for test 
conditions 1, 2, 6 and 7 
The Edwards-Venn diagram (A) represents the number of membrane transport essential 
reactions (numbers in black) which either overlapped or were found only in the test conditions 
BIT20(1) in grey, BIT50(2) in blue, LDOnly(6) in orange and LDandBIT(7) in pink. The bar 
chart (B) is used to clearly show the numbers of essential reactions within each of the test 
conditions which are coloured the same as in A).  
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Table 40. Predicted essential reactions for the membrane transport category for test conditions 1, 2, 6 and 7 
Test exposure condition
Essential 
Reaction
Reaction function Reaction formula EC number Essential genes
BIT50(2) rxn05663 L-tryptophan transport in via proton symport H+ + L-Tryptophan  <=> H+ + L-Tryptophan TC-2.A.3.1,2.A.3.1 RW109_02881
LDOnly(6) rxn05638 L-proline transport in via proton symport H+ + L-Proline  -> H+ + L-Proline - RW109_06983
LD+BIT(7)
rxn05154 L-arginine transport via ABC system H2O + ATP + L-Arginine  -> H+ + ADP + Phosphate + L-Arginine - RW109_05296
rxn05488 Acetate transport in/out via proton symport H+ + Acetate  <=> H+ + Acetate - RW109_03816
BIT50(2) & LDOnly(6)
rxn05169 L-threonine transport via ABC system H2O + ATP + L-Threonine  -> H+ + ADP + Phosphate + L-Threonine -
RW109_06501(2),                                                                                 
RW109_05105(6), 
RW109_05106(6), 
RW109_05107(6), 
RW109_06504(6)
LDOnly(6) & LD+BIT(7)
rxn05164 L-histidine transport via ABC system H2O + ATP + L-Histidine  -> H+ + ADP + Phosphate + L-Histidine - RW109_05296
rxn05318 ADNt2r H+ + Adenosine  <=> H+ + Adenosine - RW109_04831
BIT20(1) & BIT50(2) & LD+BIT(7) rxn05219 L-methionine transport via ABC system H2O + ATP + L-Methionine  -> H+ + ADP + Phosphate + L-Methionine -
RW109_071229(1 and 2), 
RW109_03660(7), 
RW109_03661(7), 
RW109_03662(7)
BIT50(2) & LDOnly(6) & LD+BIT(7) rxn10963 FeoB iron (II) transporter Fe2+ <=> Fe2+ - RW109_05695
Footnotes:  
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.                             
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.    
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6.2.7.4 Predicted essential reactions involved in xenobiotics biodegradation and 
metabolism 
Essential reactions involved in xenobiotics biodegradation and metabolism were only found within the test 
conditions POE20(3) and BIT+POE(5). The most essential reactions were identified during exposure to 
POE20, with seven predicted (Figure 60). Table 41 illustrates the groupings of these reactions and all were 
found to have a function in benzoate degradation via hydroxylation. A reaction involved in 4-
carboxymuconolactone decarboxylase (rxn02483) was predicted only to be essential in the POE20(3) test 
condition.  Six reactions with various enzymes involved in benzoate degradation were identified as 
essential in both the POE20(3) and BIT+POE(5) test conditions (Table 41).  
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Table 41. Predicted essential reactions for the xenobiotics biodegradation and metabolism category for test conditions 3 and 5 
Test exposure condition
Essential
Reaction
Reaction name Reaction function Reaction formula EC number Essential genes
POE20(3) rxn02483 4-carboxymuconolactone decarboxylase Benzoate Degradation
H+ + 4-Carboxymuconolactone  -> CO2 + 3-oxoadipate-enol-
lactone 
4.1.1.44 RW109_05826
POE20(3) & BIT+POE(5)
rxn00598 3-oxoadipyl-CoA thiolase Benzoate Degradation Acetyl-CoA + Succinyl-CoA  <=> CoA + 3-Oxoadipyl-CoA 2.3.1.16,2.3.1.174
RW109_02226(3), 
RW109_00825(5)
rxn00962 4-hydroxybenzoate 3-monooxygenase Benzoate Degradation
O2 + H+ + NADPH + 4-Hydroxybenzoate  -> H2O + NADP + 
Protocatechuate 
1.14.13.2, 1.14.13.33 RW109_00844
rxn01192 Protocatechuate 3,4-dioxygenase Benzoate Degradation O2 + Protocatechuate  -> 2 H+ + 3-Carboxy-cis,cis-muconate 1.13.11.3 RW109_00756
rxn02143 3-oxoadipate CoA-transferase Benzoate Degradation Succinyl-CoA + 3-Oxoadipate  <=> 3-Oxoadipyl-CoA + Succinate 2.8.3.6 RW109_04051
rxn02144 3-oxoadipate enol-lactonase Benzoate Degradation H2O + 3-oxoadipate-enol-lactone  -> H+ + 3-Oxoadipate 3.1.1.24 RW109_01084
rxn02369 3-carboxy-cis,cis-muconate cycloisomerase Benzoate Degradation 4-Carboxymuconolactone  <=> H+ + 3-Carboxy-cis,cis-muconate 5.5.1.2 RW109_00827
Footnotes:  
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.                             
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.    
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6.2.7.5 Predicted essential reactions involved in carbohydrate metabolism 
All conditions, except test conditions BIT20 and BIT50, were found to have predicted essential reactions 
involved in carbohydrate metabolism (Figure 60). The test exposure condition POE50 was found to have 
the greatest number of reactions with 8 predicted as essential.  The essential reactions were compared and 
7 test conditions groupings were observed (Figure 64 and Table 42). A reaction involved in butanoate 
metabolism (rxn00988) was found to only be essential during exposure to POE20. Two 
glycolysis/gluconeogenesis/Entner-Doudoroff reactions (rxn00216 and rxn00786) and one alternate 
carbon metabolism reaction (rxn01492) had predicted essentiality with only the POE50 test condition. The 
essentialities of 5 reactions with functions in glycolysis/gluconeogenesis were predicted during exposure 
to BIT+POE (Table 42). Four of these pathways were also predicted to be involved in alternative Entner-
Doudoroff pathways. Two citrate (TCA) cycle reactions were identified with the LDOnly test condition 
(Table 42) and one of these reactions (rxn00265) was specifically an additional RW109 model reaction 
(Section 6.2.3). A leucine degradation reaction (rxn00290) was predicted to be essential during exposure 
to the test conditions POE20, POE50 and BIT+POE. Three pentose phosphate cycle reactions were 
identified in exposure to POE20, POE50, LDOnly and LD+BIT. The RW109_02629 gene involved in the 
phosphogluconate dehydratase reaction (rxn01477) was previously characterised in two transposon 
mutants that reduced their light emission in response to BIT (BIT negative) in Chapter 4 (Table 17). A 
common reaction found to be essential in the 5 test conditions was a glyoxylate and dicarboxylate 
metabolism reaction, which breaks down glycoaldehyde to glycolate (rAB00001); this reaction was 
associated with the same RW109_00559 aldA gene in all the conditions.  
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Figure 64. Grouping of the carbohydrate metabolism predicted essential reactions 
The Edwards-Venn diagram (A) represents the number of carbohydrate metabolism essential 
reactions (numbers in black) which either overlapped or were found only in the test conditions 
POE20(3) in purple, POE50(4) in red, BIT and POE(5) in green, LD Only(6) in orange and             
LD and BIT(7) in pink. The bar chart (B) is used to clearly show the numbers of essential 
reactions within each of the test conditions which are coloured the same as in A).  
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Table 42. Predicted essential reactions for the carbohydrate metabolism category for test conditions 3, 4, 5, 6 and 7 
Test exposure condition
Essential 
Reaction
Reaction name Reaction function Reaction formula EC number Essential genes
POE20(3) rxn00988 Acetoacetyl-CoAsynthetase Butanoate metabolism H+ + CoA + ATP + Acetoacetate  -> PPi + AMP + Acetoacetyl-CoA 6.2.1.16 RW109_04054
POE50(4)
rxn00216 Hexokinase (D-glucose:ATP) Glycolysis/Gluconeogenesis/Entner-Doudoroff Pathway ATP + D-Glucose  -> ADP + D-glucose-6-phosphate 2.7.1.1,2.7.1.2 RW109_02630
rxn00786 Fructose-bisphosphate aldolase Glycolysis/Gluconeogenesis
D-fructose-1,6-bisphosphate  <=> Glycerone-phosphate + Glyceraldehyde3-
phosphate 
4.1.2.13 RW109_01160
rxn01492 Fructose-1-phosphate kinase Alternate Carbon Metabolism ATP + D-fructose-1-phosphate  <=> ADP + D-fructose-1,6-bisphosphate 2.7.1.56 RW109_02259
BIT+POE(5)
rxn00459 Enolase Glycolysis/Gluconeogenesis/Entner-Doudoroff Pathway 2-Phospho-D-glycerate  <=> H2O + Phosphoenolpyruvate 4.2.1.11 RW109_04052
rxn00747 Triose-phosphate isomerase Glycolysis/Gluconeogenesis Glyceraldehyde3-phosphate  <=> Glycerone-phosphate 5.3.1.1 RW109_06336
rxn00781 Glyceraldehyde-3-phosphate dehydrogenase (NAD) Glycolysis/Gluconeogenesis/Entner-Doudoroff Pathway
NAD + Phosphate + Glyceraldehyde3-phosphate  <=> NADH + 1,3-
Bisphospho-D-glycerate 
1.2.1.12,1.2.1.13,1.2.1.59 RW109_02628
rxn01100 Phosphoglycerate kinase Glycolysis/Gluconeogenesis/Entner-Doudoroff Pathway H+ + ATP + 3-Phosphoglycerate  <=> ADP + 1,3-Bisphospho-D-glycerate 2.7.2.3 RW109_01157
LDOnly(6)
rxn00256 Citrate synthase Citrate cycle (TCA cycle) H+ + CoA + Citrate  <=> H2O + Acetyl-CoA + Oxaloacetate 2.3.3.1,2.3.3.3,4.1.3.7 RW109_05443
rxn00265
Citrate oxaloacetate-lyase (forming acetate from the 
pro-S carboxymethyl group of citrate)
Citrate cycle (TCA cycle) Citrate <=>  Acetate +  Oxaloacetate 4.1.3.6 RW109_00126
POE20(3) & POE50(4) & BIT+POE(5) rxn00290
3-oxoacid CoA-transferase (Succinyl-CoA: 
acetoacetate)
Leucine degradation Acetoacetate + Succinyl-CoA  <=> Acetoacetyl-CoA + Succinate 2.8.3.5 RW109_04052
POE20(3) & POE50(4) & LDOnly(6) & LD+BIT(7)
rxn01476 6-phosphogluconolactonase Pentose Phosphate Cycle/Entner-Doudoroff pathway H2O + 6-phospho-D-glucono-1-5-lactone  -> H+ + 6-Phospho-D-gluconate 3.1.1.31 RW109_02641
rxn01477 Phosphogluconate dehydratase Pentose Phosphate Cycle/Entner-Doudoroff pathway 6-Phospho-D-gluconate  -> H2O + 2-Keto-3-deoxy-6-phosphogluconate 4.2.1.12 RW109_02629
rxn03884 2-dehydro-3-deoxy-phosphogluconate aldolase Pentose Phosphate CycleEntner-Doudoroff Pathway
2-Keto-3-deoxy-6-phosphogluconate  <=> Pyruvate + Glyceraldehyde3-
phosphate 
4.1.2.14
RW109_02692(3), 
RW109_02642(4,6,7)
POE20(3) & POE50(4) & BIT+POE(5) & LDOnly(6) & LD+BIT(7) rAB00001 Glycoaldehyde:NAD+ oxidoreductase Glyoxylate and dicarboxylate metabolism Glycoaldehyde + NAD+ + H2O <=> Glycolate + NADH + H+ 1.2.1.21 RW109_00559
Footnotes:  
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.                             
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.    
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6.2.7.6 Predicted essential reactions involved in amino acid metabolism 
Numerous groupings of the essential reactions involved in amino acid metabolism were noted and hence 
the analysis was divided to compare the essential reactions between the test conditions: (i) BIT50(2), 
POE20(3), POE50(4) and BIT+POE(5) (Figure 65 and Table 43) and, (ii)  BIT50(2), LDOnly(6) and 
LD+BIT(7) (Figure 66 and Table 44). The test conditions 2, 3, 4 and 5 were analysed together as these 
conditions signified the preservatives BIT+POE individually and in combination; POE20 had the most 
essential reactions with 6 being predicted. The test conditions 2, 6 and 7 were examined collectively as 
these conditions represented the preservative BIT and laundry detergent separately and in combination 
with each other; LD+BIT resulted in the highest number of essential reactions with 5 predicted.   
When the predicated essential amino acid metabolism reactions for the test conditions BIT50, POE20, 
POE50 and BIT+POE were compared (Table 65 and Table 43), three reactions were identified only during 
POE20 exposure; 2 were involved in arginine putriscine and spermidine metabolism (rxn00405 and 
rxn00858) and one functioned in the biosynthesis of aromatic amino acids (rxn00727). An asparagine 
metabolism reaction (rxn00260) was only predicted essential in POE50. Two reactions were observed 
solely in the test condition BIT+POE; one had a function in the biosynthesis of aromatic amino acids 
(rxn01332) and the other was involved in glycine, serine and threonine metabolism (rxn08647) and was an 
additional reaction of the RW109 metabolic model (Section 6.2.3). Exposure to the test conditions POE20 
and POE50 resulted in the essentiality of another glycine, serine and threonine metabolism reaction 
rxn00692 and the test conditions BIT50, POE20 and BIT+POE all had predicted essentiality with an 
asparagine metabolism reaction (rxn00416). A 3-dehydroquinate dehydratase reaction (rxn02213) 
involved in the biosynthesis of aromatic amino acids was identified as an essential reaction with all the 
test exposure conditions in this comparison (Table 43).  
The predicted essential amino acid metabolism reactions were compared when RW109 was exposed to the 
BIT50, LDOnly and LD+BIT test conditions (Figure 66 and Table 44). A methionine metabolism reaction 
(rxn00141) was identified only with exposure to LDOnly and the essentialities of 2 threonine and lysine 
metabolism reactions (rxn01069 and rxn01302) were recognised with LD+BIT. The reaction involved in 
the biosynthesis of aromatic amino acids (rxn01332) was predicted as essential when RW109 was exposed 
to the test conditions LDOnly and LD+BIT. An additional biosynthesis of aromatic amino acids reaction 
(rxn02213) was also found to be essential for the all 3 test conditions BIT50, LDOnly and LD+BIT.   
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Figure 65. Grouping of the amino acid metabolism predicted essential reactions 
for test conditions 2, 3, 4 and 5 
The Edwards-Venn diagram (A) represents the number of amino acid metabolism essential 
reactions (numbers in black) which either overlapped or were found only in the test conditions 
BIT50(2) in blue, POE20(3) in purple, POE50(4) in red and BIT and POE(5) in green.                   
The bar chart (B) is used to clearly show the numbers of essential reactions within each of the 
test conditions which are coloured the same as in A).  
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Table 43. Predicted essential reactions for the amino acid metabolism category for test conditions 2, 3, 4 and 5 
Test exposure condition
Essential 
Reaction
Reaction name Reaction function Reaction formula EC number 
Essential 
genes
POE20(3)
rxn00405 Arginine decarboxylase Arginine Putriscine and Spermidine Metabolism H+ + L-Arginine  -> CO2 + Agmatine 4.1.1.19 RW109_06430
rxn00727 Anthranilate synthase Biosynthesis of aromatic amino acids
L-Glutamine + Chorismate -> H+ + L-Glutamate + Pyruvate + 
Anthranilate
4.1.3.27 RW109_01274
rxn00858 Agmatinase Arginine Putriscine and Spermidine Metabolism H2O + Agmatine  -> Urea + Putrescine 3.5.3.11 RW109_00885
POE50(4) rxn00260 Aspartate transaminase Asparagine metabolism 2-Oxoglutarate + L-Aspartate  <=> L-Glutamate + Oxaloacetate 2.6.1.1 RW109_06570
BIT+POE(5)
rxn01332 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase Biosynthesis of aromatic amino acids
H2O + Phosphoenolpyruvate + D-Erythrose4-phosphate  -> H+ + 
Phosphate + DAHP 
2.5.1.54,4.1.2.15 RW109_04409
rxn08647 ATP:(R)-glycerate 2-phosphotransferase Glycine, serine and threonine metabolism ATP +  Glycerate <=>  ADP +  H+ +  2-Phospho-D-glycerate 2.7.1.165 RW109_04751
POE20(3) & POE50(4) rxn00692 Glycine hydroxymethyltransferase Glycine, serine and threonine metabolism
H2O + Glycine + 5-10-Methylenetetrahydrofolate  <=> 
Tetrahydrofolate + L-Serine 
2.1.2.1 RW109_00291
BIT50(2) & POE20(3) & BIT+POE(5) rxn00416 Asparagine synthase (glutamine-hydrolysing) Asparagine metabolism
H2O + ATP + L-Glutamine + L-Aspartate  -> L-Glutamate + PPi + 
AMP + L-Asparagine 
6.3.5.4 RW109_03968
BIT50(2) & POE20(3) & POE50(4) & BIT+POE(5) rxn02213 3-dehydroquinate dehydratase Biosynthesis of aromatic amino acids 5-Dehydroquinate  -> H2O + 3-Dehydroshikimate 4.2.1.10 RW109_00842
Footnotes:  
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.                          
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.                             
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.    
CHAPTER 6 - Genome-scale metabolic network reconstruction of an industrial         
P. aeruginosa strain, RW109
261 
The Edwards-Venn diagram (A) represents the number of amino acid metabolism essential 
reactions (numbers in black) which either overlapped or were found only in the test 
conditions BIT50 (2) in blue, LD Only(6) in orange and LD and BIT(7) in pink. The bar 
chart (B) is used to clearly show the numbers of essential reactions within each of the test 
conditions which are coloured the same as in A).  
Figure 66. Grouping of the amino acid metabolism predicted essential reactions for test 
conditions 2, 6 and 7 
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Table 44. Predicted essential reactions for the amino acid metabolism category for test conditions 2, 6 and 7 
Test exposure condition
Essential 
Reaction
Reaction name Reaction function Reaction formula EC number Essential genes
LDOnly(6) rxn00141 Adenosylhomocysteinase Methionine Metabolism
H2O + S-Adenosyl-homocysteine  <=> Adenosine + 
Homocysteine 
3.3.1.1 RW109_02760
LD+BIT(7)
rxn01069 Threonine synthase Threonine and Lysine Metabolism
H2O + O-Phospho-L-homoserine  -> H+ + Phosphate + 
L-Threonine 
4.2.3.1,4.2.99.2 RW109_02080
rxn01302 Homoserine dehydrogenase (NADPH) Threonine and Lysine Metabolism
NADP + L-Homoserine  <=> H+ + L-Aspartate4-
semialdehyde + NADPH 
1.1.1.3 RW109_02079
LDOnly(6) & LD+BIT(7) rxn01332 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase Biosynthesis of aromatic amino acids
H2O + Phosphoenolpyruvate + D-Erythrose4-
phosphate  -> H+ + Phosphate + DAHP 
2.5.1.54,4.1.2.15 RW109_03043 (6,7) 
BIT50(2) & LDOnly(6) & LD+BIT(7)
rxn00416 Asparagine synthase (glutamine-hydrolysing) Asparagine metabolism
H2O + ATP + L-Glutamine + L-Aspartate  -> L-
Glutamate + PPi + AMP + L-Asparagine 
6.3.5.4
RW109_03968 (2,6)
RW109_02340 (7)
rxn02213 3-dehydroquinate dehydratase Biosynthesis of aromatic amino acids 5-Dehydroquinate  -> H2O + 3-Dehydroshikimate 4.2.1.10
RW109_00842 (2,6)
RW109_06438 (7)
Footnotes: 
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.
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6.2.7.7 Predicted essential reactions involved in metabolism of cofactors and vitamins 
Six reactions were predicted to be essential in the metabolism of cofactors and vitamins KEGG functional 
category with no reactions being associated with only one test exposure condition (Table 45). The test 
exposure conditions BIT+POE and LD+BIT had the highest numbers of essential reactions with 6 
predicted for each. The coproporphyrinogen oxidase reaction (rxn02303) involved in tetrapyrrole 
biosynthesis was predicted as essential in all test exposure conditions except for BIT20. Two reactions 
involved in one carbon metabolism, termed as methylene-tetrahydrofolate dehydrogenase (NADP) 
(rxn00907) and methenyltetrahydrofolate cyclohydrolase (rxn01211) were predicted as essential in the test 
conditions POE50, BIT+POE, LDOnly and LD+BIT.  
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Table 45. Predicted essential reactions for the metabolism of cofactors and vitamins KEGG functional category 
Test exposure condition
Essential 
Reaction
Reaction name Reaction function Reaction formula EC number Essential genes
POE50(4) & BIT+POE(5) & LDOnly(6) & LD+BIT(7)
rxn00907 Methylenetetrahydrofolate dehydrogenase (NADP) One Carbon Metabolism
NADP + 5-10-Methylenetetrahydrofolate  <=> NADPH + 5-10-
Methenyltetrahydrofolate 
1.5.1.5
RW109_00468 (4,5)
RW109_04361 (6,7)
rxn01211 Methenyltetrahydrofolate cyclohydrolase One Carbon Metabolism
H2O + 5-10-Methenyltetrahydrofolate  <=> H+ + 10-
Formyltetrahydrofolate 
3.5.4.9,6.3.4.3
RW109_00468 (4,5)
RW109_04361 (6,7)
rxn03841 4-aminobenzoate synthase Folate Metabolism ADC  -> H+ + Pyruvate + ABEE 4.1.3.38
RW109_02038 (4,5)
RW109_02918 (6,7)
POE20(3) & BIT+POE(5) & LD+BIT(7) rxn01629 Glutamate-1-semialdehyde aminotransferase Tetrapyrrole Biosynthesis 5-Aminolevulinate  <=> L-Glutamate1-semialdehyde 5.4.3.8
RW109_07141 (3)
RW109_01591 (5,7)
POE20(3) & POE50(4) & BIT+POE(5) & LDOnly(6) & LD+BIT(7) rxn00299 GTP cyclohydrolase I Folate Metabolism
H2O + GTP  -> H+ + 7,8-Dihydroneopterin 3'-triphosphate + 
Formate 
3.5.4.16
RW109_02362(3,4,7)
RW109_04487 (5,6)
BIT50(2) & POE20(3) & POE50(4) & BIT+POE(5) & LDOnly(6) & LD+BIT(7) rxn02303 Coproporphyrinogen oxidase Tetrapyrrole Biosynthesis
O2 + 2 H+ + CoproporphyrinogenIII  -> 2 H2O + 2 CO2 + 
ProtoporphyrinogenIX 
1.3.3.3 RW109_00614
Footnotes: 
1) The test exposure conditions in column 1 are indicated by their abbreviation and test condition number e.g. POE20(3) is test condition 3: POE at 20% of the MIC.
2) The genes in the last column without numbers in brackets demonstrate a gene which was essential in all the test conditions within the corresponding row in column 1.
3) The numbers in brackets next to the genes in the last column indicates the test exposure condition where the gene was identified as essential.
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6.2.7.8 Predicted essential reactions involved in fatty acid metabolism and energy 
metabolism 
Limited essential reactions were found within the KEGG functional categories for fatty acid metabolism 
and energy metabolism. One essential reaction was identified in the fatty acid metabolism category which 
involved the was Enoyl-[acyl-carrier-protein] reductase (NADH) enzyme (rxn08398) and it was predicted 
to be essential for the 3 test exposure conditions POE50(4), LDOnly(6) and LD+BIT(7). In the energy 
metabolism functional category, the carbonic acid hydrolase reaction (rxn00102) was found to be essential 
in only the test condition BIT+POE(5).  
6.2.8 Comparison of the predicted essential reactions between POE20 and POE50 
The reactions predicted to be essential were examined when RW109 was exposed to the test conditions 
POE20 and POE50 (Figure 67 and Table 46). The essentialities of 29 reactions were predicted in both 
POE20 and POE50 and out of these 9 were found to be involved in nucleotide metabolism. When exposed 
to POE20 a notable observation were the 6 benzoate degradation reactions predicted to be essential, which 
were not identified with POE50. A higher number of lipid metabolism reactions involved in fatty acid and 
glycerolipid metabolism were identified with POE50 and a greater number of membrane transport 
reactions. This illustrates the differences in the essentiality of reactions during exposure to the same 
preservative at different concentrations.  
 Figure 67. Comparison of the predicted essential reactions between POE20 and POE50 
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Table 46.  Predicted essential reactions when RW109 was exposed to POE20 and POE50 
Exposure
condition(s)
Essential reaction Reaction name Reaction function KEGG functional category
Both POE20 
and POE50
rxn00692 Glycine hydroxymethyltransferase Glycine, serine and threonine metabolism Amino acid metabolism
rxn02213 3-dehydroquinate dehydratase Phenylalanine, tyrosine and tryptophan biosynthesis Amino acid metabolism
rAB00001 Glycoaldehyde:NAD+ oxidoreductase Glyoxylate and dicarboxylate metabolism Carbohydrate metabolism
rxn00290 3-oxoacid CoA-transferase (Succinyl-CoA: acetoacetate) Butanoate metabolism Carbohydrate metabolism
rxn01476 6-phosphogluconolactonase Pentose phosphate pathway Carbohydrate metabolism
rxn01477 Phosphogluconate dehydratase Pentose phosphate pathway Carbohydrate metabolism
rxn03884 2-dehydro-3-deoxy-phosphogluconate aldolase Pentose phosphate pathway Carbohydrate metabolism
rPY00183 Cardiolipin synthase (n-C18:0 18:1) Glycerophospholipid metabolism Lipid metabolism
rPY00184 Cardiolipin synthase (n-C16:0 16:1) Glycerophospholipid metabolism Lipid metabolism
rxn08229 Cardiolipin synthase (n-C16:0) Glycerophospholipid metabolism Lipid metabolism
rxn08230 Cardiolipin synthase (n-C16:1) Glycerophospholipid metabolism Lipid metabolism
rxn08231 Cardiolipin synthase (n-C18:0) Glycerophospholipid metabolism Lipid metabolism
rxn08232 Cardiolipin synthase (n-C18:1) Glycerophospholipid metabolism Lipid metabolism
rxn05164 L-histidine transport via ABC system Transport Membrane transport
rxn05165 L-proline transport via ABC system Transport Membrane transport
rxn05169 L-threonine transport via ABC system Transport Membrane transport
rxn05219 L-methionine transport via ABC system Transport Membrane transport
rxn09653 Urea reversible transport via proton symport (2 H+) Transport Membrane transport
rxn00299 GTP cyclohydrolase I Folate biosynthesis Metabolism of cofactors and vitamins
rxn02303 Coproporphyrinogen oxidase Porphyrin and chlorophyll metabolism Metabolism of cofactors and vitamins
rxn00364 Cytidylate kinase (CMP) Pyrimidine metabolism Nucleotide metabolism
rxn00409 Nucleoside-diphosphate kinase (ATP:CDP) Pyrimidine metabolism Nucleotide metabolism
rxn00839 Nucleoside-diphosphate kinase (ATP:dADP) Purine metabolism Nucleotide metabolism
rxn00917 GMP synthase (glutamine-hydrolysing) Purine metabolism Nucleotide metabolism
rxn01353 Nucleoside-diphosphate kinase (ATP:dGDP) Purine metabolism Nucleotide metabolism
rxn01673 Nucleoside-diphosphate kinase (ATP:dCDP) Pyrimidine metabolism Nucleotide metabolism
rxn05816 Deoxyadenosine 5'-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) Purine metabolism Nucleotide metabolism
rxn05817 Deoxyguanosine 5'-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) Purine metabolism Nucleotide metabolism
rxn05818 Deoxycytidine triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) Pyrimidine metabolism Nucleotide metabolism
POE20 Only
rxn00405 Arginine decarboxylase Arginine and proline metabolism Amino acid metabolism
rxn00416 Asparagine synthase (glutamine-hydrolysing) Alanine, aspartate and glutamate metabolism Amino acid metabolism
rxn00727 Anthranilate synthase Phenylalanine, tyrosine and tryptophan biosynthesis Amino acid metabolism
rxn00858 Agmatinase Arginine and proline metabolism Amino acid metabolism
rxn00988 Acetoacetyl-CoAsynthetase Butanoate metabolism Carbohydrate metabolism
rxn00763 Alcohol dehydrogenase (glycerol) Glycerolipid metabolism Lipid metabolism
rxn05306 L-phenylalanine transport in/out via proton symport Transport Membrane transport
rxn10963 FeoB iron (II) transporter Transport Membrane transport
rxn01629 Glutamate-1-semialdehyde aminotransferase Porphyrin and chlorophyll metabolism Metabolism of cofactors and vitamins
rxn00598 3-oxoadipyl-CoA thiolase Benzoate degradation Xenobiotics biodegradation and metabolism
rxn00962 4-hydroxybenzoate 3-monooxygenase Benzoate degradation Xenobiotics biodegradation and metabolism
rxn01192 Protocatechuate 3,4-dioxygenase Benzoate degradation Xenobiotics biodegradation and metabolism
rxn02143 3-oxoadipate CoA-transferase Benzoate degradation Xenobiotics biodegradation and metabolism
rxn02144 3-oxoadipate enol-lactonase Benzoate degradation Xenobiotics biodegradation and metabolism
rxn02369 3-carboxy-cis,cis-muconate cycloisomerase Benzoate degradation Xenobiotics biodegradation and metabolism
rxn02483 4-carboxymuconolactone decarboxylase Benzoate degradation Xenobiotics biodegradation and metabolism
POE50 Only
rxn00260 Aspartate transaminase Alanine, aspartate and glutamate metabolism Amino acid metabolism
rxn00216 Hexokinase (D-glucose:ATP) Glycolysis / Gluconeogenesis Carbohydrate metabolism
rxn00786 Fructose-bisphosphate aldolase Glycolysis / Gluconeogenesis Carbohydrate metabolism
rxn01492 Fructose-1-phosphate kinase Fructose and mannose metabolism Carbohydrate metabolism
rxn08398 Fnoyl-[acyl-carrier-protein] reductase (NADH) (n-C18:1) Fatty acid metabolism Fatty acid metabolism
rPY00162 PA160161S Fatty acid biosynthesis Lipid metabolism
rPY00163 CDP-diacylglycerol synthetase (n-C16:0 16:1) Fatty acid biosynthesis Lipid metabolism
rPY00167 PA180181S Fatty acid biosynthesis Lipid metabolism
rPY00168 CDP-diacylglycerol synthetase (n-C18:0 18:1) Fatty acid biosynthesis Lipid metabolism
rxn08087 1-hexadec-7-enoyl-sn-glycerol 3-phosphate O-acyltransferase (n-C161) Glycerolipid metabolism Lipid metabolism
rxn08089 1-octadec-7-enoyl-sn-glycerol 3-phosphate O-acyltransferase (n-C181) Glycerolipid metabolism Lipid metabolism
rxn08310 CDP-diacylglycerol synthetase (n-C161) Glycerolipid metabolism Lipid metabolism
rxn08311 CDP-diacylglycerol synthetase (n-C180) Glycerolipid metabolism Lipid metabolism
rxn08312 CDP-diacylglycerol synthetase (n-C181) Glycerolipid metabolism Lipid metabolism
rJB00225 D-Fructose transport via PEP:Pyr PTS Transport Membrane transport
rxn05151 L-lysine transport via ABC system Transport Membrane transport
rxn05161 L-leucine transport via ABC system Transport Membrane transport
rxn05168 L-valine transport via ABC system Transport Membrane transport
rxn05179 L-isoleucine transport via ABC system Transport Membrane transport
rxn05560 D-fructose transport via PEP:Pyr PTS Transport Membrane transport
rxn05663 L-tryptophan transport in via proton symport Transport Membrane transport
rxn00907 Methylenetetrahydrofolate dehydrogenase (NADP) One carbon pool by folate Metabolism of cofactors and vitamins
rxn01211 Methenyltetrahydrofolate cyclohydrolase One carbon pool by folate Metabolism of cofactors and vitamins
rxn03841 4-aminobenzoate synthase Folate biosynthesis Metabolism of cofactors and vitamins
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6.2.9 Linking up-regulated genes with those predicted as essential   
A number of essential genes from each constrained model (except for BIT20) were also significantly up-
regulated when exposed to the test condition in which they were predicted to be essential (Table 47). 
LDOnly had the greatest number of predicted essential up-regulated genes with 10 and BIT50 had the 
least with 1. A few genes were found to be up-regulated in more than one condition. The RW109_00614 
was identified in BIT50, LDOnly and LD+BIT and encoded for a coproporphyrinogen oxidase involved in 
the rxn02303 reaction. In POE20, POE50 and BIT+POE the RW109_04052 gene encoding a 3-oxoacid 
CoA-transferase (Succinyl-CoA: acetoacetate) increased in expression and) was involved in the rxn00290 
reaction. The RW109_02629 and RW109_02642 genes, both involved in alternative pentose phosphate 
pathways, were significantly up-regulated in POE50, LDOnly and LD+BIT. The essential RW109_04051 
gene associated with the benzoate degradation rxn02143 reaction in POE20 and BIT+POE was 
significantly up-regulated when exposed to these test conditions. In LD and LD+BIT the RW109_01980 
gene (encoding a nucleoside-diphosphate kinase [Ndk] enzyme) was significantly up-regulated but was 
associated with different essential reactions in the two exposure conditions; it was linked to rxn00839 in 
LDOnly and rxn00409 in LD+BIT. This was also true for the RW109_05296 gene, which had up-
regulated expression in these two, conditions; in LDOnly it was linked to the essential L-histidine 
transport reaction rxn05164 and was associated with the rxn05154 L-arginine transport reaction in 
LD+BIT.  
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Table 47. Significantly up-regulated essential genes for each preservative exposure condition  
Test exposure 
condition
Essential 
gene
Essential Reaction Reaction name Reaction function
Log2Fold 
Change
Adjusted         
P-Value
BIT50
RW109_00614 rxn02303 coproporphyrinogen oxidase Porphyrin and chlorophyll metabolism 1.6 0.009454
POE20
RW109_04052 rxn00290 3-oxoacid CoA-transferase (Succinyl-CoA: acetoacetate) Butanoate metabolism 3.5 6.64E-16
RW109_04051 rxn02143 3-oxoadipate CoA-transferase Benzoate degradation 3.7 3.67E-10
POE50
RW109_04052 rxn00290 3-oxoacid CoA-transferase (Succinyl-CoA: acetoacetate) Butanoate metabolism 2.9 2.16E-10
RW109_02629 rxn01477 phosphogluconate dehydratase Pentose phosphate pathway/Entner-Doudoroff pathway 3.3 2.58E-20
RW109_02630 rxn00216 hexokinase (D-glucose:ATP) Glycolysis / Gluconeogenesis/Entner-Doudoroff pathway 2.0 0.027894
RW109_02259 rxn01492 and rJB00225 fructose-1-phosphate kinase and D-Fructose transport via PEP Fructose and mannose metabolism and Membrane transport 2.7 0.040176
RW109_02642 rxn03884 2-dehydro-3-deoxy-phosphogluconate aldolase Pentose phosphate pathway/Entner-Doudoroff pathway 2.9 0.0000884
RW109_02258 rxn01492 and rxn0556 fructose-1-phosphate kinase and D-Fructose transport via PEP Fructose and mannose metabolism/Membrane transport 3.0 0.000165
BIT+POE
RW109_04052 rxn00290 3-oxoacid CoA-transferase (Succinyl-CoA: acetoacetate) Butanoate metabolism 3.4 1.33E-18
RW109_04051 rxn02143 3-oxoadipate CoA-transferase Benzoate degradation 4.0 3.35E-14
RW109_00825 rxn00917 GMP synthase (glutamine-hydrolysing) Purine metabolism 1.8 0.046409
LDOnly 
RW109_05695 rxn10963 FeoB iron (II) transporter Membrane transport 2.1 1.23E-15
RW109_00614 rxn02303 coproporphyrinogen oxidase Porphyrin and chlorophyll metabolism 2.8 7.3E-09
RW109_01980 rxn00839 nucleoside-diphosphate kinase (ATP:dADP) Purine metabolism 1.7 4.42E-12
RW109_02641 rxn01476 6-phosphogluconolactonase Pentose phosphate pathway/Entner-Doudoroff pathway 4.1 0.000044
RW109_02629 rxn01477 phosphogluconate dehydratase Pentose phosphate pathway/Entner-Doudoroff pathway 2.8 1.02E-18
RW109_02642 rxn03884 2-dehydro-3-deoxy-phosphogluconate aldolase Pentose phosphate pathway/Entner-Doudoroff pathway 4.2 2.31E-13
RW109_05296 rxn05164 L-histidine transport via ABC system Membrane transport 1.7 0.005361
RW109_05105 rxn05169 L-threonine transport via ABC system Membrane transport 2.2 0.038819
RW109_05106 rxn05170 L-threonine transport via ABC system Membrane transport 1.6 0.001321
RW109_05107 rxn05171 L-threonine transport via ABC system Membrane transport 1.5 0.000215
LD+BIT
RW109_00614 rxn02303 coproporphyrinogen oxidase Porphyrin and chlorophyll metabolism 2.9 7.97E-09
RW109_01980 rxn00409 nucleoside-diphosphate kinase (ATP:CDP) Pyrimidine metabolism 1.9 1.6E-18
RW109_02641 rxn01476 6-phosphogluconolactonase Pentose phosphate pathway/Entner-Doudoroff pathway 4.7 0.00000223
RW109_02629 rxn01477 phosphogluconate dehydratase Pentose phosphate pathway/Entner-Doudoroff pathway 3.2 8.17E-27
RW109_02660 rxn00364 cytidylate kinase (CMP) Pyrimidine metabolism 2.5 0.000458
RW109_02642 Rxn03884 2-dehydro-3-deoxy-phosphogluconate aldolase Pentose phosphate pathway/Entner-Doudoroff pathway 4.4 4.42E-16
RW109_05296 rxn05154 L-arginine transport via ABC system MembraneTransport 2.0 0.000298
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6.2.10  Additional modelling work 
6.2.10.1 Finding an alternative pathway in RW109 for the essential rxn00770 reaction 
A pathway encoding the essential reaction rxn00770 (identified in Section 6.2.5) involved in purine 
biosynthesis was not identified in RW109 using the standard computational modelling approaches as 
previously described. Putative genes and pathways that may encode this reaction were subsequently 
investigated as follows. Further searching on the KEGG database identified a P. aeruginosa R06836 
reaction specific to the PAO1 strain, which uses the ATP: ribose-1, 5-bisphosphate phosphotransferase 
enzyme; this reaction was found to the produce 5-Phospho-alpha-D-ribose1-diphosphate which was the 
same product of the essential rxn00770 reaction (Section 6.2.5). A BLASTp comparison of the PAO1 
gene associated with this reaction was carried out against the RW109 genome and a match was identified 
with the RW109_02429 gene (percentage identity= 99.46%, E-Value: 3.00e-130, BIT-Score = 365). This 
indicates that RW109 may use the R06836 reaction as an alternative for producing 5-Phospho-alpha-D-
ribose1-diphosphate instead of rxn00770. This R06836 reaction was identified after the simulation and 
transcriptomic integration work described to this point and hence was not included in the latter analysis.    
6.2.10.2 Growth of RW109 on various carbon sources 
The industrial sponsors carried out preliminary growth of the RW109 strain on various carbon sources 
using BIOLOG phenotype microarrays with the MicroPlates PM1 and PM2a (data not shown). The plates 
were inoculated with approximately 106 cfu/ml of an overnight culture and turbidity was read using the 
OmniLog® ID System (BIOLOG) at 30°C for 48 hours; this was carried out in triplicate. The industrial 
sponsors report the carbon utilisation results for the RW109 strain were consistent with those obtained 
with the PA14 strain (Bartell et al., 2017). 
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6.3 Discussion 
6.3.1 The outcomes of reconstructing a genome-scale metabolic model specific to an industrial                    
P. aeruginosa strain and the key characteristics of RW109  
In this project an existing PA14 genome-scale metabolic reconstruction (Bartell et al., 2017) was curated 
to represent the P. aeruginosa RW109 strain, enabling an extended understanding of the metabolic 
functionality of the industrial strain. It also provided a basis to simulate the essentiality of reactions during 
exposure to industrial conditions. The PA14 model was published in 2017 after a great deal of curation 
and validation using previous P. aeruginosa PAO1 metabolic models (iMO1056 (Oberhardt et al., 2008) 
and iMO1086 (Oberhardt et al., 2011), genome sequences, carbon source utilisation results and gene 
essentiality data sets (Bartell et al., 2017). Core genome alignment analysis had identified the large 
genome of the industrial RW109 strain as not being closely related to the PA14 strain (Chapter 3, Section 
3.2.6.2, Figure 18), but as a basis to build an initial network, the PA14 model provided comprehensive and 
up-to-date information of the biochemical networks for P. aeruginosa. The limited differences in COG 
and KEGG annotations between the PA14 and RW109 strains (Chapter 3, Section 3.2.6.1) also indicated 
the PA14 model as a suitable base for the reconstruction of the industrial metabolic model.  
Obtaining a complete well-annotated whole-genome for the RW109 strain was highly beneficial for 
accurate comparison of the PA14 model genes and for the assigning of additional model reactions using 
modelSEED and KEGG databases. The modelSEED is an informative resource regularly used for 
metabolic modelling providing a comprehensive database of experimentally and literature validated 
balanced reactions and metabolites (Henry et al., 2010, Devoid et al., 2013). The KEGG database offers a 
wide-ranging collection of pathway maps and biological functional annotations which are updated on a 
regular basis (Kanehisa et al., 2017, Thiele and Palsson, 2010). KEGG pathways are also referenced 
within the modelSEED (Bartell et al., 2017). The use of these resources during the RW109 model 
reconstruction along with the whole genome sequence provided a reliable method to establish reactions. 
There are a number of other databases available for genome-scale metabolic modelling which include 
Metacyc (Caspi et al., 2007) and Reactome (Fabregat et al., 2015) which again offer large sets of reactions 
and pathways and could be used to further expand and justify the reactions within the industrial model. 
However, because of the complexity of the analysis, these were not applied to RW109. 
Throughout this chapter, the COBRA tool box (Schellenberger et al., 2011) was used to perform FBA 
simulations. One major assumption of this analysis was the implementation of a well-defined objective 
function for accurate predictions of metabolic capabilities.  The RW109 biomass reaction was set as the 
objective function throughout this study to serve as an approximation of growth. The process of making 
the reaction specific to the industrial strain involved updating the PA14 model biomass which had 
previously been expanded to accurately represent the P. aeruginosa species (Bartell et al., 2017). Once 
converted into a COBRA model within MATLAB, the RW109 model was able to produce biomass and an 
optimal flux balance analysis solution was found, enabling further analysis to be carried out.  
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The PA14 model genes, which did not match with any in RW109, were removed using the COBRA 
toolbox and five non-essential reactions were deleted from the model (Figure 57). Four of these non-
essential reactions functioned in glycan biosynthesis and metabolism, specifically in lipopolysaccharide 
(LPS) biosynthesis of B and O band antigens. P. aeruginosa is associated with a wide-range of genes 
involved in the biosynthesis of LPS (King et al., 2009, Lam et al., 2011). This suggests an alternative 
pathway is used by the RW109 strain when compared to PA14, which is supported by the numerous 
alternative LPS associated reactions remaining within the RW109 model. A lipid-associated reaction was 
also removed which had a function in glycerophospholipid metabolism, and again a variety of similar 
reactions were kept in the industrial strain model. Comparisons between P. aeruginosa isolates have also 
identified differences between strain-specific genes which have related functions but divergent DNA 
sequences, such as those encoding for lipopolysaccharide O antigens (Spencer et al., 2003, Lee et al., 
2006a).   
The KEGG functional annotations of the 1,656 reactions of the RW109 model revealed the wide-ranging 
metabolic capabilities of the industrial strain suggesting it can adapt to survive in a variety of different 
environments. The ability of bacteria to grow quickly and persist in adverse environments has been linked 
to metabolic flexibility with the development of an 'environmental scope index' (ESI) score which is 
defined as the fraction of environments in which the strain is viable (Freilich et al., 2009). P. aeruginosa 
had a high ESI score highlighting its ability to proliferate and thrive in a diverse range of environments 
(Freilich et al., 2009). Reactions involved in lipid metabolism, transport and amino acid metabolism 
represented the highest numbers in the RW109 model which was also observed in the PA14 model 
(Bartell et al., 2017). This also suggests the reactions characterised with these functional categories are 
prominent in the overall lifestyle of P. aeruginosa.  
The RW109 metabolic model had 166 additional reactions when compared to PA14, and these represented 
15 KEGG functional categories highlighting the surplus wide-ranging metabolic capabilities of the 
RW109 strain. The xenobiotics biodegradation and metabolism functional category characterised the 
highest number of these additional reactions with the majority being linked to genes on the large plasmid 
1. The RW109 plasmid 1 was 555 kb in size and provided the RW109 strain with more additional genes
when compared to the smaller plasmid 2, which was 152 kb (Chapter 3). Xenobiotics are defined as un-
natural compounds released into an environment (Van Der Meer et al., 1992, Top and Springael, 2003) 
and HPC products are man-made un-natural environments for bacteria. The occasional growth and 
survival of bacteria within HPCs may be attributed to the ability to metabolise and degrade compounds 
found in these industrial products. Bacteria are used in bioremediation to degrade harmful chemicals 
accidently released into the environment (Das and Chandran, 2010) and P. aeruginosa strains have been 
shown to breakdown crude oil and petroleum hydrocarbons (Song et al., 2006, Pasumarthi et al., 2013). 
Within the xenobiotic functional category the reactions were mainly linked to genes from plasmid 1, 
suggesting it may play a role in the ability of RW019 to survive in harsh environments containing toxic 
hydrocarbons. The metabolism of xenobiotics by the cytochrome P450 sub-category represented 60% of 
the additional reactions within the xenobiotic functional group (Figure 56). A P. aeruginosa strain isolated 
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from oil contaminated soil was found to obtain two P450 monooxygenase enzymes which had an 
important role in the ability of the strain to degrade hydrocarbons (Liu et al., 2012). This suggests the 
cytochrome P450 enzymes have a principal function in the ability of P. aeruginosa to survive in harsh and 
un-natural environments. Cytochrome P450 enzymes also function in the detoxification of un-natural 
substances (Cerniglia, 1993, Wang and Shao, 2013) and may also play a role in the degradation of 
compounds encountered by P. aeruginosa in HPC products.   
Amino acid metabolism represented the second largest number of additional RW109 model reactions with 
43% characterised within the glycine, serine and threonine metabolism subcategory (Figure 56). This 
amino acid metabolic pathway has been associated with biofilm formation in P. aeruginosa (Vital-Lopez 
et al., 2015). Metabolites of the glycine, serine, and threonine metabolism pathways were frequently 
depleted when a genome-scale kinetic model was used to measure metabolites during biofilm associated 
reactions (Vital-Lopez et al., 2015). RW109 has an increased number of reactions within this amino acid 
metabolic subcategory, suggesting the RW109 strain has the potential for an elevated survival during 
biofilm formation. This could be evaluated experimentally by comparing the ability of the RW109 and 
PA14 strains to establish biofilms. 
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6.3.2 Important points to consider when using the RW109 model reconstruction for 
computational predictions of biological functionality  
A principal issue concerning the industrial P. aeruginosa model was the number of associated model 
genes, which only represented 18.2% of the total RW109 genome coding capacity.  The significance of 
the >80% of genes not included in the model would be overlooked during analysis and the likelihood of 
the model missing strain specific reactions would be high. Therefore, any model simulations should be 
considered as approximations of the full potential of the RW109 strain. However, as a first-look, the 
predictions provide valuable insights into the biological functionality of an industrial P. aeruginosa strain. 
They were useful in highlighting genes and reactions of interest for experimental validation in further 
investigations, such as those encoding cell membrane phospholipid biosynthesis reactions. The RW109 
model is also representative of the wide-ranging metabolic capabilities of P. aeruginosa as the reactions 
annotations are divided throughout a number of KEGG biological functional categories.  
Gene essentiality predictions carried out using the PA14 model were found to be 91% accurate when 
compared to in vitro essentiality experiments (Bartell et al., 2017). In correlation with the RW109, the 
PA14 model also only represents a small percentage of the genes (18.9%) within its own genome, 
highlighting a modelling dilemma in the applicability of these research techniques when bacteria obtain 
versatile genomes. Since the RW109 model reconstruction was based on the PA14 model, the accuracy of 
the gene and reaction essentiality predictions should be high, however there is a requirement for further 
validation of fundamental pathways using mutagenesis in vitro experimentation.  
Preliminary carbon source utilisation data for the RW109 strain, obtained from the industrial sponsors, 
was found to be comparable to PA14 (data not shown). This supports the inclusion of the PA14 reactions 
within the industrial strain model, however further work using carbon source utilisation is required to 
validate the addition of each RW109 metabolic reaction. Overall, this study presents a first, outline version 
of a P. aeruginosa model for an industrial strain. Further refinement should include gap-filling of reaction 
networks, examining the balancing of reactions, identifying any dead-end metabolites and minimal media 
simulations together with flux variability analysis as recommended by (Henry et al., 2010), (Thiele and 
Palsson, 2010, Opdam et al., 2017).  
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6.3.3 The successful integration of gene expression data to produce models specific to industry 
related conditions  
The transcriptomic data obtained from P. aeruginosa preservative exposure experiments (Chapter 5) was 
successfully integrated into the RW109 metabolic model using the MADE algorithm (Jensen and Papin, 
2011). Various methods for the integration of expression data are available, but MADE is advantageous as 
it does not rely on user-specified threshold values but focuses on the statistical significance of fold 
changes (Blazier and Papin, 2012, Jensen and Papin, 2011). Other methods which utilise constraint-based 
FBA methods to integrate gene expression data include but are not limited to, the Gene Inactivity 
Moderated by Metabolism and Expression (GIMME) algorithm (Becker and Palsson, 2008), the 
Integrative Metabolic Analysis Tool (iMAT) (Shlomi et al., 2008) and E-FLUX (Colijn et al., 2009). 
These three methods require the user to decide on a threshold for differentially regulated gene expression 
when compared to the MADE algorithm. The availability of multiple datasets for successful integration is 
required by the MADE algorithm (Jensen and Papin, 2011); this was not an issue in this project as the 
log2-fold changes for 7 test exposure conditions compared to a control condition were available. To 
validate the results of this study, the gene expression data could be integrated using one of the indicated 
alternative methods and gene and reaction essentiality results compared. A similar computational pipeline 
to the one followed in this study was also used in a recent investigation into the metabolic network for the 
malaria Plasmodium falciparum parasite (Carey et al., 2017). Transcriptomic data was integrated using the 
MADE algorithm and gene and reaction essentiality predictions used to detect unique pathways in the 
resistant and sensitive parasite phenotypes to identify candidate drug targets (Carey et al., 2017).                                                       
Essential genes and reactions are required to maintain vital functions when bacteria are exposed to 
different environmental conditions (Liu et al., 2010, Zhang and Lin, 2008, Conesa et al., 2016, 
Schellenberger et al., 2011). Those identified are also considered promising targets for the development of 
novel targeted antimicrobials due to their importance in bacterial survival (Juhas et al., 2012). This study 
predicted the essentiality of shared and unique reactions for seven industrial exposure conditions (Figure 
60). Out of all the industry relevant conditions, exposure to POE at 50% of the MIC resulted in the 
greatest number reactions predicted to be essential (n = 53). This suggests the preservative at this 
concentration had a more substantial effect on RW109. This test exposure condition did not however 
result in the largest percentage of DEGs in relation to the whole genome size (Chapter 5, Table 21). 
11.78% of the RW109 genes were differentially regulated in response to POE at 50% of the MIC whereas 
17.31% and 20.36% of RW109 genes had altered expression in response to LD Only and LD with BIT, 
respectively. After the expression data integration, the POE50 model had the least number of functional 
genes compared to the other exposure conditions (Table 36). This infers that a higher number of genes 
were considered inactive by the MADE algorithm, increasing the likelihood of the remaining functioning 
genes being predicted as essential when RW109 was exposed to POE at 50% of the MIC. BIT20 and 
BIT50 had the least number of predicted essential reactions with 1 and 10 respectively; this is consistent 
with the gene expression data where 0.03% and 1.55% of RW109 genes were differentially regulated in 
response to BIT at 20% and 50% of the MIC, respectively. This signifies the preservative BIT at these 
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concentrations had a limited effect on the RW109 strain. The growth dynamic analysis of RW109 in the 
presence of these test conditions supports these findings (Chapter 5, Figure 43). POE50 exposure after 24 
hours resulted in the greatest reductions in culture optical density and viable cell counts when compared to 
the control condition, whereas BIT20 and BIT50 demonstrated minimal differences.  
Overall, the modelling and gene expression integration suggests that POE at 50% of the MIC was more 
difficult for RW109 to grow in when compared to the other test conditions, resulting in the occurrence of 
more predicted essential genes and reactions in order to grow. The limited biological functional diversity 
of reactions predicted to be essential with BIT also suggests this preservative potentially has a more 
specific mode of action when compared to POE. The BIT20 essential reaction was involved in membrane 
transport and the BIT50 reactions had functions in amino acid metabolism, membrane transport, 
metabolism of cofactors and vitamins and nucleotide metabolism (Figure 60). There were also no essential 
reactions unique to the exposure of RW109 with BIT at both 20% and 50% of the MIC, as the predicted 
reactions were also identified with other exposure conditions. Overall, this indicates that fewer alterations 
in metabolism were required by RW109 when it was exposed to BIT.  
Interestingly, a few genes predicted as essential for survival in a test condition, were also identified as 
significantly up-regulated during exposure to that same condition (Table 47). LD only had the greatest 
number of predicted essential genes, which also had increased expression, and half of these were linked to 
reactions involved in membrane transport pathways (Table 47). This association suggests that under 
certain conditions, there might be a benefit to increasing the expression of a gene, which encodes for a 
vital enzyme/protein in a reaction essential for survival. These identified genes are of interest as potential 
targets due to their predicted essentiality and the evidence of their utilisation as recognised by the up-
regulation during exposure to the industry relevant conditions. This observation also demonstrates how 
transcriptomic profiling techniques alone may overlook the importance of essential genes in response to a 
particular condition. Not all predicted essential genes were identified as significantly up-regulated, 
suggesting the association is only relevant with certain gene types. The observed link could also be an 
increased likelihood of a gene, which is up-regulated also being predicted as essential, due to the fewer 
genes within the constrained MADE models. 
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6.3.4 The key predicted essential reactions and their potential function in the ability of  RW109 
to survive exposure to industry relevant conditions 
A large number of POE50 predicted essential reactions were found within the lipid metabolism category, 
and of these, five reactions were specifically associated with CDP-DAG-synthetase cell membrane 
phospholipid biosynthesis. CDP-DAG-synthetase is an intra-membrane liponucleotide synthetase which 
has a crucial role in phospholipid biosynthesis via catalysing the formation of cytidine-diphosphate 
diacylglycerol (CDP-DAG) during cell membrane synthesis (Liu et al., 2014). A previous study which 
carried out whole genome sequencing of Staphylococcus aureus (S. aureus) strains exposed to 
daptomycin, identified mutations in the CDP-DAG-glycerol-3-phosphate 3-phosphatidyltransferase (pgsA) 
gene which resulted in a thicker cell wall and decreased susceptibility to the antibiotic (Peleg et al., 2012). 
This suggests the requirement of CDP-DAG- synthetase associated reactions for RW109 survival during 
exposure to POE at 50% of the MIC. It also corroborates that the cellular membrane is a key target for 
POE as a preservative, which has been noted in the literature (Gilbert et al., 1977, Fitzgerald et al., 1992, 
Langsrud et al., 2016).  
When RW109 was exposed to POE at both 20% and 50% of the MIC, six cardiolipin synthase reactions 
were also predicted to be essential. Cardiolipin synthase is involved the synthesis of the bacterial inner 
membrane lipid cardiolipin (Zhang et al., 2014). The gene encoding for cardiolipin synthase was 
previously knocked out in a Pseudomonas putida (P. putida) mutant and the membrane was found to 
contain less cardiolipin (Bernal et al., 2007). Mutants, when compared to the parent strain, were more 
susceptible to several antibiotics and during exposure to ethidium bromide, an increased accumulation was 
identified within the mutant cells. This suggests that cardiolipin may play a role in impeding the 
preservative POE from crossing the cell membrane. These cardiolipin reactions were also predicted as 
essential when exposed to LD in combination with BIT at 20% of the MIC. Increased accumulation of 
cardiolipins have also been reported when bacteria are exposed to extreme environmental conditions 
(Czolkoss et al., 2016). Targeting cardiolipin components of the P. aeruginosa inner membrane with 
amphiphilic aminoglycoside derivatives, have proven successful in increasing the permeability and 
depolarization of the cell wall (El Khoury et al., 2017). Therefore, it would be beneficial to develop 
product preservation systems, which directly interact with cardiolipin-enriched areas to enhance the 
efficiency of POE preservatives.  
Lipid metabolism reactions were also predicted to be essential when RW109 was exposed to LDOnly and 
LD+BIT. Six (3R)-3-Hydroxypalmitoyl-[acyl-carrier-protein]:NADP+ oxidoreductase reactions were 
identified which have a function in fatty acid biosynthesis elongation. These reactions were all associated 
with the FabG 3-oxoacyl-[acyl-carrier-protein] reductase gene in RW109 and mutations in this gene can 
confer resistance to the biocide triclosan which blocks the final step in fatty acid elongation by inhibiting 
FabG reductase enzymes (Khan et al., 2016). The essentiality of these reactions when exposed to laundry 
detergent with and without the preservative BIT suggests they are important targets to consider during 
preservation system development. Tea catechins and related plant polyphenols can act as effective 
CHAPTER 6 - Genome-scale metabolic network reconstruction of an industrial                                
P. aeruginosa strain, RW109 
278 
 
inhibitors of FabG reductase in a wide range of Gram-positive and Gram-negative bacterial species when 
used at relatively low concentrations (Zhang and Rock, 2004, Taylor et al., 2005). These additives could 
be applied as boosters to target the fatty acid biosynthesis reactions predicted to be essential for survival in 
BIT preservative systems of laundry detergents.   
A high number of essential reactions in test exposure conditions were involved in nucleotide metabolism 
with the same reactions predicted as essential in numerous exposure conditions (Figure 60 and Table 38). 
Nucleoside-diphosphate kinase (Ndk) reactions involved in salvage pathways were commonly predicted 
as essential. These reactions function in balancing the nucleotide pool of the cell (Kamath et al., 2000) and 
have important functions in growth and virulence of P. aeruginosa under stress conditions (Chakrabarty, 
1998). The Ndk enzyme supplies guanosine triphosphate (GTP) which is required for alginate 
biosynthesis. The overproduction of the alginate exopolysaccharide is associated with establishment of 
chronic infections in the CF lung by mucoid P. aeruginosa isolates (Kamath et al., 2000). Although not 
essential for biofilm formation, alginate has a notable effect on the structural integrity of biofilms 
produced by mucoid P. aeruginosa strains (Franklin and Ohman, 1993, Tielen et al., 2005, Flemming and 
Wingender, 2010). These important survival characteristics may also be used by RW109 to survive within 
the harsh conditions found in industrial products. The Ndk enzyme in bacteria is highly conserved 
(Spooner and Yilmaz, 2012) making it an ideal antimicrobial target. A preservative booster could be 
developed which disrupts the enzyme, enhancing the effectiveness of a preservative system. The 
RW109_01980 essential gene, which is linked to reactions involving Ndk, was also significantly up-
regulated during exposure of RW109 to LD with and without BIT, highlighting the importance of the gene 
in surviving exposure to HPC preservatives and product formulations.   
Reactions associated with membrane transport were also commonly predicted as essential across all test 
exposure conditions. Membrane transporters mediate the uptake of necessary substrates for growth and are 
also used to export metabolic end products and toxic substances out of the cell (Nikaido and Saier, 1992, 
Ma et al., 2003). The majority of the transporters identified by the analysis were characterised as ATP-
binding cassette (ABC) protein exporters. ABC transporters, which transport proteins, can also have a 
secondary role in multidrug export across the cell membrane in Gram-negative bacteria (Ma et al., 2003, 
Venter et al., 2003, Rees et al., 2009). This suggests the ABC transporters predicted as essential could 
have a role in removing the preservatives from inside the cell.  
A reaction involved in the transport of L-methionine via an ABC system (rxn05219) was identified as 
essential throughout all of the test conditions except for LD only (Table 39 and Table 40). An increased 
availability of methionine has been linked with an enhanced aptitude for reducing the effects of oxidative 
stress caused by the disinfectant hydrogen peroxide (Zhang et al., 2012, Romsang et al., 2013). The 
common essentiality prediction of a methionine transport system suggests a requirement for methionine 
during exposure of RW109 to industrial preservatives.  
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Xenobiotics biodegradation and metabolism reactions were only predicted as essential when RW109 was 
exposed to POE20 and BIT+POE, with all the implicated reactions functioning in benzoate degradation. It 
is probable the 5 reactions identified when BIT and POE were in combination both at 20% of the MIC, 
occurred due to the presence of POE within the formulation, as a limited number of reactions were 
predicted to be essential when exposed to BIT20 alone. POE is an aromatic ether alcohol which is a 
derivative of benzene (Fiege et al., 2000) suggesting the same bacterial pathways used to breakdown 
benzoate structures could be active on POE. Resistance to the antibiotic tigecycline (Tgc) which contains 
4 aromatic six-carbon rings has been linked with an up-regulation of genes encoding for benzoate 
degradation enzymes in Gram-negative Acinetobacter baumannii clinical isolates (A. baumannii) (Liu et 
al., 2016). This suggests certain bacteria may use the benzene degradation pathways as a resistance 
mechanism which could be linked to surviving exposure to antimicrobial agents. The P. aeruginosa 
RW109_04051 gene associated with the essential rxn02143 benzoate degradation reaction was also 
significantly up-regulated in response to POE20 and BIT+POE, indicating its importance during exposure 
to these conditions.  
Reactions involved in carbohydrate metabolism were predicted as essential in all conditions except with 
BIT20 and BIT50 (Table 42 and Figure 64). An important observation was the common essentiality of a 
glyoxylate and dicarboxylate metabolism reaction, involving the glycoaldehyde:NAD+ oxidoreductase 
enzyme, which breaks down glycoaldehyde into glycolate (rAB00001). The glyoxylate pathway has 
previously been identified as a principal metabolic pathway used by P. aeruginosa when maintaining 
infection in the CF lung (Hagins et al., 2011, Flynn et al., 2017). Transposon insertion mutants in                                 
P. aeruginosa genes involved in glyoxylate metabolism displayed decreased fitness when growing in 
media which represented the high level of mucins found in the CF lung (Flynn et al., 2017). The frequent 
identification of the glyoxylate metabolism reaction during the RW109 essentiality predictions suggests a 
possible role for this pathway in the ability to survive to exposure of the industrial conditions. Various 
essential reactions involved in alternative pathways for glycolysis and pentose phosphate were predicted 
during exposure to POE50, BIT+POE and LD (with and without BIT). This suggests the industrial growth 
conditions could be impairing the mainstream reactions of glycolysis and the pentose phosphate pathway 
which could result in RW109 having to use alternative pathways to survive in the presence of these 
conditions. Ethanol and isopropanol have been associated with inhibiting glycolysis enzymes (Russell, 
2003c) and this could also be the mode of action used by industrial preservatives such as POE. These 
alternative reactions are also used in order to generate redox NADPH to counteract the effects of oxidative 
stress when exposed to harsh environments (Chavarría et al., 2013). A P. aeruginosa RW109 transposon 
mutant (Chapter 4) was characterised with an insertion in the essential RW109_02629 gene involved in 
the phosphogluconate dehydratase reaction (rxn01477). This reaction was identified when RW109 was 
exposed to POE at 20% and 50% of the MIC, and LD with and without BIT. Further analysis of this 
transposon mutant could be used to examine fitness in the presence of these conditions.  
Amino acid metabolism reactions were predicted to be essential in all the test exposure conditions except 
for BIT20. An interesting observation was the predicted essentiality in response to BIT+POE of a glycine, 
CHAPTER 6 - Genome-scale metabolic network reconstruction of an industrial                                
P. aeruginosa strain, RW109 
280 
 
serine and threonine metabolism reaction (rxn08647), which was an additional reaction of the RW109 
model in comparison to PA14. The glycerate 2-phosphotransferase enzyme involved in this reaction has 
functions in the detoxification of formaldehyde via a serine pathway (Chen et al., 2016, Kanehisa et al., 
2017). BIT and POE preservatives are not formaldehyde associated agents, however a glutathione-
dependent pathway with a possible role in formaldehyde detoxification was identified as a putative 
resistant determinant to the CMIT isothiazolinone preservative in Burkholderia lata (B. lata) (Thomas, 
2011). Transposon-based interruption of a glutathione synthase gene resulted in increased isothiazalinone 
susceptibility (Thomas, 2011). This suggests formaldehyde detoxification systems may be used as a 
resistance mechanism of P. aeruginosa in response to the exposure of other industrial preservatives.                                                                     
POE at 20% of the MIC had the greatest number of essential reactions (n= 6) within the amino acid 
category and one of the reactions uniquely essential was involved in the breakdown of agmatine into urea 
and putrescine with an agmatinase enzyme (rxn00858). It has previously been identified that putrescine 
reduces antibiotic-induced oxidative stress in Burkholderia cenocepacia (B. cenocepacia) (El-Halfawy 
and Valvano, 2014). A reduction in the ability to produce putrescine resulted in increased reactive oxygen 
species and also susceptibility to the antimicrobial peptide polymyxin B. Putrescine is able to protect less-
resistant cells by competing with polymyxin B in binding to the surface of B. cenocepacia (El-Halfawy 
and Valvano, 2013). The RW109 strain may be producing putrescine in order to prevent POE from 
attaching to the cell membrane. One of the other reactions found to be essential with POE20 was the 
production of agmatine with the enzyme arginine decarboxylase (rxn00405). In a study by Chou et al. 
(2008)  P. aeruginosa was grown in the presence of agmatine and demonstrated up to 16-fold increases in 
the MIC’s of aminoglycosides and quinolones antibiotics along with the dyes ethidium bromide and 
acridine orange. It was proposed that this decreased susceptibility was due to the function of agmatines in 
the induction of expression levels of the oprH-phoP-phoQ operon of the PhoPQ two-component system 
which is involved in resistance to cationic antimicrobial peptides such as polymyxin B (Macfarlane et al., 
1999, Chou et al., 2008). This two-component system was also identified as biologically feasible in the P. 
aeruginosa RW109 strain (Chapter 3, Section 3.2.3.2.1) and the predicted essentiality of the rxn00405 
reaction when exposed to POE at 20% of the MIC supports the importance of agmatine production in 
resistance to the preservative.                   
A reaction involving the glycine hydroxymethyltransferase enzyme (rxn00692) was identified as essential 
when RW109 was exposed to POE at both 20 and 50% of the MIC. This enzyme has been associated with 
the assimilation of glycine, cell signalling processes and pyocyanin biosynthesis in P. aeruginosa PAO1 
(Lundgren et al., 2013). The RW109_00291 gene, associated with the essential rxn00692 reaction, was 
encoded on the large plasmid 1 and was characterised as a component a glycine cleavage system (Chapter 
3, Section 3.2.3.1.3). During environmental stresses and starvation of nutrients, glycine metabolism has 
been identified as a nutritional cue for induction of quorum-sensing phenotypes such as pyocyanin 
production, especially in the CF lung (Lundgren et al., 2013). This glycine utilisation virulence 
mechanism could also have a role in the survival of RW109 when exposed to POE.   
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Reactions encompassing the enzymes threonine synthase (rxn01069) and homoserine dehydrogenase 
(rxn01302), were predicted to be essential solely during exposure to LD with the preservative BIT. Both 
these reactions have associations with pyoverdine production as a key virulence characteristic of                                 
P. aeruginosa (Bartell et al., 2017, Calcott et al., 2014).  It’s known that pyoverdine production increases 
resistance of P. aeruginosa to the antibiotic tigecycline (Oglesby-Sherrouse et al., 2014) suggesting it may 
have a role during survival in the presence of industrial conditions. This resistance was associated with 
pyoverdine facilitating the uptake of iron which contributes to the ability P. aeruginosa to form biofilms 
(Banin et al., 2005). Interestingly a FeoB iron (II) transporter (rxn10963) was also deemed essential during 
exposure to LD in combination with BIT, adding a further link to iron scavenging. Overall, the essentiality 
of these reactions may be due to the requirement of RW109 to produce pyoverdine for biofilm 
development and iron acquisition during growth in industrial products and their preservation systems.  
In all test conditions (excluding BIT20), a reaction involved in the biosynthesis of aromatic amino acids 
(rxn02213) via the 3-dehydroquinate dehydratase (DHQase) enzyme, was predicted as essential, 
implicating it as a possible enzyme to target for future preservations systems.  A flavonoid polyketide has 
been identified which inhibits DHQase (Cheung et al., 2014). Therapeutics which target the DHQase in 
tuberculosis infections result in the successful inhibition of Mycobacterium tuberculosis (M. tuberculosis) 
(Frederickson et al., 1999). Inhibitors of this enzyme could be used as a potential preservative booster in 
industrial products.  
A common reaction identified as essential in all test exposure conditions (except for BIT20) within the 
metabolism of cofactors and vitamins category was a tetrapyrrole biosynthesis pathway. The reaction 
requires a coproporphyrinogen oxidase enzyme (rxn02303) and mediates the oxidative decarboxylation of 
coproporphyrinogen III to form protoporphyrinogen IX in tetrapyrrole heme biosynthesis (Rompf et al., 
1998). The inhibition of the heme biosynthesis by antimicrobials such as the metalloid tellurite leads to the 
accumulation of the pathway intermediates and the resulting build up is toxic to the cell (Morales et al., 
2017). The enzyme involved in this reaction is a potential antimicrobial target of relevance for enhancing 
the effects of preservation systems and is also highly conserved in prokaryotic genomes (Dailey et al., 
2015). The RW109_00614 essential gene linked to the rxn02303 reaction was also significantly up-
regulated during exposure to POE at 20% and 50% of the MIC and BIT and POE in combination, 
corroborating the importance of the gene for survival in industrial environments.  
The integration of transcriptomic data into the P. aeruginosa RW109 metabolic model provided a valuable 
insight to predicted essential metabolic reactions when the strain was exposed to industry relevant 
conditions. The key predicted essential pathways identified in this study are shown in Figure 68. The 
wide-ranging variation in the biological functions of essential reactions highlights the multifactorial nature 
of P. aeruginosa’s resistance and survival mechanisms. Common prediction of essential pathways such as 
those associated with the enzymes NdK and DHQase, also highlights important targets to inform the 
development of targeted preservation systems. These highlighted essentiality predictions and implicated 
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pathways require validation, using techniques such as the fitness evaluation of transposon insertion 
mutants when exposed to industry relevant conditions.  
    
    
Figure 68. Key enzymes and pathways linked to reactions projected to be essential during exposure of RW109 to industry relevant conditions 
Key enzymes and pathways associated with predicted essential reactions are colour coded according to the industrial test condition where they were identified (See 
Key).  This includes POE at 20% (purple) and 50% of the MIC (red), BIT and POE (green), LD only (orange) and LD and BIT (pink). Also illustrated were reactions 
commonly predicted as essential in response to multiple test conditions (dark blue) such as the enzymes NdK and DHQase and the ABC transport pathway for L-
methionine.  
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6.3.5 Preservative concentration greatly influences essentiality predictions  
Interesting observations of this study were the differences in the prediction of essential reactions when the 
preservative POE was screened at 20% and 50% of the MIC (Figure 67 and Table 46). Reactions involved 
in benzoate degradation were predicted as essential at the lower concentration but were not identified 
during exposure to 50% of the MIC, where a greater number of lipid metabolism reactions were observed. 
At 20% of the MIC, the strain may be able to grow more and degrade POE, but when exposed to higher 
concentrations the reactions involved in cell membrane phospholipid biosynthesis become increasingly 
essential. This suggests that higher concentrations result in greater damage to the cell membrane, which 
requires the strain to focus its efforts on fixing the membrane rather than degrading the preservative. 
Membrane transport reactions were predicted to be essential in at both 20% and 50% of the MIC; 
however, more were identified at the higher concentration suggesting a greater requirement to move 
substances across the membrane.  
The essentiality of alternative glycolysis reactions were observed when exposed to 50% of the MIC.                           
A higher number of essential amino acid metabolism reactions were identified during exposure to POE at 
20% of the MIC, whereas at 50% MIC a lower number of amino acid reactions were found to be essential. 
This variations observed in the essentiality of metabolic pathways at 20% and 50% of the MIC with POE, 
highlights the alteration in the response of a strain when exposed to the same preservative used at different 
concentrations. The concentration dependant activity of antibiotics is well characterised (Bernier and 
Surette, 2013) and results from this study indicate the mechanism of action of POE is also heavily 
influenced by its concentration. It has previously been noted that POE antimicrobial activity is 
concentration dependant and bactericidal effects result from the preservative interfering with several 
targets, causing irreversible cell damage (Langsrud et al., 2016). This signifies the importance of 
concentration when formulating preservative systems and demonstrates the necessity to predict bacterial 
responses to industrial preservatives.  It also highlights a key challenge in designing research strategies 
based on microbial growth for evaluation of preservative action. 
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6.4 Conclusions  
The main conclusions from this chapter were as follows: 
1) The PacBio sequence of the RW109 strain was utilised to accurately update the PA14 metabolic 
model (Bartell et al., 2017), enabling a representation of the metabolic capabilities of an industrial 
P. aeruginosa strain for the first time.     
 
2) The model provides important insight into the biological characteristics of the industrial                                  
P. aeruginosa RW109 strain. Reactions associated with lipid metabolism were found to be the 
most abundant and in comparison to the PA14 model. RW109 had additional reactions within the 
xenobiotics biodegradation and metabolism functional category.  
 
3) Transcriptomic gene expression data was successfully integrated into the RW109 model 
reconstruction to produce condition specific models to predict the essentiality of reactions during 
exposure to industry relevant conditions.  
 
4) Exposure to the preservative POE at 50% of the MIC resulted in the highest number of predicted 
essential reactions with the majority having a function lipid metabolism. Reactions involved in 
cell membrane phospholipid biosynthesis via the CDP-DAG-synthetase enzyme were identified as 
uniquely essential when RW109 was exposed to POE at 50% of the MIC.   
 
5) The reactions predicted to be essential throughout the industrial exposure conditions had 
biologically diverse functions, suggesting a multifactorial antimicrobial response in P. 
aeruginosa. However, within this diversity the enzymes such as Ndk and DHQase were 
commonly predicted in essential reactions, and represent potential novel targets to enhance the 
effectiveness of preservative systems.   
 
6) Preservative concentration heavily influences the predicted essentiality of different metabolic 
pathways. Dissimilarities were observed in the reactions predicted to be essential when exposed to 
different concentrations of POE; at a lower concentration reactions involved in degradation of 
xenobiotics were essential and with an increase in concentration, cell membrane phospholipid 
metabolism reactions were considered as crucial. This suggests P. aeruginosa is capable of 
responding to the concentration-dependant mechanism of action of POE.  
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 7. General conclusions, discussion and future research 
7.1 Conclusions 
This study represents a novel and comprehensive investigation of an industrial P. aeruginosa strain, 
RW109. A variety of research techniques were implemented to examine the genetic and metabolic 
pathways, involved in the ability of RW109 to grow in the presence of industrial preservatives and HPC 
product formulations. A complete genome of RW109 was attained for functional annotation and for 
comparison with a panel of P. aeruginosa genome sequences representative of strains from clinical, 
environmental and industrial sources. The genetic basis of industrial preservative resistance was also 
investigated via the construction of a mini-Tn5-luxCDABE transposon mutant library, and in more depth 
with global RNA-Seq gene expression analysis. Finally, a metabolic model specific to RW109 was 
constructed by updating an existing P. aeruginosa PA14 genome-scale biochemical network 
representation. The RW109 RNA-Seq transcriptomic data was successfully integrated into this model, 
allowing for the prediction of reaction essentiality during exposure to HPC preservatives and product 
formulations. Overall, the results from this study highlight the utility of incorporating multiple research 
techniques when investigating the ability of industrial P. aeruginosa strains to resist preservatives and 
product formulations. 
The main conclusions from the study were as follows:  
1. The complete genome sequence analysis of the industrial strain RW109 revealed it’s larger than 
average sized genome, when compared to a panel of 102 P. aeruginosa genome sequences 
isolated from clinical, environmental and industrial sources (Chapter 3).   
This was the first study to obtain a whole genome sequence of an industrial P. aeruginosa strain 
specifically isolated from a home and personal care product. PacBio SMRT sequencing technology was 
successfully used to acquire a complete genome of RW109, which comprised a main chromosome and 
two plasmids. This work also allowed accurate functional annotations, which provided an important 
insight into the biological characteristics of the strain. The 7.8 Mbp size of RW109, was the largest 
genome identified within the P. aeruginosa panel used in this study (Figure 69). This genome was also 
bigger than the reported genome size range of 5.2 to 7.0 Mbp for this microorganism (Schmidt et al., 
1996, Stover et al., 2000, Juhas et al., 2005, Winsor et al., 2016). Another interesting observation was the 
significantly bigger mean genome size of the industrial strains in the panel when compared to those from 
clinical and environmental settings. The functional characteristics of the RW109 strain were also 
compared to PA14 (He et al., 2004) and PAO1 (Stover et al., 2000), the most studied clinical reference 
strains for P. aeruginosa. The comprehensive functional annotations and comparisons obtained with 
RW109 present this isolate as an appropriate reference strain for the HPC industry. 
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2. When investigating the genetic basis of preservative exposure with the RW109 strain, the use of 
a mini-Tn5-luxCDABE mutant library proved to be not as informative and was  less reliable 
when compared to RNA-Seq analysis (Chapter 4 and 5).  
The RW109 strain was successfully used to construct a mini-Tn5-luxCDABE mutant library and the 
distinct transposon insertion sites identified were evenly distributed throughout the whole genome 
sequence. Screening the mutant bank with the preservative BIT at 20% of the MIC for 24-hours, identified 
mutants of interest, which were isolated, and insertion sites identified. However, an overall fold decrease 
in light emission was observed when the mutant bank was screened with the preservative POE as well as 
increased concentrations of BIT.  When the mutant bank screening condition was analysed with RNA-Seq, 
only two genes with significantly altered expression were identified. This indicates that BIT at 20% of the 
MIC was suitable at identifying mutants of interest during mutagenesis screening, but was too low to 
induce major changes in gene expression when used during global transcriptomic analysis. RNA-Seq was 
also useful for investigating gene expression with POE, higher BIT concentrations along with HPC 
product formulations. Furthermore, the difficulties with identifying the insertions sites in mutants of 
interest, was also a drawback with using the mini-Tn5-luxCDABE library in this study. The mutant bank 
was however not used to identify mutants, which were susceptible or more tolerant to preservatives which 
maybe a useful tool for this type of investigation.  
3. Global gene expression analysis with RNA-Seq revealed both condition specific and consistent 
transcriptomic responses of RW109, following exposure to industry related conditions (Chapter 
5).  
Obtaining RNA from bacterial cells can be challenging, especially if chemically harsh compounds such as 
preservatives or HPC product formulations are present in the growth medium. In this study, good quality 
RNA was recovered following a 24-hour exposure of RW109 to conditions which reduced the percentage 
OD by up to 68%, in comparison to TSB only growth. This enabled a novel comparative RNA-Seq gene 
expression analysis to be carried out with a wide range of industrial conditions. The successful 
identification of DEGs provided an increased understanding of the complex genetic networks utilised by 
RW109, when exposed to HPC preservatives and product formulations. An interesting observation was 
the consistent up-regulation of the same operon genes in response to different test conditions, examples 
include those encoding for an efflux pump, a sialic acid transporter and acyclic isoprenoid degradation 
enzymes (Figure 69). These findings suggest the RW109 strain potentially exploits a consistent set of 
resistance mechanisms for survival in a variety of harsh industrial environments. In order to validate if the 
mechanisms identified represent strain specific mechanisms, transcriptomic comparisons with other 
industrial strains would need to be carried out. To enhance the sterility of HPC products preservation 
systems could be developed which specifically target commonly used resistance mechanisms. The 
transcriptomic changes observed in this study still require further validation with techniques such as 
quantitative RT-PCR. 
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The preliminary construction of an industrial metabolic model was the first of its kind for a P. aeruginosa 
strain isolated from a HPC product. This form of analysis was only achievable following the successful 
whole genome sequencing and transcriptomic analysis of the RW109 strain, along with the availability of 
a recently published P. aeruginosa genome-scale metabolic model for the PA14 strain (Bartell et al., 
2017). This work offers a good example of how results generated with different research techniques can 
be linked together to provide a powerful investigative tool. Building the RW109 metabolic model, 
increased the understanding of the biological characteristics of an industrial strain. There are over 100 
published and experimentally validated metabolic models which represent various microorganisms 
(Broddrick, 2017). For the important P. aeruginosa clinical references strains PAO1 and PA14, mapping 
of the biochemical networks provided a valuable insight into the metabolic potential of the strains and how 
they respond to various environmental conditions (Oberhardt et al., 2008, Oberhardt et al., 2011, Bartell et 
al., 2017). The integration of transcriptomic data into the RW109 metabolic model allowed the 
development of condition specific models. A valuable outcome of the study was the prediction of 
reactions classified essential for RW109 to survive in the industrially relevant conditions. POE at half the 
MIC resulted in the highest number of reactions expected to be vital for the strain to persist, with notable 
reactions involved in cell membrane phospholipid biosynthesis. This analysis also predicted the 
essentiality of common reactions, which highlighted enzymes for consideration as potential targets for 
preservation strategies (Figure 69). The results from this chapter require further validation of the predicted 
fundamental pathways via mutagenesis in vitro experimentation. 
 
4. A genome-scale metabolic model specific to an industrial P. aeruginosa was constructed for the 
first time and used to incorporate global gene expression data from growth under industrial 
conditions. This work provided valuable insights into the metabolic characteristics of RW109 
and was used to predict reactions essential for the strain to survive in the presence of HPC 
preservatives and product formulations (Chapter 6).  
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Figure 69. Key features of the industrial P. aeruginosa strain RW109 
This schematic provides an overview of the genome traits, differentially regulated gene clusters and predicted essential pathways, which are key to the success of 
RW109 as an industrial contaminant. Those to note include the large genome size, additional plasmids, common up-regulation of the MexPQ-OpmE efflux 
system and frequently predicted essential pathways associated with nucleotide salvage and cell wall glycerophospholipid metabolism. The predicted essential 
pathways with an adjacent star, indicate those associated with a gene which had increased expression in response to industry relevant conditions. 
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7.2 Discussion and future research  
The resistance of P. aeruginosa to antibiotics has been well studied and there is a comprehensive 
understanding of the mechanisms used by the bacterium to survive antibiotic exposure. This information 
has permitted the optimisation of clinical treatment strategies that minimise the occurrence of 
antimicrobial resistance, whilst also clearing infection effectively (Monogue et al., 2016, Paterson et al., 
2016). Conversely, details about the genetic and metabolic pathways used by P. aeruginosa in response to 
HPC industrial preservative formulations are not well characterised. A few resistance mechanisms in 
response to  isothiazolinones HPC preservatives have been characterised such as alterations in the P. 
aeruginosa outer membrane structure (Brözel and Cloete, 1994), upregulation of an RND efflux pump in 
Burkholderia lata (Rushton et al., 2013) and increased biofilm formation in Burkholderia cepacia 
(Costerton and Lashen, 1984). Recent transcriptomic investigations of a isothiazolone-resistant P. 
aeruginosa strain when exposed to the CMIT/MIT isothiazolone, identified a number of differentially 
expressed genes associated with nitrogen metabolism and oxidative phosphorylation pathways (Zhou et 
al., 2016). 
This PhD project provided beneficial understandings of the functional characteristics of an industrial P. 
aeruginosa strain, and identified genetic pathways and metabolic networks following exposure to HPC 
preservatives and product formulations (Figure 69). The overall results of the study are discussed below 
with reference to how the research could be translated into industrial practices.  Future directions for 
investigating the genetic basis of P. aeruginosa industrial preservative resistance are also suggested.  
7.2.1 The use of whole genome sequencing to extensively characterise an industrial P. aeruginosa strain 
Obtaining a complete genome for the RW109 strain facilitated the comprehensive functional classification 
and comparative analysis of an industrially prominent isolate. This study provides a well characterised 
industrial reference strain for the future whole genome sequencing of other industry isolates. The HPC 
industry would benefit from the development of a database containing complete whole genomes of key 
strains, which are sequenced, assembled and annotated using a parallel pipeline. During industrial 
contamination incidents, the routine sequencing of suspected P. aeruginosa strains could be used to 
produce a comprehensive genome collection of industry isolates. This would enable the generation of a 
genome database of industrial isolates, to assist in establishing the functional characteristics, which allow 
strains to contaminate HPC products.  
A large P. aeruginosa genome is a possible indicator of a strain’s ability to reside within an industry 
setting; this interesting observation was recognised for the first time by this study. The RW109 genome 
was considerably larger than all 102 strains analysed (Figure 69), and those isolated from an industrial 
setting had a significantly larger mean genome size when compared to clinical and environmental strains.                         
This result suggests a large genomic size as a possible predictor of a P. aeruginosa strain’s ability to cause 
industrial contamination. However this investigation only included a limited number of industrial strains 
(n=16); this further accentuates the requirement for incorporating genome sequencing into routine 
industrial practices when analysing a P. aeruginosa contamination incident. Understandably, the cost of 
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sequencing is an obstacle, but with the current exponential development of new methods in this field, 
which are increasingly accurate and cost-effective (Levy and Myers, 2016, Klemm and Dougan, 2016), 
sequencing integration may become achievable. The application of whole genome sequencing to 
collections of P. aeruginosa isolates has the ability to provide vital information on resistance profiles, 
aiding in the prediction of antimicrobial resistance (Jeukens et al., 2017, Winsor et al., 2016, Freschi et al., 
2015).  
Future research should also examine the plasmids within P. aeruginosa strains isolated from HPC 
products. The RW109 strain was unusual in having a very large plasmid (555 kb) as well as a smaller 
plasmid (152 kb) (Figure 69) and pathways were differentially expressed on both these replicons when 
exposed to industry relevant conditions (Chapter 5). The RW130, RW146, RW172, RW176 and RW184 
isolates from dishwasher liquid products all encoded the KEGG BpeEF-OprC efflux pump module 
(M00698). The 5 genes associated with this KEGG module were identified on plasmid 1 of the RW109 
strain (Figure 69) suggesting these 5 industrial isolates may also incorporate an additional plasmid 
carrying this locus. The functionality of the efflux pump should also be investigated via susceptibility 
analysis of the P. aeruginosa isolates to the trimethoprim and chloramphenicol, the substrates for the 
BpeEF-OprC system in B. pseudomallei (Kumar et al., 2006, Podnecky et al., 2013). Transcriptomic 
analysis of the efflux pump operon did not reveal an altered gene expression when exposed to the 
preservatives and product formulations investigated in this study. However, it may be used in response to 
alternative industrial antimicrobials and if the pump was knocked out, the susceptibility of the mutants to 
preservatives could be investigated. The removal of the two plasmids from RW109 may also form a 
strategy, to determine their importance for the survival of the strain in the presence of industry relevant 
conditions. The curing of the plasmids could be carried out as described by (Raja and Selvam, 2009, 
Durve et al., 2013), where plasmid removal resulted in increased susceptibility to antibiotics and heavy 
metals in P. aeruginosa strains isolated from the environment. 
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7.2.2 The efficacy of an industrial P. aeruginosa mini-Tn5-luxCDABE mutant library when 
investigating the genetic basis of industrial resistance 
An aim of Chapter 4 was to develop a transposon mutant bank in the industrial P. aeruginosa strain that 
could be used to understand differentially regulated genes when exposed to industrial preservatives. 
However, the use of a mini-Tn5-luxCDABE mutant library as a luminescent reporter did not prove an 
appropriate research tool for investigating the genetic basis of preservative resistance in this way. The lux 
reporter strategy had successfully been used as a direct method of identifying differentially regulated 
genes in the P. aeruginosa strain PAO1. Mutants with differential light emission responses when exposed 
to MgSO4, magnesium and phosphate-limiting conditions were recognised and linked to genes with 
altered expression levels (McPhee et al., 2003, Lewenza et al., 2005). However, in this study the RW109 
lux mutants could not be screened with the preservative POE as well as high concentrations of BIT and 
this limited screening to one condition involving BIT at 20% of the MIC. Even though mutants with 
altered light emission responses could be identified, difficulties were encountered with identification of 
transposon insertion sites.  
As applied, the lux-reporter transposon method did not provide a genome-scale understanding of the 
genetic basis of preservative resistance. Out of 404 mutants of interest, the putative gene function was 
successfully characterised in 157, which resulted in only 53 distinct insertion sites being recognised. Key 
mutants with increased light emission responses when screened with BIT had insertions in genes encoding 
bacterial solute binding proteins, a ferrous-iron efflux pump, a KdgR transcriptional regulator and the 
napA gene within a napEFDABC operon. Those with decreased light emission responses were associated 
with an acid active urea channel and a tripartite ATP-independent periplasmic transporter. For a complete 
validation of functional knockouts from this study, complementation can be carried out to account for 
polar effects or targeted gene knockout mutants could be generated.   
To achieve the characterisation of the small number of insertion sites identified in this study was a time 
consuming process. The initial attractiveness of the approach was the possibility of building a mutant 
panel representing key genes, where the expression responses to a variety of industry relevant conditions 
were characterised. This panel could then be passed onto industry for use as a direct measurement of gene 
expression during preservative formulation development. However, the results of the study show that the 
luxCDABE operon was possibly impaired by the activity of preservatives and not enough mutant insertion 
sites were characterised to identify key genetic functions.  
Alternatively, as mutant insertions were evenly dispersed throughout the RW109 genome, they could be 
used to assess functionality by incorporating industry relevant conditions into agar-based mutant screens. 
Furthermore, there is the requirement to characterise the insertion sites in the remaining mutants of 
interest. This could be achieved via whole genome sequencing or via an alternative approach such as 
TraDIS could be implemented to develop a large well-characterised mutant library (Langridge et al., 2009, 
Barquist et al., 2015). This future work could also enhance the gene essentiality predictions when RW109 
was exposed to industry relevant conditions (Chapters 6).  
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7.2.3 The use of RNA-Seq to characterise the global gene expression response of an industrial                                 
P. aeruginosa strain in reaction to industry relevant conditions  
The RNA-Seq gene expression analysis identified several key genetic pathways when RW109 was 
exposed to HPC preservatives and product formulations (Figure 69). The results provided a better 
understanding of the strains success as an industrial contaminant and pinpointed common resistance 
mechanisms used when exposed to different industrial conditions. In order to enhance the antimicrobial 
capabilities of product formulations, knowledge of frequently used resistance mechanisms would enable 
the selection of appropriate preservative enhancing agents. The consistent up-regulation of genes encoding 
the MexPQ-OpmE RND efflux pump was observed during transcriptomic analysis (Chapter 5) 
highlighting it as a possible target for the HPC industry during preservative system development (Figure 
69). The success of an enhancing agent at increasing the susceptibility of B. lata to the isothiazolinone 
CITMIT, was demonstrated when the bacterium was exposed to the Efflux Pump Inhibitor (EPI) 
Phenylalanine-Arginine Beta-Naphthylamide (PAβN), together with the preservative (Rushton et al., 
2013). The use of EPIs such as PAβN in antibiotic treatment strategies have proven successful against P. 
aeruginosa (Liu et al., 2010, Lamers et al., 2013). Targeting efflux systems may therefore be an 
appropriate method to enhance the effectiveness of HPC antimicrobial formulations. The growth dynamics 
and gene expression alterations of RW109 in the presence of the RNA-Seq industrial conditions combined 
with an EPI should be investigated in future research.   
Implementing transcriptomic analysis techniques such as RNA-Seq, into industrial practices should be 
considered to further the understanding of resistance mechanisms used by P. aeruginosa in response to 
preservation formulations. During the development of an antimicrobial formulation, global gene 
expression investigations would enable the selection of preservatives and enhancing agents, which work 
well in combination. This study also demonstrated resistance mechanisms used when RW109 was exposed 
to an un-preserved laundry product; these identified genes may also require consideration during 
preservation development. Understandably, the cost and complexity of transcriptomic analysis techniques 
(Ozsolak and Milos, 2011, Conesa et al., 2016) may be a hindrance when incorporating such methods into 
HPC industrial practices. Nonetheless, the wide-ranging practicality of the results generated should be 
taken into consideration. The development of a well-defined experimental pipeline comparable to the one 
used in this study, together with bioinformatics computational platforms such as CLIMB (Connor et al., 
2016), would enable the use of RNA-Seq in industry.  
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7.2.4 The construction of an industrial P. aeruginosa genome-scale metabolic model for predicting the 
essentially of reactions during exposure to industry relevant conditions 
An initial genome-scale network reconstruction for an industrial P. aeruginosa strain was constructed 
(Chapter 6), expanding the understanding of RW109 metabolic functionality. Up-dating the PA14 
metabolic model (Bartell et al., 2017) to better represent an industrial strain was greatly enhanced by the 
high-quality complete RW109 genome sequence (Chapter 3). This work also benefited from the extensive 
transcriptomic analysis (Chapter 5), which permitted in silico gene essentiality simulations of RW109, 
when exposed to industry relevant conditions. The resulting condition specific models were productively 
analysed to propose essential genes and reactions for use as candidate HPC preservation system targets 
(Figure 69).    
Metabolic modelling is highly applicable to HPC industry practices and the study provides a preliminary 
genome-scale metabolic model incorporating gene-protein-reaction associations for an important 
industrial P. aeruginosa strain. In the food industry, metabolic modelling for predicting pathogen 
behaviour in response to environmental conditions has proven beneficial for characterising essential genes 
and novel antimicrobial targets. In a newly constructed model for Clostridium difficile (C. difficile), 
transcriptomic data was integrated to represent the gene expression alterations when exposed to a variety 
of environmental conditions. (Kashaf et al., 2017). Gene essentiality predictions identified novel 
therapeutic targets in C. difficile, such as phosphoglycerate kinase, glycerate kinase and bi-functional 
carbon monoxide dehydrogenase enzymes (Kashaf et al., 2017).  
The industrial partner will take on the RW109 genome-scale and condition-specific metabolic models for 
further expansion and validation. Incorporating transcriptomic analysis into the industrial development of 
different HPC preservation formulations, could allow the production of additional condition specific 
models. This permits further predictions of novel genes and reactions considered essential for the design 
of targeted industrial antimicrobial formulations. Furthermore, exploiting whole genome sequencing of 
industrially relevant P. aeruginosa strains, could potentially allow the development of a collection of 
metabolic models for different isolates. This has the capacity to inform the design of preservation systems 
with increased relevance to a wide range of strains, which may vary in response to HPC formulations.   
Even though the metabolic model only represented 18.2% of the RW109 genome, the genes and reactions 
predicted to be essential can be used to generate hypotheses for focused driven validation investigations. 
For example, future research to assess the essentiality of genes associated with the enzymes Ndk and 
DHQase (Figure 69), which were commonly predicted as essential during exposure to a wide range of 
industrial conditions should be carried out. Also necessary is to confirm the importance of cell membrane 
phospholipid biosynthesis enzymes such as CDP-DAG-synthetase (Figure 69) in response to POE at half 
the MIC. Essential genes and reactions are considered promising targets for the development of novel 
directed antimicrobials, due to their importance in bacterial survival (Juhas et al., 2012).  
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To validate key essentiality predictions and implicated pathways, the fitness evaluation of transposon 
insertion mutants during exposure to an industry relevant condition could be examined. This verification 
approach of genome-scale metabolic modelling has proven worthwhile in the characterisation of essential 
pathogenic genes when subjected to environmental conditions, which represent the host. Transposon 
mutagenesis and genome-scale metabolic modelling were successfully used to confirm the essentiality of 
genes involved in leucine, histidine, glycine and proline amino acid production when Neisseria 
meningitidis was grown in conditions to mimic growth in blood (Mendum et al., 2011). The PA14 
transposon mutant bank database (Liberati et al., 2006) could also be exploited for further validation and 
investigation of the key genetic pathways identified in this study. This database provides a genome-wide 
set of P. aeruginosa mutations with fully characterised insertions. Since the PA14 metabolic model was 
used as a basis to map the biochemical networks of RW109, the library will be useful to assess the 
essentiality of the mutants when exposed to industry related conditions.    
In summary, this PhD project has for the first time developed a holistic genomic and metabolic 
understanding of an industrial P. aeruginosa strain. In addition to these findings, this undertaking also 
enabled broad training related to genome sequencing, bioinformatics, transcriptomic gene expression 
analysis and metabolic modelling, which are key skills for a successful career in molecular microbiology.
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